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General introduction, aims & outline thesis
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1.1
General InTroduCTIon 
The Gram-negative aerobic diplococcus Moraxella catarrhalis is an emerging human-restricted 
pathogen of the upper and lower respiratory tract. The M. catarrhalis species is positioned within 
the pseudomonadales order of the gammaproteobacteria. Before being named M. catarrhalis, 
the species underwent several name changes. In the beginning of the twentieth century, it was 
called Micrococcus catarrhalis and later renamed Neisseria catarrhalis because of morphological 
and phenotypic similarities with Neisserial species. In 1970 it was transferred to the genus 
Branhamella due to the limited genetic relatedness with Neisserial species, and thereafter, it was 
positioned within the Moraxella genus (1). The species M. catarrhalis consists of two distinct 
phylogenetic lineages, of which the seroresistant subpopulation is more strongly linked with 
virulence and disease (2, 3). 
M. catarrhalis is oxidase-positive, non-motile, expresses a type IV pili structure, and is 
unencapsulated (4-6). When cultured on blood agar plates the bacterium grows as white-grey 
opaque colonies that are non-hemolytic, and which remain intact when pushed across the agar 
plate. A variety of biochemical tests can be used to differentiate M. catarrhalis from other species, 
including non-pathogenic Neisserial species, i.e. M. catarrhalis is unable to produce acid from 
carbohydrates, it reduces nitrate and nitrite, and produces DNase (1, 7).
The relationship between M. catarrhalis and its human host begins early on in life as it rapidly 
colonizes the nasopharyngeal cavity soon after birth (8-10). For a long time M. catarrhalis was 
considered to be a commensal upper respiratory tract inhabitant, however, since the 1970s it 
became recognized as a true respiratory tract pathogen. M. catarrhalis infections mainly affect 
young children and adults with underlying disease like chronic obstructive pulmonary disease 
(COPD). M. catarrhalis is the third most common cause of otitis media (OM) after Streptococcus 
pneumoniae and nontypeable Haemophilus influenzae (NTHi) (11), with instances of OM being 
the most common reason for children to visit a physician and a major reason for prescription 
of antibiotics (12). Further, it is also the second most common cause of exacerbations of COPD 
in adults after NTHi (9), which is one of the leading causes of morbidity and mortality world-
wide (9). M. catarrhalis is also etiologically associated with sinusitis and laryngitis (13, 14), and 
occasionally causes invasive disease such as pneumonia, bacteremia, meningitis, and endocarditis 
(1, 7). The vast majority of M. catarrhalis isolates are resistant to β-lactam antibiotics through 
β-lactamase production (15) but are susceptible to amoxicillin-clavulanic acid treatment and 
broad-spectrum antibiotics (7). The widespread use of S. pneumoniae polysaccharide conjugate 
vaccines has resulted in altered nasopharyngeal colonization patterns and has led to an increase 
in the proportion of airway infection caused by M. catarrhalis (16-18). 
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MeCHanISMS oF PaTHoGeneSIS
During nasopharyngeal colonization and dissemination to other niches within the host, for example 
the middle ear cavity in OM and the lungs during exacerbation of COPD, M. catarrhalis needs 
to overcome a diverse array of challenging conditions (Fig. 1). Adherence to the respiratory tract 
mucosal surface is generally considered a first critical step in the infection process (19). Although 
M. catarrhalis mainly resides extracellularly, entry into airway epithelial cells potentially allows it 
to “hide” from the host’s immune system (20). M. catarrhalis needs to interact with members 
of the commensal flora and likely with other (opportunistic) pathogens during polymicrobial 
infections, also resulting in formation of mixed-species biofilms (21, 22). M. catarrhalis also needs 
to cope with the innate and adaptive immune systems that are tailored to control and eradicate 
infections. During its migration through different sites in the host, M. catarrhalis needs to adapt 
to different environmental conditions such as nutrient availability to expand and cause infections.
Adhesion
Invasion
Interaction 
other bugs
Biolm 
formation
Immune 
evasion
Nutrient 
acquisition
Fig. 1. Molecular mechanisms of M. catarrhalis pathogenesis. 
In recent years, research into bacterial molecular pathogenesis has shifted toward high-
throughput, genome-based technologies, generating a more comprehensive approach to 
broaden our knowledge about molecular mechanisms of pathogenesis. Progress in high-
throughput sequencing methods and computational analysis, e.g. automated gene prediction 
and annotation, has already led to an enormous expansion in the availability of whole-genome 
sequence databases. Pathogenesis-related information may be extracted from these large 
databases by using bioinformatics approaches such that predictions may be made regarding 
putative virulence mechanisms, such as adhesion, metabolic capacity, and antibiotic resistance 
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1.1
(23). Further, high-throughput negative-screenings methodologies such as signature-tagged 
mutagenesis (24) and genomic array footprinting (GAF) (25-27), could be successfully applied 
for the identification of M. catarrhalis genes (conditionally) essential for pathogenesis. The GAF 
technology, originally developed for S. pneumoniae (25), is based on the construction of a large 
mariner transposon mutant library, generation of mutant-specific DNA probes that flank the 
transposon insertion site, and subsequently, the hybridization of these probes to microarrays to 
profile the composition of the mutant library. This enables the identification of mutants that are 
negatively selected from the library due to a particular challenge or stress condition (25-27) (see 
Fig. 1, Chapter 3.1). Recently, novel technologies including Tn-seq and TraDIS (28, 29), based on 
massive parallel sequencing of transposon insertion sites, were developed and allow profiling of 
transposon mutant libraries at an even higher resolution. 
aIM and ouTlIne oF THIS THeSIS 
The aim of this thesis is to elucidate novel aspects of M. catarrhalis pathogenesis using 
comparative and functional genomic approaches, with special emphasis on identification of 
mechanisms that allow survival within its human host as depicted in Figure 1. A detailed insight 
into the mechanisms driving M. catarrhalis pathogenesis is essential to aid the development of 
new intervention strategies.
In Chapter 1.2 we summarize our current knowledge about aspects important for M. 
catarrhalis pathogenesis. In Section 2, we describe our studies regarding the genetic diversity 
of the M. catarrhalis species as a whole. At the onset of this PhD research, only the partially 
annotated genome sequence of M. catarrhalis strain ATCC 43617 was available (30, 31). As 
M. catarrhalis is considered a highly heterogeneous species, sequencing of numerous other 
isolates would greatly facilitate our understanding of M. catarrhalis pathogenesis. To this end, 
we performed a comparative genomic analysis of the M. catarrhalis species, with Chapter 2.1 
describing the first completely sequenced, assembled, and annotated genome of M. catarrhalis, 
namely that of strain BBH18, isolated from sputum of a patient with COPD during an exacerbation. 
Chapter 2.2 reports on the whole-genome sequencing of M. catarrhalis RH4, a blood isolate. The 
genomic diversity of disease-associated M. catarrhalis isolates was investigated in more detail in 
Chapter 2.3 by comparative genome analysis of eleven additional seroresistant-lineage isolates 
obtained from diseased individuals. In Chapter 2.4, we addressed the genomic diversity of the M. 
catarrhalis species as a whole by the sequencing of 18 isolates from the less virulent serosensitive 
lineage, and performing a detailed comparison of all 31 isolates sequenced at that time.
The research described in Section 3 focuses on the identification and in-depth analysis of the 
mechanisms responsible for acquisition of nutrients and host-pathogen interaction. In Chapter 3.1, 
the genetic requirements for M. catarrhalis growth under iron-limiting conditions were examined 
by using an adapted and improved version of the genomic array footprinting technology. In 
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Chapter 3.2 we investigated the molecular interplay between M. catarrhalis and respiratory tract 
epithelial cells by two genome-wide approaches: monitoring transcriptional responses of both M. 
catarrhalis and pharyngeal epithelial cells, and Tn-seq identification of genes that affect cellular 
adherence of M. catarrhalis. In Chapter 3.3 we report on a novel molecular basis for the role 
of outer membrane vesicles (OMVs) in the interaction of M. catarrhalis with its host. The global 
proteome of these OMVs was determined and by a functional approach the interaction of OMVs 
with epithelial cells as well as the immunological response was examined. In Chapter 3.4 we 
describe our research focused on the elucidation of the mechanisms responsible for M. catarrhalis 
complement-resistance. We studied the transcriptional adaptation of M. catarrhalis upon serum 
exposure and identified several (novel) genes essential for complement resistance using Tn-seq. 
The role in complement resistance of one of the newly identified targets, the disulfide bond 
formation DSB system, was studied in detail. Finally, in Chapter 3.5 we explored possibilities to 
potentiate the susceptibility of mice to M. catarrhalis respiratory tract colonization and infection. 
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Moraxella catarrhalis pathogenesis
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1.2
InTroduCTIon
Moraxella catarrhalis is a human-restricted, unencapsulated, Gram-negative mucosal pathogen. 
Further, though previously thought to be a commensal of the upper respiratory tract, the 
bacterium is now increasingly recognized as a true pathogen of both the upper respiratory 
tract and the lower respiratory tract of humans. It is the third most common bacterial cause 
of childhood otitis media (OM) after Haemophilus influenzae and Streptococcus pneumoniae, 
and it is responsible for up to 20% of cases (1-3). Next to H. influenzae, M. catarrhalis is the 
second most common cause of exacerbations of chronic obstructive pulmonary disease (COPD), 
estimated to be responsible for 10 to 15% of these exacerbations, which accounts for 2 to 4 
million episodes in the United States per year (4, 5). Rates of M. catarrhalis carriage in children 
and adults differ considerably. About two-thirds of all children are colonized within the first year 
of life, and it is expected that about half of these children will experience at least one period of 
OM during this year (6). Colonization dynamics of children appeared to be season dependent, 
with incidence peaks during autumn/winter (7). In contrast, the rate of carriage in healthy adults 
is much lower, around 3 to 5%, though in COPD patients, M. catarrhalis has been detected in 5 
to 32% of sputum samples (4).
Interestingly, there has been a rapid acquisition and spread of β-lactam resistance in M. 
catarrhalis in the last 20 to 30 years (8) such that approximately 95% of clinical isolates now 
appear to be resistant to one or more β-lactams (9). As colonization and infections of the 
upper respiratory tract are often polymicrobial in nature (7, 10, 11), it is likely that the involved 
bacterial pathogens affect each other during co-colonization or infection. For example, M. 
catarrhalis secretes outer membrane vesicles (OMVs) containing β-lactamase, which could 
protect other pathogens such as S. pneumoniae and H. influenzae from the effects of β-lactam 
antibiotic treatment (12-14). Further, these OMVs are packed with virulence factors and prevent 
complement-mediated killing of Haemophilus influenzae (15). In any case, the financial impact 
on global health care systems of the high incidence of M. catarrhalis colonization and disease is 
significant, and consequently, several research groups are currently involved in identifying and 
assessing the usefulness of putative M. catarrhalis vaccine candidates (16-19).
Fortunately, our understanding of the molecular aspects of M. catarrhalis pathogenesis is 
steadily increasing. For example, it has been clearly demonstrated that M. catarrhalis is able to 
colonize the mucosal surfaces of the middle ear in OM patients (20, 21) or the lower respiratory 
tract in COPD patients (22, 23). To facilitate this, the bacterium possesses specific receptors 
allowing it to bind to host epithelia and to components of the extracellular matrix (ECM). The latter 
has been suggested to be especially important for adhesion to damaged epithelial cell surfaces, 
as may be observed, for example, in COPD patients (5, 24-26). M. catarrhalis also appears to 
be able to invade host epithelial cells (27, 28), the intracellular survival of pathogens being an 
important aspect of host immune evasion (29). Moreover, once attached to the host mucosal 
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surfaces, M. catarrhalis has the ability to interact and/or compete with the commensal flora and 
has the apparatus to survive and multiply under challenging nutrient-limiting conditions. Such 
conditions may result in the formation of microcolonies and biofilms (30). Finally, M. catarrhalis 
has the ability to evade and survive host immune responses, a process particularly helped by its 
ability to withstand the effects of human serum.
With these aspects in mind, this review is intended to provide a detailed overview of our 
current understanding of the molecular aspects of M. catarrhalis pathogenesis and particularly 
emphasizes recent publications relating to adhesion, invasion, biofilm formation, evasion of the 
host immune system, and nutrient acquisition. In addition, we discuss research focused on the 
(genetic) heterogeneity of the M. catarrhalis species. 
adHeSIon To HoST ePITHelIuM and eCM
Adhesion to mucosal surfaces is mediated by binding of several M. catarrhalis macromolecules 
to surface receptors on eukaryotic target cells or to components of the ECM. M. catarrhalis is 
an unencapsulated Gram-negative bacterium, and its outer membrane comprises phospholipids, 
lipooligosaccharides (LOS), integral outer membrane proteins (OMPs), and lipoproteins. From 
various studies, it appears that M. catarrhalis adhesion is a multifactorial event mediated by many 
adhesin macromolecules. For example, pili may initiate adhesion at long range, while OMPs may 
be involved during more intimate contact (31, 32). In particular, several macromolecules that 
contribute to M. catarrhalis adhesion, including OMPs such as the ubiquitous surface protein A 
proteins (UspAs) (32), M. catarrhalis immunoglobulin D (IgD) binding protein/hemagglutinin (MID/
Hag) (33), M. catarrhalis adherence protein (McaP) (34), OMP CD (35), M. catarrhalis filamentous 
Hag (FHA)-like proteins (Mha proteins) (36, 37), and surface-exposed structures, such as type IV 
pili (TFP) (38) and LOS structures (28), have been identified. For reference, the major virulence 
factors currently known to be associated with M. catarrhalis pathogenesis are summarized in 
Table 1. 
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adhesion and major oMPs
Trimeric autotransporters. The M. catarrhalis UspAs and MID/Hag are classified as trimeric 
autotransporters, also known as oligomeric coiled-coil adhesins (Oca proteins) (39-42). The group 
of trimeric autotransporters is a large protein family consisting of virulence factors of diverse 
pathogenic Gram-negative bacteria, such as the YadA protein of Yersinia spp. and the Hia protein 
of H. influenzae (43, 44). Trimeric autotransporters mediate their own insertion into the outer 
membrane. Their typical tripartite structure consists of (i) an N-terminal signal peptide, (ii) an 
N-terminal passenger domain that confers the protein’s biological function, and (iii) a C-terminal 
translocator domain responsible for pore formation, which is required for translocation of the 
protein across the outer membrane (Fig. 1A). The C-terminal translocator domain consists of 
a β-barrel structure anchored in the outer membrane and is connected to the N-terminal head 
domain via a coiled-coil stalk region (39, 41).
uspas. M. catarrhalis UspAs are multifunctional proteins with important adhesion properties. 
They can be divided into three main groups: UspA1 (88-kDa), UspA2 (62-kDa), and UspA2H (92-
kDa) proteins (Fig. 1B, C, and D, respectively) (32, 45). The hybrid UspA2H protein consists of 
a UspA1-like domain at its N terminus and a UspA2-like domain at its C terminus (32). UspA1, 
UspA2, and UspA2H protrude from the bacterial cell membrane as lollipop-like structures (41). 
The N-terminal globular head domain (passenger domain) is most readily available for binding 
because it extends beyond the outer membrane. UspA1 and UspA2 share homology in the stalk 
region but display major differences in the head- and membrane-anchoring domains (22). In fact, 
the UspA proteins of different isolates are divergent but share several (apparently) interchangeable 
modular amino acid sequence cassettes (Fig. 1B to D), including the so-called VEEG, NINNY, LAAY, 
and KASS repeats. UspA variability is most evident in the N-terminal region, where UspA1 and 
UspA2H contain variable numbers of antiparallel β-strand-forming GGG repeats followed by a 
FAAG repeat, probably resulting in different sizes of the head domain. In contrast, the N-terminal 
part of UspA2 is highly divergent from UspA2 and UspA2H. Furthermore, UspA1 and UspA2 both 
have variable stalk regions, harboring the UspA1 and UspA2 variable regions (U1VR and U2VR, 
respectively) (46). Sequence variability of the UspA2H stalk region (tentatively designated U2HVR) 
has not yet been determined. The UspA1 C-terminal region is highly conserved among isolates 
and is composed of a NINNY-KASS-FET motif followed by C-terminal region 1. UspA2 variants 
are also highly conserved at the C terminus, possessing the C-terminal region 2 domain flanked 
by the NINNY-KASS-FET motif, except for that of M. catarrhalis strain TTA24, which possesses an 
incomplete carcinoembryonic antigen-related cellular adhesion molecule 1 (CEACAM1)-binding 
motif (see below) instead of the FET motif (46). Several groups have studied the functional 
role of UspAs in adhesion to human cell lines. UspA1 was found to mediate binding to Chang 
conjunctival epithelial cells (32, 47, 54), HEp-2 laryngeal epithelial cells (54, 83), and A549 type 
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II alveolar epithelial cells (47, 48). UspA1 also binds to the ECM components fibronectin (26) and 
laminin (25). Binding to Chang cells or fibronectin was found to be mediated by the VEEG-NINNY-
VEEG motif (47). Given the fact that these variable domains appear to contribute to different 
functional aspects of the UspA proteins, motif exchange could lead to acquisition of specific 
functional characteristics. In addition, this may facilitate evasion of the immune response, as 
potentially immunoreactive domains become exposed at the bacterial surface.
UspA1-mediated binding to host cells varies upon phase variation, which is regulated at 
the level of transcription by variation in a homopolymeric poly(G) tract located upstream of the 
uspA1 open reading frame. During DNA replication, these repeats are prone to slipped-strand 
mispairing, resulting in the removal of one or more G residues and thereby influencing the level 
of UspA1 expression (49). Further, expression of uspA1 correlates with the number of poly(G) 
residues, which in turn influences in vitro adherence capacity (49). In fact, isolates with 10 G 
residues express levels of uspA1 significantly higher than those of isolates with nine G residues 
in their poly(G) tract, and isolates of the same strain have been found to exist with either 9 or 10 
G residues in their poly(G) tract. Interestingly, expression of uspA1 and uspA2 has been found 
to be associated with different 16S rRNA subtypes, as strains with normal uspA1 and uspA2 
expression levels are of 16S rRNA type 1, and strains with negligible expression are predominantly 
of 16S rRNA types 2 and 3 (84). Additionally, the expression of uspA1 could be induced by cold 
shock (26°C) in strains of all three 16S rRNA subtypes (85), although upregulation was most 
prominent in strains that normally exhibited negligible uspA1 expression, namely, those of 16S 
rRNA subtypes 2 and 3. Cold-shock prolonged uspA1 mRNA half-life and resulted in increased 
adherence to respiratory tract epithelial cells through enhanced binding to fibronectin (86). In 
general, cold shock could lead to the accumulation of specific mRNAs due to transcriptional and 
posttranscriptional responses in a manner similar to that observed in Streptococcus pyogenes, 
in which 9% of the genes have been found to be differentially expressed upon cold shock (87). 
Cold shock-induced upregulation of uspA1 could be beneficial for survival in the nasopharynx, 
especially the nose, which experiences regular temperature fluctuations and is generally cooler 
than the rest of the body (85). 
One of the receptors on human epithelial cells to which UspA1 binds has been found to be 
the CEACAM1 (31, 48). This Ig-related glycoprotein is expressed on a variety of epithelial and 
endothelial cells as well as on leukocytes (88, 89). CEACAMs are also known to play a role in 
inter- and intracellular signaling events involved in growth and differentiation (88). Interestingly, 
the targeting of CEACAM receptors is also a feature of other mucosal pathogens, such as H. 
influenzae and Neisseria meningitidis (31). The CEACAM1 receptor itself consists of a single distal 
Ig variable region (IgV)-like domain and three Ig constant region 2-like domains (all four facing the 
extracellular environment), a transmembrane domain, and an immunoreceptor tyrosine-based 
inhibitory motif (ITIM) (88). UspA1 binds to the extracellular IgV-like domain of CEACAM1 on the 
surface of epithelial cells (48). The CEACAM1-binding motif is preceded by the highly conserved 
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LAAY-KASS repeat and is located in the lower half of the stalk region, apart from the N-terminal 
head domain, which contains the fibronectin-binding site (Fig. 1A) (39, 46, 90). CEACAM1 
and fibronectin induce differential bending of the UspA1 coiled-coil stalk region as recently 
demonstrated by lateral molecular-force microscopy (90). The increased bending angle induced by 
CEACAM1 relative to fibronectin possibly allows closer contact with the epithelial cell surface (39). 
Naturally occurring UspA1 variants lacking the CEACAM-binding motif were identified in several 
M. catarrhalis isolates, and these conferred different cell adhesion properties and probably elicit 
different host responses (47). Interestingly, natural transformation of M. catarrhalis strain O35E, 
harboring an uspA1 gene without the CEACAM1-binding motif, with uspA1 DNA containing 
the CEACAM1-binding motif (derived from strain MX2), showed incorporation of this domain in 
both O35E UspA1 and UspA2 proteins (91). These results also confirm the interchangeability of 
these modular amino acid sequence cassettes. Further, screening of a collection of clinical isolates 
showed that strains either express CEACAM1-binding UspA1 or UspA2. A detailed analysis 
revealed that UspA2 variants with CEACAM1 binding capacity represent a distinct cluster that 
differs from known UspA1, UspA2, and UspA2H variants, and were designated UspA2V (91). Hill 
et al. also demonstrated that in addition to binding of CEACAM1, UspA2V also interacts with 
vitronectin, the latter mediating adherence through cellular integrins (91). Binding of UspA1 to 
CEACAM1 has been proposed to induce apoptosis in pulmonary epithelial cells, which could 
contribute to the pathogeneses of COPD and emphysema by inducing secondary inflammation 
(50). Furthermore, the interaction of UspA1 and potentially UspA2V with CEACAM1 enables 
M. catarrhalis to suppress the host inflammatory response (53), a mechanism discussed in more 
detail in Evasion of the Host Immune System below.
The UspA2 protein does not interact with CEACAM molecules on host cells but does bind 
to the ECM proteins laminin (25), fibronectin (26), and vitronectin (83). Interaction of pathogens 
with vitronectin has been associated with both cell adhesion and complement resistance (83).
At the present, UspA2H is the least well studied of the M. catarrhalis UspA proteins, although 
it is reported to mediate binding to Chang cells, as it also possesses the Chang cell/fibronectin 
binding motif (Fig. 1D) (32, 46).
MId/Hag. MID (200 kDa), also referred to as Hag, has been found to be responsible for M. 
catarrhalis binding to soluble IgD and for the stimulation of high-density IgD-bearing B lymphocytes 
(33, 92-94). In fact, nonimmune binding of Igs by Gram-positive bacteria is relatively common but 
rare among Gram-negative bacteria (95, 96). Interestingly, H. influenzae also displays a strong 
affinity for soluble human IgD (97), although the protein involved in IgD binding has as yet been 
identified only in M. catarrhalis. MID is also a B-lymphocyte mitogenic stimulant that initiates 
Ig production (98), and a comparison of MIDs of five strains revealed that the overall sequence 
identity ranged between 65.3% and 85.0%, with some regions showing an identity up to 97% 
(62).
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Fig 1. Modular arrangement and functional domains of the M. catarrhalis trimeric autotransporter 
proteins. (A) Schematic representation of the basic elements of trimeric autotransporter proteins. (B, C, and 
D) The UspA proteins. The various sequence cassettes, as well as known functional domains, are indicated. 
CTER1 and CTER2, C-terminal regions 1 and 2, respectively; NTER1/2, N-terminal region 1/2. (E) MID. Indicated 
are the sequence motifs shared between MID variants, and the regions involved in adhesion and IgD binding. 
(F) Basic structural elements of McaP.
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Essentially, MID/Hag is a multifunctional protein that fulfills an important role in pathogenesis. 
For example, MID-expressing isolates agglutinate human erythrocytes and adhere to A549 cells, 
and the extent of these actions has been found to correlate with MID expression levels (60). In 
addition, Hag mediates attachment to human middle ear epithelial cells (59, 61), NCIH292 lung 
epithelial cells (58), Chang cells (58, 94), and to ciliated normal human bronchial epithelium 
(NHBE) (99). In a study by Bullard et al., isogenic hag mutants of M. catarrhalis V1171, O35E, 
McGHS1, and O12E were tested for their adhesion capacities (58). These strains expressed normal 
levels of UspA1, UspA2H, McaP, and OMP CD, but their adherence capacities were significantly 
lower after the deletion of hag (58). Additionally, a significant loss of adhesion was observed 
when a strain with high-level MID expression (Bc5) was incubated with an anti-UspA1 antibody 
(60). These results suggest that several M. catarrhalis adhesins act in concert in order to mediate 
binding to host target cells. The multimeric MID/Hag is classified as an autotransporter protein 
with a 10-β-barrel translocator domain and an N-terminal globular head domain with both 
adhesion and IgD binding activity (Fig. 1E) (56). Expression of MID/Hag is subject to translational 
phase variation via slipped-strand mispairing in a poly(G) tract located at the 5′ end within the 
open reading frame (59, 62). Möllenkvist et al. showed that mid mRNA and MID were present in 
strains with 1, 2, or 3 triplets of G residues, whereas both were found to be absent in strains with 
4, 7, 8, or 10 G residues. In addition to translational phase variation, it has been suggested that 
MID is regulated at the DNA level by trans-acting elements binding to the poly(G) tract or at the 
RNA level by regulation of the stability of the mid mRNA (62, 100). Interestingly, when isolates 
with high-level mid expression were subcultured multiple times, a population with low-level mid 
expression developed, and its members appeared to have lost a G residue in the poly(G) tract (62).
McaP. Adhesion studies using uspA1 and hag knockout mutants indicated the presence of 
another adherence factor. Indeed, a gain-of-function (adhesion) approach using a nonadherent 
Escherichia coli strain led to the identification of a novel adhesin that exhibited both phospholipase 
B and esterase activities (34). This 62-kDa OMP, named McaP, was classified as a conventional 
autotransporter protein containing a 12-β-barrel translocator domain and an N-terminal 
passenger domain that harbors both adhesion and lipolytic activity (Fig. 1F) (34, 42). McaP was 
found to be highly conserved, as sequence analysis of nine isolates showed 98 to 100% identity 
over the entire length of the protein (42). Recombinant E. coli cells expressing mcaP displayed 
increased adhesion to Chang cells, A549 cells, and 16HBE14o− polarized human bronchial 
cells (34). Further, an M. catarrhalis O35E mcaP knockout mutant displayed reduced adherence 
to different epithelial cell lines and abolished esterase activity (34). However, the exact role of 
McaP in pathogenesis remains to be elucidated. Phospholipases are known to be involved in a 
diverse range of cellular functions, inducing host inflammatory responses, changing membrane 
composition, and altering signaling cascades (101). The importance of esterase activity for 
pathogenesis is currently unknown.
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oMP Cd. OMP CD is a heat-modifiable highly conserved porin-like protein (46 kDa) that is related 
to the Pseudomonas aeruginosa OprF porin that is involved in nutrient acquisition. As mutants of 
OMP CD were shown to be larger, produce a thinner cell wall, and exhibit an increased surface 
hydrophobicity compared to their wild-type counterpart, it was proposed to be important for 
stabilizing the cell morphology (102). OMP CD also plays an important role in the process of 
adhesion (103). OMP CD functions as an adhesin for both middle ear mucin (64, 104), A549 
(35) and HEp-2 cells (102). It is anchored in the outer membrane via a β-barrel domain, which 
connects to the C-terminal domain via a linker region. Both the β-barrel domain and the linker 
region are important for adhesion to A549 cells, with bioinformatic analysis revealing that the 
linker region harbors a eukaryotic adhesion motif, the thrombospondin type III repeat (105).
Mha proteins. The FHA-like proteins MhaC, MhaB1, and MhaB2 were shown to function 
as a two-partner secretion locus (TPS) (36, 37). TPS systems are widespread in Gram-negative 
bacteria and are mostly involved in the secretion of virulence proteins. A TPS typically consists 
of a transporter protein located in the outer membrane and the transported/secreted protein 
partner(s). Well-known examples include the FHA protein of Bordetella pertussis (106) and 
Hag-related protein (Hrp) of N. meningitidis (107), both of which have also been shown to be 
functionally involved in adhesion. The MhaC protein is predicted to form a β-barrel porin-like 
structure in the outer membrane, facilitating the transport of MhaB1 and MhaB2 across the 
bacterial outer membrane. Disruption of the mhaC gene locus resulted in an absence of the 
MhaB protein in the outer membrane (36). All three Mha proteins are highly conserved and have 
been found to be expressed in several isolates (36). Bacterial mutants with mutations of the 
three mha genes (mhaB1, mhaB2, and mhaC mutants and an mhaB1 mhaB2 double mutant) 
showed reduced binding to HEp-2 cells, whereas only the mhaB2 mutant, the mhaB1 mhaB2 
double knockout mutant, and the mhaC mutant showed reduced binding to 16HBE14o− cells. 
M. catarrhalis isolates O35E, O12E, and McGSHS1 with an mhaC knockout exhibited reduced 
adhesion to HEp2, Chang, and 16HBE14o− cells but not to A549 or NCIH292 cells. No effect 
on adhesion to A549 or NCIH292 cells was seen for any of the mha knockout mutants (36). 
These results demonstrate once again that M. catarrhalis adhesion relies on the complex interplay 
between many bacterial components and target cell-specific characteristics.
adhesion and surface-exposed structures
TFP. TFP are surface-exposed filamentous polymeric structures of assembled pilin proteins. TFP 
mediate a wide range of cellular functions, including natural competence, adhesion to host cells, 
biofilm formation, and twitching motility. TFP fulfill a crucial role in pathogenesis, as a loss of TFP 
results in reduced virulence for many Gram-negative bacteria (108). For M. catarrhalis, loss of pilA 
(encoding the major pilin subunit of TFP) resulted in a significantly reduced adherence to Chang 
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cells and reduced ability to colonize the chinchilla nasopharynx, suggesting that TFP promote 
attachment to mucosal surfaces (38). Further, in vitro assays revealed that microcolony formation 
and biofilm formation were abrogated in the pilA mutant (38).
loS. LOS is a major component of the outer membrane and is generally considered to be 
important for M. catarrhalis virulence. It consists of an oligosaccharide core and lipid A. The LOS 
core oligosaccharide is connected to lipid A via Kdo (3-deoxy-D-manno-2-octulosonic acid) and is 
composed of glycosyl residues (Fig. 2) (109). Several glycosyl transferases have been reported to 
be responsible for the formation of core or branched oligosaccharide chains (78). M. catarrhalis 
LOS is distinct from the typical lipopolysaccharides of Gram-negative enteric pathogens because 
it lacks the O-antigen polysaccharide side chain. LOS of M. catarrhalis exists in three serotypes, 
the most prevalent being serotype A (72%), followed by serotypes B and C (21% and 2%, 
respectively) (110). Interestingly, a significant difference in incidence between LOS serotypes A 
and B is apparent among global M. catarrhalis isolates from children and adults, with a decrease 
in serotype A incidence being reported for adults (110).
Galp
Glcp
Glcp
KDO
KDO
Core oligosaccharide Lipid A
Galp Glcp
Glcp
Galp Galp Glcp
Galpalp Galp
Glcp
NAc
Glcp
NAc
Serotype
A
B
C
R-group
Pk epitope
R Glcp
Fig. 2. biochemical structures of M. catarrhalis loS serotypes. The lipid A moiety is connected to 
the oligosaccharide core via a Kdo residue. The three M. catarrhalis LOS serotypes differ in the nature of 
their R group (R). Abbreviations: Galp, galactose phosphate; Glcp, glucose phosphate; GlcpNAc, N-acetyl-
glucosamine phosphate.
LOS structures of several respiratory pathogens are known to be critical for adhesion to 
host target cells, including N. meningitidis and H. influenzae (111, 112). Knockout mutations 
of the genes involved in LOS assembly have been used to study the importance of LOS for M. 
catarrhalis adhesion (Table 2). LpxA, a UDP-N-acetylglucosamine acyltransferase, is involved in 
the initial step of lipid A biosynthesis. An lpxA mutant O35E strain was found to be completely 
devoid of LOS, resulting in clearly diminished adhesion to Chang, A549, and HeLa cervical cells 
(80). This reduced adhesion to Chang cells was confirmed in another study using an O35E lpxA 
knockout mutant (28). Peng et al. examined the importance of lipid A in vivo in a mouse aerosol 
challenge model. Directly after aerosol challenge, numbers of lpxA mutants recovered from the 
lungs and nasopharynx were lower (20-fold and 2-fold, respectively) than the wild-type numbers. 
Further, the lpxA mutant was more easily cleared from the nasopharynx than the wild-type strain, 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Molecular aspects of M. catarrhalis pathogenesis  |  29
1.2
although this difference was not observed to occur in the lungs (80). The observed changes could 
be due to loss of LOS interaction with host components, increased sensitivity to complement-
mediated killing by lower membrane stability, or altered surface display of adhesin molecules (80). 
The lpxL and lpxX genes encode late acyltransferases that are responsible for the incorporation of 
secondary acyl chains into lipid A. An M. catarrhalis O35E lpxX knockout mutant was shown to 
be more efficiently cleared in a mouse pulmonary challenge model than its wild-type form (77), 
and an lpxL and lpxA double mutant was cleared even more efficiently (113).
Table 2: M. catarrhalis loS biosynthesis genes and characteristics of knockout mutants
Effect of gene knockout
Gene Function LOS element LOS structure Adhesion Serum 
resistance
In vivo 
clearance
References
lpxA UDP-N-
acetylglucosamine 
acyltransferase 
Lipid A No LOS ↓ ↓ ↑ (28, 80)
lpxX Late acyltransferase Lipid A Lacking two 
decanoic acids
ND ↓ ↑ (77)
lpxL Late acyltransferase Lipid A Lacking one 
decanoic acid
ND = = (77)
kdtA KDO transferase KDO Only lipid A ↓ ↓ ↑ (78, 79)
kdsA KDO-8-phosphate 
synthase 
KDO Only lipid A ND ↓ ND (78, 79)
galE UDP-glucose-4 
epimerase
Oligo-
saccharide core
Loss of Pk 
epitope
↓ ↓ ND (76, 82)
lgt3 Glucosyltransferase Oligo-
saccharide core
Truncated core 
oligosaccharide
↓ ↓ ↑ (81)
Abbreviations: ↑, increase; ↓, decrease; =, not affected, ND, not determined.
The Kdo residues represent the next level of the complete LOS structure and link the lipid 
A moiety to the oligosaccharide core. The Kdo transferase KdtA catalyzes the addition of Kdo 
residues to the lipid A precursor. An O35E kdtA knockout mutant formed an LOS structure 
comprising only lipid A, without any core oligosaccharides. This kdtA mutant showed impaired 
adhesion to Chang and HeLa cells but not to A549 cells, suggesting that the contribution of 
Kdo to adhesion is host cell type specific. Furthermore, the kdtA mutant was found to be more 
efficiently cleared in a mouse pulmonary challenge model than its parental strain (79).
The oligosaccharide chains represent the core structure of LOS. In all three LOS serotypes, 
one of the oligosaccharide chains terminates with Galα1-4Galβ1-4Glc, which is also known as 
the Pk epitope (82). Evidence for the involvement of the Pk epitope in LOS-mediated adhesion 
was obtained from M. catarrhalis 2951 (serotype A) lacking the Pk epitope as a result of a UDP-
glucose-4-epimerase gene (galE) knockout. This galE mutant showed reduced attachment to 
a panel of pharyngeal epithelial cells isolated from healthy adults. However, treatment of the 
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wild-type isolate with LOS or a monoclonal antibody directed against the Pk epitope did not result 
in reduced adhesion. The authors of the study in question suspected that the loss of the net 
negative surface charge caused a reduction of adhesion, suggesting that the Pk epitope itself is 
not an adhesin but is indirectly involved in adhesion (76). An lgt3 (LOS glycosyltransferase gene) 
knockout mutant of strain O35E that possessed a truncated core oligosaccharide also exhibited a 
reduced adhesion capacity to Chang and HeLa cells and was more efficiently cleared in a mouse 
nasopharyngeal clearance model (81).
The role of LOS in M. catarrhalis adhesion is still open to discussion, as alterations or even the 
absence of LOS can lead to a lowered membrane integrity and could affect the surface display of 
adhesin macromolecules in the bacterial membrane. In fact, changes in OMP composition have 
been demonstrated in an LOS-deficient M. catarrhalis O35E strain (lpxA mutant) (28).
InVaSIon oF THe HoST ePITHelIuM
Once M. catarrhalis has established itself at its colonization sites, the bacterium has to survive 
both the host immunological response and environmentally challenging conditions, such as 
iron limitation. Adhesion to host epithelial cells and ECM macromolecules is an essential step 
for facilitating pathogenesis of M. catarrhalis. As discussed above, OMPs and other surface-
exposed macromolecules, such as TFP and LOS, may be key players in this process. However, after 
adhesion, a critical step of M. catarrhalis appears to be invasion of host cells, which would allow 
M. catarrhalis to hide from both the action of the host’s immune system (cellular and humoral) 
and the effects of antibiotic treatment.
An elegant study by Slevogt et al. reported the potential of M. catarrhalis to invade different 
epithelial cell types (27). Scanning and transmission electron microscopy analyses of M. catarrhalis 
strain O35E adhering to BEAS-2B bronchial epithelial cells and A549 cells demonstrated phenotypic 
changes in the epithelial cell surface. Both lamellipodia and filopodia were formed after bacterial 
adhesion, both pointing toward and eventually surrounding the M. catarrhalis bacterium, 
which indicated a macropinocytosis-like mechanism of cellular invasion. Once intracellular, the 
bacteria were found to reside in vacuolar structures. Furthermore, UV-killed bacteria were used 
to demonstrate that M. catarrhalis actively invades epithelial cells, as no structural changes in the 
epithelial membrane were observed with UV-killed bacteria and no bacteria were observed inside 
cells. Additionally, invasion did not appear to be strain dependent, as M. catarrhalis ATCC 25238 
and O35E were able to invade epithelial cells to similar extents. To examine the specific host 
factors involved in this process, specific cellular inhibitors were used. These inhibitors revealed 
that cellular invasion was dependent on microfilaments, Rho-type GTPases, and phosphoinositide 
3-kinase (PI3K)-dependent contractile mechanisms but not on microtubules, clathrin-coated pit 
formation, or tyrosine kinases (27). The exact mechanism of M. catarrhalis invasion into epithelial 
cells still needs to be unraveled, though the ability of M. catarrhalis to invade epithelial cells has 
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been reported by other authors (28), who found that the level of invasion of Chang cells by 
M. catarrhalis O35E was actually fivefold higher than the level of invasion of A549 cells by the 
same strain. These authors also demonstrated that the addition of a purified OMP preparation 
resulted in reductions of both adhesion and invasion, and a lack of UspA1 (one of the major 
adhesins) reduced both adhesion and invasion. Further, it was shown that loss of LOS (via an 
lpxA deletion mutant) impaired both adhesion and invasion, though as already mentioned, loss 
of LOS appears to influence surface display of OMPs, including adhesins. Spaniol et al. (28) also 
utilized host-specific inhibitors to study invasion and showed that invasion was dependent on 
clathrin polymerization, which seemed to contradict the earlier findings of Slevogt et al. (27). 
Furthermore, actin polymerization was also found to contribute to the invasion process, and 
antibodies directed to fibronectin and integrin α5β1 were able to inhibit invasion (28). In another 
publication, Hill et al. demonstrated that blocking of the CEACAM1-binding domain with a 
recombinant peptide (rD-7, representing the CEACAM1-binding domain of UspA1) resulted in 
inhibition of cell invasion by M. catarrhalis, H. influenzae, and N. meningitidis (31), indicating the 
importance of CEACAM1 binding for both adhesion and invasion.
The invasive capacity of M. catarrhalis was demonstrated in vivo, with M. catarrhalis being 
detected in adenoid and tonsil tissues of patients without acute respiratory disease (114). This 
subepithelial and intracellular reservoir could potentially lead to long-term persistence of M. 
catarrhalis inside the host. However, the interaction between MID/Hag and IgD was recently 
shown to results in internalization and killing of M. catarrhalis by human tonsillar B lymphocytes, 
making it unlikely that tonsillar B lymphocytes are a potential reservoir for M. catarrhalis (115). 
M. catarrhalis secretes MID/Hag-containing OMVs that are also bound and internalized by B 
lymphocytes, which possibly serves as a decoy mechanism to reduce contact with B lymphocytes 
(115). At present, the exact mechanism of epithelial cell invasion by M. catarrhalis is not fully 
understood, but it appears to be an active process involving several host cell and bacterial 
mechanisms.
bIoFIlM ForMaTIon
Biofilm formation has already been demonstrated to be an important process involved in 
colonization and persistence for (mucosal) microorganisms (116). Indeed, the capacity of M. 
catarrhalis to form biofilms has been confirmed by in vitro assays (57, 63), and M. catarrhalis 
has been found to be present in biofilms in vivo in the middle ears of OM patients (21). Pearson 
et al. attempted to identify the genes required for biofilm formation by use of a transposon 
mutagenesis approach. This led to the recognition that the presence of UspA1 positively affects 
biofilm formation, while the presence of Hag has a negative effect (63). Later, however, it became 
apparent that both UspA1 and UspA2H play a role in biofilm formation (57). Recently, Verhaegh 
et al. reported that uspA2-positive isolates were more efficient biofilm formers than isolates 
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carrying the mutually exclusive uspA2H gene, suggesting that uspA2 could also play a role in 
biofilm formation (110). This study analyzed a large cohort of M. catarrhalis isolates obtained 
from children and adults with respiratory disease from various geographical regions. The capacity 
for formation of biofilms was greater in the strains isolated from children (<5 years of age), and 
isolates derived from adults (>20 years of age) showed reduced incidence of uspA2. The role 
of TFP in the formation of microcolonies and biofilms in vitro was investigated by Luke et al. by 
using a pilA mutant, and they showed that microcolony formation and biofilm formation were 
dependent on TFP (38).
Recently, Armbruster et al. elegantly demonstrated that M. catarrhalis and H. influenzae form 
polymicrobial biofilms in vitro (117). In these polymicrobial biofilms, M. catarrhalis provided passive 
protection to β-lactam sensitive H. influenzae, and importantly, overall antibiotic resistance was 
increased compared to mono-species biofilms. Moreover, their results suggested that interspecies 
quorum signaling drives increased biofilm formation as well as persistence in a Chinchilla OM 
model (117).
Host factor 1 (Hfq) is a global regulatory protein, highly conserved among M. catarrhalis 
strains and homologous to Hfq of E. coli. Hfq probably functions as an RNA chaperone that 
facilitates the interaction between mRNAs and their cognate small RNAs and, as such, influences 
the stability or translation of the mRNA. Mutation of hfq in M. catarrhalis O35E resulted in reduced 
growth when it was challenged with osmotic and oxidative stresses. This hfq knockout mutant 
also displayed an altered OMP composition, characterized by slightly increased expressions of 
CopB, OMP J, and OMP G1b. Furthermore, the hfq mutant strain showed a growth advantage in 
a biofilm system, which could be the (indirect) result of an altered outer membrane composition 
(118).
eVaSIon oF THe HoST IMMune SySTeM
During colonization of mucosal surfaces, M. catarrhalis faces the challenge of resisting the host’s 
innate immune system, which forms the first (nonspecific) line of defense against bacterial 
pathogens, before evading the host’s adaptive immune response. The innate immune system 
comprises several key components, such as the complement system and pattern recognition 
receptors (PRRs), which include the Toll-like receptors (TLRs) (119), NOD-like receptors, and 
mannose receptors of macrophages (120).
Complement resistance
Simply speaking, activation of the complement system via the classical, alternative, and/or 
mannose-binding lectin pathway leads to deposition of complement proteins on the bacterial 
surface, resulting in the formation of the membrane attack complex (MAC) and opsonization 
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of bacteria for phagocytic killing. Publications have previously shown that M. catarrhalis may 
activate both the classical and alternative pathways (100) and is a weak activator of the mannose-
binding lectin pathway of the complement system (121). However, M. catarrhalis does possess 
mechanisms that have evolved to inhibit activation of complement pathways. Indeed, one 
important aspect of M. catarrhalis pathogenicity is the ability of most clinical isolates to survive 
complement-mediated killing by normal human serum, with almost all M. catarrhalis isolates 
recovered from OM or COPD patients being resistant to the effect of normal human serum (110). 
The most important factors responsible for complement evasion, namely, UspA2 (54), OMP CD 
(35), OMP E (65), CopB (122), and LOS (76), are discussed below.
Complement resistance and major oMPs
uspas. The multifunctional aspects of M. catarrhalis UspA proteins are illustrated by their roles 
in adhesion, invasion, and protection against the human complement system. The role of UspA 
proteins in serum resistance has been described by several authors (54, 56, 123-125). UspA2 is 
capable of binding several complement proteins: the C4-binding protein (C4bp) (51), C3 (52, 
126), and vitronectin (56, 83). The binding of the complement inhibitor C4bp on the surface 
of M. catarrhalis enables the bacterium to inhibit the classical complement system (Fig. 3A). A 
uspA1 knockout mutant of M. catarrhalis was also shown to be partially impaired with respect 
to C4bp binding, but this effect was significantly less apparent than that in a uspA2-deficient 
strain, and this result could be explained by the C4bp affinity of UspA2 being higher than that 
of UspA1 (51). The UspA2 protein has also been shown to interfere with the deposition of C3b 
on the bacterial surface by absorbing C3 from serum and thereby preventing activation of the 
alternative complement pathway (Fig. 3A). Though both UspA1 and UspA2 were found to 
be able to bind C3, a more dominant role was again observed for UspA2. UspA expression in 
different M. catarrhalis isolates was found to correlate with binding of C3 and resistance against 
complement-mediated killing (126). Vitronectin is a regulatory component of the complement 
system that inhibits the terminal stages of the complement system by blocking membrane 
binding of C5b-7 and inhibition of C9 polymerization and eventually inhibiting formation of the 
MAC (127, 128). The UspA2 head-domain has been found to bind vitronectin (Fig. 3A) (56, 83, 
125, 129), with uspA2 knockout mutants becoming more sensitive to serum-mediated killing 
and displaying lower vitronectin binding capacity. In addition, these uspA2 knockout mutants 
contained more polymerized C9 than their isogenic counterpart (56). Although the recently 
identified UspA2V proteins bind vitronectin (91), their role in complement resistance remains 
to be investigated. As described for UspA1, cold-shock (26°C) induces expression of UspA2, 
increasing binding of vitronectin and consequently enhancing complement resistance (130). 
Interestingly, the expression of uspA2 is subject to phase variation, with the promoter region of 
the uspA2 gene containing a variable number of AGAT tetranucleotide repeat sequences (55, 
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131). UspA2 expression has been found to be maximal at 18 tetranucleotide AGAT repeats, 
with levels of UspA2 correlating to increased vitronectin binding ability and lower deposition of 
polymerized C9 (55). Deletion of uspA2 AGAT repeats resulted in negligible levels of UspA2 and 
facilitated the conversion of a phenotype of serum resistance to a phenotype of serum sensitivity 
(55). Clearly, the multifunctional UspA proteins are indispensable in conferring resistance to the 
bactericidal effect of human serum.
oMP Cd. Serum resistance experiments using an O35E ompCD isogenic mutant, which expressed 
normal levels of UspA1, UspA2, and Hag, showed that this mutant was more sensitive to the 
effects of serum. However, expression of OMP CD in E. coli did not confer serum resistance to this 
normally serum-sensitive bacterium (35). The mechanism facilitating OMP CD-mediated serum 
resistance therefore appears to be functional only in M. catarrhalis itself, and further studies are 
required to determine the exact role of OMP CD in serum resistance.
oMP e. The OMP E protein is a 50-kDa heat-modifiable protein with relatively high sequence 
conservation. Comparison of the OMP E amino acid sequences of 16 M. catarrhalis isolates to the 
OMP E sequence of M. catarrhalis strain ATCC 25240 showed levels of identity of 96.6 to 100% 
(66). For both M. catarrhalis 7169 and ATCC 25240, knockout mutants lacking OMP E appeared 
to be more sensitive to serum-mediated killing than their parental counterparts. Importantly, 
sequences of the ompE genes were found to remain unchanged in isolates from three patients 
colonized with the same strain for 3 to 9 months. Further, all three patients showed detectable 
IgG directed to the OMP E protein (65). However, as with OMP CD, the exact role of OMP E in 
mediating serum resistance remains to be elucidated.
Copb. The 81-kDa OMP CopB was the first M. catarrhalis protein reported to be linked to serum 
resistance. The effect of knocking out copB in M. catarrhalis O35E has been studied both in vitro 
and in vivo. The copB mutant showed decreased serum resistance and a lesser ability to survive 
in a pulmonary clearance mouse model (68). Further, CopB is a major target of the immune 
response against M. catarrhalis (132).
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Fig. 3. M. catarrhalis immune evasion strategies mediated by the uspa oMPs. (A) Inhibition of 
the complement system. Both UspA1 and UspA2 fulfill an important role in serum resistance, with a more 
dominant role for UspA2. The UspA2 protein binds the complement inhibitor C4bp, enabling M. catarrhalis 
to inhibit the classical complement system. UspA2 also prevents activation of the alternative complement 
pathway by absorbing C3 from serum. Further, UspA2 interferes with the terminal stages of the complement 
system, the MAC, by binding the complement regulator protein vitronectin. (B) Inhibition of the TLR2-NF-
κB proinflammatory response. The UspA1 protein targets the CEACAM1 molecules on host epithelial cells. 
M. catarrhalis uses UspA1-mediated CEACAM1 binding to counteract the TLR2-initiated proinflammatory 
response. M. catarrhalis PAMP-mediated activation of TLR2 results in the recruitment of the p85α regulatory 
subunit of PI3K and finally the transcription of proinflammatory genes, which are regulated by NF-κB. Binding 
of UspA1 to CEACAM1 results in increased phosphorylation of tyrosine residues of the cytoplasmic ITIM 
domain of CEACAM1 and subsequently to the recruitment of SHP-1. SHP-1 inhibits the phosphorylation of 
p85α, thus blocking the activation of a proinflammatory response by inhibiting the activation of the PI3K-
Akt-NF-κB pathway. Further details may be found in the text. GM-CSF, granulocyte-macrophage colony-
stimulating factor.
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Complement resistance and surface-exposed structures
loS. Along with having a role in cellular adhesion, LOS structures are important for resistance 
against the bactericidal activity of human serum. As with studies examining the role of LOS in 
adhesion, defined knockout mutants have been used to assess the contribution of LOS structural 
elements to serum resistance (Table 2). Mutants with deletions of the enzymes responsible for 
synthesis of the lipid A of LOS have been tested for their ability to resist normal human serum. An 
M. catarrhalis O35E lpxA knockout mutant (totally devoid of LOS) and a kdtA knockout mutant 
(which contained only the lipid A moiety) were both found to be more sensitive to the bactericidal 
activity of human serum than their isogenic parent isolate, with the effect of normal human 
serum on the lpxA mutant being more severe than the effect on the kdtA mutant (79, 80). Strains 
with mutations of the lipid A acyltransferase enzymes, ΔlpxX, ΔlpxL and the lpxXL double mutant, 
were also tested for their sensitivity to human serum. Of these gene knockout mutants, the lpxX 
mutant strain was clearly more sensitive to human serum than its parental O35E strain, whereas 
mutation of lpxL did not affect serum resistance (77). The double lpxXL mutant showed higher 
serum sensitivity than the single lpxX mutant (113). 
The initial step in the synthesis of Kdo is catalyzed by Kdo-8-phosphatase synthase (KdsA), 
and the transfer of Kdo residues to lipid A is catalyzed by KdtA. Both the kdsA and kdtA knockout 
mutants were found to have a severely truncated form of LOS, which consisted only of lipid A 
without Kdo residues, and both mutants displayed increased sensitivity to serum-mediated killing 
(78, 79).
As mentioned previously, the M. catarrhalis 2951 galE mutant lacks the Pk epitope by loss of 
the terminal galactose residues. This mutant was shown to display elevated sensitivity to serum-
mediated killing. Further, the Pk epitope is also present on the surface of erythrocytes and several 
epithelial cell types (133), and because of this immunochemical identity, no naturally occurring 
antibodies toward the Pk epitope of M. catarrhalis LOS are likely to be present in human serum. 
Loss of the Pk epitope then apparently results in the exposure of a different LOS epitope and, 
subsequently, to the activation of the complement system (82). Further, the lgt3 knockout mutant 
of strain O35E, possessing a truncated core oligosaccharide, also showed increased sensitivity to 
serum-mediated killing (81).
Interestingly, most knockout mutants deficient for enzymes of the LOS biosynthetic pathway 
also displayed slightly to more-severely impaired growth ability, as well as increased vulnerability 
to hydrophobic compounds. This suggests that the outer membrane structure of these mutants 
is more permeable and weaker than that of their parental counterpart. With these data taken 
together, we can conclude that the LOS structure is important for M. catarrhalis virulence, directly 
or indirectly contributing to adhesion as well as to the evasion of the immune system.
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Inhibition of Tlr2-induced proinflammatory responses
M. catarrhalis uses adhesion and invasion mechanisms to colonize the mucosal surfaces of 
the human respiratory tract. At the mucosal surface, M. catarrhalis appears to activate an 
inflammatory immune response via the action of TLR2 (a PRR), which is present on the membrane 
of respiratory epithelial cells and is involved in the immune response (27). Like several other TLRs, 
TLR2 recognizes a broad range of structurally unrelated pathogen-associated molecular patterns 
(PAMPs) (134). Upon infection with M. catarrhalis, the activation of TLR2 initiates a cascade 
of reactions that results in the transcription of proinflammatory genes (120), such as those 
encoding interleukin-8 (IL-8) and the granulocyte-macrophage colony-stimulating factor (27, 53, 
135, 136). PAMP-mediated activation of TLR2 results in the recruitment of the p85α subunit 
of PI3K, a factor important in TLR2-mediated activation of the transcription factor NF-κB (53, 
120). However, research has shown that despite the activation of TLR2, M. catarrhalis is able to 
colonize mucosal surfaces without initiating a TLR2-mediated inflammatory response. In fact, M. 
catarrhalis inhibits this proinflammatory pathway via signaling through the CEACAM1 receptor 
(Fig. 3B) (53). This mechanism involves a domain present in the stalk region of UspA1, which 
binds to the IgV-like domain of the CEACAM1 receptor (48). UspA1 binding to the CEACAM1 
receptor results in an increased phosphorylation of tyrosine residues of the cytoplasmic ITIM 
domain and, subsequently, to the recruitment of Src homology 2 domain-containing cytoplasmic 
protein tyrosine phosphatase (SHP-1). SHP-1 functions by inhibiting the phosphorylation of the 
p85α regulatory subunit of PI3K, which is necessary for the activation of the PI3K-Akt-NF-κB 
pathway and thus for activation of a proinflammatory response (53). Furthermore, SHP-1 is also 
reported to inhibit T-cell signaling (88, 137). This inhibition of the TLR2-mediated proinflammatory 
response (via the action of UspA1 binding to CEACAM1) may be one of the major features 
facilitating colonization of host epithelial surfaces by M. catarrhalis.
Recognition of bacterial components also occurs once intracellular pathogens have 
invaded host epithelial cells. For example, where TLRs are PRRs present on the outside of the 
cell, nucleotide-binding oligomerization domain molecules, such as NOD1, function at the 
intracellular level. NOD1 recognizes Gram-negative peptidoglycan and subsequently triggers an 
NF-κB-regulated antimicrobial response (138). With respect to M. catarrhalis, the importance of 
TLR2 and NOD1 for the induction of an NF-κB-IL-8 inflammatory response has been investigated 
via gene silencing. Upon challenge with M. catarrhalis, IL-8 expression was reduced in both the 
TLR2- and NOD1-silenced cell lines, though the impact of TLR2 silencing was more pronounced 
than that of NOD1 silencing. This suggests that most of the M. catarrhalis bacteria were 
found extracellularly rather than in the intracellular compartment. Moreover, even though the 
intracellular bacteria appeared to be present in vacuole-like structures, recognition by NOD1 still 
led to an IL-8 response. Apparently, either M. catarrhalis can escape from intracellular vacuoles 
or NOD1 is recruited to the vacuolar membrane (27). Altogether, inhibition of proinflammatory 
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responses and binding of complement factors enable M. catarrhalis to evade the innate immune 
system, possibly facilitating persistent colonization of the host (Fig. 3).
nuTrIenT aCquISITIon 
Efficient nutrient acquisition is one prerequisite if M. catarrhalis is to successfully colonize the host 
mucosal surfaces. Growth of M. catarrhalis requires several specific environmental conditions and 
the presence of specific nutrient components. For example, M. catarrhalis cannot grow under 
strictly anaerobic conditions (139), but enzymes involved in anaerobic metabolism are present, 
and they could confer the ability to grow under microaerophilic conditions (140). Typically, M. 
catarrhalis is not able to utilize exogenous carbohydrates, because it does not harbor the enzymes 
necessary for transport and processing of these compounds, i.e., it harbors an incomplete 
Embden-Meyerhof-Parnas pathway, it has an incomplete pentose cycle, and enzymes of the 
Entner-Dourdoroff pathway are completely absent (140). M. catarrhalis can utilize acetate, lactate, 
and fatty acids for growth and is auxotrophic for arginine and possibly proline (140, 141). Other 
pathogens that colonize the nasopharynx, such as N. meningitidis and H. influenzae, are also able 
to utilize only a limited number of carbohydrates, suggesting that the nasopharynx offers a limited 
carbohydrate availability or a limited variety of carbohydrates (140, 142). This means that other 
energy-yielding biochemical pathways are likely to be especially important to M. catarrhalis. For 
instance, M. catarrhalis harbors an intact glyoxylate pathway, which is consistent with the ability 
to utilize acetate for energy generation. In addition, all enzymes of the gluconeogenic pathway 
are present, indicating the importance of this pathway (140). Unfortunately, the relationship 
between virulence and in vivo nutrient acquisition is a less-studied aspect of M. catarrhalis 
pathogenesis, although a few mechanisms have been shown to be particularly important for 
nutrient acquisition. These include iron acquisition (143), the nitrate respiratory chain (140), and 
the M35 porin, which appears to be essential for growth under nutrient-poor conditions (73).
Iron acquisition
Iron is a key nutrient that is involved in many bacteriological processes but which is not freely 
available inside the host, where it is complexed with hemoglobin, heme, transferrin, or lactoferrin. 
Lactoferrin is the primary carrier of iron on mucosal surfaces, whereas transferrin is the most 
important iron carrier in serum, and the sequestration of iron is an important line of defense 
against pathogenic bacteria (143). The acquisition of iron by M. catarrhalis is mediated by several 
surface-exposed iron-binding proteins: two lactoferrin-binding proteins (LbpA and LbpB) (144), 
two transferrin-binding proteins (TbpA and TbpB) (145), CopB (67), the heme utilization protein 
(HumA) (71), and the M. catarrhalis hemoglobin utilization protein (MhuA) (72). 
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M. catarrhalis strain ATCC 25240 was found to be able to utilize both human transferrin and 
lactoferrin as iron sources. Growth under iron-limiting conditions resulted in specific changes in 
the OMP composition, with at least four proteins being found only under iron-limiting conditions, 
one of which appeared to be CopB (146). Further, using microarrays, Wang et al. studied changes 
in gene expression when M. catarrhalis was grown under iron-limiting conditions (140). This 
study reported the upregulation of lbpA, lbpB, tbpB, and copB transcript levels, underscoring 
the importance of the proteins encoded by these genes in iron acquisition (140). The importance 
of iron-acquisition systems for survival in the human host is further underscored by the fact that 
cold exposure, for instance likely to occur when humans breathe cold air, resulted in increased 
expression proteins involved in lactoferrin and transferrin acquisition (130).
Binding of M. catarrhalis to both lactoferrin and transferrin sources of iron is functionally 
mediated by a TonB-dependent integral membrane protein (LbpA or TbpA, respectively) and a 
peripheral protein attached to the outer membrane via a lipid tail (LbpB or TbpB, respectively), 
where the LbpA or TbpA forms a channel for transport across the membrane (147). For the 
transferrin-binding duo, the tbpA gene is highly conserved between strains, whereas tbpB displays 
high-level heterogeneity (148). To study the role of Tbp in iron acquisition from transferrin, tbpA 
and tbpB mutants and the tbpAB double isogenic mutant for M. catarrhalis 7169 have been 
constructed. The tbpA and tbpAB mutants had severely reduced abilities to grow on transferrin 
as the sole iron source, whereas the tbpB mutant showed only a slight reduction in growth. This 
suggested that TbpA is essential for iron acquisition from transferrin and that TbpB fulfills only 
a facilitative role (69). This phenomenon was also confirmed for the lactoferrin-binding system 
in M. catarrhalis strain N141, in which LbpA was found to be critical for iron acquisition from 
lactoferrin, with LbpB facilitating this process (70).
The CopB protein appears to be linked to iron acquisition via both transferrin and lactoferrin, 
being one of the proteins upregulated in response to iron limitation (67, 146). An O35E copB 
mutant was severely impaired in its ability to utilize iron from transferrin or lactoferrin (67).
As well as using transferrin and lactoferrin, M. catarrhalis can also use heme as a sole source 
of iron through the action of HumA (71), although the amount of free heme on mucosal surfaces 
is rather low in humans (149). HumA, a 91.2-kDa OMP, originally described for M. catarrhalis 
isolate 7169, was found to bind directly to heme, and growth of a humA-deficient mutant was 
found to be impaired when heme was used as the sole iron source. Further, expression of the 
HumA protein was increased when the bacterium was grown in the presence of heme (71).
Another in vivo available iron source is hemoglobin; however, in most cases, it is not 
readily available to M. catarrhalis due to the fact that hemoglobin is compartmentalized within 
erythrocytes. However, it is possible that hemoglobin could become available to M. catarrhalis 
during episodes of acute OM. Furano et al. demonstrated that M. catarrhalis was able to use 
hemoglobin as a source of iron during in vitro growth (72). This led to the identification of a highly 
conserved 107-kDa OMP, MhuA, which was detected in a collection of geographically diverse 
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clinical isolates. The MhuA protein of M. catarrhalis 7169 directly binds to human hemoglobin, 
and an mhuA isogenic mutant showed reduced growth on hemoglobin as a sole iron source, 
though not when grown on heme or Fe(NO3)3 (72). Further, surface-exposed TFP also appear 
to be important for growth under iron-limiting conditions. Luke et al. reported an increased 
expression of surface-exposed pilin under iron-limiting conditions (75). Moreover, the pilA gene 
has been found to be regulated by an iron-responsive transcriptional repressor, Fur (75).
nitrate respiratory chain
As a first step to identify essential metabolic pathways that are important for in vivo survival and 
pathogenesis, Wang et al. studied gene expression profiles of M. catarrhalis ATCC 43617 grown 
in biofilms in vitro (140). Only a few categories of genes showed increased expression in biofilms, 
including genes predicted to encode proteins involved in energy generation and enzymes of 
the nitrate respiratory chain, namely, a nitrate reductase, a nitrite reductase, and a nitric oxide 
reductase. Although M. catarrhalis cannot grow under anaerobic conditions (139), the predicted 
ability to reduce nitrate to nitrous oxide (150) could provide an alternative mechanism to generate 
energy under lower oxygen tension (140, 142). The authors of that study also proposed that the 
predicted potential of nitric oxide reduction could yield some protective capacity to nitric oxide 
production by macrophages (140). This is supported by the fact that M. catarrhalis grown in the 
presence of nitric oxide-producing compounds spontaneously yielded colonies which were more 
resistant to nitric oxide (151). The production of nitric oxide by M. catarrhalis is also proposed to 
contribute to pathogenesis as in the presence of pathophysiological levels of nitrate, generation 
of nitric oxide through reduction of nitrite resulted in disruption of epithelial cell monolayers in 
vitro and modulation of tumor necrosis factor alpha secretion (152). 
M35 porin
The M35 porin is surface exposed and constitutively expressed in several M. catarrhalis isolates 
(74). The M35 porin was found to be important for growth under nutrient-limiting conditions, 
as m35-deficient mutants show impaired growth when cultured under nutrient-poor conditions 
but not under nutrient-rich conditions (73). Deletion of m35, however, did not affect general 
virulence characteristic such as serum resistance, cellular adhesion, and iron-acquisition from 
human lactoferrin (153). The impaired growth under nutrient-poor conditions could be reversed 
by the addition of glutamic acid, whereas the addition of carbohydrates had no effect. This is 
consistent with the fact that M. catarrhalis does not possess the capacity to utilize exogenous 
carbohydrates, with the enhanced uptake of glutamic acid possibly serving as an alternative 
energy source. The m35 deletion mutant also showed an upregulation of an unknown protein 
of approximately 40 kDa, which the authors of that study predicted to be responsible for the 
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enhanced uptake of glutamic acid. However, this hypothesis still needs to be confirmed (73). 
Deletion of m35 led to increased minimal-inhibitory concentrations for aminopencillins (153), 
probably as a result of M35 down-regulation, as was demonstrated after exposure of M. 
catarrhalis to amoxicillin (154). Lower expression of m35 after cold (26°C) and heat (42°C) shock, 
iron-starvation and hyperosmolar stress, suggest that regulation of m35 expression is part of 
a general stress response (154). Finally, in a mouse nasopharyngeal colonization model it was 
shown that M35 was essential for in vivo survival (73). Taken together, these results suggest that 
M35 is a general porin important for the uptake of essential nutrients, especially under nutrient-
poor conditions.
HeTeroGeneITy oF THe M. catarrhalis SPeCIeS
Population genetic studies of M. catarrhalis clinical isolates rely on both molecular and 
nonmolecular phylogenetic techniques (155-160). Early molecular epidemiological studies 
indicated that M. catarrhalis isolates are genetically diverse and revealed that there are actually 
two distinct phylogenetic lineages (155, 157, 158, 160, 161). Recently, the existence of these 
two lineages was further confirmed by Wirth et al. via multilocus sequence typing (MLST) (160). 
The first of these two phylogenetic lineages, known as the serosensitive lineage, is characterized 
by moderate virulence, and is enriched for strains that are sensitive to complement-mediated 
killing (155, 158). The other, more virulent lineage, the so-called seroresistant lineage, contains 
predominantly complement-resistant strains (155, 158) and is enriched for strains with the ability 
to adhere to epithelial cells (155). The seroresistant lineage predominantly harbors isolates of 16S 
rRNA type 1, whereas 16S rRNA type 2/3 isolates group within the serosensitive lineage (110, 
155). The uspA1 gene was found to be associated with adherent isolates (155) and could be 
detected in 87 to 99% of the isolates belonging to the seroresistant lineage, whereas only 23 
to 36% of isolates belonging to the serosensitive lineage harbored the uspA1 gene (155, 160). 
Further, it was demonstrated that all 16S rRNA type 1 isolates express UspA1, whereas this was 
not an inherited property of the 16S rRNA types 2/3 (110, 162). No difference between the uspA2 
genes of the seroresistant and serosensitive lineages was observed (155), which is contradictory 
to the fact that uspA2 is associated with serum resistance. However, it is conceivable that uspA2 
expression in the serosensitive isolates is below the threshold required to become functionally 
relevant or may even be completely abolished. In addition, Attia et al. have demonstrated that 
serum resistance is linked to UspA2, but it is not an inherited property of all UspA2 variants (123). 
The gene coding for the multifunctional Hag protein was found to be absent in almost all isolates 
belonging to 16S rRNA types 2/3 (17 out of 18), whereas hag was detected in almost all (175 
out of 176) 16S rRNA type 1 isolates (110). The CopB and OmpCD proteins are associated with 
seroresistance, and the genes encoding them were found to be present in all isolates (110, 155). 
Interestingly, copB restriction fragment length polymorphism (RFLP) types I/III and II were almost 
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exclusively associated with 16S rRNA type 1, whereas RFLP types 0 and IV were mostly associated 
with 16S rRNA types 2/3 (150). Similarly, ompCD RFLP type 1 isolates were grouped in 16S rRNA 
type 1, and all RFLP type 2 isolates were classified as being 16S rRNA types 2/3 (110). Further, LOS 
type B was found exclusively in isolates of 16S rRNA type 1 (110). Taken together, these results 
underscore the fact that putative M. catarrhalis virulence genes are more prevalent in isolates that 
are phenotypically more virulent, namely, those isolates belonging to the seroresistant 16S rRNA 
type 1 lineage.
The seroresistant lineage is characterized by a higher homologous recombination rate and 
higher mutation rate of housekeeping genes than those of the serosensitive lineage (160). 
Higher homologous recombination rates and horizontal gene transfer can facilitate the rapid 
spread and acquisition of novel virulence-associated genes in M. catarrhalis, as has been shown 
for the bro β-lactamase gene, whose sequence and genetic context suggested that it was 
acquired by interspecies gene transfer, possibly from a Gram-positive bacterium (163, 164). 
Indeed, M. catarrhalis has been shown to easily acquire DNA via its natural competence for DNA 
transformation, which appears to be dependent on TFP expression (75, 165). However, mobile 
genetic elements do not appear to play a major role in the evolution of the pathogenicity of M. 
catarrhalis compared to that for other pathogens, such as the Bordetellae (166, 167).
The serosensitive lineage is estimated to have differentiated from its ancestral lineage 
about 50 million years ago, preceding the age of Homo sapiens (160). In contrast, based on 
the branch depths of seroresistant and serosensitive lineages, it has been suggested that the 
seroresistant lineage diverged from a common forerunner more recently, about 5 million years 
ago. Interestingly, this divergence coincides with hominid expansion during the Pliocene and 
Pleistocene (19, 153). Wirth et al. suggested that the expansion of the seroresistant lineage could 
have been the result of a “second host shift” accompanied by acquisition of virulence factors 
and/or selection of a successful clone (160). Interestingly, the closest relatives of M. catarrhalis, 
Moraxella bovis and Moraxella ovis, are infectious for cows and sheep, respectively (168). The 
long branch distances between the seroresistant and serosensitive lineages suggest that they 
have been genetically separated for a relatively long period of time, possibly due to geography 
or by targeting different hosts (160). It appears likely that the serosensitive lineage originally 
evolved in a separate mammalian species, despite the fact that modern M. catarrhalis isolates 
are specific to humans. Furthermore, it is tempting to speculate that the natural competence 
of and increased recombination frequency in the seroresistant lineage could have resulted in 
adaptation to the human host many years ago. Further, both lineages are present in the human 
host in the same niche, resulting in a secondary genetic contact. Wirth et al. suggested that this 
may have allowed “gene flow” between the lineages, with, for instance, the genetic diversity of 
housekeeping genes being imported into the serosensitive lineage and uspA1 spreading in the 
opposite direction from the seroresistant lineage to the serosensitive lineage.
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In the late 1990s, Enright and McKenzie suggested that the M. catarrhalis species has a 
population structure similar to that of N. meningitidis, which possesses a nonclonal (panmictic) 
population due to its high rate of genomic recombination, with an occasional emergence of 
successful clones (169). Subsequent MLST of N. meningitidis yielded 47 sequence types (STs) from 
92 strains (170), and for M. catarrhalis, 173 MLST STs were observed among 268 isolates (160). 
In contrast, MLST of H. influenzae serotype b, considered to be monomorphic (clonal), yielded 
29 STs from 241 strains (171). These results indicate that the M. catarrhalis species comprises a 
panmictic population of isolates, although serosensitive lineage isolates appear to be more clonal 
than the seroresistant lineage (160).
The two phylogenetic lineages of M. catarrhalis also differ with respect to their disease 
associations: of the strains belonging to the seroresistant lineage, 52% were isolated from diseased 
individuals, whereas this was the case for only 14% of the strains belonging to the serosensitive 
lineage (160). This phenomenon may potentially be caused by the enhanced seroresistance and 
adhesion properties of the seroresistant lineage (155). Verhaegh et al. performed both phenotypic 
and genotypic analyses on a large cohort of global clinical M. catarrhalis isolates cultured from 
children and adults with respiratory disease (110). Interestingly, the isolates cultured from the 
adult population showed a reduced incidence of uspA2 and a drift from LOS serotype A to 
serotype B, possibly due to an increased incidence of anti-UspA2 and anti-LOS serotype antibodies 
in the adult population, although this hypothesis remains to be confirmed. Additionally, the 
immunodominant Hag proteins appeared to be downregulated in isolates derived from the adult 
population (110), also possibly indicating an immune escape mechanism. Clearly, M. catarrhalis 
is a heterogeneous and genetically flexible bacterium that possesses the potential to alter its 
phenotypic characteristics in order to evade the human immune response.
ConCludInG reMarKS
Our understanding of the factors facilitating M. catarrhalis pathogenesis is far from complete. 
However, it has already been shown that a complex, multifactorial interaction, involving a wide 
range of bacterium- and host-specific macromolecules, takes place between M. catarrhalis and 
its human host. Currently known factors associated with virulence include OMPs, LOS, and 
metabolic pathways, which are involved in adhesion, invasion, biofilm formation, modulation of 
the host immune system, and acquisition of nutrients (Table 1).
M. catarrhalis is an exclusively human pathogen, which means that the applicability of 
animal models to elucidate its pathogenesis is rather limited. At the present, most experiments 
are conducted using the mouse pulmonary clearance model and the chinchilla middle ear 
colonization model (38, 68, 79-81, 172, 173), in the latter model co-infection with respiratory 
syncytial virus (RSV) co-infection may facilitate induction of experimental OM (174). Although 
interpretation of the data obtained from such animal experiments is difficult, application of these 
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models can still yield valuable information regarding the in vivo molecular pathogenesis of M. 
catarrhalis. However, a suitable animal model or an in vitro experimental system that accurately 
and reproducibly mimics M. catarrhalis-human interactions has yet to be developed.
Several research groups are focusing their attention on the identification of novel vaccine 
candidates for M. catarrhalis. However, the phase-variable expression of important virulence 
factors, such as UspA1 (49), UspA2 (55), UspA2H (175), and MID/Hag (62), as well as the presence 
of immune evasion mechanisms, e.g., differences in OMP gene incidence, drift of LOS serotypes 
(110), and high genotypic heterogeneity, may have major implications for the development of 
a successful vaccine against M. catarrhalis. On the other hand, several virulence factors, such as 
the UspA family and MID/Hag, contain conserved and immunodominant regions, indicating that 
antigenic variation may play a more limited role in the immune response to vaccines based on 
these proteins (162, 176). Nonetheless, current research indicates that a multivalent vaccine will 
be required to protect against M. catarrhalis colonization and pathogenesis.
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abSTraCT
Moraxella catarrhalis is an emerging human-restricted respiratory tract pathogen that is a 
common cause of childhood otitis media and exacerbations of chronic obstructive pulmonary 
disease in adults. Here, we report the first completely assembled and annotated genome sequence 
of an isolate of M. catarrhalis, strain BBH18, originally isolated from sputum of a patient with 
COPD during an exacerbation. The BBH18 genome consists of 1,863,286 nucleotides that form 
1,886 protein-encoding genes. Comparison of the BBH18 genome to the ATCC 43617 contigs 
demonstrated that the gene content of both strains is highly conserved. In silico phylogenetic 
analyses based on both 16S rRNA and multilocus sequence typing revealed that BBH18 belongs 
to the seroresistant lineage. We were able to identify almost the entire repertoire of known 
M. catarrhalis virulence factors and mapped the members of the biosynthetic pathways for 
lipooligosaccharide, peptidoglycan, and type IV pili. Reconstruction of the central metabolic 
pathways suggested that BBH18 relies on fatty acid and acetate metabolism, as the genes 
encoding the enzymes required for the glyoxylate pathway, the tricarboxylic acid cycle, the 
gluconeogenic pathway, the nonoxidative branch of the pentose phosphate pathway, the beta-
oxidation pathway of fatty acids, and acetate metabolism were present. Moreover, pathways 
important for survival under challenging in vivo conditions, such as iron-acquisition pathways, 
nitrogen metabolism, and oxidative stress responses, were identified. Finally, we showed by 
microarray expression profiling that ~88% of the predicted coding sequences are transcribed 
under in vitro conditions. Overall, these results provide a foundation for future research into the 
mechanisms of M. catarrhalis pathogenesis and vaccine development.
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InTroduCTIon
Moraxella catarrhalis is an emerging human-restricted unencapsulated Gram-negative mucosal 
pathogen. Long considered to be a commensal of the upper respiratory tract, this bacterium has 
now firmly been established to be an etiological cause of otitis media (OM) and exacerbations of 
chronic obstructive pulmonary disease (COPD). It is the third most common cause of childhood 
OM after Haemophilus influenzae and Streptococcus pneumoniae (1, 2), and it is responsible 
for up to 20% of the cases (2, 3). Further, M. catarrhalis is the second most common cause of 
exacerbations of COPD after H. influenzae; it is responsible for 10 to 15% of the exacerbations 
and annually causes 2 to 4 million episodes in the United States (4, 5). Antibiotics are widely used 
for the treatment of OM, but the high prevalence of this disease and the increasing incidence 
of antibiotic-resistant strains mean that multivalent vaccines, preferably vaccines with protective 
antigens for all three causative bacterial agents, must be developed (6). 
M. catarrhalis is able to colonize the mucosal surfaces of the middle ear in OM patients and 
the lower respiratory tract in COPD patients (5, 7). Successful colonization of the human host 
is a complex process which requires the expression of adhesins and the activation of metabolic 
pathways to overcome specific challenging environmental conditions, such as nutrient limitation 
(8, 9). M. catarrhalis also possesses several mechanisms for evasion of the host immune system 
(8, 9), such as the ability to withstand the action of the human complement system. Importantly, 
most clinical isolates obtained from OM or COPD patients are able to survive complement-
mediated killing by normal human serum (10). 
Various molecular typing methods, such as 16S rRNA sequencing (11) and multilocus sequence 
typing (MLST) (12), have shown that the species M. catarrhalis can be divided into two distinct 
phylogenetic lineages, referred to as the serosensitive and seroresistant lineages. The seroresistant, 
more virulent lineage contains predominantly strains that are resistant to complement-mediated 
killing and that are able to adhere to epithelial cells (11, 12).
Even though our understanding of the molecular pathogenesis of M. catarrhalis has increased 
over the past few years, a complete M. catarrhalis genome sequence would undoubtedly be a 
valuable resource for improving our understanding of the biology of this organism. At present, 
however, only the partial genome of M. catarrhalis strain ATCC 43617 is available (13, 14). Here, 
we report the first completely assembled and annotated genome sequence of M. catarrhalis 
strain BBH18, which was originally isolated from sputum of a patient with COPD during an 
exacerbation (15), and we compared the gene content of this sequence to that of the strain 
ATCC 43617 sequence. In silico phylogenetic typing revealed that the BBH18 strain belongs 
to the seroresistant lineage. We were able to identify most of the known virulence factors and 
reconstructed several important biochemical pathways, including central metabolic pathways and 
pathways for nitrate metabolism, biosynthesis of lipooligosaccharides (LOS), peptidoglycan, type 
IV pilus (TFP) biosynthesis, and iron acquisition. In addition, several components that combat 
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oxidative stress were identified. Finally, we confirmed by transcriptional profiling that most of the 
predicted coding sequences (CDSs) are expressed in vitro. 
reSulTS and dISCuSSIon
General genome features and comparative genomics. The BBH18 genome (Fig. 1) consists 
of 1,863,286 nucleotides (nt), and the overall G+C content of 41.7%. Both the length and 
the G+C content are comparable to the unassembled, partial ATCC 43617 genome (~1.9 Mb), 
which is represented by 41 contigs (13, 14). The BBH18 genome is predicted to include 1,964 
genes, 1,886 of which are protein-encoding genes (Table 1), similar to the 1,761 to 1,849 ORFs 
predicted for ATCC 43617 (13, 14). Of the 1,886 protein-encoding genes predicted for BBH18, 
63.6% could be assigned to a functional category based on similarity of their products to proteins 
in public databases, while the functions of 172 predicted proteins are unknown. The products 
of the remaining 515 ORFs are classified as either conserved hypothetical proteins (102 ORFs) or 
hypothetical proteins (413 ORFs) (Table 1). The majority (~62%) of the best BlastP hit proteins 
were found to be proteins of Psychrobacter species (data not shown). 
Comparative genome analysis of the BBH18 genome and the ATCC 43617 contigs revealed 
that for 416 BBH18 coding sequences (CDSs) there was an exact match in the ATCC 43617 
genome (Table 2). When a maximum of 20% mismatches was allowed, 1,252 full-length BBH18 
CDSs were identified in the ATCC 46317 contigs. A total, of 1,793 (~95%) of the predicted CDSs 
were found to be conserved in BBH18 and ATCC 43617 with a minimum of 80% of the CDS 
covered. As expected, BBH18 genes encoding highly variable virulence factors, such as members 
of the ubiquitous surface protein A (uspA) family (16), showed lower levels of homology with 
ATCC 43617 sequences. Further, 68 CDSs were found to be unique to BBH18, 41 of which are 
annotated as genes encoding (conserved) hypothetical proteins. Conversely, using the preliminary 
annotation of the partial ATCC 43617 genome (14), 14 CDSs were found to be unique for ATCC 
43617, 12 of which encode hypothetical proteins.
The BBH18 genome contains genes encoding 50 tRNAs for all twenty amino acids. There are 
four identical rRNA operons (16S, 23S, and 5S genes) in which the 16S and 23S rRNA genes are 
interspersed with genes encoding tRNAs for isoleucine and alanine (Table 1). Genes encoding the 
RNA polymerase core subunits (α, β, β’, ω), the σ70 sigma factor, and the alternative σ32 sigma 
factor were identified, as were genes encoding the transcription elongation factor GreA and the 
transcription termination-antitermination factors NusA, NusB, Rho, and NusG. Interestingly, the 
BBH18 genome is predicted to encode only 32 transcription factors, 4 two-component regulatory 
systems and to contain 2 orphan two-component system genes. This raises the possibility that 
M. catarrhalis has other, alternative mechanisms for adapting its gene expression to changing 
environmental conditions, such as phase-variable expression or noncoding RNA-based regulation. 
Phase-variable expression has been described previously for two M. catarrhalis virulence factors, 
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ubiquitous surface protein A1 (UspA1) (18) and M. catarrhalis immunoglobulin D binding protein 
(MID) (15), but a preliminary search for additional homopolymeric tracts known to be involved in 
phase variation did not result in the discovery of novel candidates in the BBH18 genome. Clearly, 
further studies to elucidate the main mechanism of transcription regulation in M. catarrhalis are 
required.
Moraxella
 catarrhalis BBH18
1800 kbp
1600 kbp
200 kbp
400 kbp
600 kbp
800 kbp
1000 kbp
1200 kbp
1400 kbp
1,863,286 nt
Fig. 1. diagram of the M. catarrhalis bbH18 genome. Diagram of the M. catarrhalis BBH18 genome. 
Gene coordinates are indicated. From the inside to the outside, the circles show the GC skew, the G+C 
content, the genes on the forward strand, and the genes on the reverse strand. The colors in the two 
outermost rings indicate the functional classes of the genes and correspond to the colors in Table 1. The 
diagram was generated using CGview (17) 
In silico phylogenetic analysis classified BBH18 as a 16S rRNA type 1 strain (Fig. S1A); such 
strains are predominantly members of the seroresistant lineage (11). MLST-analysis assigned 
BBH18 to sequence type 128 (Fig. S1B), like M. catarrhalis GRJ 11, which was isolated from a 
diseased individual in Salamanca (Spain) and also belongs to the seroresistant lineage (12). In line 
with this, experimental evidence also demonstrated that BBH18 has a seroresistant phenotype 
(data not shown).
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Table 1. General genome features and functional classification of the predicted bbH18 proteins
Color-code Feature Value
  Genome size (nt) 1,863,286
G+C content (%) 41.7
No. of genes 1964
No. of protein encoding ORFs 1886
Avg ORF size (bp) 850
Coding density (%) 86.1
  No. of rRNA genes 12
  No. of tRNA genes 50
Color-code Functional class No. of proteins % of total
  Amino acid biosynthesis 77 4.0
  Purines, pyrimidines, nucleosides, and nucleotides 36 1.9
  Fatty acid and phospholipid metabolism 40 2.1
  Biosynthesis of cofactors, prosthetic groups, and carriers 90 4.7
  Central intermediary metabolism 33 1.7
  Energy metabolism 140 7.4
  Transport and binding proteins 148 7.8
  DNA metabolism 78 4.1
  Transcription 35 1.8
  Protein synthesis 141 7.4
  Protein fate 89 4.7
  Regulatory functions 31 1.6
  Signal transduction 11 0.6
  Cell envelope 168 8.8
  Cellular processes 61 3.2
  Mobile and extrachromosomal element functions 21 1.1
  Unknown function 172 9.0
  Hypothetical proteins 515 27.1
  Disrupted reading frame 16 0.8
Table 2. Comparison of M. catarrhalis bbH18 and aTCC 43617 genomes
% BBH18 CDSs 
in alignment
% of mismatches
allowed in alignment
No. of CDSs % of total
100 0 416 22.1
100 <20 1,252 66.4
>80 <20 125 6.6
60-80 <20 10 0.5
40-60 <20 7 0.4
0-40 <20 8 0.4
No match   68 3.6
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expression profiling. Microarray expression profiling for three phases of in vitro growth in 
BHI medium (lag, exponential, and stationary) showed that 88.1% of the predicted CDSs were 
expressed during at least one growth phase and that 84.6% of the predicted CDSs were expressed 
in all three growth phases. Of the predicted CDSs for which no transcripts were detected, ~81% 
were annotated as (conserved) hypothetical. Further, we observed expression for 30 of the 41 
(conserved) hypotheticals CDSs that were not present in the ATCC 43617 strain. Expression of 
specific genes is discussed in detail below. 
Virulence factors. Various proteins have been described as proteins that play pivotal roles in M. 
catarrhalis pathogenesis (for recent reviews, see references (8, 9)), and all but one these proteins 
were found to be encoded by genes in the BBH18 genome (Table 3). The ubiquitous surface 
proteins (UspAs) are among the major virulence factors; UspA1 mediates binding to epithelial 
cells and extracellular matrix (ECM) components, and the mutually exclusive UspA2 and UspA2H 
proteins have a role predominantly in immune evasion (19, 20). Determination of the modular 
structure of the predicted UspA1 and UspA2H proteins (the strain did not possess a uspA2 gene) 
revealed the presence of the VEEG-NINNY-VEEG amino acid sequence motif involved in binding 
to Chang conjunctival cells or fibronectin (16) in UspA1, whereas this motif was not present in 
UspA2H (Fig. 2). BBH18 contains several other adhesins, namely, M. catarrhalis immunoglobulin D 
(IgD) binding protein (also referred to as hemagglutinin [HAG]) (21), the M. catarrhalis adherence 
protein (McaP) (22) and the outer membrane protein (OMP) CD (23). Resistance to the action of 
the human complement system is an important aspect of M. catarrhalis virulence. Previous studies 
have shown that, in addition to UspA proteins mentioned above, the M. catarrhalis proteins 
CopB (24), OMP CD (23), and OMP E (25) play a role in serum resistance, and the corresponding 
genes are all present in BBH18. All of the virulence factors describe above were found to be 
expressed at intermediate or high levels during all three phases of in vitro growth examined. 
Interestingly, the only known virulence locus not present in BBH18 is the mha locus encoding 
filamentous hemagglutinin-like proteins involved in adhesion (26, 27). We did identify three ORFs 
(MCR_0770, MCR_0777, and MCR_0778) with a small region of homology (37-71 amino acids) 
to mhaB1, but transcriptional profiling indicated that there was either no expression (MCR_0778) 
or low levels of expression (MCR_0770 and MCR_0777) of these loci.
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Fig. 2. Modular arrangement and functional domains of uspa1 (a) and uspa2H (b) of bbH18. Both 
proteins are drawn to scale. The various sequence cassettes and the known functional domains are indicated. 
The VEEG repeats of UspA2H are indicated by asterisks because they only partially match the repeat motif. 
Abbreviations: CTER1, C-terminal region 1; CTER2, C-terminal region 2.
biosynthesis of cell wall structures. A prominent surface component of M. catarrhalis that 
is generally considered to be an important virulence factor is lipooligosaccharide (LOS). Genes 
encoding LOS glycosyl transferases (Lgt), which are enzymes that catalyze the formation of core 
or branched oligosaccharide chains (28), as well as genes required for biogenesis of the deoxy-
D-manno-2-octulosonic acid (KDO)-lipid A moiety (for a review, see Raetz et al. (29)), were all 
identified in the BBH18 genome (Table S1) Expression was detected for all components of the 
pathways involved except lgt5, whose product catalyzes addition of the terminal α-(1→4)-linked 
terminal galactose of the core oligosaccharide chain (30) (Table S1). Analysis of the BBH18 lgt-
locus (lgt5, lgt1, lgt2b/c, and lgt3) revealed that BBH18 is a LOS type B strain (Fig. S1C) (31); LOS 
type B strains are exclusively 16S rRNA type 1 isolates (10).
The peptidoglycan layer is the main target for β-lactam antibiotics that can be degraded by 
the BRO β-lactamases produced by M. catarrhalis (BBH18 expresses the bro-2 gene; Table 3) 
(32). The complete set of genes required for biosynthesis of peptidoglycan (33) was identified in 
BBH18 and was found to be expressed in all growth phases (Table S2).
Type IV pili (TFP) have a wide variety of functions, including adhesion to epithelial cells, biofilm 
formation, and motility (34). Biogenesis of TFP is a complex process requiring a large set of 
proteins (35), and the genes encoding these proteins are present in the BBH18 genome (Table S3). 
Overall, low levels of expression were detected for most genes encoding components of the TFP 
pathway, except for pilA, which encodes the major pilin subunit, which on average was found to 
be highly expressed (Table S3).
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Protein secretion. Gram-negative bacteria transport proteins from the cytosol across the inner 
membrane (IM) to the periplasm via one of two protein secretion systems, either the Sec system 
or the Tat system (36, 37). BBH18 was found to contain a complete Sec-machinery, as well as the 
main components of the Tat-system (Table S4). After their deposition into the periplasmic space, 
proteins reach their final destination by other means. For instance, outer membrane lipoproteins 
are inserted into the outer membrane by the components of the Lol-system (38) (Table S4). 
Furthermore, several ORFs are predicted to encode components of resistance-nodulation-division 
(RND) efflux systems, such as components of the Acr and Mtr systems (39); components of both 
these systems share homology with type I secretion system components (Table S4). Strikingly, no 
components of the general secretory pathway, a type II secretion system, were found, although 
the evolutionary related TFP assembly machinery (40) is present, as mentioned above. Even 
though a homologue of the type III secretion effector (HopJ) was identified (MCR_0582), other 
components of type III secretion systems were not found, nor did we identify components of type 
IV, V, and VI secretion systems. An overview of protein secretion components and their detected 
expression levels is shown in Table S4.
Protein localization prediction. A complete genome sequence provides an opportunity to 
discover novel vaccine targets, and surface-exposed and secreted proteins are of special interest 
for vaccine development. Ruckdeschel et al. used a genome mining approach on the partial 
genome sequence of M. catarrhalis ATCC 43617, which led to the discovery and animal model 
testing of novel vaccine targets (13, 41). Extensive subcellular localization prediction revealed 
that 134 (7.1%) of the predicted BBH18 proteins localize to the outer membrane or are secreted 
into the extracellular environment. These surface-exposed proteins include vaccine candidates, 
such as the lipid-anchored outer membrane protein Msp22 (13) and OMP E (25). In addition, 
we identified 35 (1.9%) proteins that are predicted to localize to the cytoplasm, but are possibly 
secreted via nonclassical secretion pathways (i.e. not via the Sec or Tat pathway), including, 
for example, the autotransporter McaP (42). The subcellular compartment distribution of the 
predicted BBH18 proteome is summarized in Table 4.
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Table 4. Subcellular compartment distribution of the predicted bbH18 proteins
Subcellular localization a No. of proteins % of total
Cytoplasm, intracellular 1,284 68.1
Cytoplasm (possibly secreted via nonclassical pathways), intracellular or secreted 35 1.9
Inner membrane, multitransmembrane 257 13.6
Inner membrane, multitransmembrane (lipid-modified N terminus) 4 0.2
Inner membrane, C terminally anchored (with CS) 1 0.1
Inner membrane (periplasm), N terminally anchored (no CS) 124 6.6
Inner membrane (periplasm), N terminally anchored (with CS) 14 0.7
Inner membrane (periplasm), Lipid anchored 12 0.6
Periplasm, secreted (with CS) 22 1.2
Outer membrane, lipid anchored 53 2.9
Outer membrane, β-barrel protein (no CS) 19 1.0
Outer membrane, β-barrel protein (with CS) 23 1.2
Outer membrane (no clear SP found but have β-barrel), intracellular or β-barrel 20 1.1
Extracellular, secreted (with CS) 18 1.0
a Abbreviations: CS, cleavage site; SP, signal peptide.
Central metabolic pathways. As a respiratory tract pathogen, M. catarrhalis is at least 
partially dependent on nutrients available inside its human host to fulfill its needs for energy 
and intermediates for biosynthesis of essential macromolecules. M. catarrhalis is reported to be 
incapable of utilizing exogenous carbohydrates and consequently does not produce acid from 
carbohydrates (43). In line with this, no genes encoding carbohydrate transport or catabolism 
components were found in the BBH18 genome. Reconstruction of the central metabolism (Fig. 
3 and Table S5) showed that while BBH18 possesses an incomplete glycolytic pathway, all of the 
enzymes of the gluconeogenic pathway are present, indicating that carbohydrate intermediates 
can be synthesized. Gluconeogenesis uses phosphoenolpyruvate (PEP) as a starting substrate, 
which can be generated from tricarboxylic acid (TCA) cycle intermediates. The TCA cycle is 
supplied with acetyl-CoA via the degradation of fatty acids and acetate assimilation, and the 
genes required for these processes were identified in BBH18. The incomplete TCA cycle, which 
lacks both subunits of succinyl-CoA synthetase, can be bypassed by the glyoxylate pathway, 
which is complete in BBH18. The glyoxylate pathway has an anaplerotic function and supplies the 
TCA cycle with oxaloacetate (acetyl-CoA acceptor molecule). Furthermore, the enzymes required 
for oxidative stages of the pentose phosphate pathway are not present, but transaldolase and 
the enzymes of the nonoxidative branch are present. As mentioned above, BBH18 possesses all 
of the genes required for beta-oxidation of long-chain fatty acids (Table S5) (44). Long-chain fatty 
acids are transported across the cell membrane by the combined action of the outer membrane 
protein FadL and the inner membrane-associated FadD protein, an acyl-CoA synthase. We predict 
that the highly conserved OMP E protein (25) serves as the FadL homolog in BBH18. Two adjacent 
ORFs (67% identical) appear to encode homologs of FadD (aerobic) or its anaerobic counterpart, 
FadK (45). Interestingly, we did not detect obvious homologs of known fatty acid metabolism 
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regulators, such as FadR, although we did identify members of the family containing such 
proteins, such as GntR and DeoR family regulators (44). Unfortunately, no obvious function could 
be assigned to these ORFs. Further, we identified two ORFs with homology to the 3-oxoacid CoA-
transferase involved in the degradation of short-chain fatty acids (46). Finally, we identified all of 
the genes encoding for enzymes required for completion of fatty acid biosynthesis (44) (Table S5).
Expression profiling showed that all genes of the gluconeogenensis, TCA cycle, fatty acid 
degradation, acetate assimilation, and pentose phosphate pathway are expressed during in vitro 
growth (Table S5). However, expression of malate synthase, the second enzyme of the glyoxylate 
pathway, was not detectable in the lag and exponential phases of growth, and the levels during 
the stationary growth phase were low. This suggests that glyoxylate is further processed via 
other enzymes, e.g. glycerate dehydrogenase (MCR_1529) and phosphoglycolate phosphatase 
(MCR_0365), which are both expressed at intermediate levels in all growth phases.
nitrogen metabolism. It has been suggested that in M. catarrhalis a truncated denitrification 
pathway (reduction of nitrite to nitrous oxide) described by Wang et al., provides an alternative 
mechanism to generate energy under low oxygen tension and contributes to biofilm formation 
and in vivo virulence (47). In diagnostic microbiological laboratories, reduction of nitrate is one 
of the differential tests used to confirm the identity of M. catarrhalis (43). The genes encoding 
the nitrate reductase complex (narGHJI), nitrite reductase (aniA), the nitric oxide reductase (norB), 
and the narX/narL two-component system were identified in BBH18 (Table S6). In addition, a 
putative regulator of fumarate and nitrate reduction was identified; however, the true function 
of this FNR/CRP family member remains to be elucidated (47). In addition to the nitrate ABC 
transport system, encoded by nrtABCD, we identified two other candidates that could play a role 
in nitrate/nitrite transport, namely NarK1, and a putative nitrate/nitrite transporter designated 
NarK2 (Table S6). The levels of expression of the denitrification pathway components were not 
uniform; e.g. the nitrate reductase expression ranged from undetectable to low, whereas nitrite 
reductase was expressed at high levels during the lag and the exponential phases (Table S6).
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Fig. 3. Predicted central metabolism of M. catarrhalis bbH18. The glycolysis pathway is incomplete, and 
lacks the key enzymes phosphofructokinase and pyruvate kinase. The enzymes of glycolysis are expected 
to be involved in the gluconeogenic pathway, all enzymes of which were found to be present. Fatty acid 
degradation and acetate assimilation are probably of very important, as they supply the tricarboxylic acid 
(TCA) cycle with acetyl-CoA. The complete glyoxylate pathway is present and allows bypass of the TCA cycle, 
which lacks both subunits of succinyl-CoA synthetase.
Iron acquisition. Iron is a key nutrient that is functionally involved as a cofactor in various 
metabolic processes and is essential for both M. catarrhalis and its human host (48). The BBH18 
genome contains genes encoding components of many iron acquisition and transport systems 
(Table S7), including all of the following M. catarrhalis proteins previously described proteins 
involved in this process: lactoferrin binding protein A and B (49), transferrin binding protein A 
and B (50), heme utilization protein (51), M. catarrhalis hemoglobin utilization protein (52), CopB 
(53), and the main regulator of iron-responsive genes, Fur (54). In addition, iron may be acquired 
through the degradation of heme, which is catalyzed by a heme-oxygenase. An iron transport 
system for transport of Fe3+ from the periplasm to the cytosol, encoded by the fbpABC gene 
cluster, was identified by homology to the corresponding locus in H. influenzae (55). Further, the 
afeABCD gene cluster was identified in BBH18; a cluster that has been proposed to be involved in 
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the acquisition of chelated iron, as described previously for Actinobacillus actinomycetemcomitans 
and Yersinia pestis, and regulated by Fur in these species (56, 57). Interestingly, the levels of 
expression of the iron binding components of fbpABC and afeABCD ABC transporter systems 
were higher than the levels of expression of the other components of these systems. Two putative 
NRAMP homologs, which are involved in transport of Fe2+ and Mn2+, may compete with the 
host divalent ion transporters of the NRAMP family (58). In addition, BBH18 possesses two 
putative bacterioferritins, which are intracellular iron-storage proteins important for preventing 
the presence of free iron (59), both of which were found to be expressed at high levels during 
all phases of growth. Overall, all iron acquisition and transport systems of BBH18 were found to 
be expressed in vitro, but the importance of the individual pathways remains to be investigated.
oxidative stress. Inherent to aerobic metabolism is oxidative stress caused by reactive oxygen 
species (ROS) (60). As mentioned previously, acquisition of iron is essential for growth of M. 
catarrhalis, but it can also be harmful for the bacterium, as iron can react with hydrogen peroxide, 
resulting in the formation of hydroxyl radicals via the Fenton reaction (60). The well-studied 
superoxide dismutase/catalase system is able to counteract the effect of oxidative stress by 
catalyzing the conversion of superoxide to water and oxygen. BBH18 contains and expresses 
the sodA and catalase genes, but lacks the sodB gene (Table S8). Catalase production is used 
during routine identification processes, but has limited differential value because not all strains 
produce catalase (43). Further, BBH18 was found to encode and express several putative bacterial 
peroxiredoxins (Prx) that catalyze the reduction of peroxide, peroxynitrite, and diverse organic 
hydroperoxides (ROOH) (61), as well as alkyl hydroperoxide reductase-thioredoxin family members 
(62). Despite the presence of a large number of antioxidant genes in the BBH18 genome, we 
could not identify homologues of known oxidative stress regulators such as OxyR and SoxR (62).
CrISPr elements. Clustered regularly interspaced short palindromic repeats (CRISPRs) are 
widespread in genomes of prokaryotic organisms and are thought to be transcribed and 
processed into small RNAs that confer resistance to phages (63). CRISPR direct repeats are 
separated by nonrepetitive spacer elements and are often located near gene clusters encoding 
CRISPR-associated (Cas) protein family members. Two CRISPR repeat regions, I and II, and one 
putative repeat region (CRISPR region III) were identified in the BBH18 genome. CRISPR repeat 
region II, localized at nt 30997-28086, is in vicinity of six genes encoding proteins with significant 
homology to known Cas proteins, showing high similarity to the Yersinia pestis subtype (63). 
BBH18 CRISPR repeat regions I and II are characterized by an average repeat length of 28.1 nt (Y. 
pestis 28.0 nt) and a spacer length of 32.0 nt (Y. pestis 32.1 nt). Microarray analysis showed that 
there was constitutive expression of both the CRISPR region I and the CRISPR II region only from 
the minus strand (Fig. 4). In addition, intermediate levels of expression of the six cas genes were 
detected during all three growth phases (data not shown). The exact role for the CRISPR system 
in M. catarrhalis remains to be determined.
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Fig. 4. expression profiles of chromosomal CrISPr regions I (CrISPr1) and II (CrISPr2). The exponential 
growth phase log2 probe signal intensities of both strands (open circles, reverse strand probes; filled circles, 
forward strand probes) demonstrate that there is reverse strand expression of both CRISPR1 and CRISPR2. 
The localization of the CRISPR1 and CRISPR2 regions is indicated below the graph. Comparable results were 
obtained during the lag and stationary growth phases (data not shown).
Concluding remarks. In this study, we describe the completely assembled and annotated 
genome of the clinically important bacterial pathogen M. catarrhalis strain BBH18. Comparative 
genomics revealed a high degrees of similarity and sequence conservation for the BBH18 and 
ATCC 43617 genomes. Like BBH18, the ATCC 43617 strain is classified as a 16S rRNA type 1 
strain (11), and MLST-analysis showed that it also belongs to the seroresistant lineage (12). The 
completely assembled and annotated genome of a clinical isolate of M. catarrhalis described 
here should facilitate identification of novel (surface-exposed) vaccine targets, should provide the 
basis for omics-based research, such as transcriptomics and proteomics, and is indispensable for 
a complete understanding of the biology of M. catarrhalis.
MaTerIalS and MeTHodS
bacterial strain and growth conditions. M. catarrhalis strain BBH18 was isolated from sputum 
of a patient with COPD during an exacerbation (15). BBH18 was grown on Bacto-brain heart 
Infusion (Bacto-BHI) agar plates (Difco) in an atmosphere containing 5% CO2 at 37°C or in broth 
at 37°C with agitation (200 rpm).
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Sequencing of the M. catarrhalis bbH18 genome. Whole-genome sequencing was performed 
using a hybrid strategy consisting of Roche 454 and Illumina Solexa sequencing by Agowa 
Genomics (Berlin, Germany). For Roche 454 sequencing, genomic DNA was extracted using the 
Wizard Genomic Purification kit (Promega), after which a fragment library was prepared and 
sequenced using Roche standard procedures. This resulted in a total of 591,043 sequences with 
an average read length of 224 bp covering approximately 134 Mb, which is more than 70-fold 
coverage of the total genome. De novo assembly using the Roche 454 software Newbler resulted 
in 44 contigs of over 500 bp, which were aligned with the 41 contigs of the ATCC 43617 
strain (deposited at NCBI under patent WO0078968, GenBank accession numbers AX067426 to 
AX067466) using the gap4 assembler program (Staden Package, Roger Staden, Cambridge). Gap 
closure by PCR and Sanger sequencing resulted in a contiguous sequence of 1,863,286 bp, which 
was verified using Solexa sequencing as follows. Genomic DNA was isolated with the genomic 
DNA kit (Qiagen), a fragment library (150-200 bp) was prepared according to Illumina’s standard 
genomic DNA library preparation procedure, and the library was sequenced with an Illumina 
Genome Analyzer II. The data was analyzed using the standard Genome analyzer pipeline, which 
yielded a total of 7,057,256 raw 36-bp reads. The 454-assembled genome was corrected by 
Solexa short read sequence data using ROAST, an in-house developed tool (S.A.F.T van Hijum, 
V.C.L. de Jager, B. Renckens, and R.J. Siezen, unpublished data). Briefly, Solexa reads were aligned 
with the assembled genome sequence using BLAT (64). Alignment of reads with the reference 
sequence was allowed provided that nucleotide substitutions (single nucleotide polymorphisms 
[SNPs]) or gaps (small insertions or deletions [indels]) were at least 4 bp from the end of read. Only 
SNPs and indels were allowed with a sequence depth of at least six reads unanimously calling a 
genotype, and with a maximum of one read indicating a different genotype. Altogether, three 
SNPs, one insertion, and one deletion were corrected in the reference genome sequence.
annotation. Open reading frames (ORFs) and initial automated annotation were obtained 
using both Pedant-Pro and the Institute for Genomics Sciences (IGS) annotation engine (http://
ae.igs.umaryland.edu/cgi/ae_pipeline_outline.cgi), and the minimal ORF length was 90 nt. The 
IGS-derived annotation was subjected to manual curation using the Pedant-Pro data, DBGET 
database (http://www.genome.jp/dbget/), and data described previously. The putative origin of 
replication was identified using Ori-Finder (65), and bp 1 was assigned to the extreme of the CG 
disparity curve. Functional classification of the predicted ORFs was based on the IGS functional 
classification, which was manually improved with data from Clusters of Orthologous Groups 
(COGs) of proteins and Non-supervised Orthologous Groups (NOGs), both obtained by searches 
using Signature (66).
A comparative genomics of the BBH18 and ATCC 43617 strains was performed by alignment 
of the BBH18 CDSs to the ATCC 43617 contigs using BLAT (64). CDSs potentially unique to ATCC 
43617 were identified by alignment of the ATCC 43617 contigs with the BBH18 sequence. 
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Pathway analysis was performed using the KEGG Pathway database (67) with KEGG Orthology 
(KO)-identifiers and was complemented by pathway reconstructions based on previously 
described data. KO-identifiers were assigned with the web-based KEGG Automatic Annotation 
Server (KAAS, http://www.genome.jp/kegg/kaas/) using the bidirectional best-hit method for a 
set of prokaryotic reference genomes (organism codes: prw, par, pcr, abm, aby, aci, ngo, nmc, 
hso, nma, acb, apl, cvi, hin, hit, hip, and pmu), manually selected based on high abundance 
in Pedant-Pro BlastP-hits. The acquired list was complemented with KO-identifiers assigned by 
searching against the prokaryotic reference set. Finally, the BBH18 genome was analyzed for the 
presence of CRISPR repeat regions using CRISPRFinder (68).
The subcellular localization of the BBH18 proteins was predicted through an extended version 
of the LocateP software (69) and was validated with a highly curated list of Escherichia coli 
proteins. The protein localization prediction was tailored for the Gram-negative organism M. 
catarrhalis by replacement of specific Gram-positive components with tools suitable for Gram-
negative bacteria (M. Zhou, K. Mezger, S.A.F.T. van Hijum, and R.J. Siezen, unpublished data), 
such as BOMP (70), CELLO (71), LipoP (72), and SecretomeP (73).
Detailed annotation, including localization prediction and comparative genomics data, is 
shown in File S1.
in silico phylogenetic typing. The 16S rRNA type was determined as described by Bootsma et 
al. (11). Multilocus sequence typing (MLST) of sequence fragments of eight housekeeping genes 
was performed as described by Wirth et al. (12). Allelic sequences were analyzed (http://mlst.ucc.
ie/mlst/dbs/Mcatarrhalis) and compared to the reference database containing 282 M. catarrhalis 
strains. Lipooligosaccharide (LOS) serotype was determined by using the method described by 
Edwards et al. (31), and copB-typing was performed as described by Verhaegh et al. (10).
Microarray expression profiling. Bacteria were grown in BHI medium at 37°C with agitation 
(200 rpm), harvested by centrifugation at lag phase (OD620 of 0.2-0.3), exponential phase (OD620 
of 1.2-1.4), and stationary phase (OD620 of 2.0-2.2), and treated with 2 volumes of RNAprotect 
bacteria reagent (Qiagen). Total RNA was extracted using the RNeasy Mini kit (Qiagen), after 
which contaminating genomic DNA was removed by treatment with DNase (DNAfree; Ambion). 
Total RNA was labeled essentially as described by Ouellet et al. (74). Briefly, 10 µg of RNA was 
incubated for three hours with 7 µg of 5’Cy3-labeled random nonamers (TriLink Biotechnologies) 
and Superscript III reverse transcriptase (800 U; Invitrogen) under appropriate reaction conditions 
(1x First-Strand buffer, 5 mM DTT, 0.33 mM dNTPs, 21 mM actinomycin D (Sigma Aldrich), and 
40 U RNaseOut). After first strand synthesis, RNA was degraded by incubating with sodium 
hydroxide, which was followed by neutralization of the reaction with hydrochloric acid. Labeled 
cDNA was purified and concentrated with CyScribe columns (GE Healthcare Life Sciences), 
followed by Micron-30 columns (Millipore). Two micrograms of labeled cDNA was applied in 
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duplicate to 4x72K custom design NimbleGen arrays. Overnight hybridization at 42°C and 
subsequent washing of arrays were performed according to the manufacturer’s instructions. The 
Nimblegen array contained 1 to 118 probes per predicted CDS with an average coverage of 
15 probes per CDS, probes on both strands in the CRISPR1 and CRISPR2 regions (no specific 
probes could be designed for the putative CRISPR3 region), and 1,103 negative control probes 
with a length distribution and C+G content similar to those of the experimental probes. Array 
images were acquired with a NimbleGen MS200 scanner, and images were processed with 
NimbleScan software using the RMA algorithm. Normalized and background-corrected probe 
signal intensities obtained in this way were used to calculate the median expression level of the 
CDSs. An expression threshold was defined by the median of the log2 signal intensity of the 
random control probes plus four times the standard deviation. Expression levels for CDSs were 
classified as follows: low (+, log2 <10), moderate (++, log2 = 10-12.5), high (+++, log2 >12.5), or 
no expression (4/6 replicates [biological triplicate and technical duplicate] less than the threshold 
value). Expression data for the BBH18 predicted CDSs are shown in File S1. 
nucleotide sequence accession number and microarray data. The genomic sequence of 
M. catarrhalis BBH18 has been deposited in the GenBank database under accession number 
CP002005. Microarray data have been deposited in the NCBI Gene Expression Omnibus (GEO) 
database (www.ncbi.nlm.nih.gov/geo/) under GEO Series accession number GSE21632.
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SuPPleMenTary InForMaTIon 
Supplemental file S1. Detailed annotation of the M. catarrhalis BBH18 genome, please refer to: 
http://jb.asm.org/content/192/14/3574/suppl/DC1
Table S1. Genes and encoded protein involved in lipooligosaccharide (loS) biosynthesis
BBH18 locus Gene Description Note
Expression per 
growth phase in BHI
Lag Exp Stat
MCR_0431 lpxC UDP-3-O-acyl N-acetylglucosamine 
deacetylase LpxC
  ++ ++ ++
MCR_0547 lpxD UDP-3-O-[3-hydroxymyristoyl] 
glucosamine N-acyltransferase LpxD
++ ++ ++
MCR_0549 lpxA UDP-N-acetylglucosamine 
acyltransferase LpxA
++ ++ ++
MCR_0658 lpxH UDP-2,3-diacylglucosamine hydrolase 
LpxH
+ + +
MCR_0818 lpxK tetraacyldisaccharide 4’-kinase LpxK + + +
MCR_0819 kdsB 3-deoxy-D-manno-octulosonate 
cytidylyltransferase KdsB
+ + +
MCR_0855 lpxL dodecanoyltransferase LpxL ++ ++ ++
MCR_1017 lgt6 glucosyltransferase Lgt6 As in M. catarrhalis O35E 
and 7196, lgt6 resides 
next to lpxX (75, 76)
++ ++ ++
MCR_1093 lgt3 glucosyltransferase Lgt3 Part of lgt-locus + + ++
MCR_1094 lgt2b/c galactosyltransferase Lgt2B/C Part of lgt-locus ++ ++ ++
MCR_1095 lgt1 glucosyltransferase Lgt1 Part of lgt-locus +++ +++ +++
MCR_1096 lgt5 galactosyltransferase Lgt5 Part of lgt-locus - - -
MCR_1098 msbA lipid A export permease/ATP-binding 
protein MsbA
+ + +
MCR_1164 lpxB lipid A disaccharide synthase LpxB + + +
MCR_1188 lpxX decanoyltransferase LpxX ++ + ++
MCR_1318 kdsA 3-deoxy-8-phosphooctulonate 
synthase KdsA
++ ++ ++
MCR_1375 kdtA 3-deoxy-D-manno-octulosonic-acid 
transferase KdtA
+ + +
MCR_1799 galE UDP-glucose 4-epimerase GalE   + + +
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Table S3. Genes and encoded proteins involved in type IV pilus (TFP) biogenesis
BBH18 locus Gene Description Note
Expression per 
growth phase in BHI
Lag Exp Stat
MCR_0107 pilD type IV prepillin peptidase PilD Part of pilBCD gene cluster + + -
MCR_0108 pilC type IV pilus assembly protein PilC Part of pilBCD gene cluster + + +
MCR_0109 pilB type IV pilus assembly ATPase PilB Part of pilBCD gene cluster + + +
MCR_0335 pilT type IV pilus retraction ATPase 
PilT, powering pilus retraction
Flanked by fur iron-responsive 
transcriptional repressor, which 
is involved in regulation of pilA 
expression (77)
- + -
MCR_0392 pilA type IV pilin PilA, major pilin 
subunit
+++ ++ +++
MCR_1382 pilW type IV pilus assembly protein 
PilW
Part of pilVW gene cluster + + +
MCR_1383 pilV type IV pilus biogenesis protein 
PilV 
Part of pilVW gene cluster + ++ +
MCR_1439 pilQ type IV pilus secretin PilQ Part of pilMNOPQ gene cluster + + +
MCR_1440 pilP type IV pilus biogenesis secretin 
PilP
Part of pilMNOPQ gene cluster + + +
MCR_1441 pilO type IV pilus biogenesis protein 
PilO
Part of pilMNOPQ gene cluster + + +
MCR_1442 pilMN type IV pilus biogenesis protein 
PilMN
Part of pilMNOPQ gene cluster, 
apparent gene fusion between 
pilM and pilN, a phenomenon 
also observed in the partial 
genome sequence of ATCC 
43617 (14)
+ + ++
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
M. catarrhalis BBH18 genome  |  81
2.1
Table S4. Genes and encoded proteins involved in protein secretion pathways
BBH18 locus Gene Description Note
Expression per growth 
phase in BHI
Lag Exp Stat
MCR_0100 mtrC membrane fusion protein MtrC ++ ++ ++
MCR_0101 secretion protein HlyD fragment + + +
MCR_0125 tatC twin-arginine translocation protein subunit TatC Tat-pathway ++ + +
MCR_0126 tatB twin-arginine translocation protein subunit TatB Tat-pathway ++ ++ ++
MCR_0127 tatA twin-arginine translocation protein subunit TatA Tat-pathway ++ +++ +++
MCR_0186 lolB outer membrane lipoprotein LolB + ++ ++
MCR_0192 yidC protein translocase insertase subunit YidC Sec-pathway + ++ ++
MCR_0213 secA protein translocase subunit SecA, peripheral motor 
protein
Sec-pathway ++ ++ ++
MCR_0251 secE protein translocase subunit SecE, subunit of 
protein-conduction channel
Sec-pathway ++ ++ ++
MCR_0474 acrA RND system membrane fusion protein AcrA ++ ++ ++
MCR_0475 acrB RND system efflux pump AcrB ++ ++ +
MCR_0476 oprM RND system membrane channel OprM ++ ++ +
MCR_0499 lspA signal peptidase II ++ ++ ++
MCR_0582 HopJ type III effector protein +++ ++ ++
MCR_0650 lolCE lipoprotein ABC transporter permease protein 
LolC/E
Lol-pathway ++ ++ ++
MCR_0651 lolD lipoprotein ABC transporter ATPase subunit LolD Lol-pathway ++ ++ ++
MCR_0703 lolA outer membrane lipocarrier protein LolA Lol-pathway +++ +++ +++
MCR_0921 ftsY signal recognition particle-docking protein FtsY Sec-pathway ++ ++ ++
MCR_0974 HlyD family secretion protein ++ + +
MCR_0975 putative RND family drug transporter ++ ++ ++
MCR_1007 yajC protein translocase subunit YajC, accessory protein Sec-pathway ++ ++ ++
MCR_1008 secD protein translocase subunit SecD, accessory protein Sec-pathway ++ ++ ++
MCR_1009 secF protein translocase subunit SecF, accessory protein Sec-pathway ++ ++ +
MCR_1267 secB protein translocase chaperone SecB, post 
translocational chaperone
Sec-pathway +++ +++ +++
MCR_1342 ffh signal recognition particle subunit FFH/SRP54 Sec-pathway ++ ++ ++
MCR_1465 putative efflux pump component MtrF + + +
MCR_1565 secY protein translocase subunit SecY, subunit of 
protein-conduction channel
+++ +++ ++
MCR_1703 lepB signal peptidase I ++ ++ ++
MCR_1771 secG protein translocase subunit SecG, subunit of 
protein-conduction channel
Sec-pathway ++ ++ ++
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Table S5. Genes and encoded proteins involved in central metabolism, fatty acid degradation and 
biosynthesis
BBH18 locus Gene Description Note
Expression per growth 
phase in BHI
Lag Exp Stat
Glycolysis/gluconeogenesis      
MCR_0073 lpdA
pyruvate dehydrogenase E3 component 
(dihydrolipoamide dehydrogenase)
1.8.1.4 +++ +++ +++
MCR_0403 fbp fructose-1,6-bisphosphatase 3.1.3.11 ++ ++ ++
MCR_0663
putative glyceraldehyde-3-phosphate 
dehydrogenase
++ ++ +
MCR_0892 aceE
pyruvate dehydrogenase E1 component pyruvate 
dehydrogenase complex
1.2.4.1 +++ +++ +++
MCR_0893 aceF
pyruvate dehydrogenase E2 component 
(dihydrolipoamide acetyltransferase)
2.3.1.12 +++ +++ +++
MCR_1001 pckA phosphoenolpyruvate carboxykinase 4.1.1.32 ++ ++ ++
MCR_1028 fbaB fructose-bisphosphate aldolase class II 4.1.2.13 ++ +++ +++
MCR_1030 pgk phosphoglycerate kinase 2.7.2.3 ++ ++ ++
MCR_1064 gpmI phosphoglycerate mutase 5.4.2.1 ++ ++ ++
MCR_1104 ppsA phosphoenolpyruvate synthase/water dikinase 2.7.9.2 ++ ++ ++
MCR_1222 gapA glyceraldehyde-3-phosphate dehydrogenase 1.2.1.12 +++ +++ +++
MCR_1317 eno enolase 4.2.1.11 ++ ++ ++
MCR_1772 tpiA triose-phosphate isomerase 5.3.1.1 ++ ++ ++
MCR_1808 pgi glucose-6-phosphate isomerase 5.3.1.9 ++ ++ ++
Tricarboxylic acid cycle
MCR_0064 gltA citrate synthase 2.3.3.1 +++ +++ +++
MCR_0066 sdhC succinate dehydrogenase subunit C 1.3.99.1 ++ ++ ++
MCR_0067 sdhD succinate dehydrogenase subunit D 1.3.99.1 ++ ++ ++
MCR_0068 sdhA succinate dehydrogenase subunit A 1.3.99.1 ++ ++ ++
MCR_0069 sdhB succinate dehydrogenase subunit B 1.3.99.1 +++ +++ ++
MCR_0071 sucA 2-oxoglutarate dehydrogenase E1 component 1.2.4.2 ++ +++ +++
MCR_0072 sucB 2-oxoglutarate dehydrogenase E2 component 2.3.1.61 +++ +++ +++
MCR_0327 icd isocitrate dehydrogenase NADP-dependent 1.1.1.42 ++ ++ +++
MCR_0394 acnB aconitase 4.2.1.3 ++ ++ +++
MCR_0455 maeB
malate dehydrogenase (oxaloacetate-
decarboxylating) 
1.1.1.40 ++ ++ ++
MCR_1072 fumC fumarate hydratase class II 4.2.1.2 ++ ++ ++
MCR_1446 mdh malate dehydrogenase 1.1.1.37 +++ +++ +++
MCR_1621 aceB malate synthase G 2.3.3.9 - - +
MCR_1622 aceA isocitrate lyase 4.1.3.1 + + ++
MCR_1744 fumA fumarate hydratase class I 4.2.1.2 ++ ++ +
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Acetate assimilation
MCR_1480 pta phosphate acetyltransferase 2.3.1.8 ++ ++ ++
MCR_1481 ackA acetate kinase 2.7.2.1 +++ +++ +++
Pentose phosphate pathway
MCR_0184 prsA ribose-phosphate pyrophosphokinase 2.7.6.1 ++ ++ ++
MCR_0537 tkt transketolase 2.2.1.1 ++ ++ +++
MCR_1077 rpe ribulose-5-phosphate 3-epimerase 5.1.3.1 +++ +++ +++
MCR_1086 rpiA ribose-5-phosphate isomerase A 5.3.1.6 ++ ++ ++
Fatty acid degradation Lag Exp Stat
MCR_0042
putative acyl-CoA 
dehydrogenase FadE
1.3.99.10 ++ ++ +
MCR_0091 fadB
enoyl-CoA hydratase/3-
hydroxyacyl-CoA 
dehydrogenase FadB, aerobic 
variant (45)
4.2.1.17 + + ++
MCR_0092 fadA
3-ketoacyl-CoA thiolase FadA, 
aerobic variant (45)
2.3.1.16 + ++ ++
MCR_0231
putative acyl-CoA 
dehydrogenase FadE
1.3.99.10 ++ ++ ++
MCR_0459
putative 3-ketoacyl-CoA 
thiolase FadI, anaerobic FadA 
homolog (45)
2.3.1.16 ++ ++ ++
MCR_0737
putative 3-oxoacid CoA-
transferase alpha subunit, Ato 
family (46)
2.8.3.5 ++ ++ ++
MCR_0738
putative 3-oxoacid CoA-
transferase beta subunit, Ato 
family (46)
2.8.3.5 ++ ++ ++
MCR_0858 ompE
outer membrane protein E, 
putative FadL homolog, long-
chain-fatty-acid transporter
+++ +++ +++
MCR_1388
putative acyl-CoA synthetase 
(long-chain-fatty-acid-CoA 
ligase) FadD/FadK. FadD is the 
aerobic variant, whereas FadK 
is its anaerobic counterpart (45)
6.2.1.3 ++ ++ +++
MCR_1389
putative acyl-CoA synthetase 
(long-chain-fatty-acid-CoA 
ligase) FadD/FadK. FadD is the 
aerobic variant, whereas FadK 
is its anaerobic counterpart (45)
6.2.1.3 ++ ++ ++
MCR_1476
putative enoyl-CoA hydratase/
isomerase FadJ, anaerobic FadB 
homolog (45)
4.2.1.17 ++ ++ ++
MCR_1526 fadH
2,4-dienoyl-CoA reductase 
FadH
1.3.1.34 + + +
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Fatty acid biosynthesis      
MCR_0224 fabB 3-oxoacyl-ACP synthase I FabB 2.3.1.41 +++ +++ +++
MCR_0548 fabZ
3-hydroxyacyl-ACP dehydratase 
FabZ
4.2.1.- ++ ++ ++
MCR_0840 accC
acetyl-CoA carboxylase biotin 
carboxylase AccC
6.4.1.2 +++ +++ +++
MCR_0841 accB
acetyl-CoA carboxylase biotin 
carboxyl carrier protein AccB
4.1.1.3 +++ +++ +++
MCR_0863 fabH
3-oxoacyl-ACP synthase III 
FabH
2.3.1.41 +++ +++ +++
MCR_1078 fabI
NADH-dependent enoyl-ACP 
reductase FabI
1.3.1.9 +++ +++ +++
MCR_1424 accD
acetyl-CoA carboxylase 
carboxyl transferase AccD
6.4.1.2 ++ +++ +++
MCR_1553 fabG 3-oxoacyl-ACP reductase FabG 1.1.1.100 +++ +++ +++
MCR_1554 fabD
malonyl CoA-ACP transacylase 
FabD
2.3.1.39 +++ +++ +++
MCR_1612 accA
acetyl-CoA carboxylase 
carboxyl transferase AccA
6.4.1.2 +++ +++ +++
MCR_1846 fabF 3-oxoacyl-ACP synthase II FabF 2.3.1.41 +++ +++ +++
Table S6. Genes and encoded proteins involved in nitrogen metabolism
BBH18 locus Gene Description Note
Expression per 
growth phase in BHI
Lag Exp Stat
MCR_0038 nrtCD
nitrate ABC transporter ATPase 
subunits C and D 
Part of nrtABCD gene cluster ++ ++ -
MCR_0039 nrtB
nitrate ABC transporter permease 
protein NrtB
Part of nrtABCD gene cluster ++ ++ -
MCR_0040 nrtA
nitrate ABC transporter nitrate-
binding protein NrtA
Part of nrtABCD gene cluster ++ ++ -
MCR_0131 norB nitric oxide reductase NorB ++ ++ ++
MCR_0135 aniA nitrite reductase AniA/Msp78 +++ +++ ++
MCR_0744
Crp/Fnr family transcriptional 
regulator 
Putative regulator of nitrate 
and fumarate reduction (47)
+ + -
MCR_0746 narG nitrate reductase alpha subunit NarG Part of narGHJI gene cluster + + +
MCR_0747 narH nitrate reductase beta subunit NarH Part of narGHJI gene cluster + + -
MCR_0748 narJ nitrate reductase delta subunit NarJ Part of narGHJI gene cluster - + +
MCR_0749 narI
nitrate reductase gamma subunit 
NarI
Part of narGHJI gene cluster - + +
MCR_0763 narL 
two-component system nitrate/nitrite 
response regulator NarL
+ ++ +
MCR_0764 narX
two-component system nitrate/nitrite 
sensor histidine kinase NarX
++ ++ ++
MCR_0765 narK2
putative nitrate/nitrite transporter 
NarK2
- + -
MCR_0766 narK1 nitrate transporter NarK1   - - -
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Table S7. Genes and encoded proteins involved in iron acquisition
BBH18 locus Gene Description Note
Expression per 
growth phase in BHI
Lag Exp Stat
MCR_0217 lbpB lactoferrin binding protein B LbpB   ++ + +
MCR_0219 lbpA lactoferrin binding protein A LbpA ++ + +
MCR_0293 fbpC
Iron (III) ABC transporter ATPase subunit 
FbpC
Part of fbpABC 
gene cluster
+ + +
MCR_0294 fbpB
Iron (III) ABC transporter membrane 
permease FbpB
Part of fbpABC 
gene cluster
++ + +
MCR_0295 fbpA
Iron (III) ABC transporter iron binding protein 
FbpA
Part of fbpABC 
gene cluster
+++ +++ +++
MCR_0333 fur ferric uptake regulation protein Fur ++ +++ +++
MCR_0492 copB outer membrane protein CopB +++ +++ ++
MCR_0645 NRAMP family Mn2+ and Fe2+ transporter + + +
MCR_0690 tbpA transferrin binding protein A TbpA ++ ++ ++
MCR_0694 tbpB transferrin binding protein B TbpB ++ ++ ++
MCR_0739 mhuA hemoglobin utilization protein MhuA ++ ++ ++
MCR_0789 NRAMP family Mn2+ and Fe2+ transporter + + +
MCR_0810 heme oxygenase + + +
MCR_1038 bfrB bacterioferritin B
Iron-storage 
protein (59)
+++ +++ +++
MCR_1039 bfrA bacterioferritin A
Iron-storage 
protein (59)
+++ +++ +++
MCR_1311 humA heme utilization protein HumA + + +
MCR_1867 afeA
chelated iron ABC transporter substrate 
binding protein AfeA
Part of afeABCD 
gene cluster
++ ++ ++
MCR_1868 afeB
chelated iron ABC transporter ATPase 
subunit AfeB
Part of afeABCD 
gene cluster
++ + +
MCR_1869 afeC
chelated iron ABC transporter permease 
protein AfeC
Part of afeABCD 
gene cluster
+ + +
MCR_1870 afeD
chelated iron ABC transporter permease 
protein AfeD
Part of afeABCD 
gene cluster
+ + +
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Table S8. Genes and encoded proteins involved in oxidative stress response
BBH18 locus Gene Description Note
Expression per 
growth phase in BHI
Lag Exp Stat
MCR_0043   AhpD-like alkylhydroperoxidase   +++ +++ +++
MCR_0230 trxB thioredoxin reductase ++ +++ +++
MCR_0287 ahpC
alkyl hydroperoxide reductase 
subunit C
+++ +++ +++
MCR_0291 ahpF
alkyl hydroperoxide reductase 
subunit F
+ + ++
MCR_0506
putative alkyl hydroperoxide 
reductase/thioredoxin
+ + +
MCR_0637 sodA superoxide dismutase A +++ +++ +++
MCR_0722 hybrid peroxiredoxin HyPrx5
This hybrid peroxiredoxin is 
also present in Haemophilus 
influenzae and Helicobacter 
pylori (62, 78)
++ +++ +++
MCR_1038 bfrB bacterioferritin B
Iron-storage protein, 
prevent presence of free 
iron (59)
+++ +++ +++
MCR_1039 bfrA bacterioferritin A
Iron-storage protein, 
prevent presence of free 
iron (59)
+++ +++ +++
MCR_1464 katA catalase   ++ ++ ++
lgt5lgt1lgt2B/Clgt3
Pr408 Pr406
1088300 1091626
Pr 406/408 amplicon = 3327 nt
Type 1 GAAAGGGGGCTTTTAGCTCTCGCTATTAGATGAGCCTAAGTCGGATTAGCTGGTTGGTGGGGTA
Type 2 GAAAGGGGGCTTTTAGCTCTCGCTATTAGATGAGCCTAAGTCGGATTAGCTAGTTGGTGGGGTA
Type 3 GAAAGGGGGCGCATAGCTCTCGCTATTAGATGAGCCTAAGTCGGATTAGCTAGTTGGTGGGGTA
BBH18 GAAAGGGGGCTTTTAGCTCTCGCTATTAGATGAGCCTAAGTCGGATTAGCTGGTTGGTGGGGTA
Gene 
glyRS  ppa efp fumC trpE  mutY adk abcZ ST  Strain 
32 3 2 7 2 3 30 8 128 BBH18 
32 3 2 7 2 3 30 8 128 GRJ 11   
A
C
B
Fig. S1. in silico typing of M. catarrhalis bbH18. (A) 16S rRNA gene sequence analysis according to 
Bootsma et al. (11) showed that BBH18 is a type I strain. (B) In silico multilocus sequence typing (MLST) 
according to Wirth et al. assigned BBH18 to sequence type (ST) 128, which is identical to the GRJ 11 strain 
(12). (C) The BBH18 lgt-locus and in silico LOS serotyping according to Edwards et al. (31). In silico PCR with 
the Pr 406 and Pr 408 oligonucleotide primers yielded a PCR product of 3327 nucleotides, and therefore the 
BBH18 strain was classified as being a LOS serotype B strain.
2.2 
Genome sequence of Moraxella catarrhalis rH4, 
an isolate of seroresistant lineage
aldert Zomer†, Stefan P.W. de Vries†, Kristian riesbeck, andreas l. Meinke, 
Peter W.M Hermans, Hester J. bootsma
†These authors contributed equally to this work
Journal of Bacteriology, 2012, 194(24):6969.
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abSTraCT
Here we report the annotated genome sequence of Moraxella catarrhalis strain RH4, a 
seroresistant-lineage strain isolated from the blood of an infected patient. This genome sequence 
will allow us to gain further insight into the genetic diversity of clinical M. catarrhalis isolates and 
will facilitate study of M. catarrhalis pathogenesis.
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2.2
GenoMe announCeMenT
The Gram-negative diplococcus Moraxella catarrhalis is an emerging human-restricted respiratory 
tract pathogen. It is the third-most-common cause of childhood otitis media and is frequently 
associated with exacerbations of chronic obstructive pulmonary disease (COPD) in adults. We 
reported the first completely assembled and annotated M. catarrhalis genome in 2010 (1), of 
strain BBH18 (erroneously referred to as RH4 at the time), a sputum isolate from a COPD patient 
during an exacerbation (2). In 2011, an additional 10 genome sequences of clinical Moraxella 
isolates were published (3) and compared to the BBH18 genome and the partial genome sequence 
of strain ATCC 43617 (4). This indicated a modest diversity in gene content and chromosomal 
organization between these isolates. Here we present the annotated genome sequence of the 
clinically relevant RH4 strain, which was originally isolated from the blood of an infected patient 
(5).
The draft genome sequence of M. catarrhalis RH4 was obtained using Illumina 50-bp paired-
end technology (a total of 13,826,736 reads, with 700x coverage). Reads were assembled with 
the Ray assembler software program (6), resulting in a total of 31 contigs (>100 bp in size). 
Contigs were ordered using the program Projector 2 (7) with the BBH18 sequence as a scaffold, 
and the correct order was verified by gap-spanning PCRs. When possible, gaps were filled or 
corrected by Sanger sequencing of PCR products, followed by use of GapFiller (8). After manual 
contig assembly, 9 contigs covering a total of 1,836,691 bp were obtained, which is within the 
size range of the reported genomes (1.78 to 1.96 Mbp).
The RH4 genome sequence was annotated using the RAST (rapid annotations using 
subsystems technology) server (9) and manually corrected for errors in open reading frame 
(ORF) calling. The total genome has a G+C content of 41.6% and is composed of 1,904 genes, 
including 1,845 protein-encoding genes, 4 rRNA operons, and at least 43 tRNAs. RH4 has a novel 
sequence variant for the abcZ allele and thus a novel multilocus sequence type (MLST) but clearly 
belongs to the seroresistant lineage (10). The RH4 genome contains the bro-1 β-lactamase gene 
and all of the major known M. catarrhalis virulence factors, among which UspA1, UspA2H, MID/
Hag, and in contrast to, for instance, BBH18, a complete mha locus. Compared to all Moraxella 
genomes published to date, the RH4 genome contains 10 unique genes, 8 of which are located 
consecutively on a 10.1-kb fragment. In addition to 4 putative restriction-modification protein-
encoding genes, this cluster contains a putative CiaB-encoding gene, where the ortholog in 
Campylobacter jejuni is involved in internalization into mammalian cells (11).
nucleotide sequence accession numbers. This whole-genome shotgun project has been 
deposited in DDBJ/EMBL/GenBank under the accession no. AMSO00000000. The version 
described in this article is the first version, AMSO01000000.1.
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abSTraCT
M. catarrhalis is a Gram-negative, gamma-proteobacterium and an opportunistic human pathogen 
associated with otitis media (OM) and exacerbations of chronic obstructive pulmonary disease 
(COPD). With direct and indirect costs for treating these conditions annually exceeding $33 billion 
in the United States alone, and nearly ubiquitous resistance to beta-lactam antibiotics among M. 
catarrhalis clinical isolates, a greater understanding of this pathogen’s genome and its variability 
among isolates is needed. The genomic sequences of ten geographically and phenotypically 
diverse clinical isolates of M. catarrhalis were determined and analyzed together with two 
publicly available genomes. These twelve genomes were subjected to detailed comparative and 
predictive analyses aimed at characterizing the supragenome and understanding the metabolic 
and pathogenic potential of this species. A total of 2,383 gene clusters were identified, of which 
1,755 are core with the remaining 628 clusters unevenly distributed among the twelve isolates. 
These findings are consistent with the distributed genome hypothesis (DGH), which posits that 
the species genome possesses a far greater number of genes than any single isolate. Multiple 
and pair-wise whole genome alignments highlight limited chromosomal re-arrangement. 
M. catarrhalis gene content and chromosomal organization data, although supportive of the 
DGH, show modest overall genic diversity. These findings are in stark contrast with the reported 
heterogeneity of the species as a whole, as wells as to other bacterial pathogens mediating 
OM and COPD, providing important insight into M. catarrhalis pathogenesis that will aid in the 
development of novel therapeutic regimens.
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InTroduCTIon
Moraxella catarrhalis are pathogenic, Gram-negative diplococci that colonize the mucosal tissues 
of the human nasopharynx and respiratory tract by forming biofilms (1-4). M. catarrhalis is one of 
the three primary bacterial pathogens etiologically associated with otitis media (OM), along with 
non-typeable Haemophilus influenzae (NTHi) and Streptococcus pneumoniae (1, 2). Instances of 
OM are responsible for more visits to healthcare providers than any other pediatric disease in the 
developed world and infections with M. catarrhalis cause approximately 20% of all incidences, 
recently reviewed in (5-7). Additionally, OM is a leading cause of preventable hearing loss in 
children worldwide (7, 8), adding greatly to its public health cost. Furthermore, M. catarrhalis 
is the second most common bacterial cause of exacerbations of chronic obstructive pulmonary 
disease (COPD) after H. influenzae (9). COPD is among the top five causes of death worldwide 
and infections with M. catarrhalis cause 2-4 million exacerbations of COPD per annum in the 
United States alone (7, 10). Collectively, these respiratory tract infections create a major burden 
on the healthcare system, accounting for a combined annual loss conservatively estimated at $33 
billion in the United States alone (10, 11). From a public health perspective, however, the point 
of greatest concern regarding OM and COPD is the high frequency of antibiotic administration, 
leading to the development of multiply resistant isolates (6, 7). Nearly 100% of M. catarrhalis 
clinical isolates are beta-lactam resistant, underscoring the need to develop alternative treatment 
modalities, including a M. catarrhalis vaccine, recently reviewed in (1). 
Recently, de Vries et al. published the first complete M. catarrhalis genome, strain BBH18, 
and compared it to the unpublished genome sequence of ATCC 43617 (12). The gene content 
of these two strains demonstrated a high degree of homology, suggesting M. catarrhalis clinical 
isolates may possess only limited genetic diversity, in contrast to the reported heterogeneity of 
the species (13-15). The Distributed Genome Hypothesis (DGH) holds that pathogenic bacteria, 
especially those causing chronic infections, have access to a supragenome that is larger than that 
of any individual member of that species and that, through homologous recombination, individual 
strains shuffle their genetic information as a defensive response to assault by the host (16). 
Consequently, any effort at controlling M. catarrhalis, whether via vaccine or chemotherapeutic 
intervention, must be rooted in a firm understanding of the core and distributed elements of 
this species genomic composition. Toward that end, we characterized the supragenome of 
M. catarrhalis, determined from the sequencing and comparative genomic analysis of twelve 
clinical isolates. Furthermore, mathematical modeling demonstrated that we have sequenced a 
sufficient number of M. catarrhalis genomes to have adequately characterized both the core and 
supragenomes of this pathogen. Finally, we provide a context-rich, detailed analysis of the M. 
catarrhalis supragenome and its implications towards pathogenesis.
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reSulTS 
descriptive characteristics of the finite M. catarrhalis supragenome model. Detailed 
descriptions of the strains utilized in this analysis are present in Table 1. The strains chosen for 
this analysis represent a geographically and clinically diverse collection of isolates from the middle 
ear and the respiratory tract collected from North America and Europe ((17, 18); this study). 
M. catarrhalis genomes range between 1.78 to 1.96 Mbp (an 10.1% difference), with a mean 
size of 1.89 Mbp (Table 1). This range represents 95.3% to 105.3% of the previously published 
M. catarrhalis BBH18 genome (12). Interestingly, BBH18 is among the smallest sequenced 
isolates reported to date; only strains O35E, 46P47B1, and 12P80B1 are as small or smaller. 
The remaining strains possess an average of 57 Kbp of additional DNA compared to BBH18. 
The twelve M. catarrhalis strains analyzed in this study collectively contain 21,960 predicted 
coding sequences (CDS). These data were used to predict both the percent coverage of the 
species supragenome we had achieved, and the total number of genes present in the species 
using the finite supragenome model as described previously (19, 20). Grouping of the CDS into 
clusters of orthologous genes identified 2,383 clusters; of these, 1,755 are present in each strain, 
representing the core genome of M. catarrhalis (Table 2). The remaining 628 gene clusters are 
either present in multiple, but not all, strains (453 clusters) or found only in a single strain (175 
clusters), and represent the distributed and unique gene clusters of the supragenome, respectively 
(Fig. 1). Figure 2A describes the change in the number of both the core and total gene clusters 
predicted by the finite supragenome model as each additional genome is sequenced. Likewise, 
Figure 2B illustrates the expected number of novel gene clusters identified with the inclusion of 
each additional sequenced genome to the supragenome. 
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Fig. 1. distribution of gene clusters among genomes. The 2,383 gene clusters of the M. catarrhalis 
supragenome were plotted according to the number of genomes in which they are present.
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Table 2. Comparison of core, contingency and unique gene clusters by genome
Contingency
Strain Genome size Core Distributed* Unique Total clusters % distributed % core
103P14B1 1.96 Mbp 1755 299 24 2054 14.6 85.4
BC1 1.95 Mbp 1755 278 5 2033 13.7 86.3
CO72 1.95 Mbp 1755 274 6 2029 13.5 86.5
ATCC 43617 1.91 Mbp 1755 231 12 1986 11.6 88.4
BC8 1.91 Mbp 1755 223 13 1978 11.3 88.7
7169 1.90 Mbp 1755 224 6 1979 11.3 88.7
BC7 1.90 Mbp 1755 235 86 1990 11.8 88.2
46P47B1 1.86 Mbp 1755 187 18 1942 9.6 90.4
101P30B1 1.87 Mbp 1755 185 1 1940 9.5 90.5
O35E 1.78 Mbp 1755 67 0 1822 3.7 96.3
BBH18 1.86 Mbp 1755 147 4 1902 7.7 92.3
12P80B1 1.81 Mbp 1755 120 2 1875 6.4 93.6
* denotes the inclusion of unique clusters within the distributed category
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Fig. 2. M. catarrhalis supragenome predictions. (A) Number of gene clusters in each genome expected 
by the finite supragenome model. The number of core (diamonds) and total gene clusters (squares) predicted 
by the finite supragenome model are plotted as a function of N genomes. The dividing line identifies the end 
of values for which we have observed data for comparison and the beginning of the prediction. (B) Number 
of new gene clusters predicted to be identified by the sequencing of additional genomes. Each diamond 
represents the number of new gene clusters predicted to be identified by the sequencing of one genome and 
its subsequent addition to N genomes present in the model. The dividing line identifies the end of values for 
which we have observed data for comparison and the beginning of the prediction.
relationship analysis of M. catarrhalis genome isolates. MLST analyses demonstrated that 
each of the twelve genomes represented a different sequence type, including four novel sequence 
types and novel sequence variants for the fumC and adk alleles present in O35E (Table 3 and Fig. 
3A), indicating success in selecting a diverse group of strains for sequence analysis. Because of the 
expected high degree of genomic mosaicism resulting from extensive horizontal gene transfer, 
relationship dendrograms were constructed by employing a non-phylogenetic identity-by-state, 
whole-genome clustering method (13, 22). In one case, sequence polymorphisms present in the 
core genes were used to construct the relationships, and in a second analysis gene possession 
data were used (Fig. 3B and 3C, respectively). These analyses revealed intriguing differences 
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depending upon the analytical method; no clear clade structure could be determined using allelic 
differences within the core genome, however, the use of the distributed genome data produced 
a dendrogram that was broadly similar to that generated from the MLST data, albeit with several 
exceptions. Interestingly, all three methods consistently formed two clusters; one cluster consisting 
of strains ATCC 43617, 7169, and BC1, and a second group comprised of 101P30B1, CO72, and 
103P14B1. Notably, the consistent clustering of these two groups of strains does not correlate 
with patient age group, geographic origin, COPD exacerbation or OM. These data suggest that 
using any of these methods alone is insufficient for correctly inferring the relationships among 
M. catarrhalis isolates.
Table 3. MlST sequence variants by genome
  Sequence variant  
Strain abcZ adk efp fumC
glyBETA 
(RS)
mutY ppa trpE
Sequence 
type
12P80B1* 50 25 12 3 37 52 3 2 185
103P14B1* 8 26 2 3 2 22 41 2 187
ATCC 43617* 3 3 3 4 18 3 3 2 25
46P47B1* 3 20 2 7 62 15 8 2 186
7169 3 18 3 4 3 9 3 2 82
BC1 25 18 3 4 6 9 3 2 NP-ST
BC7 8 18 12 3 29 3 3 2 NP-ST
BC8 2 2 12 7 20 6 3 2 162
CO72 8 8 2 3 2 3 9 2 199
101P30B1 8 26 2 3 2 3 25 2 NP-ST
035E 2 NP-SV 2 NP-SV 57 22 8 2 NP-ST
BBH18* 8 30 2 7 32 3 3 2 128
Unless previously determined (*), the eight genes used for the M. catarrhalis MLST typing scheme were 
identified within each genome and used to query the MLST database for the corresponding sequence variant 
number (12, 15). The sequence number combinations were then used to identify the sequence type, where 
NP-ST and NP-SV denote sequence types and sequence variants not present in the MLST database at the time 
of analysis, respectively.
analyses for mobile genetic elements and codon bias. Searches were performed to identify 
known mobile genetic elements by querying the annotation records of each genome for plasmid, 
transposon or phage-associated genes (Table 4). Plasmid-specific sequences were identified in a 
single genome (BC7), underscoring the paucity of naturally occurring plasmids reported in the M. 
catarrhalis literature (23, 24), and reviewed in (25). 
Interestingly, the BC7 plasmid-associated contig sequence possesses homologs of the 
bacteriocin/immunity factor complex first described in the M. catarrhalis plasmid, pLQ510 (24, 
26); however, annotation records for this region also identify an incomplete VirB-family type 
four secretion system (T4SS), multiple transposases and a resolvase not reported in pLQ510, 
suggesting that this sequence may represent either an extra-chromosomally maintained 
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conjugative plasmid or an integrative and conjugative element (ICE; recently reviewed in (27)). 
Phage-associated annotations varied between strains, but comprised only 0.2% to 2.5% of all 
identified ORFs per genome, while transposon-associated annotations accounted for only 0.15% 
to 0.44% of all ORFs per genome. Each genome contains at least one homolog of the IS4, IS200 
and IS1016 transposon families or subfamilies, while five genomes contain an additional IS605 
family transposon. Interestingly, an IS1016 element was found adjacent to a nitrate uptake locus 
in all twelve strains and, in those strains that contained a second IS1016 element, this element 
was often inserted in near a collection of dehydrogenases and hypothetical proteins. Likewise, 
the IS4 element was consistently flanked by a predicted aspartate kinase and amino acid/peptide 
transporter and, in strains with an additional IS4 element, could also be found in close proximity 
to the IS1016 element located within the nitrate uptake locus. The IS200 element was also found 
within a locus containing the mechanosensitive ion channel, mscS, and the CRISPR-associated 
protein, NE0113. IS605 elements were found nearby an IS200 element in all cases. These data 
illustrate a substantial conservation of transposon elements among M. catarrhalis clinical isolates.
Table 4. analysis of mobile genetic elements
Strain Genome size No. CDS No. Phage % phage
Plasmid 
ORFs
% 
plasmid
Transposon 
ORFs % Tn
103P14B1 1.96 Mbp 1944 49 2.5 0 0 3 0.15
BC1 1.95 Mbp 1892 19 1.0 0 0 6 0.32
CO72 1.95 Mbp 1875 20 1.1 0 0 3 0.16
ATCC 43617 1.91 Mbp 1862 26 1.4 0 0 6 0.32
BC8 1.91 Mbp 1844 19 1.0 0 0 7 0.38
7169 1.90 Mbp 1850 28 1.5 0 0 6 0.32
BC7 1.90 Mbp 1859 9 0.5 12 0.6 7 0.38
46P47B1 1.86 Mbp 1818 21 1.2 0 0 8 0.44
101P30B1 1.87 Mbp 1793 22 1.2 0 0 3 0.17
BBH18 1.86 Mbp 1777 11 0.6 0 0 7 0.39
O35E 1.78 Mbp 1720 3 0.2 0 0 6 0.35
12P80B1 1.81 Mbp 1726 11 0.6 0 0 7 0.41
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Fig. 3. relatedness among strains. Each strain was assayed for its relatedness to every other strain by 
several methods. (A) The MLST type of each isolate was identified as described in the Methods; the scale bar 
indicates topological distance in relative distance units (RDU) between strains. Isolate O35E was excluded from 
(A) as it contained two sequence variants (adk and fumC alleles) that were not present in the M. catarrhalis 
MLST database at the time of submission. In addition, * denotes strains whose MLST types were taken from 
the M. catarrhalis MLST database (15); all other data presented here are taken from pyrosequencing efforts. 
Neighbor-Joining analysis of was performed for both point mutations in the core genome (B), and genic 
differences in the distributed (C) genome. Branches in the same neighbor group are identically color-coded 
and length bars indicate the topological distance measured in 1-average nucleotide identity between each 
genome.
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Fig. 4. Pair-wise comparisons of the gene content of the 12 M. catarrhalis strains used in this study. 
Strain versus strain comparisons are characterized as described in the text. Values in which one strain differs 
from its partner by one or more standard deviations are denoted by color code.
Genes stably maintained within a species tend to exhibit similar codon usage, whereas recently 
acquired genes often use less frequent or rarely utilized codons, reviewed in (28). This difference 
in codon usage may result from selective pressure towards optimal translational efficiency in 
each organism, shaped by differences in the iso-accepting tRNA pools available to the donor and 
recipient bacterial species (29-31). To this end, a comprehensive analysis of codon usage was 
undertaken. The total codon usage of the supragenome demonstrates that leucine and cysteine 
are the most and least encoded amino acids, respectively, while five amino acids (Asn, Lys, Val, 
Ala, and Gly) demonstrated minor alterations in usage within proteins encoded by the core and 
distributed genomes (data not shown). A plot of GC usage in the synonymously variable third 
position (GC3s) against the effective number of codons (Nc) encoded for in each gene present 
in the core and distributed genome subsets identified a spherical distribution approximately 
centered at 35% GC3s for the core genes, whereas the distributed genes were more diffuse, with 
no central location (Fig. 5). These data highlight a preference in the core genome for codons with 
adenosine or thymidine in the synonymously variable third position, as >80% of core sequences 
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have a GC3 s between 30 and 45%. Conversely, no such An organism demonstrating an absolute 
bias toward optimal translational efficiency would utilize a single codon per amino acid in each 
gene (Nc = 20), whereas an organism displaying no codon usage bias would utilize each codon 
equally for any given amino acid in a gene (Nc = 61) (32). As relatively few genes are comprised 
solely of optimal codons, a gene suspected of exhibiting a translational efficiency bias would be 
expected to have an Nc score less than 40 (32, 33). The observed mean Nc values for the core 
and distributed genome subsets are 46.9 ± 5.9 and 46.1 ± 7.4, respectively. However, closer 
inspection reveals that only 10% (126/1,668) of the core genes subset has an Nc value < 40, 
whereas 18% (170/573) of the distributed genes subset fulfill this criterion, highlighting another 
difference in codon usage between core and distributed genes and supporting a possible role for 
translational efficiency in shaping the codon bias of the distributed genome.
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Fig. 5. Comparison of GC3s plotted against nc. Representative sequences from each cluster present in 
the core (blue) and distributed genomes (green) were graphed following the of removal of clusters whose 
sequences were incompatible with the analysis as described in the Methods.
Conservation of CrISPr elements and loci among M. catarrhalis isolates. Clustered 
regularly interspaced short palindromic repeat (CRISPR) elements serve as a means of bacterial 
selfdefense against bacteriophage and plasmid infection, recently reviewed in (34, 35). An 
average prokaryotic genome contains one CRISPR element comprised of 28 repeat-spacer units. 
The genome of M. catarrhalis BBH18 possesses a greater than average number of CRISPR loci, 
containing one putative and two known CRISPR elements (12). We sought to determine if elevated 
numbers of CRISPR elements are common amongst isolates of M. catarrhalis by analyzing each 
genome for the number, placement and context of CRISPR loci. Of the twelve strains, only O35E 
did not contain a CRISPR element. The remaining eleven strains contained an average of 1.4 
± 0.5 CRISPR elements (Table 5). These elements were comprised of direct repeats of 28.1 ± 
0.3 nucleotides separated by spacer sequences 32 ± 0.7 bp in length, consistent with previous 
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reports (36, 37). Additional analysis of the direct repeat segments indicated that the direct repeat 
sequence consensus for each CRISPR element could be split into one of two clades, of which clade 
1 contains 80% of the repeat sequences (12/15; Fig. 6). While the length of the direct repeat 
and spacer sequence elements demonstrated only minor variation between strains, the number 
of spacer sequences varied substantially, ranging between 3 to 48 per element (18.3 ± 11.7 bp). 
No similarity could be found amongst the spacer consensus sequences between strains, nor does 
similarity exist between the spacer consensus sequences and a non-M. catarrhalis nucleic acid 
sequence, presently precluding the identification of the invading nucleic acid(s) these sequences 
defend against. 
Analysis of the gene content flanking the CRISPR elements revealed that half were flanked 
by CRISPR-associated (cas) genes. However, a review of the CRISPR position on the draft genome 
contigs showed several CRISPR regions were present at contig ends, suggesting that the flanking 
cas genes may be present in other contig sequences. Concordantly, the genome annotation data 
identified cas genes in all genomes, including O35E. Analysis of the surrounding non-cas genes 
revealed that CRISPR elements were often located in close proximity to DNA recombination and 
repair genes. For the eleven strains with confirmed CRISPR elements, the percentage of phage-
associated sequence per genome displayed a moderate inverse correlation (r = -0.66) with the 
number of CRISPR elements.
Table 5. analysis of CrISPr content by genome*
Strain BC
1 
BC
7
BC
8
  C
07
2
10
1P
30
B1
10
3P
14
B1
12
P8
0B
1
  46
P4
7B
1
BB
H
18
  71
69
A
TC
C
 4
36
17
CRISPR 1 1 2 1 2 1 1 1 1 2 1 1 2 1 1
No. Spacer 24 26 22 9 16 3 15 14 6 22 30 3 48 14 23
Avg. Spacer length 32 34 32 32 33 31 32 32 32 34 32 32 32 32 32
Direct repeat length 28 28 28 28 28 29 28 28 28 28 28 28 28 28 28
No. Direct repeats 25 27 23 10 17 4 16 15 7 23 31 4 49 15 24
* Isolate O35E is not present in this analysis, as no CRISPR elements were identified in this genome.
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 99
Fig. 6. M. catarrhalis CrISPr direct repeat consensus sequences cluster into two clades. The 
relationship of the direct repeat (DR) consensus sequences of the 15 identified CRISPR loci were analyzed 
by the Neighbor-Joining method with distances calculated from the absolute number of differences with 
proportionally distributed gaps, computed from 1000 bootstrapping replications with random tie-braking.
Whole genome comparison of M. catarrhalis isolates and analysis of homologous 
recombination. To facilitate an overview of genetic re-arrangements at the chromosome level, 
the individual contigs of the 10 M. catarrhalis genomes sequenced for this study, as well as the 
publically available ATCC 43617 draft genome, were ordered relative to the completed BBH18 
genome. These eleven reordered pseudo-molecules where then compared to BBH18 in both 
whole genome multiple and pair-wise alignments using Mauve (38). Mauve identifies discrete 
regions of local homology between genomes that have no internal re-arrangements, known as 
local collinear blocks (LCBs). The multiple alignment results indicate a high degree of structural 
conservation, as the alignment is primarily comprised of a small number of large LCBs common to 
multiple genomes (Fig. 7). The overall similarity of LCB placement among the genomes suggested 
that one or more genomes might be considerably more divergent from BBH18 than the majority. 
Indeed, pair-wise comparisons of each genome to BBH18 indicated that the majority of the 
strains exhibited a high degree of chromosomal synteny with BBH18, often comprising the entire 
genome in 1-4 LCBs (Fig. 8). ATCC 43617 differs the most from BBH18 (11 LCBs), whereas O35E 
is nearly identical (1 LCB).
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Fig. 7. Whole-genome multiple alignment of twelve isolates of M. catarrhalis. Genome sequences 
were categorized by patient group and each homologous local collinear blocks (LCB) is identically colored in 
each genome. LCB’s oriented above the center line for each alignment are in the same orientation as BBH18, 
whereas LCBs oriented below the line indicates an inversion. Unconnected red lines denote contig breaks 
present in the eleven unfinished genomes.
Metabolic reconstruction of the M. catarrhalis supragenome. A detailed comparative 
analysis of the central metabolic pathways of the twelve sequenced M. catarrhalis strains 
was performed (Table S1). In general, CDS of the enzymes of the central metabolic pathways 
were highly conserved among all M. catarrhalis strains, with only a few instances of apparent 
frameshift-disrupted ORFs. In some cases, shorter CDSs were identified in one genome, e.g. 
phosphoglycerate kinase in the ATCC 43617 genome, but none of the genes were completely 
absent in any genome. 
Similar to BBH18, all sequenced M. catarrhalis genomes appear to possess an incomplete 
glycolysis pathway, lacking the genes encoding the key enzymes phosphofructokinase and 
pyruvate kinase, while the gluconeogenic pathway was intact in all analyzed genomes. The 
tricarboxylic acid (TCA) cycle, while incomplete in M. catarrhalis due to the absence of genes 
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encoding both succinyl-Coenzyme A (CoA) synthetase subunits, is otherwise conserved in each 
genome and this disruption may be bypassed by the conserved glyoxylate shunt. The reversible 
conversion of succinyl-CoA to succinate by succinyl-CoA synthetase may be substituted by 
succinyl- CoA:3-oxo-acid CoA-transferase (SCOT, 2.8.3.5), which catalyzes the reversible transfer 
of Coenzyme A (CoA) from one carboxylic acid to another, e.g. transfer of CoA from succinyl-
CoA to oxaloacetate (39, 40). Two ORFs previously annotated in BBH18 as putative 3-oxoacid 
CoA-transferase alpha subunit (MCR_0737) and putative beta subunit (MCR_0738) could 
potentially catalyze this reaction (12). However, MCR_0737 only encodes the N-terminal partof 
the alpha subunit whereas MCR_0738 only encodes the C-terminal part of the beta subunit. 
Interestingly, a detailed comparative analysis of the corresponding chromosomal region in all 
strains revealed four variant regions encoding the putative SCOT subunits (Fig. 9). Two strains, 
O35E and 46P47B1 (type 1 region), showed the same organization as BBH18, containing two 
CDS encoding the N-terminal part of the alpha subunit and the C-terminal part of the beta 
subunit, respectively. Strains 101P30B1 and 103P14B1 (type 2 region) harbored the same genes, 
but the MCR_0737-ortholog contained an internal deletion, and the MCR_0738-ortholog was 
found to be truncated. The type 3 and 4 regions contained overlapping ORFs that could encode 
the missing C-terminal part of the alpha subunit and the missing N-terminal part of the beta 
subunit, with a small size-difference in the latter (Fig. 9). The TCA cycle requires the supply of 
acetyl-CoA, which may be derived from the degradation of fatty acids and assimilation of acetate, 
for which the required CDS were identified in all strains. Finally, as in BBH18, genes encoding the 
enzymes of the non-oxidative branch of the pentose-phosphate shunt were present in all strains.
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Fig. 8. Comparison of pair-wise alignments of the eleven draft genomes to bbH18. Data are plotted 
as the (A) number of local collinear blocks (LCB) common between each labeled genome and BBH18, as well 
as (B) the mean of the LCB weights, as defined in (38) present in (A).
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distribution of M. catarrhalis virulence factors. A number of virulence factors have been 
described in M. catarrhalis, ranging from cell-to-cell adhesins (Hag; UspA1/2/2H; McaP; MchA1/
A2) and inflammatory mediators (LOS) to biofilm formation (type IV pilus (TFP); recently reviewed 
in (1, 6, 41). Each of the genomes was assessed for the presence of known or putative virulence 
factors (Table S2). Interestingly, with few exceptions, genes encoding all known virulence factors 
were present in each strain. While the presence of uspA2 or uspA2H is mutually exclusive, the 
extreme skew in genomes containing uspA2H is inconsistent with previous reports and would 
appear to be the result of an automatic assembly and/or annotation bias resulting from the 
repetitive sequence cassettes that comprise these genes (42, 43). In addition, the presence of 
mchA1/A2 is also considerably more varied than the literature would suggest; however, the high 
degree of sequence homology shared between these two adhesins makes an absolute accounting 
of their presence challenging without a targeted sequencing effort, see Discussion; (44, 45).
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Fig. 9 overview of variant regions encoding putative succinyl-Coa:3-oxo-acid Coa-transferase 
(SCoT) subunits in M. catarrhalis strains. Four variant regions were identified: type 1 regions contain two 
ORFs encoding the N-terminal part of the alpha subunit and the C-terminal part of the beta subunit; type 2 
regions hold the same ORFs but one with an internal deletion and one in a truncated form; type 3 regions 
have two sets of overlapping ORFs encoding the N-terminal (501 nt) and C-terminal part (198 nt) of the alpha 
subunit and the N-terminal (249 nt) or the C-terminal part (363 nt) of the beta subunit, respectively; type 4 
regions are identical to type 3 regions except that the ORF encoding the N-terminal part of the beta subunit 
is 273 nt in length.
dISCuSSIon
In the present study, we report genome assemblies for 10 M. catarrhalis clinical isolates that 
exceed the criteria established by the Human Microbiome Project for draft genome sequences 
and illustrate that the sequencing of each genome is practically complete (46). Comparative 
genomic analysis has revealed 2,383 orthologous gene clusters, 74% of which are present in 
all strains (Table 2). The remaining 26% are found among the twelve genomes in an uneven 
distribution; 67% of the 628 distributed gene clusters are found in four or fewer genomes 
(Fig. 1). Figure 2 demonstrates that the core genome size is unlikely to decrease substantially 
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with the sequencing of additional genomes; hence the M. catarrhalis core has been essentially 
characterized. Moreover, the finite supragenome model predicts that >85% of the M. catarrhalis 
species supragenome is contained within these twelve strains, and that the vast majority of 
additional genes to be found are likely to be rare genes, present in less than 10% of strains. The 
uneven nature of the distributed genome serves to highlight the diversity of this segment of the 
supragenome and is consistent with the distributed genomes of S. pneumoniae and the NTHi 
(19, 20). In contrast with NTHi and S. pneumoniae, whose supragenomes are divided almost 
evenly among the core and distributed genomes, the division of these genomes in M. catarrhalis 
is 3:1, respectively. Hiller et al. suggested that the large size of the distributed genomes in S. 
pneumoniae and NTHi result, at least partially, from their natural competency and ability to 
survive within the human host in biofilms, forming a close proximity environment in which genetic 
information could be exchanged (19). Despite sharing those two phenotypes with S. pneumoniae 
and the NTHi, a given isolate of M. catarrhalis shares 74% of its coding potential with every other 
isolate, suggesting that some other mechanism(s) function to constrain horizontal acquisition of 
genetic information in this bacterium (2). Horizontal gene transfer in H. influenzae via natural 
transformation is skewed toward DNA from members of the Pasteurellaceae by the use of uptake 
signal sequences (USS), which have been recently suggested to facilitate the molecular drive of 
family-specific DNA (47, 48). While S. pneumoniae does not possess an USS, it does contain a 
stress-induced competence system associated with the fratricidal secretion of antibiotics that has 
been suggested to contribute to the S. pneumoniae distributed genome (49). However, no system 
analogous to either of these has been reported in M. catarrhalis. Instead, the smaller size of the 
M. catarrhalis distributed genome may be the result of genetic frugality; as M. catarrhalis, NTHi, 
and S. pneumoniae are commonly present in polymicrobial infections, M. catarrhalis does not 
need to duplicate the coding potential of these bacteria to benefit from the indirect pathogenicity 
provided by the substantially more diverse supragenomes of these species (19, 20, 50). Support 
for a model of genomic efficiency in M. catarrhalis is found in the recent observation that M. 
catarrhalis 7169, one of the twelve strains analyzed in this study, responds to autoinducer-2 signal 
produced by the NTHi strain 86-028NP, substantially increasing its already robust capacity to form 
a biofilm (3, 51). Armbruster et al. posit that such a relationship with NTHi is reciprocal as M. 
catarrhalis releases substantial amounts of beta-lactamase into the local environment, conferring 
beta-lactam resistance to other bacteria in close proximity (51-55). Furthermore, the work of 
Armbruster et al. is consistent with the observation of Tan et al. that M. catarrhalis and NTHi 
cooperate to avoid clearance by components of the innate immune system (56). Clearly, further 
studies are warranted to explore this multispecies interaction at the supragenome and population 
levels. Interestingly, analysis of the 16S rRNA sequence of all strains indicated that they are type 
1 isolates (data not shown), which is reported to predominately group within the seroresistant 
lineage (13). Therefore, it is possible the recent divergence of serum-resistant M. catarrhalis, 
estimated at 5 million years ago, may have limited the opportunity to acquire distributed genes 
in general and virulence-specific factors in particular (15). 
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M. catarrhalis isolates possess a wide array of virulence factors known or suspected of 
mediating pathogenesis, reviewed in (1). Interestingly, the vast majority of the known/putative 
virulence factors of M. catarrhalis are present in the core genome. This finding is instructive, as 
it demonstrates that the large pool of conserved genes in this species includes many of the most 
promising vaccine candidates. In particular, these core virulence factors include the type IV pilus 
(TFP) and several adhesin-like proteins, both of which are surface exposed (1, 57). In particular, TFP 
and UspA1 have been demonstrated to be important in biofilm formation (3), recently reviewed 
in (1). Notably, mchA1/2 sequences have been completely sequenced in ATCC 43617, 7169, and 
O35E, as well as identified by PCR product amplification in 16 additional M. catarrhalis isolates 
(44, 45). Despite this high level of conservation, only eight out of twelve strains in this study 
contained large partial ORFs homologous to either mchA1 or mchA2. However, the absence of 
complete mchA1/2 sequences must be carefully interpreted; mchA1 and mchA2 are 5.4 kb and 
5.2 kb long, respectively, with 100% identity over the first 3.6 kb (44, 45). Furthermore, nine 
of twelve strains in the present study contain the cognate two-partner secretion pore, mchB, 
suggesting that these strains likely contain a functional mchA1 and/or mchA2. Similar challenges 
were observed with uspA2/2H sequencing, as automatic annotation resulted in the identification 
of fragmented sequences corresponding to twelve uspA2H homologs and no uspA2 homologs. 
While expression of uspA2 and uspA2H are exclusive of one another, the automatic PGAAP 
annotation of the O35E and 7169 genomes incorrectly identifies the uspA2 sequence fragments 
as uspA2H (42). The fragmented disposition of the uspA2 sequence appears to have confounded 
the automated annotation process, likely caused by the uspA1- and uspA2-homologous regions 
that characterize the hybrid nature of uspA2H (43). These long, repetitive sequence features 
collectively make it difficult for the automated assembly and annotation programs to correctly 
characterize certain HMW adhesins like mchA1/2 and uspA2/2H from medium- read genome 
sequencing data. It should be noted that the mchA genes were first identified in M. catarrhalis 
ATCC 43617, whose unpublished draft genome sequence was determined using longer Sanger 
sequencing reads (44, 45). Similarly, uspA1 and uspA2/2H sequences were elucidated by 
traditional sequencing methods (42, 43). 
The consistency with which virulence factors in particular, and most genes in general, 
are present within each genome is remarkable. The general absence of plasmid carriage in 
the sequenced M. catarrhalis isolates is instructive and suggests that the processes of natural 
transformation, phage- and transposon-mediated horizontal gene transfer serve as the primary 
means of acquiring genic diversity in this species. The number and sequence diversity of CRISPR 
elements present in these isolates supports this premise and further suggests that, as a species, 
M. catarrhalis is comes into contact with a diverse population of bacteriophages and other 
invading nucleic acids in the human host. While the deviation in both CRISPR spacer number and 
spacer consensus sequences suggests that these strains have likely evolved independently of one 
another in terms of the specific infectious agents and temporal distribution of resistance events, 
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a conclusive statement requires additional analyses. Hansen and colleagues observed in separate 
studies that the functional bacteriocin/immunity complex identified in pLQ510 is chromosomally 
maintained in many isolates and the identification of a putative conjugative plasmid/ICE 
containing this complex in the BC7 genome may represent another means of shuttling genetic 
information between M. catarrhalis isolates (24, 26). It is interesting to note that all genomes 
possess at least one transposase from each of the IS4, IS200, and IS1016 families that is present 
in a similar chromosomal context in each strain, while 5 genomes possess an additional IS605 
family transposase. IS200 family transposases have been proposed as a sub-group of the larger 
IS605 family and the most commonly observed DNA re-arrangement mediated by IS200 family 
transposases are deletion mutations (58). Additionally, IS200/605 transposases lack terminal 
repeats, permitting them to repair the disrupted gene faithfully without gene duplication upon 
excision, thus limiting the potential for the creation of novel and potentially advantageous ORFs 
(58, 59). While IS4 elements utilize a similar “cut-and-paste” form of non-replicative transposition, 
they do possess terminal inverted repeats and can encourage gene duplication upon excision 
(60). While IS1016 family transposons are not found in all H. influenzae isolates, they were first 
described in this species as a novel class of compound transposon facilitating the amplification 
of a polysaccharide capsule loci (61, 62); given their apparent ubiquitous distribution among M. 
catarrhalis genomes and the intimate relationship between these two bacteria, it is possible that 
IS1016 originated in M. catarrhalis and has only been recently acquired by H. influenzae. 
It is notable that, while the sequenced M. catarrhalis isolates are nearly devoid of plasmid 
sequences and consistently display the same repertoire of transposons, the distributed and core 
genomes show evidence of differential codon bias. Such differences are often the result of the 
acquisition of foreign DNA (28), but the observations that 1) the distributed genome is predicted 
to be better suited than the core genome for optimal translation and 2) the limited number of 
sequences suspected to be of foreign origin present in the M. catarrhalis supragenome suggest 
that a primary source of genic diversity in this species may be the acquisition of novel genetic 
elements that have arisen by mutation in another strain of M. catarrhalis. Hence, the differences 
in codon usage in the core and distributed genomes may be due to differing rates of molecular 
evolution as this pathogen continues its maturation. However, we cannot rule out the possibility 
that the differences in codon usage witnessed in the core and distributed genomes are the 
result of an unrecognized bias. Further studies investigating the mutation rates of the core and 
distributed genomes, as well as characterization of the in vitro and in vivo transcriptomes, of 
multiple M. catarrhalis strains would be useful in characterizing the evolution of this species. 
In addition to characterizing the M. catarrhalis supragenome, we investigated the possibility 
that clinical isolates from patients with OM and COPD represented two distinct populations with 
respect to chromosomal organization and coding potential. As such, we evaluated each strain at 
the genomic and genic levels. Multiple and pair-wise whole genome alignments indicate that M. 
catarrhalis isolates exhibit a high degree of chromosomal synteny and have undergone only limited 
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large scale genome re-arrangement as a species (Fig. 7). Similarly, while a metabolic reconstruction 
analysis revealed intriguing differences in the composition of four variant loci encoding putative 
SCOT enzyme subunits, the lack of additional differences in the central metabolic pathways of 
these isolates highlights the nearly identical metabolic potential of the twelve analyzed strains 
(Fig. 9 and Table S2). While the number of gene clusters present in the distributed genome 
increases as anticipated with concomitant increases in genome size, strains isolated from COPD 
or OM patients do not trend toward either end of the genome size spectrum. Furthermore, 
dendrograms generated using sequence data from the core and distributed gene clusters revealed 
that the use of either set of gene clusters had a demonstrable differential effect on branch 
placement within each dendrogram (Fig. 3). Additionally, as neither dendrogram correlates with 
MLST type, geographic origin, patient age group, disease type or SCOT loci variant, these data 
illustrate the potential for a very minute number of sequence differences to exert an undue 
bias in the grouping of certain strains. This core/non-core-dependent variation in dendrogram 
topology is in discordance with similar trees created from the core and distributed genomes of 
NTHi and S. pneumoniae, where the use of either data generated similar dendrograms ((19, 
20); G. Ehrlich, unpublished). Taken together, the data presented in this study do not support a 
genomic differentiation between strains isolated from children and adults and moreover suggest 
that most strains of M. catarrhalis would be capable of causing either OM or exacerbations of 
COPD.
ConCluSIonS
This study describes the M. catarrhalis supragenome and provides an in-depth characterization of 
twelve genomes, including ten sequenced expressly for this effort. Comparative analyses revealed 
that all twelve isolates are highly similar within the context of their virulence and metabolic 
potential, CRISPR and mobile genetic element content, chromosomal synteny and gene content. 
Interestingly, while the distribution of gene content among strains is consistent with the DGH, 
the proportion of genes found in the core and distributed genomes differs considerably with 
that reported for the OM and COPD-associated pathogens S. pneumoniae and NTHi. With 
nearly three-quarters of genes common to all isolates, including the vast majority of virulence-
associated genes, M. catarrhalis would appear especially suitable to control via vaccination. It is 
also of substantial interest that these studies do not reveal obvious genomic differences between 
isolates recovered from COPD and OM patients, suggesting that, should a distinction exist, it 
would be mediated by an extremely small number of genes and/or mediated by an unrecognized 
epigenetic mechanism. The data presented in this study significantly increases our knowledge 
of M. catarrhalis biology and these data could be instrumental in the development of novel 
antimicrobial treatments designed to lessen the substantial individual, social and economic 
burdens of COPD and OM.
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MaTerIalS and MeTHodS
dna sequencing. Genomic DNA was isolated from overnight cultures of M. catarrhalis 
strains (Table 1) using the Genomic-tip 500/G kit (Qiagen, Valencia, CA) as per manufacturer’s 
instructions. Genome sequencing was performed using a 454 Genome sequencer (Roche) using 
either GS-20 or Titanium chemistries. Strain 7169 was sequenced by a combination of 3-kb and 
8-kb 454 Titanium paired-end sequencing, while strains 12P80B1, 103P14B1 and 46P47B1 were 
subjected to 454 GS-20 whole genome shotgun sequencing; all four strains were sequenced by 
the Infectious Disease & Genomics Core facility at the NYS Center of Excellence in Bioinformatics 
and Life Sciences (University at Buffalo, SUNY). Strains BC1, BC7, BC8, CO72, 101P30B1 and 
O35E were sequenced by 454 Titanium whole genome shotgun sequencing at the Center for 
Genomic Sciences at the Allegheny-Singer Research Institute. All sequencing protocols and 
chemistries used were performed as per manufacturer’s instructions. 
draft genome assembly. Genomes were assembled using the Newbler assembly program 
(v2.0.01.14 or later) and complete genome assembly statistics are present in Table 1. Each 
genome was sequenced to a high level of coverage (>19x) and each draft genome was evaluated 
by the high-quality draft genome assembly criterion established by the Human Microbiome 
Project consortium (46).
accession numbers and nCbI project Ids. The genome sequences novel to this study have 
been deposited at DDBJ/EMBL/GenBank and are denoted by the following master accession 
numbers: AEPC00000000 (101P30B1), AERC00000000 (7169), AERE00000000 (103P14B1), 
AERF00000000 (46P47B1), AERG00000000 (12P80B1), AERH00000000 (BC1), AERI00000000 
(BC7), AERJ00000000 (BC8), AERK00000000 (CO72) and AERL00000000 (O35E). Accession 
numbers for BBH18 and ATCC 43617, as well as the version described in this manuscript, are 
listed in Table 1.
Gene identification and gene clustering. The assembled contig files were submitted to the 
NCBI’s Prokaryotic Genomes Automatic Annotation Pipeline (PGAAP). Putative gene sequences 
identified by this system were used in a clustering algorithm implemented at the Center for 
Genomic Sciences. Each gene’s nucleotide sequence was aligned against every other gene 
nucleotide sequence from all twelve genomes. To account for sequences that were present in 
the genome, but not identified by the automatic annotation, the amino acid sequence of each 
gene was aligned against every nucleotide contig from all twelve genomes. Alignments were 
done using either the threaded Fasta or Tfasty program version 3.6 (63). Genes were clustered 
together by comparing alignment scores. If a gene matched at least one other gene in a cluster 
with 70% identity, over 70% of the smaller gene length, it was added to a cluster. For a more 
rigorous mathematical reasoning of this threshold choice, see (20). 
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neighbor grouping analysis. All genomes in this study were compared using a neighbor 
grouping analysis, as described (22). Essentially, after the gene clustering procedure, two sub-sets 
of gene clusters were identified, a modified core, defined as a gene cluster that had only one 
member from every strain, and a modified distributed set, defined as a cluster which had fewer 
than all strains as a member, but greater than just a single strain. Two grouping analyses were 
done: creating a distance matrix from allelic differences in the modified core set, and a distance 
matrix based on the genic presence/absence in the modified distributed set. In short, genomes 
that shared high percent identities between core genes are “closer” or “less distant” from one 
another in the allelic comparison. Likewise, genomes that shared membership in many of the 
same distributed gene clusters would also be more closely related. Distance matrices and statistics 
were computed using a custom Perl implementation. Genomes whose distances from each other 
were less than the total average distance minus the standard error were grouped together. Trees 
were built from these matrices using the Phylip Neighbor-Grouping software v3.6, with default 
settings. 
Finite supragenome model. Predictions for the number of genomes required for the percent 
coverage of total genome size, novel gene clusters added per genome, and number of core gene 
clusters was computed via the method described in (20). The only alteration made to the model 
was to allow gene class population frequencies to vary; previously the values were fixed. 
MlST analysis. Multi-locus sequence typing was inferred from the best-hit homologs of glyRS 
(glycyl-tRNA synthetase beta subunit), ppa (pyrophosphate phospho-hydrolase), efp (elongation 
factor P), fumC (fumarate hydratase), trpE (anthranilate synthase component I), mutY (adenine 
glycosylase), adk (adenylate kinase) and abcZ (ATP-binding protein) present in each genome in 
compliance with the M. catarrhalis MLST scheme developed previously (15). Each homolog was 
used to query the M. catarrhalis MLST database to identify the sequence variant (SV) number 
for each gene, as well as the composite sequence type (ST). Phylograms were constructed using 
the PHYLIP and Phylodendron packages implemented in the PUBMLST Tree-drawing application. 
Whole genome alignment. Prior to whole genome alignment, contig sequences from each 
of the eleven draft genome were ordered relative to the closed, completed BBH18 chromosome 
using the contig mover application (Mauve Package v2.3.1; (38)). Pair-wise and multiple genome 
alignments were performed with the progressive Mauve application (Mauve Package v2.3.1). 
Both applications were run with their default settings. 
Codon usage analysis. Cumulative codon usage was calculated for the total M. catarrhalis 
supragenome and the core and distributed genomes using the GCUA software package 
(v1.2; (64)). As this analysis is dependent on confident predictions of start sites and in-frame 
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translation, 908 of 21,960 sequences were excluded from GCUA analysis for meeting one or 
more of the following criteria: 1) presence of internal stop codons, 2) incomplete final codons, 
3) unrecognized start codons and/or 4) the absence of synonymous codon usage. The CodonW 
software package (v1.4) was used to calculate various codon usage statistics using default 
settings. In order to prevent sample size-dependent bias during these calculations, one sequence 
for each of the 2,383 gene clusters was computationally selected without human intervention for 
further analysis. Of the 2,383 sequences selected, 142 were excluded from these analyses as they 
fulfilled the exclusion criterion described previously. Inspection of the reduced dataset identified 
a similar number of sequences from each genome (data not shown). 
Mobile genetic element analysis. Phage and plasmid-derived genes were identified by 
querying the PGAAP database entry of each genome for phage or plasmid-associated annotation 
data. A gene was determined to be phage or plasmid-associated if annotations records contained 
the terms “phage”, “plasmid”, “transposon” or “Tn”. 
CrISPr analyses. Putative CRISPR elements were identified using CRISPRFinder (65). CRISPR 
elements were reported only if CRISPRFinder determined these elements to be of high confidence; 
possible CRISPR elements were not included in these analyses. High confidence CRISPR elements 
were subjected to sequence homology analyses using the MacVector package (v11.1.1; 
MacVector, Inc., Cary, NC) to ascertain homology. 
Metabolic reconstruction analysis. Reconstruction of the central metabolic pathways of 
the BBH18 strain was performed as described (12). Briefly, KEGG orthology (KO) identifiers 
were assigned with the web-based KEGG automatic annotation server (KAAS; (66)) using the 
bidirectional best-hit method with the prokaryotic reference set. The central metabolic pathways 
of all M. catarrhalis strains were compared to the BBH18 genome (12) using the KO identifiers 
and PGAAP-based comparative genomics data. For genes that appeared to be missing in the 
initial PGAAP annotation, the respective genomic regions were examined by additional GLIMMER 
analysis (67) and manual inspection. Further, for genes that were absent in BBH18 (12, 68), 
BlastN searches were performed using coding sequences of bacterial species closely related to M. 
catarrhalis, namely Psychrobacter sp., Acinetobacter sp., and Neisseria sp. 
Statistical analysis. Pearson correlation analysis was utilized for comparisons of various data 
sets as denoted in the text. All statistical analyses were performed with Prism v4.0 (GraphPad 
Software, Inc).
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SuPPleMenTary InForMaTIon 
For supplemental Table S1 (reconstruction of M. catarrhalis central metabolic pathways) and 
Table S2 (conservation of known and putative virulence factors) please refer to: http://www.
biomedcentral.com/1471-2164/12/70/additional.
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Comparative genomic analyses of the Moraxella 
catarrhalis serosensitive and seroresistant lineages 
demonstrates their independent evolution
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abSTraCT
The bacterial species Moraxella catarrhalis has been hypothesized as being composed of two 
distinct lineages (often referred to as the seroresistant and serosensitive lineages) with separate 
evolutionary histories based on several molecular typing methods, whereas 16S ribotyping 
has suggested an additional split within the serosensitive lineage. Previously we characterized 
whole genome sequences of 12 seroresistant-lineage isolates, which revealed a relatively small 
supragenome when compared to other opportunistic nasopharyngeal pathogens, suggestive of 
a relatively short evolutionary history. Here, we performed whole genome sequencing on 18 
strains from both ribotypes of the serosensitive lineage, followed by detailed comparisons of all 
31 sequenced strains. Our data clearly show that there are two, not three, major lineages and 
that the two ribotypes that comprise the serosensitive lineage are not associated with distinct 
subpopulations. Moreover, the seroresistant and serosensitive lineages are widely separated based 
on both allelic differences observed among core genes, and possession of lineage-specific sets 
of core and distributed genes, with the serosensitive lineage displaying much longer inter-strain 
branches. There is evidence of extensive horizontal gene transfer within each of the lineages, and 
to a lesser degree between the lineages. The two lineages, although distinct, clearly form a single 
species based on multiple criteria including a large common core genome, average nucleotide 
identity values, nearly identical GC ratios, and ability to exchange genes. Neither lineage is 
obviously ancestral to the other leading to the question of how and when these lineages split 
and then subsequently reunited in the human nasopharynx.
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2.4
InTroduCTIon
Moraxella catarrhalis is a human-specific opportunistic respiratory tract pathogen within the 
pseudomonadales order of the gammaproteobacteria. This Gram-negative bacterium frequently 
colonizes the upper respiratory tract of young children, with two-thirds being colonized in their 
first year of life (1). In healthy adults colonization is less frequent, ranging from 3 to 5%, but this 
can increase up to 32% in adult patients with chronic obstructive pulmonary disease (COPD) 
(2). Although asymptomatic colonization is common, M. catarrhalis is an important etiological 
agent of upper respiratory tract infections in children; it is the third major cause of otitis media 
(OM) after Streptococcus pneumoniae and Haemophilus influenza (3-6). Furthermore, it is the 
second most common cause of infectious exacerbation of COPD, accounting for 2 to 4 million 
exacerbations in the United States per year (1, 2). In rare instances it has been associated with 
bacteremia and septic arthritis (7).
Several molecular phylogenetic typing methods, including restriction fragment length 
polymorphism (RFLP) analyses and multilocus sequence typing (MLST), have suggested that 
the M. catarrhalis species is composed of two lineages (8-10). The first described phylogenetic 
lineage, often referred to as the seroresistant (SR) lineage, contains 16S ribotype (RB) 1 strains 
and displays a more pathogenic profile as the vast majority of its members are complement 
resistant and adhere efficiently to respiratory epithelial cells. The other lineage, also known 
as the serosensitive (SS) lineage, consists of strains with RB2 and RB3, and mainly harbors M. 
catarrhalis isolates that are sensitive to complement-mediated killing and show less efficient 
adherence to respiratory epithelial cells (8-10). Importantly, the two lineages differ significantly 
in their association with disease, with 51% of isolates from seroresistant lineage isolated from 
diseased individuals, while only 15% of the serosensitive isolates were from diseased individuals 
(11). Wirth et al. also demonstrated that the serosensitive lineage is genetically more diverse than 
the seroresistant lineage, and may represent remnants of an ancestral M. catarrhalis population. 
Further, phylogenetic analysis indicated that the two lineages were genetically separated for an 
extended period (10). Wirth et al. concluded that genetic variation in the serosensitive lineage 
appeared to be mainly the result of point mutation events, whereas seroresistant lineage displayed 
increased mosaicism due to homologous recombination (10).
Comparative whole genome analyses of a collection of 12 clinically diverse SR isolates of M. 
catarrhalis showed only limited genetic diversity (12-14) as compared to other nasopharyngeal 
pathogens including H. influenzae and S. pneumoniae (15-18). Although these sequenced strains 
each represent a unique MLST, they all clustered within the SR lineage (12-14). In the current 
study, we examined the evolution of the M. catarrhalis species as a whole through genome 
sequencing (WGS) of members of the SS lineage and comparison of these results with those 
obtained for the SR lineage strains (12).
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reSulTS
Phenotyping of M. catarrhalis strains. Previous gene-based phylogenetic studies have 
suggested that the M. catarrhalis species contains at least two distinct groups, with the SR lineage 
strains forming a unique clade separate from the larger SS grouping(s). Phenotypically, the SR and 
SS lineages have been shown to differ in their capacity to withstand the action of the human 
complement system and to adhere to host epithelial cell lines (8-11). In the present study, using 
WGS and comparative genome analytics, we endeavored to determine the total clade structure 
of M. catarrhalis and any ancestral relationships among the various subpopulations identified. 
All strains used in these analyses were subjected to phenotyping with respect to their ability to 
survive in 40% normal human serum (NHS). These studies demonstrated that all but one (ATCC 
43617) of the strains previously determined by gene-based studies (12) to belong to the SR group 
were intermediate to highly resistant to NHS, whereas all of the strains previously characterized 
as SS were highly sensitive to killing by NHS (Fig. 1A). Similarly, all but two (C072 and 7169) of 
the SR lineage strains showed efficient adherence to A549 type II alveolar cells and Detroit 562 
pharyngeal epithelial cells, whereas all but one (N1) of the SS strains adhered poorly to these 
human cells types (Fig. 1B). All of these phenotypic findings were statistically significant.
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Fig. 1. Phenotypic characterization of sequenced M. catarrhalis strains. (A) Survival in 40% normal 
human serum (NHS). Strains of the seroresistant (SR) lineage were intermediate to highly resistant to the 
action of NHS, except strain ATCC 43617, whereas all strains of the serosensitive (SS) lineage were efficiently 
killed in the presence of active complement. Percentage survival (n ≥ 3) in NHS is expressed relative to the 
survival in heat-inactivated NHS (NHS-HI). (B) Adhesion characteristics of M. catarrhalis strains to A549 type 
II alveolar and Detroit 562 pharyngeal epithelial cells. SS lineage strains showed less efficient binding to both 
respiratory tract epithelial cell lines as compared to SR lineage isolates, which attached to both cell lines with 
variable efficiency. Binding of SS lineage isolates was more efficient to pharyngeal epithelial cells than to 
alveolar epithelial cells. Adherence is expressed relative to the inoculum (n ≥ 4). Statistical difference (A-B) was 
determined with a Mann–Whitney test with * P < 0.05, *** P < 0.001.
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2.4
Whole genome sequencing of M. catarrhalis strains. Previously, work by Davie et al. described 
the sequencing and comparative genomic analyses of 12 SR lineage strains, all of 16S ribotype 1 
(RB1), which were selected on the basis of their divergent clinical and geographic sites of isolation 
(12). To gain further insight into the overall genetic diversity of the M. catarrhalis species as a 
whole, in the present study 18 SS lineage strains (Table 1) and one additional SR lineage strain 
were subjected to whole genome sequence analysis. Isolates for sequencing were selected based 
on their genetic diversity, as determined both by 16S ribotypes RB2 (n = 12) and RB3 (n = 6) and 
MLST data (8-10), as well as their clinical sites of recovery, which represented diverse niches from 
both diseased and healthy hosts. The sequencing platform, assembly software, levels of coverage, 
numbers of contigs, genome size, and GC content for all 31 M. catarrhalis strains are presented 
in summary form (Table 2).
These genomic data were then analyzed to obtain lineage-specific and ribotype-specific 
measures of diversity within and between the groups including: percent GC base content, average 
genome size, the range of genome sizes, average nucleotide identity (ANI), and tetranucleotide 
identity. Comparing the WGS data among all strains showed that both SR and SS lineages, as 
well as all three ribotypes, contained member strains spanning the entire percent GC spectrum 
(41.4 - 41.7%) of the species. Both the narrow range of percent GC contents, and the fact that 
all sub-groupings spanned the entire range are supportive of the current taxonomy in which the 
SR and SS lineages form a single M. catarrhalis species. In contrast, Moraxella macacae (26), 
which we used as an outgroup for the phylogenetic tree (Fig. 5C), based on concatenated core 
regions, had a GC content of 39%. With regard to genome sizes, the SR lineage displays a 
significantly smaller average genome size than the SS lineage, 1.89 vs. 1.93 Mb (P = 0.0275, 
Mann-Whitney test), with both the RB2 and RB3 ribotypes displaying essentially identical genome 
size averages. The range in genome sizes for both lineages is ~100 Kb. A MAUVE alignment of all 
31 M. catarrhalis strains and the M. macacae genome revealed that the overall genome structure 
is reasonably conserved (data not shown). There is, however as discussed below, evidence of 
frequent horizontal gene transfer (HGT) and moderate scale inversions, insertions and deletions 
among all strains of the species.
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Table 2. Genome characteristics of 31 M. catarrhalis strains
Strain Bnum Size  
(Mb)
Coverage Contigs N50 % GC Sequencing 
Method
Assembly Software
Serosensitive lineage strains
A9 B743 1.91 27.4 24 220795 41.7 454 Titanium Newbler v. 2.6
C031 B620 1.95 31.9 47 122961 41.5 454 Titanium Newbler v. 2.6
C10 B621 1.98 28.6 9* 412591 41.4 PacBio C1 Celera v. 7.0
F18 B744 1.95 24.3 26 131591 41.7 454 Titanium Newbler v. 2.6
F20 B745 1.95 24.4 61 89759 41.6 454 Titanium Newbler v. 2.6
F21 B618 1.95 15.7 52 106722 41.5 454 Titanium Newbler v. 2.6
F23 B746 1.97 20.5 56 125588 41.5 454 Titanium Newbler v. 2.6
F24 B747 1.94 18.9 40 182702 41.7 454 Titanium Newbler v. 2.6
N1 B748 1.88 34.1 22 231375 41.6 454 Titanium Newbler v. 2.6
N12 B617 1.89 36.1 26 195908 41.6 454 Titanium Newbler v. 2.6
N15 B622 1.93 26 45 190441 41.4 454 Titanium Newbler v. 2.6
N19 B749 1.94 17.2 71 80324 41.5 454 Titanium Newbler v. 2.6
N4 B615 1.94 38.4 46 186739 41.4 454 Titanium Newbler v. 2.6
N6 B616 1.95 25.2 40 190206 41.5 454 Titanium Newbler v. 2.6
R4 B619 1.95 21.3 41 153844 41.6 454 Titanium Newbler v. 2.6
Z18 B750 1.88 17.3 30 126434 41.6 454 Titanium Newbler v. 2.6
MX1 212 1.9 449.7 189 16796 41.7 Illumina HiSeq Newbler v. 2.6
S11 213 1.88 505.5 120 30531 41.5 Illumina HiSeq Newbler v. 2.6
Seroresistant lineage strains
BBH18 BBH18 1.86 70 1 na 41.7
454 Titanium, 
Iluminia & Sanger
Newbler v. 2.6
7169 7169 1.9 182.3 35 176884 41.7 454 Titanium Newbler v. 2.3
103P14B1 103P14B1 1.96 33.4 99 74903 41.5 454 Titanium Newbler v. 2.0.01.14
12P80B1 12P80B1 1.81 23.3 53 73658 41.7 454 GS-20 Newbler v. 2.0.01.14
46P47B1 46P47B1 1.85 20.6 69 53508 41.6 454 Titanium Newbler v. 2.0.01.14
O35E B583 1.86 56.9 42 104658 41.7 454 Titanium Newbler v. 2.3
BC1 B496 1.95 40.3 43 143587 41.4 454 Titanium Newbler v. 2.0.01.14
BC7 B502 1.9 28.7 37 152590 41.5 454 Titanium Newbler v. 2.0.01.14
BC8 B503 1.91 43.8 32 173870 41.6 454 Titanium Newbler v. 2.0.01.14
C072 B507 1.95 37 25 153832 41.4 454 Titanium Newbler v. 2.0.01.14
101P30B1 B508 1.86 33.2 26 215599 41.7 454 Titanium Newbler v. 2.0.01.14
RH4 RH4 1.84 200 9 284836 41.6 Illumina & Sanger Assembler v. 2.0.0
ATCC 43617 43617 1.91 NP 41 89047 41.7 NP NP
Mcat Averages 1.91       41.6    
Moraxella macacae** 2.08   1   39.0 454/PacBio/Illumina Ray (27)
legend: Bnum = alternative strain designation; MB, megabase; coverage = the average number of time each 
base in the genome was sequenced; contigs = the number of fragments the genome is in after assembly; 
N50 = the minimum contig length that contains 50% of the total lengths of all contigs; NP, not published; 
* contigs shorter than 10kb not counted due to low coverage; **obtained from NCBI (http://www.metalife.
com/NCBI%20Taxonomy/480).
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We calculated empirical values for species-wide and lineage-specific core genomes, distributed 
genomes, and supra(pan)genomes. These data were then used as inputs into the Revised Finite 
Supragenome Model (FSM) (15, 18) to model the total diversity present in each lineage, and the 
species as a whole. Gene content analyses for all 31 M. catarrhalis strains revealed a species-
based core genome of 1970 genes and a supragenome of 3233 genes (Fig. 2; Tables 3 and 4). 
The latter figure includes over 200 unique genes, i.e. genes that are each found in only 1/31 
strains. We also performed exhaustive pair-wise comparisons in which each of the 31 strain’s 
gene content was compared to every other strain’s gene content, resulting in a total of 465 
such two-way comparisons (Table S1). A summary of these data show that the mean number 
of gene possession differences among all possible strain pairs was 347 ± 116 with a range from 
6 - 574 (Table 5). These whole species gene possession difference data are much higher than was 
observed for the SR lineage alone (217 ± 56) (12), with the SS lineage values (260 ± 73) being 
intermediate (Table 6).
Seroresistant lineage Serosensitive lineage
10
3P
14
B1
12
P8
0B
1
AT
C
C
 4
36
17
46
P4
7B
1
71
69
BC
1
R
H
4
BB
H
18
BC
7
BC
8
C
07
2
10
1P
30
B1
O
35
E N
4
N
6
N
12 F2
1
R
4
C
03
1
C
10
N
15 A9 F1
8
F2
0
F2
3
F2
4
N
1
N
19 Z1
8
M
X1 S1
1
1500
2000
2500
3000
3500 Total Core
To
ta
l c
lu
st
er
 n
um
be
r
Fig. 2. M. catarrhalis species core- and supragenome plots. The closed circles show the size of the 
supragenome as each individual strain’s genome is added and open circles show the size of the core genome 
as each strain is added. The seroresistant strains were added first (strains 1-13), and then the serosensitive 
strains were added (strains 14-31). Note the large increase in the size of the supragenome associated with 
the addition of the first several serosensitive lineage strains indicative of their larger distributed genome. In 
contrast the core genome is largely unaffected by the addition of the second lineage strains. y-axis = number 
of gene clusters; x-axis shows the name of each strain added to the analysis.
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Table 3. observed and predicted core and supragenome sizes for various M. catarrhalis groupings
Group Core 
observed
Core 
predicted
SG 
observed
SG size
(n = col 1 n)
Predicted
SG 
maximum
# of 
distributed 
genes 
observed
# of core 
genes 
predicted
(N = 50)
Total # 
of genes 
predicted
(N = 50)
SR (N = 13) 1947 1943 2560 2398 2462 613 1887 2444
SS (N = 18) 1953 1951 2782 2624 2639 829 1906 2639
Species 1970 1969 3233 3028 3051 1292 1952 3048
legend: SR, seroresistant M. catarrhalis; N = number of genomes in a supragenome analysis; SS = serosensitive 
M. catarrhalis; SG = supragenome.
Analyses of the lineage-specific data yielded an observed 13-strain SR core genome of 1947 
genes and an observed 18-strain SS core genome of 1953 genes (Table 3). Similarly, the observed 
supragenomes for these lineages contained 2560 and 2782 genes, respectively. To compare 
similar numbers of strains for each of the M. catarrhalis lineages, as well as the species as a 
whole, we used the FSM to make core and supragenome size predictions for collections of 50 
strains each (Fig. 3A-C). For both the SR and SS lineages the FSM supragenome is greater than 
90% complete following the addition of just three genomes, and the species-level supragenome 
is 90% complete following the addition of only seven genomes. It should be noted that, like 
other models, the FSM uniformly under predicts the number of unique genes (genes found in 
only a single strain of a species) which are traditionally the most difficult to estimate. For example, 
the unique gene calls account for 56% of the total variation in the model’s predictions for the SR 
supragenome versus the observed values, thus this single gene frequency class, which represents 
3.2% (1/31) of all gene frequency classes, is responsible for >50% of the total error generated 
by the model. This results in the predicted supragenome sizes being somewhat smaller than 
those based on observed data (compare Fig. 2 and 3C). The FSM, based on the actual number 
of genomes sequenced (n = 13, 18, and 31, for the SR, SS and species as a whole respectively), 
gave supragenome size predictions of 2462, 2639, and 3051 for the SR, SS, and combined data 
sets, respectively (Table 3). More importantly, the FSM supragenome size predictions based on 
50 genomes for each of the independent lineages and the species as a whole (2444, 2639, and 
3048, respectively) were essentially identical (with the exception of the unique gene class) to 
those achieved using the empiric data from smaller numbers of strains. Combined these data 
strongly suggest that we have essentially captured the entire supragenome(s) of the species and 
its component lineages, with the probable exception of some unique genes.
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Table 4. Changes in size of the M. catarrhalis supra- and core genomes as each additional strain is 
added
Strain # Strain Lineage SG Core
1 103P14B1 SR 2045 2045
2 12P80B1 SR 2140 1900
3 43617 SR 2243 1894
4 46P47B1 SR 2297 1876
5 7169 SR 2314 1866
6 B496 SR 2359 1883
7 RH4 SR 2384 1890
8 BBH18 SR 2419 1910
9 BC7 SR 2508 1922
10 BC8 SR 2542 1943
11 C072 SR 2548 1944
12 101P30B1 SR 2553 1949
13 O35E SR 2560 1947
14 N4 SS 2760 1922
15 N6 SS 2871 1927
16 N12 SS 2923 1930
17 F21 SS 2969 1948
18 R4 SS 3062 1954
19 C031 SS 3063 1953
20 C10 SS 3079 1955
21 N15 SS 3081 1955
22 A9 SS 3114 1962
23 F18 SS 3127 1966
24 F20 SS 3143 1966
25 F23 SS 3160 1973
26 F24 SS 3171 1972
27 N1 SS 3203 1975
28 N19 SS 3211 1979
29 Z18 SS 3216 1981
30 MX1 SS 3225 1976
31 S11 SS 3233 1970
legend: SR, seroresistant M. catarrhalis; SS, serosensitive M. catarrhalis; boldface and underlined type 
denotes a significant change in the size of the supragenome (SG) associated with the addition of the first SS 
strain to a stabilized SR-based SG.
Table 5. Summary statistics for all possible (n = 465) pair-wise comparisons among 31 M. catarrhalis 
isolates
  Similarity Difference Comparison Pair unique
Min 2078 6 1555 0
Max 2388 574 2374 25
Average 2179.8 347.4 1832.4 0.2
SD 63.4 116.5 171.3 1.5
legend: Similarity = the number of gene clusters shared between strain-pairs; Difference = the number 
of gene clusters not shared between strain-pairs; Comparison = the difference between the similarity and 
difference scores for strain-pairs; Pair unique = the number of genes that are uniquely found for a given strain 
pair, i.e. are not found in any other strain; Min = minimum; Max = maximum; SD = standard deviation.
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Table 6. Summary statistics for all possible (n = 153) pair-wise comparisons among 18 serosensitive 
lineage M. catarrhalis strains
  Similarity Difference Comparison Pair unique
Min 2050 5 1714 0
Max 2265 368 2245 19
Average 2123.7 260.3 1863.4 0.4
SD 46.4 73.1 114.3 1.9
legend: Similarity = the number of gene clusters shared between strain-pairs; Difference = the number 
of gene clusters not shared between strain-pairs; Comparison = the difference between the similarity and 
difference scores for strain-pairs; Pair unique = the number of genes that are uniquely found for a given strain 
pair, i.e. are not found in any other strain; Min = minimum; Max = maximum; SD = standard deviation.
The fact that we observed a slight increase (~20 gene clusters) in the size of the core genome for 
the species-level analysis compared to either of the lineage analyses was indicative of novel gene 
annotations made by later versions of RAST for the more recently annotated SS strains for which 
our FASTA analyses (18)then found matches among the contig sequences for each of the SR 
strains as part of our clustering pipeline. To ensure that this technical artifact was not masking a 
significant structural difference in the core genomes of the SR and SS lineages we also examined 
the number of clusters actually lost from the core genome as additional strains were added 
(Table S2). The number of genes lost from the SR core upon the addition of the first SS strain 
was 89, corresponding to 4.6% decrease in size, in line with what would be expected for lineage 
differences (16). The limited difference in the sizes of both the empirically-derived, FSM-derived 
lineage-specific, and species-wide core genomes is additional evidence that the two lineages, 
while clearly divergent, are members of the same species. Analysis of the various distributed gene 
frequency classes of the species-level supragenome revealed small, but significant increases at 
the 13 and 18 genome classes which correspond to the numbers of SR and SS strains and are 
indicative of the small numbers of genes that are exclusively core to each of these lineages (Fig. 
4). As expected, a gene by gene analysis using our standard clustering criteria (70% homology 
over 70% of the alignment) (18) showed that in spite of the high degree of similarity between the 
SR and SS core genomes, there are 33 SR core-specific genes that are not found in any of the SS 
strains (Table 7). Conversely, there are 49 SS lineage core genes that are not found in any of the 
SR strains. Annotations for all M. catarrhalis genes are available in GenBank. 
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Fig. 3. Finite supragenome model (FSM) predictions with respect to the Sr and SS lineages, and 
the M. catarrhalis species as a whole. The closed circles model the increase in size of the supragenome 
for each analysis; the open circles model the decrease in size of the core genome for each analysis; and the 
squares model the number of new genes identified by the addition of each additional strain for each analysis. 
The y-axes represent the number of genes; and the x-axes indicate the number of strains in the analysis. (A) 
FSM predictions for a 50 strain SR lineage collection of strains; (B) FSM predictions for a 50 strain SS lineage 
collection of strains; (C) FSM predictions for a 50 strain M. catarrhalis species-level collection. The arrow 
indicates the number of strains required to achieve capture of 90% of the supragenome for a given strain 
grouping.
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Table 7. Seroresistant lineage core genes not present among the serosensitive lineage strains
BBH18 locus_tag Gene BBH18 annotation
MCR_0008 glycerophosphoryl diester phosphodiesterase
MCR_0619 hypothetical protein
MCR_0622 hypothetical protein
MCR_0623 mapA acid phosphatase autotransporter
MCR_0640 CRISPR-associated protein NE0113 (Cas_NE0113) family protein
MCR_0646 IS200 family transposase
MCR_0811 hypothetical protein
MCR_0920 conserved hypothetical protein
MCR_0968 hypothetical protein
MCR_0969 hypothetical protein
MCR_0970 hypothetical protein
MCR_0971 hypothetical protein
MCR_1013 hypothetical protein
MCR_1123 conserved hypothetical protein
MCR_1199 hypothetical protein
MCR_1427 hypothetical protein
MCR_1721 HAD-superfamily subfamily IB hydrolase
MCR_1722 polyamine ABC transporter ATPase subunit
MCR_1723 polyamine ABC transporter permease protein
MCR_1724 polyamine ABC transporter permease protein
MCR_1725 type I phosphodiesterase/nucleotide;pyrophosphatase
MCR_1726 extracellular solute-binding protein family 1;protein
MCR_1731 pstB phosphate ABC transporter ATPase subunit PstB
MCR_1732 pstA phosphate ABC transporter permease protein PstA
MCR_1733 pstC phosphate ABC transporter permease protein PstC
MCR_1734 pstS phosphate ABC transporter substrate binding protein PstS
MCR_1871 putative membrane protein
Unannotated BBH18 genes   Annotation
103P14B1_285   hypothetical protein
12P80B1_301 serine protease
12P80B1_1567 hypothetical protein
B496_1518 hypothetical protein
B583_283   hypothetical protein
legend: BBH18 genes refer to seroresistant (SR) core genes that were annotated in the SR strain BBH18 (13). 
This genome was chosen as it has been closed. Unannotated BBH18 genes refer to SR core genes that were 
annotated in one or more of the other SR strains, but not in BBH18, however all SR strains including BBH18 
were determined by FASTA homology analyses (17, 28) to contain these genes.
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Fig. 4. number and distribution of gene clusters as a function of frequency within the species, 
and as the percent similarity requirement increases. x-axis = number of genomes containing a given 
gene cluster; y-axis = number of gene clusters; z-axis = percent identity to be grouped in a cluster. Note the 
significant increases in the gene frequency classes at 13 and 18 which correspond to the numbers of SR and 
SS strains analysed; these represent genes which are uniquely core to each lineage.
Phylogeny and evolution of the M. catarrhalis species. We performed three different 
neighbor-net analyses for the 31 strains using the Splitstree4 program (29) in which we used as 
input: 1) allelic data for all of the core genes (Fig. 5A); 2) gene possession data for the distributed 
genes (Fig. 5B); and 3) a multiple sequence alignment of a concatenation of the locally collinear 
blocks (physical core regions irrespective of gene annotations) as defined by a default MAUVE 
(30) alignment of all 31 M. catarrhalis genomes, and an M. macacae genome (representing 
an outgroup) (Fig. 5C). Each of these independent methods demonstrated a clear separation 
between the SS and SR lineages, but the two SS ribotypes were randomly distributed within the 
larger SS clade and did not cluster together. The reticulations (webbing) present within these 
diagrams are suggestive of HGT events as they represent alternative phylogenetic branching. 
These reticulations are present both within the individual lineages, but also between them 
which would be consistent with inter-lineage gene flow. In particular, it is clear that there is 
substantial distributed gene flow between the two lineages, indicating that they are not currently 
reproductively isolated. The decreased number of reticulations in the concatenated core region 
tree is a direct result of the selection process for inclusion of regions in the analysis as only regions 
that are core across all strains were included. The concatenation network in which we included 
M. macacae as an out group (Fig. 5C insert) showed that it was equidistant from both lineages.
We then evaluated the various groupings for evidence of diversity generation by determining 
both the intra- and inter-lineage levels of HGT, and by determining the extent of allelic diversity 
as measured by single nucleotide polymorphisms (SNPs) of core genes within and between each 
group as a measure of their relative phylogenetic ages. These last two measures were designed 
to determine if there were different evolutionary mechanisms acting on the two main lineages as 
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has been previously suggested (10). These investigators speculated that the SR and SS lineages 
evolved primarily by different mechanisms (10). However, we find no support for this conjecture 
as it is clear that HGT of distributed genes is just as prevalent among the SS lineage as the 
SR lineage, and that exchange of different core gene alleles between and among strains of all 
lineages is also consistent, the only reason that more allelic variation is observed in the SS lineage 
is due to the age of the lineage. 
ANI analyses (31) were performed by Jspecies (32) using both BLAST and MUMmer 
algorithms; both analyses revealed ANI values of > 95% for all pair-wise strain comparisons 
across the entire species indicating that M. catarrhalis, in spite of its distinct clade structure, is a 
single species. Similarly, we performed tetranucleotide analyses using the same software package 
(32) and obtained regression numbers, all being > 0.99, and again supporting the single species 
framework.
The independent evolution of the SS and SR lineages with neither appearing to be ancestral 
to the other raises two questions: when did the split occur that resulted in their isolation, and 
when were they reunited? Towards this end we performed an evolutionary divergence analysis 
with BEAST (33) which suggested a split between the SS and SR lineages at ~265,000 years ago. 
Virulence factor distribution. To date, numerous M. catarrhalis virulence factors have been 
described that play a role in immune evasion, cellular adherence, biofilm formation, and survival 
during iron-starvation, which have been reviewed (34, 35). Previous evaluation of virulence factor 
distribution in twelve SR lineage isolates (12) demonstrated that, with a few exceptions, all known 
virulence factors were present in each SR lineage strain. In this study, we found 33 gene clusters 
that were core to the SR lineage and missing from all of the SS strains (Table 7). None of these 
gene clusters are obvious virulence factors, however, the majority of these clusters that are unique 
to the SR lineage either are predicted to encode hypothetical proteins of unknown function or 
are under-annotated, suggesting that there remains much important biology to be developed 
to understand the observed phenotypic differences. Within the small group of SR-specific genes 
almost all of those that were annotated were associated with phosphate metabolism, including 
at least ten genes with putative annotations as phosphodiesterases, phosphatases, phosphate 
permeases and ATP transporters clustered together on the chromosome and likely assembled into 
one or more tightly linked operons. In addition, there were also a number of orphan phosphatases, 
phosphodiesterases and transporter genes associated with phosphate flux.
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Fig. 5. Continued on next page.
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Fig. 5. neighbornet analyses performed using SplitsTree4. Branch length is proportional to the degree 
of variation between and among strains. Reticulations (webbing) are indicative of horizontal gene transfer 
(HGT) as they represent ambiguities with respect to lineal descent. (A) Diagram prepared using core gene 
allelic data; (B) diagram prepared using presence/absence of distributed gene clusters; (C) diagram prepared 
using concatenated core sequences independent of annotation; inset shows phylogenetic distance between 
M. catarrhalis and M. macacae. The latter was used as outgroup to root the tree and to look for any ancestral 
relationships within the M. catarrhalis species. In all diagrams the SS lineage is displayed on the left and the 
SR lineage on the right. Note that the greatest degree of HGT both within and between lineages is observed 
with the distributed gene analyses, however, it is also evident that the core genes and regions are exchanged 
as well.
The known virulence factor genes were found also, somewhat surprisingly, to be nearly 
universally conserved across the panel of sequenced SS strains (Table S3). One of the few 
exceptions was the gene encoding the Opa-like protein A (OlpA) which was absent from strain 
ATCC 43617, confirming previous findings (36). The prevalence of genes encoding the M. 
catarrhalis filamentous haemagglutinin-like proteins (Mha/Mch) (37, 38) could not be accurately 
analyzed due to high sequence homology and inconsistent assembly of whole genome sequence 
data, as previously pointed out by Davie et al. (12). All of the strains contained the uspA2/A2H 
gene. The uspA1 gene was detected in all SR isolates and in 16 out of 18 SS isolates, with isolates 
N4 and N15 being uspA1-negative, confirming previous PCR-screening results by Bootsma et al. 
(8). These results are comparable with those reported in a publication by Verhaegh et al. (39) 
who showed that in a panel of 112 M. catarrhalis isolates (n = 22 SR-lineage, n = 90 SS-lineage 
based on ribotyping), 97% were uspA1 PCR positive, and all strains were PCR-positive for either 
uspA2 or uspA2H. In that study, mid/hag was only detected by PCR in 80% of isolates, while it 
was present in 100% of the isolates in our study.
Interestingly, the presence of the β-lactamase gene bro-1/2 differed between the lineages 
as out of the 18 sequenced SS strains, 8 did not harbor the β-lactamase gene, in contrast to 
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only two bro-1/2 negative SR isolates. In silico typing of lipooligosaccharide (LOS) gene clusters 
(40) demonstrated that most isolates harbor the type A gene cluster (24/31), although the 
prevalence was higher in the sequenced SS lineage isolates (17/18) than in the SR lineage (7/13), 
which is in line with previous observations (11). The presence of lgt4, encoding a predicted 
N-acetylglucosylamine transferase, is characteristic for LOS type A and C strains (41). In our panel 
of sequenced isolates, a LOS type B gene cluster lacking lgt4 was only found in 4 SR lineage 
isolates and not in any SS lineage isolates. Further, the LOS type C gene cluster was detected in 1 
and 2 SS and SR lineage isolates, respectively. 
Phenotype-genotype association. We analyzed the association of M. catarrhalis virulence 
phenotypes (Fig. 1AB) with genotypes using PhenoLink (42). However, given the clearly 
independent lineages and the ability of the SR stains to resist complement-mediated killing, 
the value of this analysis was limited, yielding primarily the lineage-specific genes identified 
above. Moreover, manual comparison of the SR lineage isolates with strain ATCC 43617, the 
only complement sensitive SR lineage isolate in our panel, showed that there are no genes 
that were absent only from the ATCC 43617 genome, suggesting this defect is not allelic in 
nature. Similar observations were made for association with A549 adherence phenotypes, as all 
SS lineage isolates were found to attach to A549 cells with low efficiency. Comparing the low 
binding SR isolates (7169 and C072) with the intermediate and/or high binding SR isolates did 
not reveal any genes that were lacking specifically from these two isolates. Association analyses 
for the Detroit 562 adherence phenotype showed that two genes (MCR_1831 and MCR_1286, 
encoding a type I restriction modification DNA specificity protein and a membrane protein-like 
protein, respectively) were present in the high binding SS isolate N1 and absent from all other 
SS lineage isolates, however, these genes were also found to be present in the low binding SR 
lineage isolates 103P14B1, 12P80B1, and BC7. 
dISCuSSIon
The relative overall average gene possession differences among all M catarrhalis strains (347±16) 
is somewhat less than has been observed for two other supragenomically characterized 
nasopharyngeal pathogens of similar genomic size, namely H. influenzae (395 ±94) (18) and S. 
pneumoniae (407 ± 91) (17). Moreover, the mean M. catarrhalis species similarity score, a measure 
of the number of genes shared between a pair of strains (2180 ± 63), is much higher than that 
observed for H. influenzae (1628 ± 51) or S. pneumoniae (1794 ± 50), which is indicative of 
its significantly larger core genome. Comparing M. catarrhalis to two other genomically well-
characterized human bacterial pathogens, Helicobacter pylori and Gardnerella vaginalis, also 
helps to emphasize the overall relatedness of M. catarrhalis. Both H. pylori and G. vaginalis 
are characterized by large-scale genomic rearrangements between and among clades leading 
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to an almost total loss of synteny between strains of different clades (43-45), but the overall 
genomic synteny is maintained even between the SR and SS M. catarrhalis clades. In addition, 
for G. vaginalis the individual clade’s core genomes are much larger than the “species-level” 
core genome, which is only 73% of the size of the smaller of the individual clade’s core genome, 
leading to the suggestion that this species probably more accurately reflects a genus-level taxon 
(43). In contrast, the M. catarrhalis core genome captures almost the entirety (> 95%) of each 
of its lineages core genomes. Donati et al. have proposed using the core genome as test of 
whether individual strains should be grouped within the same species; they showed that even a 
single Streptococcus mitis strain’s genome added to the S. pneumoniae supragenome resulted in 
a precipitous drop in the combined core genome size (16). Thus, we have proposed a bacterial 
species definition based on core genome relatedness such that any strain that results in less than a 
10% decrease in the size of an established (at or near its asymptote) core genome belongs within 
a species and conversely those that result in a greater than 10% decrease belong in a different 
species (46). Although many of the pathogenic enterobacteriaceae species such as Escherichia 
coli have very large supragenomes (43) comparison across clades shows little variability among 
core genomes. Thus, of the well characterized human pathogens, M. catarrhalis appears to be 
one of the least genomically diverse.
The relative lack of genomic diversity within the M. catarrhalis species is also evident in the 
fact that it only takes seven strains to achieve a 90% complete supragenome whereas the other 
mucosal pathogens discussed above each require several dozen strains to get to 90% of their 
respective supragenome sizes (17, 18, 43). Moreover, the core genomes for all M. catarrhalis 
groupings (SR, SS, and species), based on observed and FSM predictions, were very close in size 
with there being fewer than 30 gene clusters difference between the smallest grouping (SR, n 
= 13) and the largest grouping (all strains, n = 31). This is an indication that there is very little 
divergence between the core genomes of the two lineages and is highly supportive of a single 
species model. If we had observed a dramatic decrease in the size of the M. catarrhalis SR core 
genome upon the addition of the SS lineage strains, as was seen with the combining of multiple 
Gardnerella vaginalis clades (43), that would have been supportive for a species-level taxonomic 
split. In spite of the relative similarity between the SR and SS clades they each possess a small 
clade-specific core genome. These genes are, respectively, excellent candidates for virulence 
analyses and suppressors of pathogenicity. It is tempting to hypothesize that the cluster of genes 
associated with phosphate metabolism that are core to the SR lineage may be involved in a 
nucleotide second messenger system that controls virulence gene expression (47). The fact that 
many traditional virulence genes were highly conserved across the SS and SR lineages indicates 
that individual gene presence is not predictive of virulence, which may suggest that it is gene 
combinations or expression that control differences that drive virulence potential. 
The finding that the M. macacae is equidistant from the two M. catarrhalis lineages is 
suggestive that neither of the lineages are directly ancestral to the other. However, the independent 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Independent evolution of M. catarrhalis lineages  |  143
2.4
evolution of the SS and SR lineages raises two questions: when did the split occur that resulted in 
their isolation, and when were they reunited? Based on their possession of nearly identical core 
genomes, and the amount of horizontal gene flow between the two lineages they are clearly 
still a single species by any criteria, however, the BEAST analysis we performed suggested a split 
~265,000 years ago. It is interesting to speculate that one of the lineages may have evolved 
independently in the Neanderthal population which diverged from the ancestors of modern 
humans ~370,000 years ago (48) and was then subsequently reintroduced into anatomically 
modern humans, where the other lineage evolved, during the short period of geographic and 
social overlap of these distinct peoples (49) in Europe approximately 30-45,000 years before the 
present following the latter’s migration out of Africa. Although the estimated separation dates 
are somewhat different they are still supportive of the general hypothesis as it is very difficult to 
perfectly synchronize evolutionary clock rates across species particularly those as divergent as 
microbe and man. However, these data could also support other early human population splits 
and reunions.
Summary. The analyses presented herein support the hypothesis that the M. catarrhalis species 
consists of two distinct lineages with separate evolutionary histories and small, but distinct, clade-
specific core genomes; however, it is also clear that the two clades have been reunited and now 
share a single environmental niche and regularly exchange DNA via HGT. Thus, the questions 
of how and when the lineages diverged and then at some later point re-converged need to be 
further addressed.
MeTHodS and MaTerIalS
M. catarrhalis strains and growth conditions. The M. catarrhalis SS lineage isolates sequenced 
for this study (8, 19, 49) and the previously sequenced SR lineage isolates (12-14) are described 
in Table 1. M. catarrhalis strains were routinely cultured on brain heart infusion (BHI) agar plates 
at 37°C in a humidified atmosphere containing 5% CO2, or in BHI broth at 37°C with agitation 
(200-250 rpm). For DNA isolations, strains were cultured until early exponential phase growth 
(OD620nm of 0.2-0.4); chromosomal DNA was isolated using Genomic-tip 20/G columns (Qiagen; 
Venlo, Netherlands) according to manufacturer’s instructions. 
Genome sequencing assembly and annotation. WGS was performed for all strains as 
described previously (12, 15-18, 43) using a 454 LifeSciences FLX genome sequencer (Roche; 
Branford, CT) with Titanium chemistry except for the C10 strain which was sequenced on a Pacific 
Biosciences RS system (Menlo Park, CA) using SMRT chemistry according to the manufacturer’s 
instructions. Following sequencing, the number of reads, the average read lengths, and depth 
of coverage for each strain was determined. All sequencing was conducted at the Center for 
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Genomic Sciences (CGS) at the Allegheny-Singer Research Institute. As previously described (12, 
43), the 454 raw sequence reads for each strain were assembled into contigs using the Roche 454 
Life Sciences GS de novo Newbler assembler (version 2.0.00.20) using the default parameters 
except for minimum overlap identity which was adjusted to obtain the fewest contigs. The C10 
strain was assembled using the Celera WGS-assembler assembler (50). The final assemblies have 
been deposited in GenBank, the accession numbers are pending. The assembled genomes were 
submitted to RAST (Rapid Annotation using Subsystems Technology; http:///RAST. nmpdr.org) for 
automated annotation (51). Specific gene functions were inferred to be present in a genome if 
any region of that genome was inferred to be homologous to a region in another genome (see 
below) with the annotated function (18).
 
Gene clustering and comparative genome analyses. The CGS comparative genomics pipeline 
(12, 15-18, 43) was used to take the RAST-derived annotated coding sequences (CDS) and 
perform gene cluster analyses. The gene clusters were then binned as either core or distributed 
based on their possession profiles. Inter-strain comparisons were then performed for all strain 
pairs with regard to the number of gene possession similarities and differences. Gene clustering 
was determined on the basis that all genes in a cluster must be connected by a network of good 
matches (single-linkage/70% amino-acid identity/70% length) (18). Non-annotated homologs 
were identified by a search of contig sequences for regions that matched annotated genes with 
at least 70% identity over 70% of the length of the annotated gene homologous sequences 
among the genomes using the FASTA v3.6 alignment package similarity statistics (18, 28). This 
results in a set of gene clusters, each of which is either present or absent in each genome, and 
may have multiple representatives from a given genome; clusters represented in all genomes are 
designated “core” and those remaining are designated “distributed”. Whole genome alignments 
were performed using Mauve (30). 
Strain groupings. The allelic and gene possession networks were calculated from distance 
matrices. Allelic pairwise distance was calculated as 1 minus the average percent identity of all 
aligned core genes, and the gene possession pairwise distance was calculated as 1 minus the 
total number of distributed genes either both present, or both absent in each genome, divided 
by the total number of distributed genes in the supragenome (52). NeighborNet diagrams were 
generated by SplitsTree4 (29).
Supragenome modeling. Modeling of the lineage-specific and whole species supragenomes 
was performed as described using the modified Finite Supragenome Model (15, 18).
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Phylogenetic Inference Modeling. BEAST, a Bayesian-based model utilizing Markov chain 
Monte Carlo methods for calculating the age of evolutionary divergence (33) was used to 
calculate the timing of the split between the SR and SS M. catarrhalis lineages. We used a 
multiple sequence alignment of M. macacae and M. catarrhalis core sequences in the model 
and the generally accepted date of 23.5 million years ago (MYA) for the cercopithoid-hominoid 
split as the Bayesian prior for the date of the split at the tree root (53) as we reasoned that the 
independent evolution of these two species would have tracked with the divergence of their host 
ancestors. The BEAST results suggest an earlier split between the M. macacae and M. catarrhalis 
populations at 37 MYA, and a split between the SS and SR M. catarrhalis clades at 0.265 MYA. 
Phenotype-Genotype association mapping. The web-based tool PhenoLink (42) was used 
to link observed serum-resistance/sensitivity and adherence phenotypes to genome content. To 
this end, strains were divided into two classes for each examined phenotype as follows: serum-
resistant (> 10% survival) versus serum-sensitive (< 10% survival); intermediate to high-adherent 
(> 20%) versus low-adherent (< 20%). Subsequent association analyses were performed using 
default parameter settings.
in silico phylogenetic analysis. The 16S rRNA type was determined according to Bootsma et 
al. (8). Allelic sequences of the eight multilocus sequence typing (MLST) genes were analyzed 
via http://mlst.ucc.ie/mlst/dbs/Mcatarrhalis as detailed (10). LOS serotyping was done according 
to Edwards et al. (40), and typing of the beta-lactamase bro gene was performed according to 
Bootsma et al. (54).
Serum resistance assay. M. catarrhalis isolates were cultured until mid-log phase (OD620nm ~ 
1.0). Cultures were washed in 4 volumes of PBS supplemented with 0.15% gelatin (PBS-G) and 
resuspended in 5 volumes PBS-G supplemented with 1 mM CaCl2 and 0.2 mM MgCl2 (PBS-G Mg
2+ 
Ca2+). Resuspended bacterial cultures were mixed with an equal volume of 80% pooled normal 
human serum (NHS, GTI diagnostics) diluted in PBS-G Mg2+ Ca2+ or NHS that was heat-inactivated 
for 30 minutes at 56°C (NHS-HI). Colony forming units (CFUs) were monitored after 0 and 60 
minutes incubation by plating 10-fold serial dilutions on BHI plates. The survival percentage was 
calculated relative to NHS-HI (n ≥ 3) and statistical significance was tested with a Mann-Whitney-
test in GraphPad Prism 5.0. 
adhesion to respiratory tract epithelial cells. Adhesion of M. catarrhalis strains to the human 
pharyngeal epithelial cell line Detroit 562 (ATCC CCL-138) and the type II alveolar epithelial cell 
line A549 (ATCC CCL-185) was performed as detailed in de Vries et al. (55). Briefly, cells were 
seeded in 24-well plates at 2·105 Detroit 562 cells per well (2 days prior to the experiment, after 
one day medium was refreshed) or 4·105 A549 cells (one day prior to the experiment). For both 
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cell lines, monolayers of approximately 1·106 cells per well were used for adherence assays. M. 
catarrhalis isolates were cultured until mid-log phase (OD620nm ~ 1.0) and stored in the presence 
of 20% glycerol at -80° C. Cells were washed twice with PBS before the bacteria were allowed 
to adhere to the epithelial cells (multiplicity of infection, 10:1) for a 1 hour period in infection 
medium (DMEM-GlutaMAX™-I with 1% fetal calf serum). Thereafter, cells were washed 3 times 
with PBS to remove non-adherent bacteria. After detachment and lysis of the epithelial cells 
through addition of 1% saponin (Sigma-Aldrich; St. Louis, MO) in PBS-G, CFUs were enumerated 
by plating 10-fold serial dilutions on BHI plates. The percentage adherence (n ≥ 4) was calculated 
as the percentage of the inoculum that bound to epithelial cells. Statistical significance was tested 
with a Mann-Whitney test in GraphPad Prism 5.0.
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Table S1. Pairwise comparisons of every M. catarrhalis strain against each other
Strain 12P    
80B1
ATCC 
43617
46P 
47B1
7169 BC1 RH4 Z18 BC7 BC8 C072 101P 
30B1
O35E N4 N6 N12 F21 R4 C031 C10 N15 A9 F18 F20 F23 F24 N1 N19 Z18 MX1 S11 Category
2207 2251 2216 2268 2267 2199 2207 2232 2273 2306 2288 2166 2132 2153 2137 2157 2129 2162 2142 2131 2135 2154 2130 2142 2134 2133 2153 2133 2106 2124 Similarity
248 270 276 231 274 281 282 311 208 180 148 273 533 510 464 482 574 499 553 533 481 515 550 544 557 447 487 474 536 481 Difference
1959 1981 1940 2037 1993 1918 1925 1921 2065 2126 2140 1893 1599 1643 1673 1675 1555 1663 1589 1598 1654 1639 1580 1598 1577 1686 1666 1659 1570 1643 Comparison
0 2 0 0 0 0 1 0 6 0 2 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 PairUnique
2201 2195 2211 2213 2201 2200 2215 2224 2209 2206 2175 2124 2125 2106 2123 2110 2130 2128 2123 2108 2109 2115 2129 2121 2104 2122 2107 2095 2091 Similarity
206 154 181 218 113 132 181 142 210 148 91 385 402 362 386 448 399 417 385 371 441 416 406 419 341 385 362 394 383 Difference
1995 2041 2030 1995 2088 2068 2034 2082 1999 2058 2084 1739 1723 1744 1737 1662 1731 1711 1738 1737 1668 1699 1723 1702 1763 1737 1745 1701 1708 Comparison
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 PairUnique
2195 2289 2276 2201 2205 2199 2242 2215 2213 2149 2132 2138 2128 2130 2133 2147 2152 2131 2114 2159 2138 2153 2146 2106 2136 2136 2107 2115 Similarity
264 135 202 223 232 323 216 308 244 253 479 486 428 482 512 475 479 479 469 451 480 468 479 447 467 414 480 445 Difference
1931 2154 2074 1978 1973 1876 2026 1907 1969 1896 1653 1652 1700 1648 1621 1672 1673 1652 1645 1708 1658 1685 1667 1659 1669 1722 1627 1670 Comparison
0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 PairUnique
2212 2227 2195 2208 2199 2193 2225 2217 2164 2121 2124 2129 2121 2121 2127 2138 2121 2112 2122 2120 2132 2121 2114 2124 2124 2104 2113 Similarity
225 236 171 162 259 250 224 172 159 437 450 362 436 472 451 443 435 409 461 452 446 465 367 427 374 422 385 Difference
1987 1991 2024 2046 1940 1943 2001 2045 2005 1684 1674 1767 1685 1649 1676 1695 1686 1703 1661 1668 1686 1656 1747 1697 1750 1682 1728 Comparison
0 0 0 0 0 0 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 PairUnique
2305 2200 2201 2216 2256 2241 2244 2172 2136 2144 2117 2135 2130 2151 2143 2135 2129 2161 2130 2147 2138 2112 2143 2123 2108 2105 Similarity
139 220 235 284 183 251 177 202 466 469 445 467 513 462 492 466 434 442 491 475 490 430 448 435 473 460 Difference
2166 1980 1966 1932 2073 1990 2067 1970 1670 1675 1672 1668 1617 1689 1651 1669 1695 1719 1639 1672 1648 1682 1695 1688 1635 1645 Comparison
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 0 0 0 0 0 0 0 0 PairUnique
2222 2222 2216 2256 2299 2246 2174 2141 2143 2134 2132 2145 2150 2164 2140 2118 2145 2150 2167 2151 2114 2143 2142 2120 2121 Similarity
217 234 325 224 176 214 239 497 512 452 514 524 505 491 497 497 515 492 476 505 467 489 438 490 469 Difference
2005 1988 1891 2032 2123 2032 1935 1644 1631 1682 1618 1621 1645 1673 1643 1621 1630 1658 1691 1646 1647 1654 1704 1630 1652 Comparison
0 0 0 0 25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 PairUnique
2216 2196 2211 2201 2192 2177 2133 2125 2122 2121 2121 2129 2153 2132 2103 2124 2140 2149 2132 2106 2123 2127 2101 2111 Similarity
117 236 185 243 193 104 384 419 347 407 443 418 384 384 398 428 383 383 414 354 400 339 399 360 Difference
2099 1960 2026 1958 1999 2073 1749 1706 1775 1714 1678 1711 1769 1748 1705 1696 1757 1766 1718 1752 1723 1788 1702 1751 Comparison
0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 PairUnique
2231 2200 2219 2220 2190 2138 2123 2135 2120 2139 2130 2154 2138 2113 2137 2141 2149 2139 2103 2124 2132 2118 2117 Similarity
183 224 224 154 95 391 440 338 426 424 433 399 389 395 419 398 400 417 377 415 346 382 365 Difference
2048 1976 1995 2066 2095 1747 1683 1797 1694 1715 1697 1755 1749 1718 1718 1743 1749 1722 1726 1709 1786 1736 1752 Comparison
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 PairUnique
2214 2241 2235 2176 2163 2164 2120 2161 2146 2170 2170 2162 2127 2120 2154 2168 2141 2121 2160 2117 2103 2112 Similarity
275 259 203 202 420 437 447 423 489 432 446 420 446 532 451 441 492 420 422 455 491 454 Difference
1939 1982 2032 1974 1743 1727 1673 1738 1657 1738 1724 1742 1681 1588 1703 1727 1649 1701 1738 1662 1612 1658 Comparison
0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 3 0 0 0 0 PairUnique
2236 2212 2177 2125 2126 2104 2128 2117 2130 2136 2124 2126 2144 2118 2132 2127 2103 2123 2106 2101 2092 Similarity
248 228 179 475 492 458 468 526 491 493 475 427 463 502 492 499 435 475 456 474 473 Difference
1988 1984 1998 1650 1634 1646 1660 1591 1639 1643 1649 1699 1681 1616 1640 1628 1668 1648 1650 1627 1619 Comparison
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 PairUnique
2283 2171 2136 2149 2122 2141 2132 2157 2151 2135 2129 2129 2138 2152 2136 2116 2149 2121 2110 2109 Similarity
124 229 491 484 460 480 534 475 501 491 459 531 500 490 519 447 461 464 494 477 Difference
2159 1942 1645 1665 1662 1661 1598 1682 1650 1644 1670 1598 1638 1662 1617 1669 1688 1657 1616 1632 Comparison
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 PairUnique
2172 2126 2136 2114 2138 2120 2144 2142 2125 2127 2118 2131 2141 2127 2111 2138 2112 2101 2102 Similarity
159 443 442 408 418 490 433 451 443 395 485 446 444 469 389 415 414 444 423 Difference
2013 1683 1694 1706 1720 1630 1711 1691 1682 1732 1633 1685 1697 1658 1722 1723 1698 1657 1679 Comparison
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 PairUnique
2100 2091 2094 2092 2088 2095 2106 2100 2090 2092 2089 2099 2088 2090 2090 2089 2078 2080 Similarity
376 413 329 391 435 412 404 374 350 418 411 409 428 312 392 341 371 348 Difference
1724 1678 1765 1701 1653 1683 1702 1726 1740 1674 1678 1690 1660 1778 1698 1748 1707 1732 Comparison
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 PairUnique
2250 2203 2230 2244 2257 2303 2380 2202 2223 2287 2294 2252 2192 2243 2201 2203 2195 Similarity
287 303 307 315 280 202 6 318 348 207 211 292 300 278 309 313 310 Difference
1963 1900 1923 1929 1977 2101 2374 1884 1875 2080 2083 1960 1892 1965 1892 1890 1885 Comparison
0 0 0 0 0 0 15 0 0 0 0 0 0 0 0 0 0 PairUnique
2219 2317 2254 2388 2290 2247 2239 2218 2289 2296 2252 2215 2367 2225 2194 2205 Similarity
290 152 314 37 247 291 263 377 222 226 311 273 49 280 350 309 Difference
1929 2165 1940 2351 2043 1956 1976 1841 2067 2070 1941 1942 2318 1945 1844 1896 Comparison
0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 PairUnique
2211 2213 2224 2228 2203 2211 2215 2223 2229 2200 2211 2209 2307 2188 2280 Similarity
286 318 287 293 301 241 305 276 282 337 203 287 38 284 81 Difference
1925 1895 1937 1935 1902 1970 1910 1947 1947 1863 2008 1922 2269 1904 2199 Comparison
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 PairUnique
2242 2320 2285 2227 2237 2203 2278 2282 2230 2200 2302 2215 2182 2198 Similarity
318 153 237 311 247 387 224 234 335 283 159 280 354 303 Difference
1924 2167 2048 1916 1990 1816 2054 2048 1895 1917 2143 1935 1828 1895 Comparison
1 0 1 0 1 0 0 0 0 0 0 0 0 1 PairUnique
2264 2270 2243 2203 2334 2253 2257 2341 2183 2251 2215 2305 2199 Similarity
301 303 315 351 161 310 320 149 353 297 316 144 337 Difference
1963 1967 1928 1852 2173 1943 1937 2192 1830 1954 1899 2161 1862 Comparison
3 0 0 0 0 0 0 1 0 0 0 0 0 PairUnique
2294 2254 2242 2226 2293 2299 2258 2218 2369 2226 2201 2212 Similarity
246 284 264 368 221 227 306 274 52 285 343 302 Difference
2048 1970 1978 1858 2072 2072 1952 1944 2317 1941 1858 1910 Comparison
0 0 0 0 0 0 0 1 0 0 0 0 PairUnique
2300 2254 2254 2359 2371 2272 2196 2274 2233 2225 2217 Similarity
206 254 326 103 97 292 332 256 285 309 306 Difference
2094 2000 1928 2256 2274 1980 1864 2018 1948 1916 1911 Comparison
0 4 0 0 1 0 0 0 0 0 0 PairUnique
2202 2224 2284 2292 2251 2192 2240 2201 2203 2195 Similarity
316 344 211 213 292 298 282 307 311 308 Difference
1886 1880 2073 2079 1959 1894 1958 1894 1892 1887 Comparison
0 0 0 0 0 0 0 0 0 0 PairUnique
2217 2247 2250 2208 2183 2223 2214 2183 2196 Similarity
314 241 253 334 272 272 237 307 262 Difference
1903 2006 1997 1874 1911 1951 1977 1876 1934 Comparison
1 0 0 0 0 0 0 0 0 PairUnique
2232 2244 2324 2193 2214 2215 2331 2198 Similarity
343 337 174 324 362 307 83 330 Difference
1889 1907 2150 1869 1852 1908 2248 1868 Comparison
0 0 1 0 0 0 0 0 PairUnique
2365 2267 2183 2273 2228 2206 2206 Similarity
82 275 331 231 268 320 301 Difference
2283 1992 1852 2042 1960 1886 1905 Comparison
1 0 0 0 0 0 0 PairUnique
2273 2186 2277 2234 2216 2207 Similarity
281 343 241 274 318 317 Difference
1992 1843 2036 1960 1898 1890 Comparison
0 0 0 0 0 0 PairUnique
2180 2245 2204 2291 2185 Similarity
352 302 331 165 358 Difference
1828 1943 1873 2126 1827 Comparison
0 0 0 0 0 PairUnique
2211 2212 2167 2206 Similarity
258 203 301 204 Difference
1953 2009 1866 2002 Comparison
0 0 0 0 PairUnique
2214 2191 2196 Similarity
279 333 304 Difference
1935 1858 1892 Comparison
0 0 0 PairUnique
2189 2279 Similarity
284 85 Difference
1905 2194 Comparison
0 0 PairUnique
2172 Similarity
307 Difference
1865 Comparison
0 PairUnique
A
9
N
15
C
03
1
C
10
M
X1
Z1
8
N
19
N
1
F2
4
F2
3
F2
0
F1
8
O
35
E
N
4
N
6
N
12
F2
1
R
4
R
H
4
B
B
H
18
B
C
7
B
C
8
C
07
2
10
1P
30
B
1
10
3P
14
B
1
12
P8
0B
1
A
TC
C
 4
36
17
46
P4
7B
1
71
69
B
C
1
Color Key
Similarity Mean +/- 1 SD
Similarity Mean +/- 2 SD
Similarity Mean +/- 3 SD
Difference Mean +/- 1 SD
Difference Mean +/- 2 SD
Difference Mean +/- 3 SD
Comparison Mean +/- 1 SD
Comparison Mean +/- 2 SD
Comparison Mean +/- 3 SD
PairUnique Mean +/- 1 SD
PairUnique Mean +/- 2 SD
PairUniqueMean +/- 3 SD
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
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Table S2. Change in the M. catarrhalis core genome composition as additional strains are added
Genome added Total genomes* Core added Core lost Difference
43617 3 740 746 -6
46P47B1 4 1225 1243 -18
7169 5 9 19 -10
B496 6 24 7 17
RH4 7 18 11 7
BBH18 8 33 13 20
B502 9 16 4 12
B503 10 34 13 21
B507 11 8 7 1
B508 12 5 0 5
B583 13 10 12 -2
B615 14 64 89 -25
B616 15 32 27 5
B617 16 19 16 3
B618 17 31 13 18
B619 18 16 10 6
B620 19 4 5 -1
B621 20 8 6 2
B622 21 2 2 0
B743 22 11 4 7
B744 23 9 5 4
B745 24 9 9 0
B746 25 7 0 7
B747 26 5 6 -1
B748 27 6 3 3
B749 28 9 5 4
B750 29 4 2 2
MX1 30 11 16 -5
S11 31 11 17 -6
  Totals 2380 2310 70
* Initial pair of genomes used: 103P14B1 and 12P80B1 
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Host-pathogen interaction 

3.1 
Genetic requirements for Moraxella catarrhalis growth 
under iron-limiting conditions
Stefan P.W. de Vries, Peter burghout, Jeroen d. langereis, aldert Zomer, 
Peter W.M Hermans, Hester J. bootsma
Molecular Microbiology. 2013, 87(1):14-29.
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abSTraCT
Iron-sequestration by the human host is a first line defence against respiratory pathogens 
like Moraxella catarrhalis, which consequently experiences a period of iron-starvation during 
colonization. We determined the genetic requirements for M. catarrhalis BBH18 growth during 
iron-starvation using the high-throughput genome-wide screening technology genomic array 
footprinting (GAF). By subjecting a large random transposon mutant library to growth under iron-
limiting conditions, mutants of the MCR_0996-rhlB-yggW operon, rnd, and MCR_0457 were 
negatively selected. Growth experiments using directed mutants confirmed the GAF phenotypes 
with ΔyggW (putative heme-shuttling protein) and ΔMCR_0457 (hypothetical protein) most 
severely attenuated during iron-starvation, phenotypes which were restored upon genetic 
complementation of the deleted genes. Deletion of yggW resulted in similar attenuated phenotypes 
in three additional strains. Transcriptional profiles of ΔyggW and ΔMCR_0457 were highly altered 
with 393 and 192 differentially expressed genes, respectively. In all five mutants, expression of 
nitrate reductase genes was increased and of nitrite reductase decreased, suggesting an impaired 
aerobic respiration. Alteration of iron-metabolism may affect nasopharyngeal colonization 
as adherence of all mutants to respiratory tract epithelial cells was attenuated. In conclusion, 
we elucidated the genetic requirements for M. catarrhalis growth during iron-starvation and 
characterized the roles of the identified genes in bacterial growth and host-interaction.
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3.1
InTroduCTIon
Moraxella catarrhalis is an emerging pathogen of the human upper and lower respiratory tract. 
This Gram-negative bacterium colonizes the upper respiratory tract with a high frequency in 
infants; approximately two-thirds of this population becomes colonized within their first year 
of life. Importantly, M. catarrhalis is the third most common cause of childhood otitis media 
(OM) after Streptococcus pneumoniae and Haemophilus influenzae. Further, M. catarrhalis is 
responsible for about 10-15% of the exacerbations in patients suffering from chronic obstructive 
pulmonary disease (COPD) (1-3).
Iron is an essential nutrient throughout all kingdoms of life. It acts as a cofactor in various 
cellular processes including aerobic respiration, DNA metabolism, and the oxidative stress response 
(4). Because the host is devoid of free iron, all bacterial pathogens will encounter a period of iron 
starvation. In line with this, sensing iron depletion can serve as an indicator of host tissue (5). 
In the human host, iron is sequestered by high-affinity iron-binding proteins such as lactoferrin, 
transferrin, haemoglobin, and heme. The process of iron-sequestration is an important line of 
defence against invading bacterial pathogens, a process which is also referred to as nutritional 
immunity (5). To counteract this nutritional immunity, M. catarrhalis expresses several iron-
acquisition systems that allows it to extract iron from host iron-sequestration proteins such as the 
lactoferrin- and transferrin-binding proteins LbpA/B and TbpA/B and the outer membrane protein 
CopB, linked to iron acquisition from both lactoferrin and transferrin, reviewed in (1). Upon iron-
starvation, M. catarrhalis alters its gene expression to enhance acquisition of iron, e.g. expression 
of genes encoding LbpA/B, TbpA/B, and CopB is increased, as is expression of iron-transport 
factors such as the inner membrane complex TonB-ExbB-ExbD (6, 7). 
Importantly, differential gene expression does not always directly translate into gene 
essentiality, and reversely, genes that are required for growth under iron-limiting conditions are not 
necessarily differentially expressed upon iron-starvation. To assess whether a gene is conditionally 
essential, specific gene deletions or disruptions are commonly used. Hansen and co-workers 
clearly demonstrated the applicability of transposon mutagenesis to identify genes essential for 
biofilm formation of M. catarrhalis in a comprehensive fashion (8, 9). In these studies, a large 
number of transposon mutants were tested individually to determine their biofilm-formation 
phenotype. At present, however, no high-throughput method is available that allows screening 
of a large number of M. catarrhalis mutants simultaneously.
Here, we report the adaptation and improvement of the genomic array footprinting (GAF) 
technology to identify conditionally essential genes in M. catarrhalis. GAF, originally developed for 
S. pneumoniae (10-12), is a high-throughput genome-wide negative selection screenings method 
that combines marinerT7 transposon mutagenesis with microarray technology to identify mutants 
that are negatively selected from a library due to a particular challenge or stress condition. We 
have used GAF to gain insight into the genetic requirements for M. catarrhalis growth under 
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iron-limiting conditions, in this way mimicking a stress condition that the pathogen faces inside 
the human host. The requirement of the identified genes in iron-starvation was validated using 
directed gene deletion mutants and genetic complementation. Finally, functional characterization 
of the newly identified genes was performed by exposure to various peroxides, adhesion to 
respiratory tract epithelial cells, and microarray expression profiling. 
reSulTS
Genome-wide identification of genes essential for growth under iron-limiting 
conditions. To identify genes that are essential for M. catarrhalis growth under iron-limiting 
conditions, we used an adapted version of the GAF technology (Fig. 1). To this end, a large 
marinerT7 transposon mutant library (~28,000 independent transposon mutants) of strain BBH18 
was grown under iron-limiting conditions, achieved by sequestration of iron by Desferal, and 
under control growth conditions. Transposon mutants were recovered during the exponential 
and early-stationary growth phase. Notably, under iron-limiting conditions growth of the mutant 
library was reduced to approximately 50% of the growth in the control condition (Fig. 1B), 
which implies that our challenge condition was sufficiently stringent to negatively select for 
iron-dependent mutants. To improve the readout of the challenged and control mutant libraries 
with GAF microarrays, we made several important modifications to the original GAF procedure 
developed for S. pneumoniae. Firstly, we redesigned the setup of the GAF microarrays by using 
single-stranded oligonucleotide probes of 50-72 nucleotides (nt) in length, spaced about 200 
base pairs (bp) apart on both strands of the reference genome. Secondly, we implemented an 
actinomycin D-based protocol for the asymmetrical generation of single stranded mutant-specific 
cDNA probes. With these improvements, we could map the location of a transposon insertion site 
to a 200-bp region of the target genome, as shown in Fig. 1C and D. Changes in the probe signal 
intensities (SI) adjacent to the transposon insertion site in the challenge versus the control growth 
condition indicated conditional attenuation or enrichment of transposon mutants. 
In total, eight transposon insertion mutants corresponding to five genes were negatively 
selected from the library during growth under iron-limiting conditions, while one mutant appeared 
to be enriched (Table 1). The largest change in GAF signal was observed for mutants of the yggW 
gene, predicted to be involved in the biosynthesis of heme (formation of protoporphyrinogen) 
based on homology to HemN family coproporphyrinogen-III oxidase proteins. Furthermore, 
we identified the rhlB and MCR_0996 genes located adjacent to yggW, which are predicted 
to encode an ATP-dependent RNA helicase and a hypothetical protein, respectively. The other 
transposon insertions which reduced growth under iron-limiting conditions were in the rnd gene 
(MCR_0843, ribonuclease D) and the MCR_0457 gene encoding a hypothetical protein. All of the 
identified genes were found to be highly conserved across M. catarrhalis clinical isolates (13, 14), 
with levels of identity ranging from 99-100% (data not shown).
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Table 1. Genes that play a role during growth under iron-limiting conditions a
        exponential phase early-stationary phase
locus_tag Gene description alui fragment dF0/
dF30
Pbayes Fdr dF0/
dF30
Pbayes Fdr
MCR_0457 hypothetical protein 474102..474292 1.9 1.2E-09 1.9E-06
MCR_0843 rnd ribonuclease D 847210..847362 2.1 9.9E-09 1.0E-05
MCR_0994 yggW oxygen-independent 
coproporphyrinogen III 
oxidase-like protein
992384..9993292 3.2 1.1E-05 8.5E-04 2.8 8.5E-06 4.0E-03
993293..993517 1.9 2.5E-12 2.5E-08
993518..994377 2.3 5.8E-10 8.7E-07 2.1 6.8E-07 1.5E-03
MCR_0995 rhlB ATP-dependent RNA 
helicase
994654..994894 2.2 7.5E-09 8.4E-06
MCR_0996 hypothetical protein 994896..995101 2.1 1.3E-11 6.6E-08
995301..995509 2.0 1.9E-10 3.7E-07 1.9 1.3E-06 2.8E-03
MCR_0112 purL phosphoribosyl-
formylglycinamidine 
synthase
126308..127090 -2.0 2.8E-06 4.3E-03
a Differential cut-off criteria: fold-change > 1.9, Pbayes <0.001, False discovery rate (FDR) < 0.01. Values given 
are the average values of the probes that met the selection criteria.
Characterization of identified genes in bbH18 and other M. catarrhalis isolates: 
phenotypic validation, chemical and genetic complementation. To validate the attenuated 
GAF phenotypes, directed gene deletion mutants of all five identified genes were generated in M. 
catarrhalis BBH18. In addition, we included mutants of M. catarrhalis genes encoding the known 
iron-acquisition factors CopB (6) and LbpA (15), which were not identified in this GAF screen. 
Growth rate constants (generations per hour) of all directed mutants were determined. Under 
control growth conditions all mutants displayed wild-type growth characteristics (Fig. 2A and S1). 
However, under iron-limiting conditions ΔyggW and ΔMCR_0457 did not survive, and growth 
of ΔrhlB, ΔMCR_0996, and Δrnd was significantly attenuated (Fig. 2B and S1). Importantly, the 
ΔcopB and ΔlbpA strains did not show differential growth under iron-limiting conditions (Fig. 2B 
and S1), which is consistent with the fact that they were not negatively selected from the mutant 
library during our GAF screen. To confirm that the attenuated growth was the effect of the 
reduced availability of iron, mutants were grown under iron-repleted conditions, created through 
the addition of iron sulphate (Fig. 2C and Fig. S1) and hemin (Fig. 2D and Fig. S1). Growth of 
yggW, rhlB, MCR_0996, and rnd mutants was completely restored to wild-type levels after iron-
repletion, while growth of ΔMCR_0457 was partially restored.
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➔
 Fig. 1. Genomic array footprinting (GaF). (A) GAF Flow-scheme. Chromosomal DNA of M. catarrhalis 
strain BBH18 is isolated and used as acceptor DNA in an in vitro marinerT7 transposition reaction. Integration 
of the marinerT7 transposon element in TA-sites results in random disruption of genes. In vitro mutagenized 
DNA is transformed into competent M. catarrhalis BBH18 cells, and transposon mutants are selected on 
spectinomycin-containing agar plates. The mutant library is prepared by pooling of ~28,000 single colonies. 
(B) Experimental setup for iron-limitation GAF screen. The marinerT7 transposon mutant library was either 
grown under control or iron- limiting conditions (challenge), after which T7 RNA was generated from DNA 
of recovered mutants and used for the asymmetrical generation of Cy3-labeled mutant-specific probes that 
were hybridized to custom-designed Nimblegen microarrays. Mutants that failed to survive under iron-
limiting conditions were identified by differential hybridization patterns. (C) Strand-specific probe generation. 
AluI-digested chromosomal DNA of recovered mutants was used for the asymmetrical generation of Cy3-
labeled forward strand and reverse strand mutant-specific probes by in vitro transcription of the T7 promoter 
at the end of the marinerT7 transposon. The yggW AluI-fragment is shown as an example. (D) GAF analysis. 
Asymmetrically generated mutant-specific cDNA probes were hybridized to GAF microarrays designed based 
on AluI restriction fragments, with single stranded oligonucleotide probes spaced every ~ 200 bp on both 
strands. For the yggW AluI fragment shown here, the highest signals intensities (SI) were observed on the 
reverse strand (RS) probes (red bars) located at position 35, 249, 450, and 657, whereas on position 858 the 
SI was higher on the forward strand (FS) probes (green bars), indicating the presence of a transposon element 
between position 657 and 858, disrupting yggW. Iron-starvation resulted in loss of mutant-specific probe 
signal, indicating that yggW is essential for growth under this condition. *** denote statistically significance 
difference between SI of DF0 and DF30 (Pbayes < 0.001, and FDR < 0.01). Graph shows means and standard 
error of the mean (SEM) (n = 4).
The most prominent growth defects under iron-limiting conditions were observed after deletion 
of yggW and MCR_0457 in M. catarrhalis BBH18. To confirm that the observed phenotypes 
were indeed due to the gene deletions, we generated genetically complemented mutants by 
expression of the respective genes from the plasmid pSV001. To ensure expression, the yggW 
gene (lacking a likely promoter sequence directly upstream) was fused to the bro-1 promoter, 
while for MCR_0457 the predicted native promoter was included. Real-time quantitative PCR 
(RT-qPCR) analysis showed that expression of both genes was completely restored, and even 4 to 
10-fold higher than wild-type (Fig. 3A). Importantly, growth of the complemented ΔMCR_0457 
mutant under iron-limiting conditions was indistinguishable from wild-type (Fig. 3C). The yggW 
mutant showed near wild-type levels of growth upon genetic complementation, possibly the 
result of both the severe phenotype of the gene deletion mutant, and the relatively high yggW 
expression in the complemented mutant (Fig. 3B).
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Fig. 2. in vitro growth characteristics of bbH18 directed gene deletion mutant strains. Mutants were 
cultured under control (A, BHI-DF0), iron-limiting (B, BHI-DF30), and iron-repleted (C, BHI-DF30 supplemented 
with 100 µM iron sulphate; D. BHI-DF30 supplemented with 20 µM hemin) conditions. The growth speed 
(generations per hour) of the mutant and wild-type (WT) strains was determined during exponential growth. 
Growth of directed mutant strains was severely affected under iron-limiting conditions and completely 
restored upon iron-repletion via the addition of iron sulphate and hemin, although no full rescue was 
observed for the MCR_0457 mutant. Statistical difference with the wild-type strains under control and iron-
limiting conditions (n ≥ 3) (A-B) was determined with a Mann-Whitney test. Statistical analysis for growth in 
iron-repleted medium (n = 2) (C-D) was determined with an unpaired t-test with Welch’s correction. For all 
experiments, data shown are means and SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.
To examine whether the importance of yggW and MCR_0457 for growth during iron-starvation 
is conserved across M. catarrhalis isolates, we deleted these genes in three other strains, namely 
O35E, 7169, and 46P47B1. Since these wild-type strains turned out to be more sensitive to 
Desferal than the BBH18 strain (data not shown), we examined growth in BHI pre-treated 20 µM 
Desferal. In all three strains deletion of yggW results in attenuated growth during iron-starvation 
(Fig. 3D-F), indicating a conserved role of yggW across the M. catarrhalis species. No effects of the 
MCR_0457 deletion were observed, although a minor attenuation was observed in strain 7169 
and 46P47B1, albeit not statistically significant.
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Fig. 3. Genetic complementation of yggW and MCr_0457 mutants and directed gene deletions in 
other M. catarrhalis isolates. (A) Real-time quantitative PCR analysis showed that yggW and MCR_0457 
gene expression was restored in genetically complemented BBH18 mutant strains. Data are expressed as 
log2 fold-change relative to wild-type. Graphs shows mean and SEM based on analysis of three biological 
replicates. (B-C) Growth under iron-limiting conditions of the yggW and MCR_0457 mutants genetically 
complemented with pSV002 and pSV003, respectively (n ≥ 5). The severe attenuation of ΔyggW was 
restored, although partially, by trans expression of yggW, i.e. significantly higher than ΔyggW but lower as 
compared to the wild-type strain. The attenuated growth of the ΔMCR_0457 mutant was completely rescued 
upon genetic complementation. (D-F) Growth of yggW and MCR_0457 mutants of strains O35E, 7169, and 
46P47B1 under iron-limiting conditions (DF20) (n = 4). In all three tested strains deletion of yggW resulted in 
attenuated growth during iron-starvation. Growth was only slightly inhibited after deletion of MCR_0457 in 
strains 7169 and 46P47B1. Statistical significance (B-F) was tested on log10-transformed data with a two-way 
ANOVA and the Bonferroni post-hoc test. * P < 0.05, ** P < 0.01; ***, P < 0.001. Data shown are means 
and SEM.
The genetic structure of the MCR_0996-rhlB-yggW cluster suggests that it functions as an 
operon (Fig. 4A). Gene-spanning PCR reactions on BBH18 cDNA demonstrated that this gene 
cluster is indeed transcribed as a polycistronic messenger (Fig. 4B). For each individual deletion 
mutant of the MCR_0996-rhlB-yggW operon genes, we confirmed that expression of the other 
two operon genes was not affected (Fig. 4C), ruling out that polar effects caused the attenuated 
growth phenotypes under iron-limiting conditions. 
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Fig. 4. MCr_0996-rhlB-yggW operon validation and expression analysis. (A) Chromosomal organization 
of the gene cluster and illustration of gene spanning PCR amplicons for operon analysis. (B) Gene spanning 
PCR reactions on cDNA showed that the MCR_0996-rhlB-yggW gene cluster functions as an operon. No 
products were observed for the mock reverse transcriptase (RT) reaction. (C) Deletion of one gene did not 
affect expression of other genes in operon as only expression of the deleted gene was found to be absent, 
indicated with arrows.
There is a link between iron metabolism and oxidative stress as the reaction of iron with 
peroxide (i.e. Fenton reaction) results in the generation of highly reactive oxygen species (ROS). 
In this light, we assessed the sensitivity of the directed mutants to the oxidative agent hydrogen 
peroxide, tert-butyl peroxide, cumene hydroperoxide, and tellurite (16, 17). However, none of the 
mutants displayed increased sensitivity for the tested peroxides and tellurite (data not shown).
link between iron metabolism and adherence to respiratory tract epithelial cells. Next 
to acquiring essential nutrients such as iron, M. catarrhalis also needs to be able to adhere to the 
epithelial cell layer, as this is a critical first step towards colonization and infection. Therefore, we 
tested the ability of the directed mutants to adhere to two human respiratory tract epithelial cell 
lines, Detroit 562 pharyngeal and A549 type-II alveolar epithelial cells. Since the deletion mutants 
were attenuated for growth under iron-limiting conditions, aliquots for adherence were prepared 
in standard BHI medium. Compared to wild-type, adhesion of all mutants to both Detroit 562 and 
A549 cells was significantly reduced, similar to the reduction that was observed for a mutant of 
the major adhesin of M. catarrhalis uspA1 (18) (Fig. 5AB). This adhesion defect was not caused 
by a growth defect of the mutants in the infection medium used for the adhesion assay (data not 
shown). Neither was it the result of our mutagenesis approach, as the adhesion levels of a mutant 
of the olpA gene was unaffected, which is consistent with a previous study (19) (Fig. 5AB). 
Examination of the outer membrane protein composition of wild-type and the mutant strains 
(Fig. 5C) did not reveal obvious differences, and expression of UspA1 was detected in all mutant 
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strains (Fig. 5D), indicating that the observed defect in epithelial cell adherence of the mutants 
was not due to changes in outer membrane composition or alteration of known adhesion factors. 
Importantly, adhesion of the yggW and MCR_0457 mutants was restored to wild-type levels 
upon genetic complementation, confirming that the diminished adherence was indeed the result 
of the deletion of these genes (Fig. 5AB).
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Fig. 5. adhesion characteristics of mutants to respiratory tract epithelial cells, analysis of outer 
membrane profiles, and uspa1 protein expression. Adherence of the yggW, rhlB, MCR_0996, rnd, and 
MCR_0457 mutants to Detroit 562 pharyngeal epithelial cells (A) and A549 type II alveolar epithelial cells (B) 
was found to be significantly attenuated as compared to the wild-type strain. Adhesion of complemented 
ΔyggW and ΔMCR_0457 was fully restored to wild-type levels. Deletion of uspA1, encoding the major adhesin 
of M. catarrhalis, clearly diminished adherence, whereas this was not the case upon deletion of the olpA gene. 
Adherence is expressed as percentage of wild-type (WT) (n ≥ 4) and shown as means and SEM. Statistical 
difference was determined with a Mann-Whitney test with *** P < 0.001. (C) Outer membrane profiles of 
directed mutant strains, as analyzed by SDS-page and colloidal Coomassie staining, were highly similar to 
the pattern observed for the wild-type strain. (D) Western blot analysis showed that UspA1 expression was 
detected in all mutant strains. The band of ~ 115 kDa (indicated with black arrow) was lacking in the UspA1 
mutant but present in the other mutant strains.
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effect of gene deletions on transcriptional profiles. To further characterize the functional 
consequences of the gene deletions, we determined transcriptome profiles of the wild-type 
and directed mutant strains during exponential growth in BHI medium. Standard broth growth 
conditions were chosen because none of the directed mutant strains were able to grow sufficiently 
under iron-limiting conditions. The highest number of differentially expressed genes were due to 
the deletion of yggW and MCR_0457 (Fig. 6A), 393 and 192 genes, respectively. Considerably 
fewer differentially expressed genes were found in ΔrhlB (9 genes), ΔMCR_0996 (22 genes), and 
Δrnd (38 genes) (Fig. 6A). All genes that met the selection criteria for differential expression (see 
experimental procedures) are listed in Table S1.
40 30 20 10 0
  
# genes differentially expressed
reduced increased reduced increased
40302010 40 80 12
0 40 30 20 10 0 40302010
 Amino acid biosynthesis
Purines pyrimidines nucleosides and nucleotides
Fatty acid and phospholipid metabolism
Biosynthesis of cofactors prosthetic groups and carriers
Central intermediary metabolism
Energy metabolism
Transport and binding proteins
DNA metabolism
Transcription
Protein synthesis
Protein fate
Regulatory functions
Signal transduction
Cell envelope
Cellular processes
Unknown function
ΔyggW ΔMCR_0457
**
*
**
*
**
*
yg
gW
∆
rhl
B
∆
MC
R_
09
96
∆
rnd∆
MC
R_
04
57
∆
0
10
20
increased
reduced
25
75
125
175
225
275
D
iff
er
en
tia
lly
 e
xp
re
ss
ed
 g
en
es
A B
236
ΔyggW
ΔMCR_0457
Increased expression
119
ΔyggW ΔMCR_0457
Reduced expression
20 55 18 99
C
Mobile and extrachromosomal element functions
Conserved hypothetical and hypothetical proteins
Fig. 6. differentially expressed genes identified by transcriptional profiling of directed mutant 
strains. (A) Number of genes with increased or reduced expression per directed mutant strain (n ≥ 3). 
Deletion of yggW and MCR_0457 resulted in a high number of differentially expressed genes, whereas 
considerably less genes were differentially expressed in the other mutant strains. (B) Overlap of differentially 
expressed genes in ΔyggW and ΔMCR_0457. Only a limited overlap between both mutants was observed. 
(C) Functional class distribution of differentially expressed genes in ΔyggW and ΔMCR_0457. Functional class 
enrichment was determined using Fishers exact test and corrected for multiple testing, *** Q-value < 0.001.
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Expression of the narGHJI gene cluster, encoding nitrate reductase subunits, was higher in 
all mutants, while expression of the gene encoding nitrite reductase (AniA), which catalyzes 
the next step of denitrification (conversion of nitrite to nitric oxide), was lower in all mutant 
strains. Furthermore, expression of MCR_0136, encoding a conserved hypothetical protein, was 
decreased in all mutant strains by 2.3- to 4.9-fold compared to wild-type. Interestingly, expression 
of the gene encoding the multifunctional ubiquitous surface protein A2H (UspA2H), involved in 
adhesion, biofilm formation, and complement-resistance (1, 20), was increased 2.3- and 2.5-fold 
in the ΔMCR_0996 and ΔMCR_0457 strains, respectively. Only a limited overlap was observed 
between the gene sets of the mutant strains with the highest number of differentially expressed 
genes, ΔyggW and ΔMCR_0457, which shared 20 genes that showed higher expression and 18 
of which expression was reduced (Fig. 6B). These included elevated levels of narK2, encoding a 
putative nitrate/nitrite transporter and lower expression of the nitrate-binding protein gene nrtA 
of a nitrate ABC transporter. 
The differentially expressed genes in the ΔyggW strain were distributed among a variety of 
functional categories (Fig. 6C and Table S2), with a significant enrichment of the “conserved 
hypothetical and hypothetical proteins” class among the higher expressed genes, and enrichment 
of “protein biosynthesis” genes among the genes of which expression was decreased, including 
30 genes that code for the ribosomal subunits and 2 genes encoding translation elongation 
factors. In the ΔMCR_0457 strain, significant enrichment of “transport and binding proteins” 
was observed in the gene set with reduced expression (Fig. 6C and Table S2).
Interestingly, in the ΔyggW strain there was a ~23-fold increase in expression of a putative 
bacterioferritin-associated ferredoxin (MCR_1040) that is predicted to be involved in the release 
of iron from the intracellular iron-storage protein bacterioferritin, as well as higher expression of 
the genes encoding the ferredoxins MCR_0899 and MCR_1709, glutaredoxin and glutaredoxin-
like proteins (MCR_0600 and MCR_1266, respectively), AhpC/TSA family protein (MCR_1068), 
and the thioredoxins MCR_1740 and MCR_0506. Further, we observed lower expression of the 
genes coding for a rubredoxin family protein (MCR_0041), cytochrome c biogenesis proteins 
(MCR_1234-1235 and MCR_1321), and NADH-quinone oxidoreductase subunit H (MCR_0715). 
These results might reflect a changing/altered redox-balance in the ΔyggW strain. In addition, 
deletion of the yggW gene resulted in increased expression of 15 genes encoding putative 
membrane proteins, as well as 120 conserved hypothetical and hypothetical proteins (46.8 % of 
the total number of genes with increased expression). 
Considerably fewer genes were found to be differentially expressed in the mutants of the two 
other genes of the MCR_0996-rhlB-yggW operon, namely rhlB and MCR_0996 (Fig. 6A). Among 
the lower expressed gene set of ΔMCR_0996 were genes encoding the iron-sulphur protein 
assembly chaperones HscA (MCR_0604) and HscB (MCR_0605). An example of a differentially 
expressed gene in the Δrnd mutant is the NRAMP family Mn2+ and Fe2+ transporter gene 
(MCR_0789), with a 4.5-fold increase in expression.
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In the ΔMCR_0457 strain, several genes belonging to the functional category “transport 
and binding proteins” were lower expressed, including transporters for nitrate (MCR_0038-
0040), phosphate (MCR_1732-1734), sulphate (MCR_0997-0998), zinc (MCR_0370), and 
the NRAMP family Mn2+ and Fe2+ transporter (MCR_0789), as well as the oligopeptide ABC 
transport system (MCR_1304-1306). Interestingly, several genes that were previously found to 
have increased expression under iron-limiting conditions were identified as higher expressed in 
this mutant, including genes encoding LbpB, TbpA, and the BadM/Rrf2 family transcriptional 
regulator MCR_0609 (7). Finally, several genes of the heme biosynthesis pathway were 
differentially expressed in the ΔMCR_0457 mutant, more specifically, hemCD expression was 
higher, and expression of cobA, hemF, and hemN was decreased.
dISCuSSIon
Since the human host is devoid of free iron, respiratory tract pathogens like M. catarrhalis will 
encounter a period of iron-starvation upon entering their host. In this study, we aimed to extend 
our knowledge of iron metabolism in M. catarrhalis by the genome-wide identification of genes 
essential for growth under iron-limiting conditions using an improved GAF technology. As such, 
this is the first high-throughput genome-wide screen to identify conditionally essential genes in 
M. catarrhalis. 
By GAF we were able to identify five genes (yggW, rhlB, MCR_0996, rnd, and MCR_0457) as 
being essential for growth of M. catarrhalis BBH18 under iron-limiting conditions. The importance 
of these five genes during iron-starvation was confirmed using directed mutants and attenuated 
growth could be restored upon iron-repletion. Even though we analysed close to the whole 
BBH18 genome by screening of a ~28,000 mariner transposon mutant library, the number of 
individual attenuated transposon mutants (8 transposon insertion mutants corresponding to 5 
genes) was rather low, which could indicate a relatively high rate of false negatives. There are 
several factors that may have influenced the number of identified attenuated transposon mutants. 
Firstly, our GAF microarrays do not allow identification of all transposon insertion sites, as the 
cDNA probes of more than one transposon mutant can contribute to the signal of individual 
array probes (spaced every 200 bp). Furthermore, our experimental set-up was aimed at reducing 
the number of false-positives rather than avoiding false-negatives, as we combined sufficient 
biological variation between replicates with stringent selection criteria during data analysis. 
We did not identify any of the known iron-acquisition factors such as CopB and LbpA/B in our 
screen, presumably due to the high redundancy in iron acquisition and transport mechanisms, 
underscored by our observation that the growth rate of ΔcopB and ΔlbpA under iron-limiting 
conditions did not differ from the wild-type strain.
A shared characteristic between all the mutant strains was the increased expression of genes 
encoding the nitrate reductase subunits, which may point towards a non-functional aerobic 
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respiration or to low oxygen tension. Importantly, expression of aniA, responsible for the next 
step in denitrification, was decreased in all mutants, probably resulting in the accumulation of 
nitrite. In ΔyggW and ΔMCR_0457 this may be counteracted by the decreased narK2 levels, 
encoding a putative nitrate/nitrite transporter. Further, a large number of conserved hypothetical 
and hypothetical proteins was differentially expressed, especially in ΔyggW. As pointed out 
by Galperin and Koonin (21), many of the highly conserved hypothetical proteins are typically 
associated with processes such as translation, transcription, or ribosome biosynthesis, whereas 
hypothetical genes with less conservation may be involved in cellular maintenance processes that 
deal with waste products generated during various cellular- and metabolic-processes. This might 
be particularly important for aerobic organisms that have to cope with spontaneous oxidation of 
nucleotides, amino acids, lipids, and other cellular components.
The yggW mutant showed the most prominent growth defect under iron-limiting conditions, 
which was restored to near wild-type levels by genetic complementation. Deletion of yggW 
in three other M. catarrhalis isolates resulted in similar attenuated phenotypes, indicating a 
conserved role in M. catarrhalis. Based on homology, yggW is predicted to encode for an oxygen-
independent coproporphyrinogen III oxidase-like protein, catalyzing the oxidative decarboxylation 
of coproporphyrinogen III to protoporphyrinogen, but experimental evidence that YggW or 
homologous proteins can catalyze this enzymatic conversion is lacking. M. catarrhalis YggW 
shares low levels of amino acid identity with HemN (23.9%) and HemF (9.6%) proteins, which 
are reported to catalyze this oxidative decarboxylation reaction (22), providing indirect evidence 
that YggW fulfils another function. Recently, it was reported that Lactococcus lactis hemN was 
incorrectly annotated as an oxygen-independent coproporphyrinogen III dehydrogenase (CPDH) 
as the purified protein was devoid of CPDH activity (23). The gene was re-annotated as hemW 
and functional characterization showed that L. lactis HemW plays a role in heme trafficking. 
Phylogenetic analysis clearly showed that M. catarrhalis YggW, as well as homologs in other 
closely related species such as Psychrobacter sp. and Acinetobacter sp., group into the cluster 
of HemW- and HemW-like proteins, especially those of Gram-negative origin (Fig. 7). Further 
proof that M. catarrhalis YggW belongs to this family can be found in HemW-specific sequence 
domains and motifs (23). As with all HemW family proteins, M. catarrhalis YggW harbors the 
iron-sulfur cluster CxxxCxxC motif, whereas HemN proteins possess the radical SAM enzyme 
motif CxxxCxxCxC with four cysteine residues, which is also present in M. catarrhalis HemN. 
In addition, the HemW conserved HNxxYW motif is also present in M. catarrhalis YggW. Heme 
is involved in various processes ranging from respiration to oxidative stress responses, being a 
cofactor of cytochromes and catalase, respectively. The transcriptome of ΔyggW suggested a 
changing or altered redox-balance, which may be the result of an improper functioning of the 
cytochromes in the respiratory chain due to a reduced heme loading of cytochromes. We could 
not identify a potential link between YggW function and the oxidative stress response, as the 
sensitivity for several chemical oxidants was not affected by the deletion of yggW. Therefore, 
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the YggW protein is expected to be involved in the shuttling of heme from the cytoplasm to the 
periplasm or vice versa. We speculate that YggW is involved in heme loading of cytochromes. 
Pseudomonas aeroginosa YP_001345880.1
Pseudomonas fluorescence YP_002875260.1
Escherichia coli NP_417430
Teredinibacter turnerae YP_003071895.1
Moraxella catarrhalis YggW ADG61259.1
Psychrobacter cryohalolentis YP_580433.1
Acinetobacter sp. YP_045195.1
Staphylococcus aureus NP_374696.1
Bacillus subtilis NP_390428.2
Lactococcus lactis NP_267295
Moraxella catarrhalis HemN YP_003627755
Pseudomonas aeruginosa YP_001349140.1
Vibrio cholerae NP_229775.1
Escherichia coli NP_418303.2
HemW- HemW-like
HemN
Amino Acid Substitutions (x100)
020406080100120
Psychrobacter cryohalolentis YP_581710.1
Fig. 7. Phylogenetic relationship analysis of the M. catarrhalis yggW protein. YggW belongs to 
the group of HemW- and HemW-like proteins as it clusters with Psychrobacter sp. and Acinetobacter sp. 
HemW- and HemW-like proteins. Analysis was conducted using the ClustalW alignment method in MegAlign 
(Lasergene).
YggW was shown to be part of an operon, of which the other two genes, MCR_0996 and 
rhlB, were also picked up in our GAF screen. However, based on their annotation, no obvious 
functional connection between the genes that comprise the MCR_0996-rhlB-yggW operon 
exists. In line with this, no relationship between these genes in other species could be found 
using the Search Tool for the Retrieval of Interacting Genes (STRING) (24) (data not shown). The 
potential function of the hypothetical MCR_0996 remains as yet unknown, as no functional 
homologs in other species exist, and it does not possess any known conserved domains. The 
rhlB gene, like rnd, the fourth identified gene, may potentially play a role in the adaptation to 
changing environmental conditions. The RhlB protein is part of the multi-component complex 
called the degradosome, which is involved in the degradation of RNAs (25). RND is one of many 
ribonucleases that is present in the M. catarrhalis BBH18 genome. In Escherichia coli RND is 
involved in the 3’ maturation of several stable RNAs including 5S rRNA, tRNA, but also small 
structured RNAs (26). In this light, RND could intervene in the translation of mRNA into proteins. 
RND requires divalent metal ions to fulfill its function, however, it remains unclear which ion 
is required for M. catarrhalis RND activity. The combined effect of regulation of tRNA, rRNA 
availability, and RNA decay likely enables the bacterium to adapt to the iron-limiting conditions 
that are also faced at the host mucosa. The transcriptional profiles of the ΔrhlB and Δrnd mutants 
were very similar to the wild-type strain, but our microarrays did not provide for analysis of small 
RNAs, which may be altered in these mutant strains.
The fifth identified gene was MCR_0457, encoding a hypothetical protein. The role of 
MCR_0457 in growth under iron-limiting conditions was confirmed by genetic complementation, 
but appeared to be specific for strain BBH18. BLAST analysis only revealed low level identity (23 
to 37%) homologs of MCR_0457 in Enhydrobacter sp., Psychrobacter sp., and Acinetobacter 
sp., and no functional domains were detected. However, we did find a potential link with heme 
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metabolism, as MCR_0457 resides in a putative operon with MCR_0456, encoding a delta-
aminolevulinic acid dehydratase (porphobilinogen synthase, HemB), which is involved in heme 
biosynthesis. Interestingly, some of the differentially expressed genes in this mutant are also 
known to be differentially expressed under iron-limiting conditions including lbpA, tbpA, and 
the gene encoding the BadM/Rrf2 family transcriptional regulator, which also showed increased 
expression in a Chinchilla colonization model (7, 27).
For any pathogen, successful colonization and infection of the respiratory tract mucosa 
depends on its ability to adhere to the epithelial cell layer as well as to acquire essential nutrients 
such as iron. As iron is an important co-factor in various cellular and metabolic processes, 
changes in iron-metabolism may reduce virulence and/or bacterial fitness. For example, studies 
in Bordetella pertussis showed that iron-starvation resulted in increased adherence to respiratory 
tract epithelial cells by enhancing mucin-binding (28). In Neisseria meningitidis, deletion of znuD, 
involved in heme utilization, resulted in reduced adherence to A549 type II alveolar cells (29). In 
this study, we observed that the M. catarrhalis mutants attenuated for growth under iron-limiting 
conditions, were also attenuated for adherence to both A549 type II alveolar and Detroit 562 
pharyngeal epithelial cells. Importantly, gene expression of the known M. catarrhalis adhesion 
factors such as UspA1 (also confirmed on protein level by Western blot), Moraxella catarrhalis 
adherence protein (McaP), or Moraxella IgD binding protein (MID/Hag) was not changed in the 
mutant strains. In line with this, Wang et al., showed that exposure of M. catarrhalis to iron-
limiting conditions did not affect gene expression of UspA1 or MID/Hag (7), which may suggest 
that restricted iron availability influences the physiology or fitness of the bacterium in a more 
general way. 
In conclusion, we describe the successful use of the adapted GAF technology for high-
throughput identification of genes required for M. catarrhalis growth/survival during iron-
starvation. Future application of this technology to various in vivo relevant conditions will increase 
our understanding of M. catarrhalis pathogenesis.
eXPerIMenTal ProCedureS
bacterial strains, growth conditions, and plasmids. All strains and plasmids are summarized 
in Table S3. M. catarrhalis strains were routinely cultured on brain heart infusion (BHI) agar plates 
at 37°C in an atmosphere containing 5% CO2 or in BHI broth at 37°C at 200-250 rpm. Transposon 
mutant libraries, gene deletion mutants, and genetically complemented strains were cultured in 
BHI in the presence of 30 µg ml-1 spectinomycin (BHI-spec) and/or 15 µg ml-1 kanamycin. Naturally 
competent M. catarrhalis bacteria were obtained by growing cultures until early log-phase 
(OD620nm ~ 0.2-0.3). Aliquots of bacteria were routinely stored in the presence of 20% glycerol at 
-80°C. The mariner T7 transposon from pR412T7 (30) was amplified with a single phosphorylated 
primer PBGSF20 and cloned into the pCR2.1 vector (Invitrogen) to obtain pGSF8. For genetic 
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complementation of directed mutants, the spectinomycin resistance cassette of pWW115 (31) 
was replaced a kanamycin resistance cassette as follows. The kanamycin resistance cassette was 
amplified from pR410 (11) and subcloned in pGEMT-easy (Promega). Via restriction digestion, the 
kanamycin resistance cassette was ligated into the PciI and BsrGI sites of pWW115 downstream 
of the spectinomycin resistance cassette promoter, resulting in pSV001.
Construction of M. catarrhalis transposon mutant libraries. A large random mariner 
transposon mutant library was generated in M. catarrhalis BBH18 essentially as described 
previously (10, 11). For in vitro transposon mutagenesis, 10 µg BBH18 chromosomal DNA 
(Qiagen Genomic-tip 20/G isolated) was incubated with 5 µg pGSF8 and 10 µg purified HimarC9 
transposase in a 200 µl reaction volume. After repair of the transposition reaction, 1 ml naturally 
competent BBH18 bacteria was transformed with 100 µl mutagenized DNA in a total volume of 
5 ml (adjusted with BHI medium). After a 3 hour incubation at 37°C and 200 rpm, transformants 
were selected on BHI-spec plates. Subsequently, 28,000 independent transformants were scraped 
from the plates, pooled, expanded to an OD620nm ~ 0.6, and stored at -80°C.
GaF screen under iron-limiting conditions. The marinerT7 mutant library was pre-cultured to 
mid-log phase (OD620nm ~ 1.0), washed in 2 volumes of PBS supplemented with 0.15% gelatin 
(PBS-G), and resuspended in 0.5 volume PBS-G. This suspension was used to inoculate either 
BHI-spec medium that was pre-treated overnight with 30 µM Desferal (Sigma Aldrich) (challenge 
condition, BHI-DF30) or untreated BHI-spec medium (control condition, BHI-DF0) to an OD620nm 
~ 0.1. At the mid-log and early-stationary phase mutants were recovered from the cultures and 
stored at -80°C. This experiment was performed four times (two times on two different days). 
The recovered mutants were expanded for chromosomal DNA isolation using Genomic-tip 20/G 
columns. Next, 4 µg DNA was digested with 30 U AluI restriction enzyme (New England Biolabs). 
Digestions were assessed for completion on a 1% agarose gel and purified using the MinElute 
reaction clean-up kit (Qiagen). 2 µg digested DNA served as a template for a T7 RNA polymerase 
reaction (T7 MegaScript kit, Ambion) using the outward-facing T7 sites of the transposon 
element. This resulted in the generation of mutant-specific T7 RNA fragments that flank both 
sides of the transposon insertion. The template DNA was degraded with DNase I and the T7 RNA 
was purified using the RNeasy Minelute kit (Qiagen). 2 µg T7 RNA was reverse transcribed into 
cDNA in the presence of 16.7 ng µl-1 actinomycin D (ActD, Sigma Aldrich) using 1 µg Cy3-labeled 
random nonamers (Nimblegen) for priming, essentially as described in (14). Through the addition 
of ActD, formation of double stranded cDNA is inhibited (32), ensuring strand-specific cDNA 
synthesis and thus asymmetrical generation of mutant-specific cDNA probes. The obtained Cy3-
labeled mutant-specific cDNA was purified using CyScribe columns (GE healthcare Life Sciences), 
concentrated using YM-30 columns (Millipore), and subsequently used for hybridization to 
custom-designed Nimblegen microarrays.
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GaF microarray analysis. The custom-designed Nimblegen 4x72K GAF microarray design was 
based on the AluI-restriction fragments of the M. catarrhalis BBH18 genome (14). Nimblegen 
probes (50-72 nt) were designed on the 3’ and 5’ ends of all AluI fragments >70 nucleotides 
(nt) and in case of fragments >400 bp, spaced every ~ 200 bp on both strands. This allowed 
mapping of the transposon insertion with a ~200 bp resolution. Of the 6,085 AluI fragments 
larger than 70 nt, probes could be designed for 6,003 fragments, resulting in a total of 20,078 
experimental probes. In addition to three replicates of each experimental probe, the array 
contained 11,803 negative-control probes with a length distribution and G+C content similar to 
those of the experimental control probes. 2 µg Cy3-labeled mutant-specific cDNA was hybridized 
to the GAF microarrays overnight at 42°C using a Nimblegen hybridization station according 
to the manufacturer’s instructions. After washing, raw images were obtained using the MS200 
microarray scanner (Nimblegen) and processed using NimbleScan software. ANAIS (33) was 
used for intra-array (background adjustment) and inter-array (quantile) normalization to obtain 
normalized probe signal intensities (SI). Normalized probe SI were corrected for a threshold of 
five times the median SI of the negative-control probes. Statistical analysis was performed on 
the ratio between the SI of the control and challenge (iron-limiting) conditions using the CyberT 
implementation of Student’s t-test (cybert.microarray.ics.uci.edu). The false discovery rate (FDR) 
was calculated from the Pbayes as described in (34). Final selection criteria consisted of a fold-
change > 1.9 (control/challenge), a Pbayes < 0.001, and a FDR < 0.01.
Generation of directed mutants. Directed gene deletion mutants of M. catarrhalis BBH18 
were generated by allelic exchange of the target gene with a spectinomycin resistance cassette, 
essentially as described in (11). In short, an extension PCR was performed to join 400-500 bp 5’ 
and 3’ flanking sequences of a target gene with the spectinomycin resistance cassette (obtained 
from pR412T7), which was subsequently transformed into naturally competent M. catarrhalis 
BBH18 bacteria. For this, 10 µl PCR product was mixed with 100 µl competent cells and 400 µl 
BHI medium, incubated for 3 to 5 hours at 37°C and 200 rpm, and transformants were selected 
on BHI-spec plates. Transformants were checked by PCR for recombination at the desired 
location on the chromosome. Next, 0.5 - 1 µg DNA of the first generation directed mutants was 
crossed back into the BBH18 wild-type strain and selected on BHI-spec plates. At the same time, 
competent cells were also processed through the transformation procedure to obtain a coupled 
wild-type strain. Gene deletions of yggW and MCR_0457 in strains O35E, 7169, and 46P47B1 
were generated by transformation of a PCR product amplified from the corresponding BBH18 
mutants containing the spectinomycin resistance cassette and gene flanking regions. All primers 
used in this study (obtained from Biolegio, Nijmegen, The Netherlands) are shown in Table S4.
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Genetic complementation of yggW and MCr_0457 directed mutants. For genetic 
complementation of the BBH18 yggW mutant, PCR products of the yggW coding sequence 
(CDS) and the bro-1 promoter of strain BC7 (13) were joined via an overlap PCR. To this end, 
the reverse bro-1 promoter primer contained an overhang complementary to the forward yggW 
amplicon primer. The joined bro-1 promoter-yggW sequence was ligated into the XmaI and SacI 
sites of pSV001. To complement ΔMCR_0457, the CDS and upstream region was amplified from 
BBH18 and ligated into the BamHI and SacI sites of pSV001. For restriction digestions, amplicons 
were first subcloned into pGEMT-easy (Promega). To obtain the complemented mutants, plasmid 
ligation mixtures were first transformed into ΔyggW and ΔMCR_0457 of M. catarrhalis O35E 
as this strain is more easily transformable than BBH18. Subsequently, plasmid DNA was isolated 
from resulting O35E transformants and used to transform BBH18 mutants and wild-type strains.
in vitro growth under iron-limiting and iron-repleted conditions. The directed mutants 
and their parental wild-type strains were expanded to mid-log phase, washed in 2 volumes 
PBS-G, and resuspended in PBS-G to an OD620nm of 1.0. From this suspension, 200 µl was used 
to inoculate either overnight DF30 pre-treated BHI or untreated BHI. Colony forming units (CFUs) 
were determined at 0, 2, 4, and 5.5 hours of growth by plating 10-fold serial dilutions. For GAF 
validation and chemical complementation experiments with M. catarrhalis BBH18 mutants and 
wild-type strains, growth speed of the directed mutants was calculated between the 2 and 5.5 
hour time point as follows: n (number of generations) = 3.3 (log CFU at 5.5 hour time point – 
log CFU at 2 hour time point), generation time g (hours) = n/2.5 hour, growth rate constant 
Κ (generations per hour) = ln 2/g. For chemical complementation, DF30 treated medium was 
supplemented with iron sulphate (Sigma Aldrich) or bovine hemin (Sigma Aldrich) to a final 
concentration of 100 µM and 20 µM, respectively. For GAF validation experiments (n ≥ 3) with 
BBH18 mutants and wild-type strains, statistical difference was determined with a Mann-Whitney 
test. Statistical analysis of chemical complementation experiments (n = 2) was done with unpaired 
t-test with Welch’s correction. Growth experiments with genetically complemented yggW and 
MCR_0457 BBH18 mutant strains (n ≥ 5) were conducted in BHI pre-treated with DF30. The 
statistical differences were determined on log10-transformed data with a two-way ANOVA and 
a Bonferroni post-hoc test. Growth of O35E, 7169, and 46P47B1 (n ≥ 4) mutant strains under 
iron-limiting conditions were conducted at 30 µM and 20 µM (DF20). Statistical analysis were 
performed on log10-transformed data with a two-way ANOVA and a Bonferroni post-hoc test.
MCr_0996-rhlB-yggW operon validation and expression analysis. Cultures of directed 
mutants (ΔyggW, ΔrhlB, ΔMCR_0996) and their parental wild-type strain were grown in BHI to 
an OD620nm of ~ 1.0 and RNA was isolated as described in (14). cDNA was generated using the 
Superscript III reverse transcriptase kit (Qiagen) by using gene-specific primers for operon analysis 
and random hexamers for the single gene expression analysis. Amplifications were performed 
using the AmpliTaq system (Sigma Aldrich) and analyzed on 1% and 2% agarose gels, respectively. 
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adhesion of directed mutants to respiratory tract epithelial cells. The human pharyngeal 
epithelial cell line Detroit 562 (ATCC CCL-138) and the type II alveolar epithelial cell line A549 
(ATCC CCL-185) were routinely grown in DMEM with GlutaMAX™-I and 10% fetal calf serum 
(FCS) (Invitrogen) at 37°C and 5% CO2. Two days prior to the adherence assay, 2·10
5 Detroit 
562 cells per well were seeded into a 24-well tissue culture plate, and after one day, the growth 
medium was refreshed. A549 cells were seeded into 24-well tissue culture plates one day prior 
to the assay at 4·105 cells. For both cell lines, monolayers of approximately 1·106 cells per well 
were used for adherence assays. M. catarrhalis BBH18 wild-type and mutant strains were cultured 
under standard growth conditions (BHI medium, iron-rich) until mid-log phase (OD620nm ~ 1.0) 
and stored at -80°C. The bacteria were washed once in DMEM with GlutaMAX™-I and 1% FCS 
(infection medium) and resuspended in the infection medium to 1·107 CFU ml-1. Epithelial cells 
were washed twice with PBS, infected with 1 ml of the M. catarrhalis suspension (multiplicity of 
infection, 10 bacteria per cell), centrifuged for 5 minutes at 200x g, and incubated 1 h at 37°C in 
a 5% CO2 environment. Non-adherent bacteria were removed by 3 washes with PBS, after which 
1 ml 1% saponin (Sigma Aldrich) in PBS-G was added to detach and lyse the Detroit or A549 cells. 
CFUs were enumerated by plating 10-fold serial dilutions on BHI plates supplemented with the 
appropriate antibiotics. The percentage adherence of the mutants was expressed relative to the 
percentage adherence of the wild-type. Each experiment was performed at least four times and 
statistical difference was determined with a Mann-Whitney test.
analysis of outer membrane protein profiles and uspa1 expression. Wild-type and mutant 
strains were cultured till OD620nm of 1.0 to 1.2 and harvested by centrifugation. Outer membranes 
were isolated using the ReadyPrep Membrane I kit (Biorad) accordance to manufacturer’s 
instructions. During the lysis procedure, glass beads were added for homogenization with 
the TissueLyser LT (Qiagen). Protein quantification was performed using the 2D-Quant Kit (GE 
Healtcare). Five microgram of outer membrane preparations were separated on a 4-15% TGX gel 
(Biorad) and analyzed by colloidal Coomassie staining (35). To analyze UspA1 protein expression, 
five microgram was separated on a 6% SDS-page gel and blotted on PVDF membranes. Blots 
were blocked overnight in blocking buffer (1% BSA and 2% skimmed milk powder in PBS with 
0.1% tween20 (PBS-T)). Polyclonal anti-UspA1/A2 rabbit serum was diluted 1:500 in blocking 
buffer and incubated for 2 hours at room temperature. Blots were washed three times in PBS-T 
and incubated with swine anti-rabbit conjugated with horse radish peroxidase (Dako) for 1 hour. 
Proteins were detected with ECL plus reagent (GE healthcare). 
rT-qPCr expression analysis. Strains were expanded to OD620nm ~ 1.0 (n = 3) and RNA was 
isolated as previously described (14). DNA-free total RNA (500 ng) was reverse transcribed into 
cDNA with random primers (300 ng) using the Superscript III kit (Invitrogen). Expression of yggW 
and MCR_0457 in mutants or complemented mutants was determined relative to wild-type with 
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the ΔΔCt method (36). Real-time quantitative PCR (RT-qPCR) reactions were performed using 
SYBR green chemistry on a 7500 Fast real-time PCR machine (Applied Biosystems). The rpoD gene 
was included as a reference gene for data normalization.
Gene expression profiling of directed mutants. M. catarrhalis BBH18 directed mutants (n = 
3) and their parental wild-type BBH18 strain (n = 4) were expanded to mid-log phase (OD620nm, 
1.2 to 1.4) and RNA was isolated as previously described (14). Total RNA (5 µg) was labeled 
according to standard Nimblegen gene expression array protocols. The Nimblegen M. catarrhalis 
BBH18 expression array contained 8 probes per CDS, with each probe represented four times, 
and 7,298 negative control probes. CDS represented on the array included all ORFs predicted in 
BBH18 (14), as well as unique CDS predicted using ZCURVE (37), Prodigal (38), Glimmer (39), 
or GeneMarkHMM (40), sequences are available upon request. Normalization and threshold 
correction were performed as described for the M. catarrhalis GAF arrays, with the exception 
that the normalized probe SI were corrected for a threshold of seven times the median SI of 
the negative-control probes.Statistical analysis was performed on the median SI of the 8 probes 
representing a single CDS. Genes were considered to be differentially expressed at a fold-change 
>2 or <-2, Pbayes <0.0001, FDR <0.0001, and with the additional criteria that at least 6 out of 8 
probes met the fold-change cut-off, Pbayes <0.001, and FDR <0.001. Genes were also excluded 
if the expression was low (SI < 500) in both the wild-type and the mutant strain. Functional 
class distribution was assessed using the Institute for Genomic Sciences (IGS) classification (14). 
Functional class enrichment was assessed using the Fishers exact (one-tail) test, corrected for 
multiple testing per directed mutant strain according to Storey and Tibshirani (41).
Microarray data. All microarray data have been deposited in NCBI Gene Expression Omnibus 
(GEO) database (http://www.ncbi.nlm.nih.gov/geo/) under GEO Series Accession No. GSE41548, 
subseries GSE41546 for GAF microarrays and subseries GSE41547 for expression profiling data.
Statistical analysis. Statistical analyses were performed in GraphPad Prism 5.0 (GraphPad 
Software) unless indicated otherwise, with P < 0.05 considered to be significant.
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Fig. S1. in vitro growth characteristics of M. catarrhalis bbH18 directed gene deletion mutant 
strains. Mutants and wild-type strains were cultured under control (BHI-DF0), iron-limiting (BHI-DF30), or 
iron-repleted (BHI-DF30 supplemented with 100 μM iron sulphate (FeSO4) or BHI-DF30 supplemented with 
20 μM hemin) conditions. No growth of directed mutant strains ΔyggW (A), ΔrhlB (B), ΔMCR_0996 (C), Δrnd 
(D) and ΔMCR_0457 (E) was observed under iron-limiting conditions, whereas, ΔcopB (F), and ΔlbpA (G) 
were still able to expand during iron-limiting conditions. The growth defect under iron-limiting conditions was 
restored upon iron-repletion via the addition of iron sulphate and hemin (A-E, H).
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Table S1. Please refer to: http://onlinelibrary.wiley.com/doi/10.1111/mmi.12081/suppinfo.
Table S2. Functional class enrichment of genes differentially expressed in M. catarrhalis bbH18 
directed mutant strains. Statistical significance was determined with a one-tail (left) Fisher exact test, 
corrected for multiple testing per directed mutant strain according to (41), and considered significant at a 
Q-value < 0.001, indicated by bold and underlined font
  ΔyggW ΔrhlB ΔMCR_0996 Δrnd ΔMCR_0457
Functional class (14) up down up down up down up down up down
Amino acid biosynthesis 1 1 1 1 1 1 1 1 1 1
Purines, pyrimidines, 
nucleosides, and nucleotides
1 1 1 1 1 1 1 1 1 1
Fatty acid and phospholipid 
metabolism
1 1 1 1 1 1 1 1 1 1
Biosynthesis of cofactors, 
prosthetic groups, and 
carriers
1 1 1 1 1 1 1 1 1 1
Central intermediary 
metabolism
1 1 1 0.87 1 1 1 1 1 0.20
Energy metabolism 1 1 0.87 1 0.14 1 0.62 1 0.62 1
Transport and binding 
proteins
1 1 1 1 1 1 1 1 1 4.32e-06
DNA metabolism 1 1 1 0.87 1 1 1 1 1 1
Transcription 1 1 1 0.87 1 1 1 0.62 1 1
Protein synthesis 1 1.15e-07 1 1 1 1 1 1 1 1
Protein fate 1 1 1 1 1 1 1 1 1 1
Regulatory functions 1 1 1 1 1 1 1 1 1 1
Signal transduction 1 1 1 1 1 1 1 1 0.55 1
Cell envelope 1 1 1 1 1 1 1 1 1 1
Cellular processes 1 1 1 1 1 1 1 0.85 0.34 1
Mobile and 
extrachromosomal element 
functions
1 1 1 1 1 1 1 1 1 1
Unknown function 1 1 1 1 1 1 1 1 1 1
Conserved hypothetical and 
hypothetical proteins
1.12e-07 1 1 1 1 1 0.62 1 1 1
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Table S3. bacterial strains and plasmids used in this study
Strain or plasmid Relevant feature a b Reference
Moraxella catarrhalis    
BBH18 Wild-type isolate (42)
BBH18 ΔyggW yggW (MCR_0994) deletion mutant, SpecR This study
BBH18 ΔrhlB rhlB (MCR_0995) deletion mutant, SpecR This study
BBH18 ΔMCR_0996 MCR_0996 deletion mutant, SpecR This study
BBH18 Δrnd rnd (MCR_0843) deletion mutant, SpecR This study
BBH18 ΔMCR_0457 MCR_0457 deletion mutant, SpecR This study
BBH18 ΔcopB copB (MCR_0492) deletion mutant, SpecR This study
BBH18 ΔlbpA lbpA (MCR_0219) deletion mutant, SpecR This study
BBH18 ΔolpA olpA (MCR_1761) deletion mutant, SpecR This study
BBH18 ΔuspA1 uspA1 (MCR_1198) deletion mutant, SpecR This study
BBH18 ΔyggW + yggW yggW (MCR_0994) deletion mutant, SpecR, 
complemented with pSV002, KanR
This study
BBH18 ΔMCR_0457 + MCR_0457 MCR_0457 deletion mutant, SpecR, complemented 
with pSV003, KanR
This study
O35E Wild-type isolate (43)
O35E ΔyggW This study
O35E ΔMCR_0457 This study
7169 Wild-type isolate (13)
7169 ΔyggW yggW deletion mutant, SpecR This study
7169 ΔMCR_0457 MCR_0457 deletion mutant, SpecR This study
46P47B1 Wild-type isolate (13)
46P47B1 ΔyggW yggW deletion mutant, SpecR This study
46P47B1 ΔMCR_0457 MCR_0457 deletion mutant, SpecR This study
Escherichia coli
DH5α Host for pGSF8 and pR412T7 plasmids
XL1-blue Host for pGEMT-easy plasmids
Plasmids
pR412T7 Donor for SpecR cassette (10)
pGSF8 Donor for mariner transposon, containing SpecR and 
outward facing T7 sites
This study
pR410 Donor for KanR cassette (11)
pWW115 Plasmid used for generation of pSV001 (31)
pSV001 Derived from pWW115 by replacement of SpecR by 
KanR from pR410
This study
pSV002 Derived from pSV001, bro-1 promoter region fused to 
the yggW coding sequence cloned in XmaI and SacI 
sites
This study
pSV003 Derived from pSV001,MCR_0457 coding sequence 
plus upstream region cloned in BamHI and SacI sites
This study
a SpecR, spectinomycin resistance, b KanR, kanamycin resistance cassette
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3.2 
Characterization of the molecular interplay between 
Moraxella catarrhalis and human respiratory tract 
epithelial cells
Stefan P.W. de Vries, Marc J. eleveld, Peter W.M Hermans, Hester J. bootsma
PLoS One. 2013, 8(8):e72193.
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abSTraCT
Moraxella catarrhalis is a mucosal pathogen that causes childhood otitis media and exacerbations 
of chronic obstructive pulmonary disease in adults. During the course of infection, M. catarrhalis 
needs to adhere to epithelial cells of different host niches such as the nasopharynx and lungs, 
and consequently, efficient adhesion to epithelial cells is considered an important virulence trait 
of M. catarrhalis. By using Tn-seq, a genome-wide negative selection screenings technology, we 
identified 15 genes potentially required for adherence of M. catarrhalis BBH18 to pharyngeal 
epithelial Detroit 562 and lung epithelial A549 cells. Validation with directed deletion mutants 
confirmed the importance of aroA (3-phosphoshikimate 1-carboxyvinyl-transferase), ecnAB 
(entericidin EcnAB), lgt1 (glucosyltransferase), and MCR_1483 (outer membrane lipoprotein) 
for cellular adherence, with ΔMCR_1483 being most severely attenuated in adherence to both 
cell lines. Expression profiling of M. catarrhalis BBH18 during adherence to Detroit 562 cells 
showed increased expression of 34 genes in cell-attached versus planktonic bacteria, among 
which ABC transporters for molybdate and sulfate, while reduced expression of 16 genes was 
observed. Notably, neither the newly identified genes affecting adhesion nor known adhesion 
genes were differentially expressed during adhesion, but appeared to be constitutively expressed 
at a high level. Profiling of the transcriptional response of Detroit 562 cells upon adherence of 
M. catarrhalis BBH18 showed induction of a panel of pro-inflammatory genes as well as genes 
involved in the prevention of damage of the epithelial barrier. In conclusion, this study provides 
new insight into the molecular interplay between M. catarrhalis and host epithelial cells during 
the process of adherence.
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3.2
InTroduCTIon
Moraxella catarrhalis is a human-restricted pathogen that is responsible for respiratory tract 
infections such as childhood otitis media (OM) and exacerbations of chronic obstructive pulmonary 
disease (COPD) in adults (1). Successful colonization and infection by M. catarrhalis depends on 
its ability to attach to the respiratory tract mucosa. Various molecular typing methods, including 
multi-locus sequencing-typing, have demonstrated the existence of two phylogenetic lineages 
within the M. catarrhalis species. Isolates grouped into the more virulent lineage 1 are more 
frequently isolated from diseased individuals and adhere more efficiently to respiratory tract 
epithelial cells than do isolates of lineage 2 (2, 3). 
Adhesion is a multifactorial process mediated by many adhesin molecules including fimbrial 
adhesins such as type IV pili (4) and non-fimbrial adhesins like the Ubiquitous surface proteins 
A1 and A2H (UspA1 and UspA2H) (5), the M. catarrhalis IgD-binding protein/haemagglutinin 
(MID/Hag) (6), outer membrane protein CD (OMP CD) (7), and M. catarrhalis adhesion protein 
(McaP) (5), recently reviewed by Su et al., (8). Of importance, the UspA proteins are built out of 
interchangeable sequence motifs and consequently large variation exists between isolates, which 
could affect the adherence capability of each isolate (9). Strain to strain variation in adhesion 
efficiency is also reported to be dependent on adhesin expression as isolates with low MID/Hag 
(6) or UspA1 (10, 11) expression showed reduced adhesion. The different adhesins bind to a 
variety of receptors or structural molecules expressed on respiratory tract epithelial cells: UspA1 
for instance mediates adhesion through binding to carcinoembryonic antigen-related cellular 
adhesion molecule 1 (CEACAM1) (12), and to the ECM proteins fibronectin (13) and laminin (14). 
Host receptors for other adhesin molecules of M. catarrhalis such as MID/Hag or McaP remain to 
be identified. Further, Ahmed et al. postulated that the negative charge of M. catarrhalis may be 
important for binding to positively charged surface structures present on pharyngeal epithelial 
cells (15). The complete repertoire of adhesion mechanisms is proposed to allow M. catarrhalis to 
attach to epithelial cell types of different anatomical niches (8).
The interaction of M. catarrhalis and its human host is a dynamic process and imbalance 
or failure to induce a proper innate immune defense is thought to enable M. catarrhalis to 
expand and persist in the human airways (16). Transcriptional reprogramming of respiratory tract 
epithelial cells upon contact with M. catarrhalis is considered to be central to the host defense. 
The upper airway epithelial cells play a key role together with macrophages, dendritic cells, 
neutrophils, and mast cells in steering the host inflammatory response against M. catarrhalis. This 
inflammatory response is trigged by binding of pathogen-associated molecular patterns (PAMPs) 
such as the M. catarrhalis lipooligosaccharide (17), to pattern-recognition receptors (PRRs). The 
resulting activation of signal transduction pathways (18) by M. catarrhalis is mainly dependent 
on Toll-like receptor (TLR)-2 and drives NF-κB-mediated production of interleukin-8 (IL-8), which 
guides granulocyte recruitment to the site of infection (18, 19). Increased secretion of the pro-
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inflammatory cytokines IL-6, IL-1β, and IL-8 and granulocyte-macrophage colony-stimulating 
factor (GM-CSF/CSF3) by airway epithelial cells and macrophages is characteristic of M. catarrhalis 
infections (8). Interestingly, through UspA1 interaction with CEACAM1 on epithelial cells M. 
catarrhalis is able to partially suppress IL-8 production (20).
The aim of this study was to increase our understanding of the complex interaction of M. 
catarrhalis and its human host during the first critical strep of infection, adherence to epithelial 
cells. Although several factors are already known to facilitate M. catarrhalis adherence, the 
complete repertoire of adhesins and genes indirectly affecting adhesion has not been completely 
characterized yet. Here, we have used the genome-wide negative selection screenings technology 
Tn-seq to identify novel bacterial factors influencing adhesion of M. catarrhalis to pharyngeal 
Detroit 562 and lung A549 epithelial cell lines. The findings of our transposon mutant library 
screen were validated by testing a panel of directed gene deletion mutants for their ability to 
adhere. To gain insight into the multifactorial interaction that takes place between the pathogen 
and the host, the transcriptional responses of both were monitored during adherence of M. 
catarrhalis to Detroit 562 cells.
reSulTS and dISCuSSIon
Identification of genes affecting M. catarrhalis bbH18 adherence. To comprehensively 
identify the genes relevant for cellular adherence of M. catarrhalis, a genome-wide negative 
selection Tn-seq screen (21, 22) was performed. For this a ~7,000 mariner transposon mutant 
library was generated in M. catarrhalis BBH18 as described previously (23), and screened during 
adherence to two respiratory tract epithelial cells of distinct anatomical locations, the pharynx 
(Detroit 562 cells) and lung (A549 type-II alveolar epithelial cells). Examination of the relative 
abundance of each individual transposon mutant in the library under control conditions (not 
exposed to epithelial cells) by Tn-seq revealed transposon insertions covered by at least 10 
sequence reads in 5,543 unique TA-sites, representing a total of 1,077 genes. 
For the adherence Tn-seq screen, the mutant library was allowed to attach to A549 and 
Detroit 562 cells for 1 hour. Subsequently, adherent, non-adherent, and control (incubation in the 
infection medium alone) fractions were recovered and the relative abundance of each transposon 
mutant in all fractions was profiled using Tn-seq. Genes of which transposon mutants were 
attenuated in adherence were identified by a significant fold-change of at least log2 1.6 between 
the adherent and non-adherent library fractions. To accommodate for potential effects, either 
positive or negative, of epithelial cells on the composition of the non-adherent fraction, we also 
included a minimum log2 fold-change of 1.2 between the adherent fraction and the library that 
was incubated in the infection medium alone (control). Based on these selection criteria, 35 genes 
were found to be required for cellular adherence of BBH18, of which 15 were identified with 
both Detroit 562 and A549 cells, 13 were specific for A549, and 7 were specific for Detroit 562 
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3.2
(Figure 1 and Table S1). Conversely, insertional inactivation of seven genes appeared to result in 
enhanced cellular adherence: two for both cell lines, one specific for A549, and four for Detroit 
562 (Figure 1 and Table S1).
1513 7
A549 Detroit 562 
1 2 4
Attenuated
Enriched
Tn-seq
Adherence 
phenotype
Fig. 1. Genes affecting adherence of M. catarrhalis to respiratory tract epithelial cells. Overlap 
between genes identified by Tn-seq as important for adherence of M. catarrhalis BBH18 to A549 and Detroit 
562 epithelial cells. 
Of the 35 Tn-seq-identified genes potentially required for M. catarrhalis BBH18 adherence, 
21 genes are classified as (conserved) hypothetical or of unknown function. Four genes belong 
to the functional class of “cell envelop”, namely uspA2H, lgt1 involved in LOS biosynthesis (24), 
the putative lipoprotein MCR_1483, and the outer membrane protein MCR_1742. Further, genes 
were identified that are involved in DNA repair (ruvA and the putative holiday junction resolvase 
MCR_1850), cellular processes (entericidin ecnAB), energy metabolism (pfkB family carbohydrate 
kinase MCR_1654 and adenosyl-homocysteinase ahcY), biosynthesis of aromatic amino acids 
(aroA), regulatory functions (badM/rrf2 MCR_0609 and metR family transcriptional regulator 
MCR_0330), transcription (endoribonuclease L-PSP MCR_0348), and protein synthesis (trmB) 
(Table S1).
Our screen did not identify all genes previously shown to be involved in cellular adhesion 
of M. catarrhalis such as genes encoding UspA1 (5), MID/Hag (6), OMP CD (7), and McaP (5). 
Some of these, such as ompCD, were not represented by mutants in the library, likely because 
ompCD mutants have attenuated in vitro growth (7). Furthermore, we most likely haven’t reached 
saturation for the number of genes that could potentially be hit by a transposon with our mutant 
library. However, we deliberately constructed a smaller library to ensure sufficient coverage of 
each mutant in the fractions samples (at least 200-fold), and thus prevent random loss of mutants 
from the library during the screen (i.e., false-positives). 
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Another possible factor limiting the number of genes identified in our screen may be the 
relatively small level of attenuation of single mutants. For instance, we have previously shown 
that a BBH18 mutant of uspA1, one of the main adhesion factors, still adhered to Detroit 562 and 
A549 cells at levels 34% and 57% of wild-type, respectively (23). This could possibly originate 
in outer membrane surface charge mediating non-specific adhesion (15) and/or the fact that M. 
catarrhalis adhesion is a multifactorial process. The complex interplay between multiple adhesin 
molecules was also demonstrated by Bullard et al. who showed that while purified recombinant 
MID/Hag bound to A549 cells, expression of MID/Hag in Escherichia coli did not enhance binding 
to A549 cells, whereas binding of MID/Hag-expressing E. coli to human middle ear epithelial cells 
(HMEE) was increased (25). It was proposed that the MID/Hag interaction with A549 requires 
co-expression of UspA1 and/or other adhesins such as OMP CD (25). As a consequence, loss 
of a single adhesin does not completely abolish adhesion, also exemplified by Timpe et al. who 
demonstrated that reduced adherence after deletion of mcaP from strain O35E was only observed 
in a uspA1, uspA2, and mid/hag triple mutant background and not in wild-type (26). Along this 
line, screening a transposon mutant library generated in an uspA1 mutant background may result 
in the identification of more genes affecting adhesion. 
adherence efficiency of directed gene deletion mutants. Since the focus of this study was to 
identify novel factors that affect adhesion of M. catarrhalis, we generated directed gene deletion 
mutants for a selection of eight genes (MCR_0609, MCR_0837, aroA, ecnAB, lgt1, MCR_1483, 
and MCR_1742) that have not previously been linked to adhesion (Table 1). Importantly, deletion 
of these genes did not affect growth or survival of BBH18 in the infection medium during 1 
hour (data not shown). Adherence of mutants of MCR_1483, aroA, lgt1, and ecnAB to both 
A549 and Detroit 562 cells was significantly attenuated compared to wild-type, confirming the 
Tn-seq results (Fig. 2AB). Mutants of trmB, MCR_0609, and MCR_0837, however, displayed 
wild-type adherence levels, while deletion of MCR_1742, encoding an uncharacterized outer 
membrane protein, even appeared to result in enhanced adhesion to both cell lines (Fig. 2AB). 
This apparent discrepancy may be explained by the difference in experimental setup between 
the Tn-seq screen and the validation experiments: adherence of transposon mutants during the 
screen was assessed in a competition setup (i.e., between a particular mutant and the remainder 
of the library), whereas directed deletion mutants were assayed individually for their adherence 
ability in validation experiments, which is a less stringent approach as has also been shown by 
others (27, 28). Furthermore, differences in inter-bacterial interaction dynamics may have resulted 
in the increased adherence of the MCR_1742 deletion mutant. 
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Fig. 2. adhesion of directed gene deletion mutants to respiratory tract epithelial cells. Adherence of 
aroA, ecnAB, lgt1, and the putative lipoprotein MCR_1483 to both Detroit 562 (A) and A549 (B) cells was 
significantly attenuated compared to wild-type (WT). Adherence levels are expressed relative to WT (n ≥ 3) 
and shown as means and SEM. Statistical difference was determined with a Mann-Whitney test with * P < 
0.05, ** P < 0.01, and *** P < 0.001.
Loss of the putative outer membrane lipoprotein gene MCR_1483 and aroA resulted in 
the most severe attenuation of adherence, to 30-39% and 34-39% of wild-type, respectively. 
MCR_1483 encodes a small 48 amino acid putative lipoprotein sharing 58% identity with the 
LppL protein of Pseudomonas sp. GM102. In M. catarrhalis BBH18 MCR_1483 is part of a 
putative operon together with lysA, dapF, and xerC, whereas the representative gene cluster 
in Pseudomonas sp. contains two additional uncharacterized ORFs (29). In Pseudomonas 
fluorescens WCS365 this operon, more specifically xerC encoding a site specific recombinase, is 
required for root colonization (30). Others postulated that in Pseudomonas sp. LppL is involved 
in regulation of the lysine biosynthesis gene lysA (29). The attenuated adhesion of the aroA 
mutant is intriguing, especially since a direct role of this predicted cytoplasmic protein in cellular 
adhesion is unlikely. The aroA gene encodes a 3-phosphoshikimate 1-carboxyvinyltransferase that 
is involved in aromatic amino acid metabolism and generation of chorismate-derived metabolites 
(31). Deletion of aro genes leads to attenuated virulence in many bacterial pathogens and often 
results in defective cell envelope biosynthesis (32). It could be possible that a defective outer 
membrane function in M. catarrhalis BBH18ΔaroA caused in incorrect localization of “true” 
adhesins, thereby leading to attenuated adhesion. Interestingly, both MCR_1483 and aroA were 
also found to be required for complement resistance of M. catarrhalis (De Vries et al., unpublished 
data) and thus appear to fulfill or affect an essential virulence mechanism. More subtle effects 
on adherence efficiency were observed upon deletion of ecnAB and lgt1, 59-78% and 64-80% 
of wild-type, respectively. In E. coli, ecnAB is reported to direct the biosynthesis of two small 
outer membrane lipoproteins that regulate programmed cell death (33). Deletion of lgt1, which 
encodes an α-(1-2) glucosyltransferase involved in LOS biosynthesis (24), is expected to result in 
a truncated LOS structure. An altered LOS structure may lead to decreased membrane stability 
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and altered surface display of adhesins as has been shown for a LOS-deficient mutant of strain 
O35E (34). 
differential expression of M. catarrhalis upon adhesion. To monitor changes in the 
transcriptional profile of M. catarrhalis BBH18 early after adherence to upper airway epithelial 
cells, we compared expression of the adherent (cell-attached) and non-adherent (planktonic) 
fractions after 1h adherence to Detroit 562 cells. In addition, we examined expression of bacteria 
that were only incubated in the infection medium (control fraction). Rather surprisingly, very 
few expression differences (~3-fold increased expression of lbpB and MCR_0218) were observed 
between control and non-adherent bacteria, indicating that in the absence of direct contact, 
host cells had a limited impact on M. catarrhalis, and that the non-adherent fraction is likely to 
represent basal expression levels under our assay conditions. Therefore, we focused our analysis 
on the differences between the cell-attached and non-adherent fractions.
In total, we found increased expression of 34 genes and reduced expression of 16 genes in 
adherent relative to non-adherent bacteria (Table S2). Next to (conserved) hypothetical genes 
(19, 55.8%), predominant classes found among the genes with increased expression in the 
cell-attached fraction were metabolic genes (7, 20.6%) and genes encoding “transport and 
binding” proteins (5, 14.7%) (Fig. 3A). For example, increased expression was found for the 
putative acyl-CoA dehydrogenase gene fadE (MCR_0042) involved in beta-oxidation of fatty 
acids (35), and for ABC transporter genes for molybdate (modABC-cluster). An increased need 
for molybdenum could arise due to higher redox activity in sulfur, nitrogen en carbon metabolism 
for which molybdenum is required (36). In line with this, gene expression of nitrate reductase 
(narJ), encoding a molybdenum cofactor-dependent enzyme (36), was also increased, potentially 
to fulfill the energy need required for adaptation during epithelial cell adherence. In addition, 
several sulfate metabolism genes displayed increased expression in cell-attached bacteria, namely 
ABC transporter genes that mediate uptake of sulfur (cysP and cysU) and genes that participate 
in biosynthesis of reduced sulfur metabolites (cysH and cysI). Interestingly, deletion of cysH from 
Mycobacterium tuberculosis resulted in attenuated virulence in mice and reduced resistance 
against oxidative stress (37). The majority of lower expressed genes in cell-attached bacteria were 
(conserved) hypotheticals (9, 56.3%), but reduced expression was also found for genes encoding 
a putative lipoprotein (MCR_1168), glutaredoxin-like protein (MCR_0600), and 50S ribosomal 
protein L33 (rpmG).
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Fig. 3. Gene expression of M. catarrhalis bbH18 during adherence to detroit 562 cells. (A) Functional 
class distribution of genes differentially expressed in cell-attached relative to non-adherent (planktonic) 
M. catarrhalis (n = 4), depicted as number of genes per functional class category. (B) Distribution of gene 
expression levels of known adhesins and structural components associated with adherence in cell-attached 
M. catarrhalis. Average log2 microarrays signal intensities (SI) per gene were grouped into bins (1-log interval 
per bin), and the total number of genes within a bin is shown here. 
Interestingly, none of the genes encoding the known M. catarrhalis adhesion factors UspA1/
A2H (5), MID/Hag (6), OMP CD (7), McaP (5), and LOS (38) and type IV pili biosynthesis genes 
(4) were differentially expressed in cell-attached bacteria. Grouping of the microarray log2 signal 
intensities obtained for each gene in cell-attached bacteria into bins (1-log intervals) showed 
that the adhesin genes ompCD, mid/hag, and uspA2H were among the highest expressed genes 
(Fig. 3B). This may suggest that they are constitutively expressed at relatively high level, and 
are not subject to transcriptional regulation on a population level, although transcriptional and 
translational phase variation has been shown to affect expression of UspA1/A2H (39) and MID/
Hag (40) at single bacterium level. 
differential host gene expression upon M. catarrhalis adhesion. Next to the bacterial 
response upon epithelial cell adhesion, we examined the concurrent host response during 
attachment of M. catarrhalis to Detroit 562 cells. After 2h adherence of M. catarrhalis BBH18, 77 
Detroit 562 genes showed a more than 2-fold enhanced expression relative to control Detroit 562 
cells incubated in the infection medium alone, whereas reduced expression was only observed 
for thioredoxin-interacting protein TXNIP (Table S3). In particular, expression of various pro-
inflammatory genes was increased during attachment of M. catarrhalis (Table 2), namely of genes 
encoding tumor necrosis factor (TNF), Interleukin (IL)-1β, IL-6, IL-8, IL-17C, colony stimulating 
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factor 2 and 3 (G-CSF and GM-CSF, respectively), and chemokines CXCL1, CXCL2, CXCL3, 
and CCL20. These genes are known to be induced during acute infection by many bacterial 
pathogens, and serve as a general alarm signal that increases the likelihood that the infection is 
detected by the host (41). The increased expression (~129-fold) of CCL20 was most pronounced. 
CCL20 is a strong attractant for lymphocytes and weakly chemotactic for granulocytes (42), 
and can also be induced by IL-1β (43). Epithelial cells are the main source of IL-17C and its 
receptor (IL-17RE/IL-17RA heterodimer) is predominantly expressed on epithelial cells. Therefore, 
the increased expression of IL-17C is expected to result in autocrine signaling to enhance gene 
expression of factors that regulate the local and systemic response (44). In line with other studies, 
binding of M. catarrhalis to Detroit 562 cells induced expression of the cell adhesion molecule 
ICAM1, which regulates leukocyte recruitment and facilitates neutrophil bacterial killing (17). 
Enhanced gene expression was observed for various transcriptional regulators and components 
of signal transduction pathways such as the transcription activator JUN, and the cyclic AMP-
dependent transcription factor ATF-3. In addition, increased expression of immune dampening 
factors was found for the NF-κB pathway suppressors IκB-α (NFKBIA), acting in the cytoplasm to 
sequester NF-κB, and the kinase MAP3K8 (41). The panel of immune suppressors was extended 
by increased expression of TNFAIP3, which functions in a negative feedback loop regulating TLR-
ligand and TNF induced responses (45). 
Noteworthy, M. catarrhalis binding induced expression of α-1-antichymotrypsin (SERPINA3), 
a serine protease inhibitor that protects host tissue from oxidative and proteolytic damage (46) in 
order to counteract the action of neutrophil secreted factors such as elastase, metalloproteases and 
reactive oxidative radicals. Previously it was proposed that UspA-mediated α-1-antichymotrypsin 
binding by M. catarrhalis confers resistance against host proteases. This potentially allows M. 
catarrhalis to induce more severe inflammation, which may result in excessive tissue damage and 
subsequently exposure of ECM that facilitates bacterial attachment and colonization (8, 46). Of 
note, upon binding of M. catarrhalis expression of anti-apoptotic genes BCL2A1 and BIRC3 was 
also increased, potentially compensating for apoptotic stimuli and preventing damage to the 
epithelial barrier (Table 2). 
Overall, the abundantly induced inflammatory response characterizing M. catarrhalis 
airway inflammation is key to infiltration of neutrophils, lymphocytes, and macrophages, and 
contributes to COPD exacerbation and OM pathogenesis (8, 47). The potential of M. catarrhalis 
to induce high levels of inflammation may cause higher disease burden during co-infection 
with other respiratory tract pathogens such as S. pneumoniae and NTHi. For S. pneumoniae, 
a pro-inflammatory environment has been shown to be required for progression to the middle 
ear and its ability to cause OM, exemplified by Short et al. who demonstrated that viral or 
lipopolysaccharide-induced inflammation is sufficient for S. pneumoniae to cause OM in an infant 
murine model (48). Interestingly, co-infection of M. catarrhalis with S. pneumoniae resulted in 
increased incidence of OM, higher pneumococcal load, and prolonged infection in a murine 
nasopharyngeal colonization model (49).
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Table 2. Selection of detroit 562 genes induced in response to M. catarrhalis bbH18
Gene Description Log2 FC 
a
Immune system
CCL20 chemokine (C-C motif) ligand 20 7.0
IL1A interleukin 1, alpha 5.3
CD69 CD69 molecule 5.2
CXCL3 chemokine (C-X-C motif) ligand 3 5.0
IL1B interleukin 1, beta 4.8
TNF tumor necrosis factor (TNF superfamily, member 2) 4.2
IL8 interleukin 8 4.1
SERPINA3 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 4.0
IL6 interleukin 6 4.0
PTX3 pentraxin-related gene, rapidly induced by IL-1 beta 4.0
IL29 interleukin 29 3.6
CSF3 (G-CSF) colony stimulating factor 3 (granulocyte) 3.5
NFKBIZ nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor, zeta 3.2
TA-NFKBH T-cell activation NFKB-like protein 3.2
JUN v-jun sarcoma virus 17 oncogene homolog (avian) 3.1
LTB lymphotoxin beta (TNF superfamily, member 3) 3.0
IL17C interleukin 17C 2.7
IL1F9 interleukin 1 family, member 9 2.6
ICAM1 intercellular adhesion molecule 1 (CD54), human rhinovirus receptor 2.5
IRAK2 interleukin-1 receptor-associated kinase 2 2.3
CSF2 (GM-CSF) colony stimulating factor 2 (granulocyte-macrophage) 2.2
CXCR4 chemokine (C-X-C motif) receptor 4 2.2
EDN2 endothelin 2 2.1
IL32 interleukin 32 2.1
TNFSF18 tumor necrosis factor (ligand) superfamily, member 18 2.1
MAP3K8 mitogen-activated protein kinase kinase kinase 8 2.1
LIF leukemia inhibitory factor 2.0
CXCL1 chemokine (C-X-C motif) ligand 1 1.9
CXCL2 chemokine (C-X-C motif) ligand 2 1.9
NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, α 1.9
TIFA TRAF-interacting protein with a forkhead-associated domain 1.6
ICOSLG inducible T-cell co-stimulator ligand 1.5
EDN1 endothelin 1 1.4
CD83 CD83 molecule 1.3
ATF3 activating transcription factor 3 1.2
apoptosis and negative regulation of apoptosis
ANGPTL4 angiopoietin-like 4 4.4
TNFAIP3 tumor necrosis factor, alpha-induced protein 3 4.0
C8orf4 chromosome 8 open reading frame 4 3.3
BIRC3 baculoviral IAP repeat-containing 3 3.1
ZC3H12A zinc finger CCCH-type containing 12A 2.8
DDIT4 DNA-damage-inducible transcript 4 1.1
BCL2A1 BCL2-related protein A1 1.7
IER3 immediate early response 3 1.3
a FC; fold-change BBH18-infected / mock-infected Detroit
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Conclusions. In this paper, we used a combination of genome-wide approaches to increase our 
understanding of the molecular interplay between M. catarrhalis and respiratory tract epithelial 
cells during cellular adhesion, which is the critical first step towards colonization and infection. 
One of the newly identified factors that affect M. catarrhalis adhesion was the putative outer 
membrane lipoprotein MCR_1483. Both host and microbe were found to undergo transcriptional 
adaptation during adherence, with expression changes in cell-attached M. catarrhalis mainly 
restricted to metabolism and transport. In the epithelial cells, a significant induction of a pro-
inflammatory response was observed, which may affect disease progression during (poly)-
microbial respiratory tract infections. The results described in this study should provide basis for 
future investigations characterizing M. catarrhalis pathogenesis. 
MaTerIalS and MeTHodS
bacterial strains and growth conditions. All strains used in this study are listed in Table S4. 
M. catarrhalis was cultured on brain heart infusion (BHI) agar plates at 37°C in an atmosphere 
containing 5% CO2 or in BHI broth at 37°C at 200-250 rpm. M. catarrhalis BBH18 transposon 
mutant libraries and gene deletion mutants were cultured the presence of 30 µg ml-1 spectinomycin 
(BHI-spec). Aliquots of bacteria were routinely stored in the presence of 20% glycerol at -80°C. 
Construction of a M. catarrhalis transposon mutant library. A M. catarrhalis BBH18 mariner 
transposon mutant library consisting of ~7,000 independent transformants was generated as 
described in De Vries et al. (23). 
Generation of M. catarrhalis directed gene deletion mutants. Directed gene deletions were 
introduced in M. catarrhalis BBH18 by allelic exchange of the target gene with a spectinomycin 
resistance cassette as described in De Vries et al. (23). Chromosomal DNA of a first generation 
mutant was used to PCR-amplify the spectinomycin resistance cassette and the gene flanking 
regions using the L1 and R1 primers (Table S5). The obtained PCR product was subsequently 
introduced into a wild-type recipient by natural transformation. At the same time, competent 
cells were processed through the transformation procedure without addition of DNA to obtain a 
coupled wild-type strain. Primers used in this study are shown in Table S5.
adhesion assays with respiratory tract epithelial cells. Adhesion assays with the human 
pharyngeal epithelial cell line Detroit 562 (ATCC CCL-138) and the type II alveolar epithelial cell 
line A549 (ATCC CCL-185) were performed essentially as described previously (23). Both cell lines 
were routinely cultured in DMEM with GlutaMAX™-I and 10% fetal calf serum (FCS) (Invitrogen) 
at 37°C and 5% CO2. For adherence assays, monolayers of ~1·10
6 (24-well format) or ~4·106 (6-
well format) cells per well were infected at a multiplicity of infection (MOI) of 10 bacteria per cell 
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in 1 ml or 4 ml infection medium (DMEM with 1% FCS), respectively. Non-adherent bacteria were 
removed by 3 washes with PBS, after which 1% saponin (Sigma Aldrich) in PBS supplemented 
with 0.15% gelatin was added to detach and lyse eukaryotic cells. CFUs were determined by 
plating 10-fold serial dilutions.
Identification of genes affecting adherence using Tn-seq. For the Tn-seq screen, the 
mutant library was first pre-cultured until mid-log phase (OD620nm ~ 1.0). Transposon mutants 
were allowed to bind to the epithelial cells for 1 h (n = 4) in a 24-well format. Non-adherent 
bacteria were collected from the supernatant and the adherent bacteria were obtained after lysis 
of the eukaryotic cells. In addition, the transposon mutant library was incubated in the infection 
medium without eukaryotic cells (control). Equivalent CFUs of the recovered adherent and non-
adherent, and control fractions were expanded to an OD620nm of 0.2-0.3. Of these cultures, 0.4 ml 
was mixed with 0.6 ml 50% glycerol in BHI medium and stored at -80°C. The obtained aliquots 
were expanded to OD620nm of 0.2-0.4 and chromosomal DNA was isolated using Genomic-tip 
20/G columns. Tn-seq technology was used to profile the relative abundance of each mutant in 
all fractions, essentially as described in Burghout et al. (21). For data analysis, FASTQ files were 
processed via the ESSENTIALS data analysis pipeline (http://bamics2.cmbi.ru.nl/websoftware/
essentials/essentials_start. php) (50). Tn-seq barcode sequences were used to attribute sequence 
reads to individual samples. Sequence reads were aligned to the BBH18 reference genome (35) 
with a minimum match of 16 nt and collected per unique insertion site (TA dinucleotide sequence) 
and per gene. The number of unique transposon insertion sites was determined using the control 
fraction only samples and defined as the positions that were covered by an average of at least 
10 sequence reads. If sequence reads were mapped to both sites of the transposon insertion 
site, the average sequence reads of the 5’ and 3’ were used. Selection criteria for genes affecting 
adherence were as follows: (1) a log2 fold-change in sequence reads between the adherent and 
non-adherent fraction smaller than -1.6 or larger than 1.6 and an adjusted P-value < 0.05 and 
(2) a log2 fold-change in sequence reads between the adherent and the control fraction < -1.2 or 
> 1.2. Genes of which transposon mutants were predicted by ESSENTIALS (50) to be essential or 
have a severely reduced fitness, defined as a log2 fold-change between actual sequence reads and 
calculated expected sequence reads < -3.84, were excluded from our analysis. 
Validation experiments using directed gene deletion mutants. Directed mutants were first 
pre-cultured until mid-log phase (OD620nm ~ 1.0) and stored at -80°C in the presence of 20% 
glycerol. Adhesion assays with directed mutants on A549 and Detroit 562 cells were performed 
in a 24-well format. Mutants were allowed to bind during 1 h (n ≥ 3). The percentage adherence 
of the directed mutant strains was calculated relative to the percentage adhesion of the wild-type 
and statistical significance was determined with a Mann-Whitney test in GraphPad Prism 5.0 
(GraphPad Software).
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Gene expression profiling of M. catarrhalis during adherence. Expression profiling of wild-
type M. catarrhalis BBH18 during adhesion to Detroit 562 was conducted in a 6-well format. 
After 1h adherence, non-adherent bacteria of two wells (6-8 ml) were combined and 2 volumes 
of RNAprotect Bacteria Reagent (Qiagen) was added. Subsequently, wells were washed 3 times 
with PBS, 1 ml RNAprotect Bacteria Reagent was added to each well, adherent bacteria were 
harvested by scraping, and pooled per 2 wells. The bacteria were also incubated in the infection 
medium without eukaryotic cells and after 1h, 8 ml RNAprotect Bacteria Reagent was added 
to 4 ml bacterial suspension. In addition, uninfected Detroit 562 cells were lysed with 1 ml 
RNAprotect Bacteria Reagent. After 5 min incubation at room temperature and harvesting by 
centrifugation, pellets were stored at -80°C. Total RNA was isolated for the adherent fraction 
(n = 4), non-adherent fraction (n =4), bacteria without Detroit 562 cells (n = 3), and uninfected 
Detroit 562 cells (n = 1), and contaminating genomic DNA was removed by treatment with Turbo 
DNase (Ambion) as previously described (35). RNA obtained from the adherent fraction was 
enriched for bacterial RNA using the MICROBEnrich kit (Ambion) according to manufacturer’s 
instructions. Thereafter, RNA was used to generate Cy3-labeled cDNA according to standard 
Nimblegen gene expression array protocols and hybridized to custom-designed Nimblegen M. 
catarrhalis BBH18 4-plex 72K expression arrays, described in De Vries et al. (23). Gene expression 
data was normalized using ArrayStar software (DNASTAR) with Quantile RMA normalization. 
Probes that cross-hybridized with Detroit 562 cDNA, defined by a normalized log2 signal intensity 
(SI) > 8.965, were omitted from the analysis. Statistical analysis was performed in ArrayStar using 
a moderated t-test corrected with a Benjamini & Hochberg false discovery rate and considered 
significantly differentially expressed at an adjusted P < 0.05 and a log2 fold-change of >1 or 
<-1. Functional class distribution was assessed using the Institute for Genomic Sciences (IGS) 
classification (15) with the Fishers exact (one-tail) test, corrected for multiple testing according to 
Storey and Tibshirani (51).
Gene expression profiling of detroit 562 pharyngeal epithelial cells during adherence of 
M. catarrhalis. M. catarrhalis BBH18 wild-type was allowed to bind to Detroit-562 cells (n = 6) 
for 2h (6-well format). After removal of the unbound bacteria, Detroit 562 cells were lysed directly 
in the well by addition of 1 ml RLT buffer (Qiagen) and collected by scraping. As a control (n = 
6), Detroit 562 were incubated in the infection medium alone. Total RNA was isolated with the 
RNeasy mini kit (Qiagen) according to manufacturer’s instructions and treated with Turbo DNase 
(DNA-free kit, Ambion). DNA-free RNA was used to generate Cy3-labeled cDNA according to 
standard Nimblegen gene expression protocols. Reverse transcription was restricted to eukaryotic 
material by priming solely with oligo-dT primers. Labeled cDNA was hybridized to a Nimblegen 
12-plex 135K human gene expression array. Expression data of Detroit 562 cells with and without 
M. catarrhalis was analyzed using Arraystar (DNASTAR) with Quantile RMA normalization. Genes 
that were not expressed in either condition, defined by a log2 SI of < 5, were omitted from the 
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analysis. Statistical significance was assessed with a moderated t-test corrected with a Benjamini & 
Hochberg false discovery rate and considered significant at an adjusted P < 0.05 with a log2 fold-
change of >1 or <-1. For the genes represented by multiple sequence identifiers after statistical 
testing, an average SI and corresponding fold-change was calculated. 
Tn-seq sequencing and microarray data. All microarray data have been deposited in NCBI 
Gene Expression Omnibus (GEO) database (www.ncbi.nlm.nih.gov/geo/) under GEO Series 
accession number GSE47870 for M. catarrhalis microarrays and GSE47711 for Detroit 562 
microarrays. Tn-seq data can be found on the ESSENTIALS website (http://bamics2.cmbi.ru.nl/
websoftware/essentials/links.html).
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Table S3. detroit 562 genes induced in response to adherent M. catarrhalis bbH18
Gene Description
Log2 BBH18-
infected / mock-
infected Detroit
Immune system
CCL20 chemokine (C-C motif) ligand 20 7.0
IL1A interleukin 1, alpha 5.3
CD69 CD69 molecule 5.2
CXCL3 chemokine (C-X-C motif) ligand 3 5.0
IL1B interleukin 1, beta 4.8
TNF tumor necrosis factor (TNF superfamily, member 2) 4.2
IL8 interleukin 8 4.1
SERPINA3 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 4.0
IL6 interleukin 6 4.0
PTX3 pentraxin-related gene, rapidly induced by IL-1 beta 4.0
IL29 interleukin 29 3.6
CSF3 (G-CSF) colony stimulating factor 3 (granulocyte) 3.5
NFKBIZ nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor, zeta 3.2
TA-NFKBH T-cell activation NFKB-like protein 3.2
JUN v-jun sarcoma virus 17 oncogene homolog (avian) 3.1
LTB lymphotoxin beta (TNF superfamily, member 3) 3.0
IL17C interleukin 17C 2.7
IL1F9 interleukin 1 family, member 9 2.6
ICAM1 intercellular adhesion molecule 1 (CD54), human rhinovirus receptor 2.5
IRAK2 interleukin-1 receptor-associated kinase 2 2.3
CSF2 (GM-CSF) colony stimulating factor 2 (granulocyte-macrophage) 2.2
CXCR4 chemokine (C-X-C motif) receptor 4 2.2
EDN2 endothelin 2 2.1
IL32 interleukin 32 2.1
TNFSF18 tumor necrosis factor (ligand) superfamily, member 18 2.1
MAP3K8 mitogen-activated protein kinase kinase kinase 8 2.1
LIF leukemia inhibitory factor 2.0
CXCL1 chemokine (C-X-C motif) ligand 1 1.9
CXCL2 chemokine (C-X-C motif) ligand 2 1.9
NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 1.9
TIFA TRAF-interacting protein with a forkhead-associated domain 1.6
ICOSLG inducible T-cell co-stimulator ligand 1.5
EDN1 endothelin 1 1.4
CD83 CD83 molecule 1.3
ATF3 activating transcription factor 3 1.2
apoptosis and negative regulation of apoptosis
ANGPTL4 angiopoietin-like 4 4.4
TNFAIP3 tumor necrosis factor, alpha-induced protein 3 4.0
C8orf4 chromosome 8 open reading frame 4 3.3
BIRC3 baculoviral IAP repeat-containing 3 3.1
ZC3H12A zinc finger CCCH-type containing 12A 2.8
DDIT4 DNA-damage-inducible transcript 4 1.1
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BCL2A1 BCL2-related protein A1 1.7
IER3 immediate early response 3 1.3
Cell cycle and cell proliferation
BMP2 bone morphogenetic protein 2 2.7
TNFRSF9 tumor necrosis factor receptor superfamily, member 9 2.5
HBEGF heparin-binding EGF-like growth factor 2.5
EGLN3 egl nine homolog 3 (C. elegans) 2.1
PLK3 polo-like kinase 3 1.6
ADM adrenomedullin 1.3
VEGF vascular endothelial growth factor 1.3
KCTD11 potassium channel tetramerisation domain containing 11 1.3
SOX9 SRY (sex determining region Y)-box 9 1.2
MXD1 MAX dimerization protein 1 1.1
EFNA1 ephrin-A1 1.0
Cellular process
UBD ubiquitin D 3.6
ASB2 ankyrin repeat and SOCS box-containing 2 1.6
ANKK1 ankyrin repeat and kinase domain containing 1 1.1
Cytoskeletal organization
RND1 Rho family GTPase 1 3.5
Metabolic process
SLC2A3 solute carrier family 2 (facilitated glucose transporter), member 3 2.5
SLC2A14 solute carrier family 2 (facilitated glucose transporter), member 14 2.4
PPP1R3C protein phosphatase 1, regulatory (inhibitor) subunit 3C 2.3
PPP1R3G protein phosphatase 1, regulatory (inhibitor) subunit 3G 1.6
PPP1R3B protein phosphatase 1, regulatory (inhibitor) subunit 3B 1.5
SAMD4A sterile alpha motif domain containing 4A 1.2
Stress response
FUT11 fucosyltransferase 11 1.4
NR4A2 nuclear receptor subfamily 4, group A, member 2 1.3
GPX3 glutathione peroxidase 3 (plasma) 1.1
unknown
LOC644241 hypothetical protein LOC644240 3.2
ANKRD37 ankyrin repeat domain 37 2.6
AK131268 Homo sapiens cDNA FLJ16203 fis, clone CTONG2015633. 2.4
ARRDC3 arrestin domain containing 3 2.3
LINCR likely ortholog of mouse lung-inducible neutralized-related C3HC4 RING domain protein 1.8
LOC653691 similar to hypothetical protein FLJ40722 1.7
FAM46A family with sequence similarity 46, member A 1.6
HIG2 hypoxia-inducible protein 2 1.5
LOC391045 similar to Solute carrier family 2, facilitated glucose transporter member 3 1.4
C1orf147 chromosome 1 open reading frame 147 1.1
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Table S4. bacterial strains and plasmids used in this study
Strain or plasmid Relevant feature a Reference
Moraxella catarrhalis    
BBH18 Wild-type isolate [1]
BBH18 ΔtrmB trmB (MCR_0343) deletion mutant, SpecR This study
BBH18 ΔMCR_0609
BadM/Rrf2 family transcriptional regulator (MCR_0609) deletion 
mutant, SpecR
This study
BBH18 ΔMCR_0837
putative phosphohistidine phosphatase (MCR_0837) deletion 
mutant, SpecR
This study
BBH18 ΔaroA aroA (MCR_0888) deletion mutant, SpecR This study
BBH18 ΔencAB ecnAB (MCR_1029) deletion mutant, SpecR This study
BBH18 Δlgt1 lgt1 (MCR_1095) deletion mutant, SpecR This study
BBH18 ΔMCR_1483 putative lipoprotein (MCR_1483) deletion mutant, SpecR This study
BBH18 ΔMCR_1742 outer membrane protein (MCR_1742) deletion mutant, SpecR This study
Plasmids
pR412T7 Donor for SpecR cassette [2]
pGSF8
Donor for mariner transposon, containing SpecR cassette and mmeI 
restriction sites
[3]
a SpecR, spectinomycin resistance
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Table S5. oligonucleotide primers used in this study
Primer name Target a Sequence (5’- 3’)
Primers for generation of directed mutants
PBpR412_L SpecR cassette GCCGCTCTAGAACTAGTGG 
PBpR412_R SpecR cassette GATACCCCTCGAATTGACGC
PBTnMr9 SpecR cassette control primer CAATGGTTCAGATACGACGAC
trmB-L1-FW1 trmB left flank CCTGCCACACAATACACCAC
trmB-L2-RV1 trmB left flank CCACTAGTTCTAGAGCGGCAGACATTTTGGGCATCTTGG
trmB-R2-FW1 trmB right flank GCGTCAATTCGAGGGGTATCAATTTGAAAAGCGTGGCATC
trmB-R1-RV1 trmB right flank GGGTCAAGGTGGTGTAATGG
trmB-C-RV1 trmB control primer TTTTACGAAACTGCTCAGGTG
CvdGMCR_0609_L1 MCR_0609 left flank AGCACTCATGGTTCGTATGG
CvdGMCR_0609_L2 MCR_0609 left flank CCACTAGTTCTAGAGCGGCGTCCACGAGTTGTTAAACGC
CvdGMCR_0609_R2 MCR_0609 right flank GCGTCAATTCGAGGGGTATCCAAGTCAATCGCCTACATC
CvdGMCR_0609_R1 MCR_0609 right flank TCGGTAATGGTACCAAGCTC
CvdGMCR_0609_C MCR_0609 control primer ATCCAATAAGGCAGTGACGG
CvdGMCR_0837_L1 MCR_0837 left flank GCATTAGCCGAAATGAGTCG
CvdGMCR_0837_L2 MCR_0837 left flank CCACTAGTTCTAGAGCGGCAAAGTCGGTAAGATCTCGC
CvdGMCR_0837_R2 MCR_0837 right flank GCGTCAATTCGAGGGGTATCTTTGGCAACGACCCAAGATG
CvdGMCR_0837_R1 MCR_0837 right flank CTTATCCAAGTGAGCTACCC
CvdGMCR_0837_C MCR_0837 control primer TGTCTGCTGTACTTGCAGAC
CvdGMCR_0888-L1 aroA (MCR_0888) left flank CCAAATGTTGAACGAGTGGC
CvdGMCR_0888-L2 aroA (MCR_0888) left flank CCACTAGTTCTAGAGCGGCAGCCGATTACGCACAATTGC
CvdGMCR_0888-R2 aroA (MCR_0888) right flank GCGTCAATTCGAGGGGTATCTTGCCAATCGTGTTGGTCTG
CvdGMCR_0888-R1 aroA (MCR_0888) right flank CAATCTGAATGCCAACAGCG
CvdGMCR_0888-C aroA (MCR_0888) control primer GCATTGTGTACCGCTTGTAC
CvdGMCR_1029-L1 ecnAB (MCR_1029) left flank AGCAAGTGCCGATGAGATTG
CvdGMCR_1029-L2 ecnAB (MCR_1029) left flank CCACTAGTTCTAGAGCGGCAGTTTGTTGACTGCAGGCAG
CvdGMCR_1029-R2 ecnAB (MCR_1029) right flank GCGTCAATTCGAGGGGTATCAAGCACCTGAAGACCAACAG
CvdGMCR_1029-R1 ecnAB (MCR_1029) right flank TAATCAGCTGGAGTCTTGCC
CvdGMCR_1029-C ecnAB (MCR_1029) control primer GCTTGACTGGCTGAATCTTG
lgt1-L1-FW1 lgt1 (MCR_1095) left flank TAACGCATAACTGCCTGTGG
lgt1-L2-RV1 lgt1 (MCR_1095) left flank CCACTAGTTCTAGAGCGGCATATTTGGTCGGTGGAATGG
lgt1-R2-FW1 lgt1 (MCR_1095) right flank GCGTCAATTCGAGGGGTATCGCAGTCAAACCAAAAGCAAAG
lgt1-R1-RV2 lgt1 (MCR_1095) right flank CAGGCACTGCAGGTTATGTC 
lgt1-C-RV1 lgt1 (MCR_1095) control primer AGGTGCATGATTGGCATTG
CvdGMCR_1483_L1 MCR_1483 left flank ATGCGAGCTTCAGGATTACC
CvdGMCR_1483_L2 MCR_1483 left flank CCACTAGTTCTAGAGCGGCGACCACAAGCTGAAAGCAAAC
CvdGMCR_1483_R1 MCR_1483 right flank GCGTCAATTCGAGGGGTATCACCCATCAGCGATGATATG
CvdGMCR_1483_R2 MCR_1483 right flank TTGGCATCGGCAACTTGAAG
CvdGMCR_1483_C MCR_1483 control primer GCGTACTTTCATCGGGTAG
CvdGMCR_1742_L1 MCR_1742 left flank TTCGTAAGCTCATGCAACCC
CvdGMCR_1742_L2 MCR_1742 left flank CCACTAGTTCTAGAGCGGCTAGCGATTAGTGCAGATGCG
CvdGMCR_1742_R1 MCR_1742 right flank GCGTCAATTCGAGGGGTATCTGCAACTGAAGCAACCGAAC
CvdGMCR_1742_R2 MCR_1742 right flank TCATCTTCGGTGATATCGCC
CvdGMCR_1742_C MCR_1742 control primer GAGCAAGCAGTTAGTGCTAG
a SpecR, spectinomycin resistance

3.3 
Multicomponent Moraxella catarrhalis outer membrane 
vesicles induce an inflammatory response and are 
internalized by human epithelial cells
Viveka Schaar, Stefan P.W. de Vries, Maria laura a. Perez-Vidakovics, 
Hester J. bootsma, lennart larsoson, Peter W.M Hermans, anders bjartell, 
Matthias Mörgelin, Kristian riesbeck
Cellular Microbiology. 2010, 13(3):432-449.
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abSTraCT
Moraxella catarrhalis is an emerging human respiratory pathogen in patients with chronic 
obstructive pulmonary disease (COPD) and in children with acute otitis media. The specific 
secretion machinery known as outer membrane vesicles (OMVs) is a mechanism by which Gram-
negative pathogens interact with host cells during infection. We identified 57 proteins in M. 
catarrhalis OMVs using a proteomics approach combining two-dimensional SDS-PAGE and 
MALDI-TOF mass spectrometry analysis. The OMVs contained known surface proteins such as 
ubiquitous surface proteins (Usp) A1/A2, and Moraxella IgD-binding protein (MID). Most of the 
proteins are adhesins/virulence factors triggering the immune response, but also aid bacteria to 
evade the host defense. FITC-stained OMVs bound to lipid raft domains in alveolar epithelial 
cells and were internalized after interaction with Toll-like receptor 2 (TLR2), suggesting a delivery 
to the host tissue of a large and complex group of OMV-attributed proteins. Interestingly, 
OMVs modulated the pro-inflammatory response in epithelial cells, and UspA1-bearing OMVs 
were found to specifically down-regulate the reaction. When mice were exposed to OMVs, a 
pulmonary inflammation was clearly seen. Our findings indicate that Moraxella OMVs are highly 
biologically active, transport main bacterial virulence factors and may modulate the epithelial 
pro-inflammatory response.
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InTroduCTIon
Moraxella catarrhalis is a Gram-negative aerobic diplococcus and an exclusive human respiratory 
pathogen. After Streptococcus pneumoniae and non-typeable Haemophilus influenzae, M. 
catarrhalis is the third most common cause of bacterial respiratory tract infections, including 
acute otitis media (AOM), sinusitis, laryngitis and pneumonia. Increasing evidence underlines the 
importance of M. catarrhalis as an emerging pathogen responsible for recurrent and persistent 
respiratory tract infections in patients suffering of chronic obstructive pulmonary disease (COPD), 
which is one of the leading causes of morbidity and mortality worldwide (1-4). M. catarrhalis 
causes approximately 10% of all COPD exacerbations and significantly contributes to the chronic 
airway inflammation, which is a hallmark of the disease (3). During exacerbations of COPD, 
the respiratory tract mucosa is exposed to bacterial components/antigens that induce a potent 
inflammatory response; this includes, for example, endotoxin, peptidoglycan fragments and 
lipoproteins.
A number of Moraxella virulence factors have been identified and characterized (5, 6). Recently, 
the first complete genome sequence of M. catarrhalis has been reported (7), which will greatly 
facilitate our ability to understand Moraxella pathogenesis and provide the basis for proteomics 
research. Ubiquitous surface proteins (UspA) and the Moraxella immunoglobulin (Ig) D-binding 
protein (MID), also designated haem-agglutinin (Hag), are among the most extensively studied 
virulence factors of M. catarrhalis. UspA, which exists as three variant proteins, UspA1, UspA2 and 
the hybrid protein designated UspA2H, are oligomeric coiled-coil adhesins with binding sites for 
multiple host macromolecules such as fibronectin and vitronectin (8-11). Interestingly, UspA1 has 
been reported to include a critical binding site for carcinoembryonic antigen-related cell adhesion 
molecule-1 (CEACAM-1), which is widely distributed on epithelial cells including those of the 
oropharynx and lower respiratory tract (12). A recent study demonstrated that the interaction 
between CEACAM-1 and M. catarrhalis UspA1 resulted in reduced Toll-like receptor-2 (TLR2)-
initiated NF-kB-dependent inflammatory responses of pulmonary epithelial cells (13). In parallel 
to the UspAs, MID is another well-studied and highly conserved OMP. MID has a unique ability 
to bind IgD in a non-immune manner, and functions as an adhesin by mediating attachment to 
lung epithelial cells (14, 15). 
Outer membrane vesicles (OMVs) secreted by pathogenic bacteria are recognized as long-
distance delivery vehicles which transport diverse virulence factors and allow pathogens to 
interact with the host, and hence have the possibility to alter the immune response without close 
contact (16). These spherical bilayered OMVs are released from the outer membrane and range 
in size from 50–250 nm in diameter. OMVs produced by pathogenic bacteria contain adhesins, 
invasins and immunomodulatory compounds such as lipopolysaccharide (LPS) (17, 18). Several 
studies have demonstrated that OMVs play a role as protective transport vesicles, delivering 
toxins, enzymes and DNA to eukaryotic cells as well as being key factors in natural competence 
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(19-23). OMVs can also improve bacterial survival in the host by directly mediating bacterial 
binding and invasion, causing cytotoxicity and modulating the host immune response (24, 25). 
We have previously shown that OMVs from M. catarrhalis contribute to an increased survival of 
Haemophilus influenzae in human serum by binding and neutralizing C3 in vitro (26). Interestingly, 
OMVs secreted by Moraxella also bind to tonsillar B cells through the superantigen MID (4). The 
interaction between MID and the B cell receptor induces Ca2+ mobilization and receptor clustering 
in lipid raft motifs followed by internalization of vesicles. Mainly TLR9, a DNA recognition receptor 
of the innate immune system, participates in the signaling induced by OMVs through sensing of 
DNA associated with the vesicles. The OMV-dependent B cell activation induces up-regulation of 
surface activation markers in addition to IL-6 and IgM secretion. In this study, we report the global 
proteome of highly purified M. catarrhalis OMVs using 2D gel electrophoresis and MALDI-TOF 
analysis. Major outer membrane proteins, i.e. MID, UspA, OMPs J, G1b, CD, E, M35 and TbpB, 
were carried by OMVs of which several are reported to contribute to the bacterial pathogenesis. 
Periplasmic, peptidoglycan-associated as well as hypothetical proteins with unknown functions 
were also present. Using a functional approach, we analysed binding and internalization of OMVs 
to human alveolar epithelial cells and alteration of cytokine profiles, which are critical activities 
during the Moraxella–host interaction. Finally, when OMVs were administered to a series of mice, 
pulmonary inflammation was observed suggesting an important role for OMVs also in vivo.
reSulTS
M. catarrhalis oMVs contain loS and dna. We have previously shown that M. catarrhalis 
has the capacity to produce OMVs in vitro as well as in vivo during infection (4, 26). The OMVs 
secreted in vitro by M. catarrhalis BBH18 were spherical, bilayered proteolipids with an average 
diameter of 50–150 nm, which is consistent with data on OMVs released by other Gram-negative 
bacteria (27-30) (Fig. 1A and B). The bacteria produced OMVs in both logarithmic and stationary 
phases, and OMVs were released from intact bacterial membranes indicating that the OMVs 
were not merely the result of bacterial cell lysis. The presence of LOS, a general component of the 
outer membrane of Gram-negative bacteria (Fig. 1C), and the well-known surface proteins MID 
and UspA1 and UspA2 (Fig. 1D) indicated that OMVs released by Moraxella were indeed derived 
from the outer membrane as previously defined in EDTA-induced OMVs by Nordstrom et al. (31). 
This was also done in order to confirm the presence of UspA1 and A2 in naturally produced 
OMVs, as these proteins could not be seen in the proteomic analysis later performed due to 
a size cut-off. M. catarrhalis is among a few Gram-negative bacteria with LPS/LOS containing 
3-hydroxydodecanoic acid as the sole 3-hydroxy fatty acid (32), which was confirmed by GC/
MSMS analysis of the OMVs. 
We have recently shown that OMVs carry DNA that interacts with TLR9 in B lymphocytes (4). 
To quantify the DNA content in OMVs, Moraxella OMVs were lysed by incubation in lysis solution 
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containing Sarkosyl to release DNA. The wild-type OMVs and MID-deficient OMVs contained 
23.5 pg DNA per mg OMV protein and 23.3 pg DNA per mg OMV protein respectively. Similar 
values were detected in UspA1- deficient OMVs (23.6 pg DNA per mg OMV protein), indicating 
that the absence of this particular virulence factor did not alter DNA content of the OMVs. 
Fig. 1. Moraxella catarrhalis outer membrane vesicles (oMVs). (A) Formation of OMVs on M. catarrhalis 
wild-type strain BBH18. Bacteria were harvested from in vitro overnight cultures and were examined by 
transmission electron microscopy (TEM). Scale bar indicates 100 nm. (B) Representative TEM micrographs 
of M. catarrhalis wild-type (wt) OMVs. Scale bar indicates 100 nm. (C) LOS analysis of M. catarrhalis OMVs. 
The presence of LOS in OMV preparations of BBH18 wt and mutants deficient in uspA1/A2 (ΔuspA1/A2), or 
deficient in both mid and uspA1/A2 (Δmid/uspA1/A2) were analysed by SDS-PAGE (10%) and visualized by 
silver staining. (D) OMVs from M. catarrhalis wt bacteria carry UspA1/A2 and MID. OMVs were isolated from 
MID-deficient (Δmid) and UspA1/A2 deficient (ΔuspA1/A2) mutant M. catarrhalis strains. Equal amounts of 
total protein (10 µg per lane) were resolved by SDS-PAGE and analysed by Western blot using rabbit anti-
MID antiserum (right panel) or rabbit anti-UspA1/A2 antiserum (left panel). Molecular weight markers are 
indicated on the left hand side of the SDS-PAGE and membrane.
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Proteomic analysis of oMVs. Two-dimensional electrophoresis (2D-SDS PAGE) followed 
by MALDI-TOF mass spectrometry analysis was used to characterize the M. catarrhalis OMV 
proteome. In Fig. 2, the M. catarrhalis OMV proteome 2D-reference map is shown. On the 
average 115 protein spots per gel were detected by silver staining. The resulting peptide mass 
fingerprints were analysed using a M. catarrhalis BBH18 protein data set (7). We were able to 
successfully identify 85 distinct spots corresponding to 57 different proteins (Table 1), displaying 
molecular masses between 14 and 115 kDa. 
Fig. 2. Separation and identification of M. catarrhalis oMV proteins using 2d-PaGe followed by 
MaldI-ToF-MS. OMV samples were resolved by IEF (pH 4–7) and 10% SDS-PAGE. Protein spots were 
visualized by silver staining. Protein spots are labelled as indicated in the Table 1.
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Characterization of M. catarrhalis OMVs  |  221
3.3
Several proteins were found to be present in more than one spot due to pI or mass variations 
and in some cases a protein was dispersed among multiple spots. As expected, the largest group 
of OMV-associated proteins identified (37%) were outer membrane and periplasmic proteins. 
Most entries were found for proteins belonging to the functional protein categories of energy 
metabolism, protein synthesis, and cell envelop, the latter predominately containing outer 
membrane proteins (Fig. 3). Some of these proteins have a role in M. catarrhalis pathogenesis as 
for example CopB and OMP E (1, 7, 33). Additionally, several proteins with unknown or putative 
function (conserved hypothetical proteins) were also identified. Taken together, proteome 
mapping demonstrated that a large proportion of Moraxella virulence factors thus are delivered 
by OMVs.
oMVs bind to and enter respiratory epithelial cells via a lipid raft-mediated pathway. 
Outer membrane vesicles are vehicles by which virulence factors including adhesins can be 
efficiently transported to host cells or tissues during bacterial colonization. To determine whether 
OMVs released by M. catarrhalis interact with human respiratory epithelial cells, the type II alveolar 
epithelial cell line A549 was incubated with purified OMVs. Analysis by fluorescence microscopy 
revealed several OMVs attached to epithelial cells as shown with green fluorescence (Fig. 4). The 
acquisition of fluorescence was dependent upon the presence of OMVs since cells that were 
not incubated with OMVs did not exhibit any detectable green fluorescence. Binding of OMVs 
was independent of the presence of UspA1 since vesicles isolated from UspA1-deficient mutants 
bound equally well to A549 cells as compared with OMVs isolated from wild-type bacteria (Fig. 
4). 
We have recently demonstrated that M. catarrhalis OMV-dependent interactions with human 
B cells is initiated by clustering of IgD B cell receptors into lipid rafts motifs and is depending 
on protein MID (4). To examine whether these cholesterol enriched domains are involved in the 
interaction of OMVs with respiratory epithelial cells, A549 cells were exposed to untreated OMVs, 
filipin-treated OMVs or formaldehyde-fixed whole bacteria (positive stimulus). After stimulation, 
A549 cell membranes were isolated by ultracentrifugation, and aliquots of the Triton-insoluble 
fraction were separated on discontinuous sucrose gradients, and screened by immunoblots using 
specific antibodies (Fig. 5A). Flotillin and caveolin were used as markers for raft fractions (34). 
Importantly, TLR2 was found in the raft fractions of cells stimulated with either OMVs or whole 
bacteria. To confirm the compartmentalization of TLR2 into lipid rafts, we treated epithelial cells 
with filipin, which intercalates into lipid motifs and thereby disrupts lipid raft structures (35). 
The partitioning of TLR2 induced by OMVs was prevented in A549 cells treated with filipin (Fig. 
5A). OMVs co-localized with flotillin as soon as 30 min after interaction with alveolar epithelial 
cells (Fig. 5B). Co-localization of TLR2 and OMVs in A549 cells was also observed (Fig. 5B). The 
interaction between OMVs and the lipid raft marker (flotillin) or TLR2 was independent of the 
presence of UspA1 in OMVs as similar patterns were detected using OMVs obtained from the 
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wild-type M. catarrhalis as compared with the Moraxella UspA1- deficient mutant (Fig. 5B). To 
confirm the internalization of OMVs, A549 cells were incubated with rhodamine-stained OMVs 
for 16 h. After fixation, permeabilized cells were incubated with rabbit anti-MID antibodies 
followed by incubation with an Alexa-conjugated secondary pAb. As shown in Fig. 5C, OMVs 
were localized intracellularly. Thus, Moraxella OMVs can be found intracellularly in epithelial cells 
and the uptake mechanism is related to lipid rafts.
Fig. 4. M. catarrhalis oMVs bind to human epithelial cells. The type II alveolar epithelial cell line A549 
was incubated for 1 h with OMVs (50 µg ml-1) isolated from M. catarrhalis wild-type (OMV wt) or an UspA1-
deficient mutant (OMV ΔuspA1). OMVs were detected using rabbit anti-MID and anti-rabbit Alexa Fluor 488 
antibodies (green). Cell nuclei were labelled with DAPI.
Fig. 5. oMVs induce clustering of Tlr2 in lipid rafts. (A) Aliquots of Triton-insoluble lysates of A549 cells 
obtained before (control) and after stimulation with formaldehyde-fixed M. catarrhalis wild-type (bacteria), 
OMVs, and A459 cells treated with filipin prior to stimulation with OMVs (filipin + OMV) were fractionated 
on discontinuous sucrose gradients and immunoblotted with anti-flotillin, anti-caveolin or anti-TLR2 mAbs. 
(B) Visualization of receptor clustering in A549 cells after binding of OMVs. A549 cells were incubated for 1 h 
with OMVs (50 µg ml-1) isolated from M. catarrhalis wild-type (OMV wt) or an UspA1-deficient mutant (OMV 
ΔuspA1). After washing, cells were fixed and incubated with anti-flotillin (Flotillin) or anti-TLR2 (TLR2) mAbs. 
OMVs were detected using rabbit anti-MID and anti-rabbit Alexa Fluor 594 Abs (green). Alexa Fluor 594 goat 
anti-mouse (red) was used as secondary antibody for flotillin and TLR2 labelling. Cell nuclei were labelled 
with DAPI (blue) and visualized through confocal microscopy. (C) MID-containing OMVs are internalized as 
revealed using permeabilized epithelial cells. A549 cells were incubated with Rhodamine-labelled OMVs (50 
µg ml-1) (Rhod-OMV) for 18 h at 37°C. Thereafter, cells were permeabilized with Triton X-100 and OMVs 
were detected using rabbit anti-MID and anti-rabbit Alexa Fluor 594 antibodies. Labelled OMVs (red) were 
identified within the intracellular compartment of A549 cells by the presence of areas of intracellular dual 
fluorescence (yellow) in permeabilized cells. Cell nuclei were counterstained with DAPI (blue). Scale bar 
represents 20 mm. In all panels, results are representative of three independent experiments.                   ➔
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a pro-inflammatory response is induced by oMVs, and uspa1-bearing oMVs inhibit the 
activation. To analyse whether the interaction of M. catarrhalis OMVs trigger a pro-inflammatory 
response, we analysed IL-8 and ICAM-1 expression in A549 epithelial cells. Formaldehyde-fixed 
M. catarrhalis and a mutant deficient in the UspA1 were included as positive controls, as UspA1 
contains a CEACAM1-binding motif that recently has been shown to abrogate the TLR2 driven NF-
kB response (13). The OMV exposure induced a significant increase in IL-8 synthesis as compared 
with non-stimulated control cells (Fig. 6A). The IL-8 concentration reached a maximum after 
24 h and did not change at later time points (data not shown). Furthermore, UspA1-deficient 
OMVs induced a higher IL-8 secretion than wild-type OMVs. The mitogenic effect of OMVs was 
concentration-dependent and saturated above 10 mg ml-1 (Fig. 6B). We also incubated Detroit 
562 pharyngeal epithelial cells with Moraxella OMVs. In parallel with A549, a pro-inflammatory 
was observed with Detroit 562 (data not shown). To analyse whether the IL-8 protein levels 
correlated with IL-8 mRNA concentrations, the IL-8 mRNA levels in OMV-stimulated A549 cells 
were assessed by a semi-quantitative reverse transcription (RT)-PCR. In accordance with the IL-8 
measurements, the IL-8 mRNA levels in OMV-stimulated A549 cells were higher compared with 
unstimulated cells and reached a maximum after 12 h in the epithelial cells stimulated with 
UspA1-deficient OMVs (Fig. 6C). 
We also examined the capacity of Moraxella OMVs to stimulate ICAM-1 expression in 
respiratory epithelial cells. The number of ICAM-1 molecules was significantly higher on 
A549 cells incubated with OMVs than on unstimulated cells after 6 h of incubation (Fig. 6D). 
Furthermore, the kinetics of ICAM-1 expression correlated with the levels of IL-8 produced after 
OMV stimulation. In conclusion, OMVs are strong activators of both IL-8 synthesis and ICAM-1 
expression in respiratory epithelial cells.
oMVs induce a pulmonary inflammation in mice. To investigate whether OMVs can trigger 
an inflammatory response in vivo, we harvested OMVs from overnight cultures and administered 
the OMVs into the lungs of mice. After 3 and 6 h lungs were stained with eosin and haematoxylin 
followed by examination by light microscopy. Interestingly, an increase in exudate was observed, 
and the lung epithelial surface developed a more ruffled appearance compared with controls 
receiving PBS only (Fig. 7A–C). To in detail examine the inflammatory response, tissue specimens 
were also stained with the anti-neutrophil mAb NIMP-R14, which recognizes a to-date-
undetermined structure on the murine neutrophil cell membrane. In the lung parenchyma from 
mice administered with Moraxella wild-type OMVs, a clear neutrophil infiltration was observed 
after 6 h (Fig. 7F), quantified as average neutrophils per field (Fig. 7G). Taken together, in addition 
to the OMV-dependent pro-inflammatory response seen with epithelial cells in vitro, OMVs were 
highly biologically active in the mouse lung. 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
228  |  Chapter 3.3
Fig. 6. oMVs binding to human alveolar epithelial cells results in a pro-inflammatory response and 
a decreased reaction is seen in the presence of uspa1. (A-B) IL-8 production by epithelial cells exposed 
to OMVs. Cell free supernatants from A549 cells either left unstimulated (control) or stimulated with fixed M. 
catarrhalis (M. cat.-fixed), wild-type OMVs (OMV wt) or UspA1-deficient OMVs (OMV ΔuspA1) were analysed 
for IL-8 production by ELISA. The data are means (± standard deviations) of at least three independent 
experiments. (C) IL-8 and GAPDH mRNA analysis of total RNA derived from A549 cells stimulated with M. 
catarrhalis fixed bacteria or OMVs as indicated. The kinetics of activation by the different OMVs was studied 
at four different time points. The graph represents the ratio of the density of IL-8 relative to GAPDH. (D) 
Analysis of ICAM-1 expression in A549 cells stimulated with M. catarrhalis or the different OMV preparations. 
Epithelial cells were labelled with FITC-conjugated rabbit anti-human ICAM-1. Thereafter, ICAM-1 density 
was analysed by flow cytometry. Mean fluorescence intensity (mfi) values are shown. (E) Raw data of one 
representative experiment of the ones shown in (C). In (C) and (E), total RNA was isolated after 12 h of 
stimulation and reversely transcribed. Various amounts of resulting cDNA were used in a semi-quantitative 
IL-8 PCR. GAPDH was included as a control reference gene. For all experiments, data shown are means and 
standard deviations of at least three independent experiments. *P ≤ 0.05, **P ≤ 0.01, where UspA1-deficient 
OMVs were compared with the unstimulated control in an unpaired Student’s t-test.
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Fig. 7. M. catarrhalis oMVs cause an inflammatory response in the mouse lung. Histological changes 
in pulmonary parenchyma post challenge at 3 h (B and E) and 6 h (C and F) are shown. A suspension of OMVs 
(50 µg in 50 µl PBS) was administered to mice via the nostrils. Tissues from control mice receiving PBS or 
mice administered OMV wt are indicated. Specimens were stained with haematoxylin/eosin (A–C) or with an 
anti-neutrophil mAb (NIMP-R14) (D–E) and subjected to light microscopy at 40x magnification. Neutrophils 
in three random fields for each specimen were counted, and average neutrophils per field were plotted (G). 
dISCuSSIon
In the present study, we have determined the proteome of M. catarrhalis OMVs and have gained 
new insights in the biological function of these protein-carrying lipid structures. Extracellular 
OMV proteomes of various Gram-positive and Gram-negative bacterial pathogens have been 
characterized (27, 28, 30, 36). Both lipid and protein analyses of M. catarrhalis OMVs suggest 
that, as expected, the OMVs are derived from outer membranes. Putative periplasmic and/or 
peptidoglycan-associated proteins (pFlbp, OppB, Lgt1, pL Mc1 and pLMc2) and 12 hypothetical 
proteins (HP Mc) with unknown functions were also present. These properties are consistent with 
the characteristics of OMVs recovered from other Gram-negative bacterial species (28-30, 37). 
Several known major OMPs of M. catarrhalis, i.e. MID, UspA1, UspA2, TbpB and OlpA were 
identified in OMVs, of which the autotransporter proteins UspA1 and MID play an important role 
in adhesion to host cells. Further, the OMPs: J, E, CD, and M35 were detected in OMVs as well as 
OMP G1b, which shares homology with Acinetobacter species proteins associated with resistance 
against beta-lactam antibiotics (imipenem and carbapenem). 
We recently demonstrated that OMVs released by Moraxella activate human tonsillar B cells 
(4). Two components of the OMVs, the MID protein and unmethylated CpG-DNA motifs, were 
found to be critical for B cell activation. Similar to the results obtained with epithelial cells in the 
present paper, lipid raft motifs were seen in B-cells and seemed to be crucial for the recruitment 
of receptors and signalling. 
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M. catarrhalis expresses surface receptor proteins involved in iron acquisition pathways that 
specifically bind host transferrin and lactoferrin. Two of these proteins, TbpB and CopB, were 
found in OMVs. TbpB is a peripheral outer membrane lipoprotein possessing transferrin-binding 
properties (38, 39). CopB is upregulated under iron limiting conditions and is involved in the 
binding of iron from transferrin and lactoferrin sources (33). A haem chaperone protein, CcmE, 
could also be identified in OMVs that is involved in the biogenesis of c-type cytochromes (40). The 
OMP E protein was predicted to be the FadL homologue in M. catarrhalis (7) and could therefore 
be potentially involved in binding and transport of fatty acids and OMP G1b, which shares 
homology with several known and hypothetical copper binding lipoproteins (41). Interestingly, 
one protein potentially involved in DNA transport was identified: a DNA uptake lipoprotein-like 
protein designated YfiO, named after the Escherichia coli homologue, which plays an essential 
role in assembly and targeting of OMPs to the outer membrane (42). The YfiO homologue in 
Neisserial species, named BamD/ ComL, is suggested to have a role in periplasmic DNA transport 
(43). 
The lack of some predicted or known outer membrane proteins in the obtained 2D pattern 
might be the result of the problematic MS identification of low-molecular-mass proteins, 
low abundance, or large molecular mass proteins (> 150 kDa), which are commonly missing 
from 2D maps. High-molecular-weight proteins might have been lost during the separation 
procedure, either at the point of IPG re-swelling or during IEF by precipitation at the isoelectric 
point. Additionally, 2D analysis of membrane extracts is a hard task to be accomplished. The 
hydrophobicity of the proteins turns them refractory to common solubilization protocols and once 
in the IPG they often precipitate at their pI, reducing their transfer to the second-dimension gel. 
In our experiments, we included trifluoroethanol (TFE) in the in-gel sample rehydration buffer to 
improve membrane protein IEF separation. This procedure was previously used in the proteomic 
analysis of Bordetella pertussis outer membrane fractions (44), and in agreement with their results 
we found a noticeable improvement in the number and resolution of the protein spots. 
Gram-negative pathogens have developed type I to VII secretion systems to transport 
active virulence factors. Secretion of OMVs is thought to be another means by which bacterial 
pathogens can secrete virulence factors to establish colonization and subsequent infection, 
eliminating the need for bacterial contact with the host cell. Thus, OMVs have been proposed to 
be specifically targeted transport vehicles that mediate entry of virulence factors into host cells. 
The present experiments showed that Moraxella OMVs adhere to human alveolar epithelial cells 
and then enter via a lipid raft-dependent endocytic pathway. It was previously reported that 
OMVs released by E. coli undergo pinocytosis via cholesterol-rich lipid rafts (22). Porphyromonas 
gingivalis, a Gram-negative bacterium that causes periodontitis in humans, also release OMVs 
that enter human epithelial cells via an endocytic pathway (45). In a recent report, Bomberger 
et al. demonstrated that Pseudomonas aeruginosa OMVs deliver multiple virulence factors into 
host airway epithelial cells (24). In accordance with our results, this occurred via OMV fusion with 
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the host cell lipid raft machinery. Based on our work and previous reports on OMV interaction 
with host cells, we propose that lipid raft-mediated OMV delivery into host cells likely represent 
a general strategy utilized by pathogenic Gram-negative bacteria to interact with the host (22, 
24, 45, 46). 
Outer membrane vesicles can also deliver bacterial factors across host barriers such as mucus 
layers and provide a mechanism for delivering a concentrated container of virulence factors at 
the same time. We demonstrate that Moraxella OMVs induce a pro-inflammatory response in 
epithelial cells with increased IL-8 secretion and ICAM-1 expression, which is expected to be 
the result of the recruitment of TLR2 to lipid raft domains after OMV binding. A recent study 
demonstrated the NF-kB-dependent pro-inflammatory activities of Helicobacter pylori OMVs in 
human gastric adenocarcinoma (AGS) and epithelial (HEK239) cell lines. NOD1 dependency but 
not TLR signalling was observed for these cell responses to OMVs (46). In contrast to A549 
type II alveolar epithelial cells, neither HEK293 nor AGS possess a functional form of TLR2 (47, 
48). NOD1 mRNA as well as TLR2 mRNA and protein were, however, detected in different lung 
epithelial cells (49), whereas at least A549 cells expressed little or no TLR4 and responded poorly 
to LPS (50, 51). Whole M. catarrhalis bacterial cells have the capacity to invade bronchial (BEAS-
2B), alveolar (A549) and primary small airway epithelial cells (SAEC) (49). In this study, Slevogt et 
al. demonstrated an involvement of both TLR2 and NOD1 in the IL-8 response to M. catarrhalis by 
gene silencing experiments; knock-down of NOD1 reduced the IL-8 production by approximately 
30–35%, whereas a 60–70% reduction was observed by TLR2 silencing. Thus, in parallel to those 
results, we observed that a TLR2-dependent pathway most likely is induced by Moraxella OMVs. 
We cannot, however, exclude a potential role also of NOD1 in the activation of epithelial cells. 
The potential role of TLR2 in the IL-8 response induced by OMVs was shown in experiments 
performed with OMVs isolated from a Moraxella UspA1-deficient mutant. A previous study 
demonstrated that the interaction of CEACAM1 with UspA1 resulted in reduced TLR2-initiated 
NF-kB-dependent inflammatory responses in primary pulmonary epithelial cells (13). Therefore, 
after demonstrating the presence of both UspA1 and UspA2 in our wild-type OMVs, we used 
OMVs from a single UspA1-mutant in subsequent experiments. We found that UspA1-deficient 
OMVs induced more IL-8 secretion than wild-type OMVs, which corroborates the importance of 
UspA1 in the inhibition of TLR2-dependent cytokine production. 
In this study, we also demonstrated that wild-type OMVs from M. catarrhalis cause 
inflammation in mouse lung parenchyma. In contrast to experiments with epithelial cells in vitro, 
no inflammation as quantified by neutrophil influx was observed in mice exposed to UspA1- 
deficient OMVs (data not shown). Since Moraxella is a human-specific pathogen limitations of the 
mouse model have to be taken into account. Consequently, the rodents could not accurately be 
used to compare the inflammatory response with the corresponding reaction in human epithelial 
cells. However, with this experiment we could clearly confirm that Moraxella OMVs were also 
stimulatory in vivo, proving the relevance of OMVs from a clinical point of view. Using TEM we 
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have observed released Moraxella OMVs in the nasopharyngeal site of a patient (4, 26), but the 
‘physiological’ concentration of OMVs in vivo is presently unknown except for lethal cases of 
meningococcal disease ((52). Most likely Moraxella would release a considerably lower number of 
OMVs upon infection, in contrast to our mouse experiments with highly purified OMVs. 
Collectively, our results show a novel molecular basis for the role of OMVs in M. catarrhalis 
pathogenesis. The protein delivery of virulence factors by OMVs, the small size of OMVs, which 
potentially allows interaction with tissue structures not readily accessible to whole bacteria, and 
the possibility to work as ‘bacterial missiles’ altering both innate and adaptive host responses, 
support the view that OMVs are an important part of Moraxella pathogenesis. 
MaTerIalS and MeTHodS
antibodies and reagents. Rabbit anti-MID962–1200 antiserum was prepared as described earlier 
(53). FITC-conjugated mouse antihuman ICAM-1 mAbs and FITC-conjugated swine anti-rabbit 
pAbs were purchased from DAKO (Glostrup, Denmark). Antihuman TLR2 mAbs were obtained 
from Imgenex (San Diego, CA, USA). Mouse anti-human flotillin-2 and mouse anti-human 
caveolin-1 were purchased from BD Bioscience (San Diego, CA, USA). Filipin III was purchased 
from Sigma-Aldrich (St Louis, MO, USA). Alexa Fluor 594 goat anti-mouse IgG and ProLong Gold 
antifade reagent with DAPI (4′, 6-diamidino-2-phenylindole) were purchased from Molecular 
Probes (Invitrogen, Carlsbad, CA, USA). 
bacterial strains and growth conditions. M. catarrhalis wild-type BBH18 and directed BBH18 
mutants (previously described in (31, 54, 55)) were routinely cultured in brain heart infusion 
(BHI) liquid broth or on BHI agar plates at 37°C. The MID-deficient mutant was cultured in BHI 
supplemented with 50 µg ml-1 kanamycin. The UspA1-deficient mutant was cultured in BHI 
supplemented with 1.5 µg ml-1 chloramphenicol (Sigma-Aldrich). Both chloramphenicol (1.5 µg 
ml-1) and zeocin (7 µg ml-1, Invitrogen) were added to BHI medium for growth of the UspA1/A2 
double mutant.
Isolation of outer membrane vesicles. Outer membrane vesicles were prepared from overnight 
cultures according to the Rosen method (56). Briefly, cell free supernatants were filtered through 
a 0.2 µm-pore size filter (Sartorius, Epson, UK) and concentrated using 100 kDa Vivaspin 
centrifugal concentrators (Vivascience, Hannover, Germany). The concentrated supernatants 
were thereafter centrifuged at 100,000 xg for 60 min. The pellet containing OMVs were washed 
three times in phosphate-buffered saline (PBS) followed by a final sterile filtration to definitely 
exclude cellular contamination from the parent OMV-producing M. catarrhalis. Protein content 
was determined by spectrophotometry using NanoDrop (NanoDrop Technologies, Wilmington, 
DE, USA). The purity of OMV samples was examined by transmission electron microscopy (TEM) 
and by excluding bacterial growth of any remaining parent cells on BHI agar. 
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dna analysis in oMVs. DNA associated with OMVs was quantified by spectrophotometry using 
NanoDrop. Briefly, Moraxella OMV samples (20 mg protein) were lysed by incubation in 0.5% 
(v/v) Sarkosyl, 100 mM EDTA lysis solution to release DNA from OMVs. DNA in OMV samples 
was also visualized by electrophoresis in agarose gel. Whole cell genomic DNA was included as 
a positive control. 
lipooligosaccharide analysis in oMVs. Lipooligosaccharide (LOS) from OMVs were solubilized 
in Laemmli sample buffer (57) and heated at 100°C for 10 min. Proteinase K (50 µg ml-1) were 
added per 50 mg of OMV proteins and incubated in a water bath at 60°C for 1 h with occasional 
vortexing. The presence of LOS in Proteinase K-treated OMV samples was analysed by SDS-
polyacrylamide gel electrophoresis (PAGE) followed by visualization with a sensitive silver stain 
method as described (58). The composition of LOS in OMVs was analysed by a gas chromatography/
ion trap mass spectrometry (GC/MS) method. Briefly, OMV samples, in Teflon-lined glass test 
tubes, were dried, heated in 1 ml of 2 M methanolic HCl at 85°C overnight, and extracted with 
1.5 ml of water : n-heptane (1:2 v/v). The heptane (upper) layer was evaporated under a stream 
of nitrogen at room temperature, redissolved in 1 ml of heptane : dichloromethane (1:1 v/v), 
and purified using a disposable silica gel column (100 mg). Prior to use the silica gel column 
was washed twice with 1 ml of diethyl ether and twice with 1 ml of heptane: dichloromethane, 
thereafter the methyl ester-containing mixture was added. Heptane: dichloromethane (2 ml) was 
added to the column to elute the non-hydroxylated fatty acid esters, the eluate was discarded. 
Diethyl ether (2 ml) was then added to the column to elute the hydroxy fatty acid esters; the 
eluate was evaporated at room temperature. Trimethylsilyl (TMS) derivatives of the hydroxy fatty 
acid esters were prepared by adding N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) (50 ml) and 
pyridine (5 µl) followed by heating for 20 min at 80°C. Heptane (50 µl) was then added. The 
preparations were analysed following storage at 4°C overnight (Sebastian and Larsson, 2003). 
A Saturn 2000 ion-trap gas chromatography-mass spectrometry (GC/MS) instrument (Varian, 
Palo Alto, CA, USA) equipped with a fused-silica capillary column (CP-Sil 8 CB low bleed, 0.25 
mm film thickness, 30 m x 0.25 mm i.d.) (Chrompack, Middelburg, the Netherlands) was used. 
Volumes of 2 µl were injected in the splitless mode with helium head column pressure of 69 kPa 
using a Combi Pal autosampler (CTC Analytics, Zwingen, Switzerland). The temperature of the 
column was programmed from 90–280°C at 20°C min-1; the temperature of injector was 280°C 
and that of transfer line (between GC and MS system) was 290°C. The ion trap temperature 
was 180°C. All analyses were made in the electron impact (EI) mode (59). Mass spectra of the 
methyl ester/TMS 3-OH FA derivatives show abundant ions of m/z (M-15), due to loss of a CH3 
group, and m/z 175, due to cleavage of C3-C4 linkage. The derivative acids were measured by 
monitoring m/z 131 (a product ion of m/z 175) in GC-tandem MA (GC/MS/MS) (59). 
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SdS-PaGe and Western blots. The protein content of OMVs was analysed on a 6% and 10% 
SDS-PAGE stained with Bio-Rad Silver Stain Plus kit (Munich, Germany). Proteins were transferred 
at 20 V overnight to an Immobilon-P membrane (Millipore, Bedford, MA, USA). After transfer, 
the membranes were blocked for 2 h using PBS with 0.1% Tween (PBS-Tween) and 5% skim milk 
powder. After several washes with PBS-Tween, the membrane was incubated with a rabbit anti-
MID962–1200 antiserum as described or with a rabbit anti-UspA antiserum (53, 55). Repeated washes 
with PBS-Tween were followed by incubation with horseradish peroxidase (HRP)-conjugated goat 
anti-rabbit pAbs (Dakopatts, Copenhagen, Denmark) for 1 h. The transferred proteins were 
detected using ECL Western blot detection reagents (Amersham Pharmacia Biotech, Uppsala, 
Sweden) and performed with the Quantity One densitometry software from Bio-Rad. 
2d gel electrophoresis. For isoelectric focusing (IEF), precast 18 cm pH 4–7 IPG gels (Immobiline 
DryStrips, Amersham Biosciences, Uppsala, Sweden) were used. OMV samples were solubilized 
during 1 h in 1 ml of TFE-rehydration buffer (Deshusses et al., 2003) [5 M urea, 2 M thiourea, 50% 
(v/v) 2,2,2-Trifluoroethanol (TFE, 99.0%; Fluka, Buchs, Switzerland), 2% (w/v) Triton X-100, 65 
mM DTT, 0.5% (v/v) Pharmalyte pH 4–7 or pH 6–11 (Amersham Biosciences), 1 mM PMSF, 4 mM 
AEBSF and 0.002% (w/v) bromophenol blue] with periodical vortexing, and further centrifugated 
at 8,000 xg for 10 min. Solubilized protein samples were mixed with freshly prepared TFE-
rehydration buffer resulting in a final protein content of 500 µg in 350 µl and applied in IPG 
strip by in-gel sample rehydration as previously described (60). IEF was performed in an IPGphor 
II electrophoresis unit (Amersham Biosciences) using the following program: 500 V for 0.01 h (1 
Vh), 3500 V for 1.30 h (gradient, 3000 Vh), 3500 V for 5.40 h (20 kVh), resulting in a total voltage 
of 23 kVh. Focused strips were either used immediately for the second dimension or were stored 
at -80°C until use. After IEF, IPG strips were soaked (15 min) in 10 ml of equilibration buffer [50 
mM Tris-Cl, pH 8.8, 6 M urea, 30% (v/v) glycerol, 2% (w/v) SDS, 20 mM DTT, and 0.002% (w/v) 
bromophenol blue] followed by incubation (15 min) in the same solution but replacing DTT for 
20 mM iodoacetamide. After the reduction/alquilation step, the IPG strips were placed on the 
top of a 10% SDS-PAGE and sealed with 0.5% agarose in electrophoresis buffer. Electrophoresis 
was performed at a constant current (25 mAmp per gel) at 20°C until the dye front reached the 
lower end of the gel, using a PROTEAN II 2D cell electrophoresis unit (Bio-Rad, Hercules, CA, USA) 
connected to a Multitemp II cooling bath (GE Healthcare). Proteins were routinely visualized by 
silver staining (61) for image analysis and alternatively by Coomassie blue staining (62) for spots 
to be submitted to tryptic digestions and MALDI-TOF-MS. 
Identification of protein spots by MaldI-ToF MS. Protein identification was performed at the 
Proteomic Service Facility from Universidad Complutense de Madrid-Parque Cientifico de Madrid, 
Spain (UCM-PCM). Briefly, Coomassie stained spots were manually excised and washed twice 
with double-distilled water. Samples were then reduced with 10 mM DTT in 25 mM ammonium 
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bicarbonate for 30 min at 56°C and subsequently alkylated with 55 mM iodoacetamide in 25 
mM ammonium bicarbonate for 20 min in the dark. Finally, samples were digested with 12.5 
ng ml-1 sequencing grade trypsin (Roche Molecular Biochemicals, Mannheim, Germany) in 
25 mM ammonium bicarbonate (pH 8.5) overnight at 37°C. After digestion, the supernatants 
were collected and 1 µl was spotted onto a MALDI target plate and allowed to air-dry at room 
temperature. Then, 0.5 µl of a 3 mg ml-1 of CHCA matrix (Sigma) in 50% acetonitrylo (ACN), 
0.1% trifluoroacetic acid (TFA) was added to the dried peptide digested spots and allowed to air-
dry again. The MS analyses were performed in a MALDI-TOF/TOF spectrometer 4700 Proteomics 
Analyzer (PerSeptives Biosystems, Framingham, MA, USA). The instrument was operated in 
reflector positive ion mode, with an accelerating voltage of 20,000 V. All mass spectra were 
internally calibrated using auto-digested trypsin peptides. Proteins that could not be identified 
with certainty by peptide mass fingerprinting were subjected to MS/MS sequencing analyses. 
Fragmentation was carried out using the acquisition method 1 kV ion reflector mode CID on and 
precursor mass window ± 10 Da. The resulting peptide mass fingerprints and MALDI TOF/TOF 
fragmentation spectra were analysed using a M. catarrhalis BBH18 protein database (7) with the 
MASCOT search engine (Matrix Science) and the genome of M. catarrhalis (7). 
epithelial cells. Human alveolar (A549) and pharyngeal (Detroit 562) epithelial cells were grown 
in DMEM supplemented with 10% FCS and 50 µg ml-1 gentamicin at 37°C and incubated at a 
90% humidity and 5% CO2. The cells were allowed to grow until confluency and were trypsinized 
and seeded in multi-well cell culture plates or eight-well chamber slide system (Lab-Tek II; Thermo 
Fisher Scientific, Roskilde, Denmark) for microscopy experiment. 
Isolation of lipid rafts. A modification of the method of Brown and Rose (1992) was used to 
isolate lipid rafts. A549 cells were exposed to M. catarrhalis (1 x 107 CFU ml-1) or OMVs (10 µg 
ml-1) for 30 min and/or filipin 20 µg ml-1 for 30 min prior to stimulation. The cells were washed 
with ice cold PBS and lysed with 0.5% Triton X-100 in TNE buffer (25 mM Tris-HCl, pH 7.5, 150 
mM NaCl and 5 mM EDTA) plus protease inhibitors for 20 min on ice. Lysed cells were harvested 
and homogenized with a loose-fitting followed by a tight-fitting Dounce homogenizer. Whole 
cells and nuclei were removed by centrifugation at 1,000 xg for 10 min. An equal volume of 
90% sucrose in TNE buffer was added to the supernatant. This 45% layer was overlaid with 30% 
and 5% sucrose in TNE buffer to form a discontinuous gradient. Samples were centrifuged at 
200,000 xg for 18 h at 4°C followed by collection of 1 ml fractions. Protein concentrations were 
determined using a NanoDrop and 5 mg was analysed on a 12% SDS-PAGE. After transfer to 
PVDF Immobilon-P (Millipore), blots were incubated in 5% skim milk blocking solution for 1 h at 
room temperature. Membranes were incubated overnight at 4°C and in presence of mouse mAbs 
against human flotilin-1, caveolin or TLR2. After several washes in PBS-Tween, HRP-conjugated 
anti-mouse IgG (DAKO) and Western Lightning Chemiluminescence Reagent Plus (Perkin Elmer 
Life Sciences, Boston, MA, USA) were used for visualization. 
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Flow cytometry analysis. Surface expression of ICAM-1 after addition of OMVs was monitored 
using flow cytometry (Becton Dickinson, Franklin Lakes, NJ, USA). A549 cells were incubated in 
complete medium with different concentrations of OMVs ranging from 0.625–10 µg ml-1 and 
analysed for ICAM-1 expression at various time points (0–24 h). Harvested cells were washed 
twice and incubated in PBS containing 2% BSA with FITC-conjugated rabbit anti-human ICAM-1 
mAb for 1 h on ice. After several washes in PBS, A549 cells were screened for ICAM-1 density 
using flow cytometry. 
Il-8 enzyme-linked immunosorbent assay (elISa). To analyse interleukin-8 (IL-8) production, 
1 x 105 A549 cells were cultured in 12-well flat-bottom plates (Nunc-Immuno Module) with or 
without 10 µg ml-1 OMVs. The cell-free supernatant was harvested after 24 h. IL-8 production 
was determined using a commercial ELISA from R&D systems (Minneapolis, MN, USA). 
Fluorescence, confocal and transmission electron microscopy. For fluorescence and confocal 
microscopy, A549 cells were grown in eight-well chamber slide system (Lab-Tek II). Slides were 
thereafter incubated with OMVs (50 µg ml-1) in DMEM complete medium for 1 h at 37°C or 
18 h at 37°C for internalization experiments (46). After several washes with ice cold PBS, cells 
were fixed with 4% paraformaldehyde solution for 10 min at room temperature, washed and 
stained with 40,6- diamidino-2-phenylindole (DAPI). Following incubation with 5% normal serum 
blocking solution (20 min at room temperature), rabbit anti-MID pAbs were added for 1 h at 
room temperature. After several washes, Alexa Fluor-conjugated secondary antibodies were 
added in the dark for 1 h at room temperature. For intracellular OMV staining, cells pre-incubated 
with rhodamine-labelled OMVs were fixed and incubated in permeabilization buffer (0.03% 
Triton X-100 and 5% normal serum blocking solution in PBS) before adding rabbit anti-MID 
pAbs. Control cells were fixed and incubated with 5% normal serum blocking solution without 
Triton X-100. Alexa Fluor-conjugated secondary antibodies were incubated in the dark for 1 h 
at room temperature. After washing twice with PBS, cells were fixed to the glass surface with 
DAPI containing Prolong Gold antifade reagent overnight and examined by immunofluorescence 
microscopy or by confocal microscopy using a Bio-Rad Radiance 2000 confocal system fitted on 
a Nikon microscope with a x60/NA 1.40 oil lens. A549 cells showing polarization of lipid rafts 
were counted by microscopic examination of 25 randomly selected fields, showing a minimum 
of three cells per field.
For electron microscopy, OMV samples were fixed in 0.15 M sodium cacodylate buffer, pH 
7.4, containing 2.5% glutaraldehyde for 1 day at room temperature. They were rinsed in isotonic 
cacodylate buffer for 30 min and postfixed in cacodylate buffer containing 1% (w/v) osmium 
tetroxide for 2 h. Specimens were then rinsed in isotonic cacodylate buffer, dehydrated in graded 
series of ethanol, embedded in Epon 812. Thin sections were cut on a Leica Ultracut S (Deerfield, 
IL, USA). Sections were poststained with 5% uranyl acetate for 2 h and then in a saturated lead 
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citrate solution for 7 min. Specimens were observed in a Jeol JEM 1230 electron microscope 
(JEOL, Tokyo, Japan) operated at 60 kV accelerating voltage. Images were recorded with a Gatan 
Multiscan 791 CCD camera (Gatan, Pleasanton, CA, USA). 
rna extraction and semi-quantitative rT-PCr analysis. Extraction of total RNA was 
performed by use of Trizol reagent (Invitrogen, CA, USA) according to manufacturer’s instructions. 
The samples were thereafter treated with the amplification grade DNaseI (Sigma) solution. To 
determine residual DNA contamination of the RNA extracts, 1 µl samples of the DNase-treated 
RNA samples were used as templates for PCR reactions without previous reverse transcription. 
All devices and solutions were treated or prepared with diethyl pyrocarbonate (DEPC) to inactive 
RNases. The quantity and purity of the total RNA were determined by spectrophotometry 
(NanoDrop, NanoDrop Technologies) using the A260/280 ratio. One microgram of RNA was reverse 
transcribed using AMV reverse transcriptase (Roche) according to the manufacturer’s instructions. 
The cDNA yield of each reverse transcription reaction was diluted with DEPC-H2O and thereafter 
different amounts of cDNA (100 ng, 25 ng, 5 ng) were used for semi-quantitative analysis by PCR. 
Amplification of the housekeeping glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and IL-8 
gene was performed using GAPDH specific primers 5′-CACCACCATGGAGAAGGCTGG-3′ and 5′-
GACC ACCTGGTGCTCAGTGTA-3′ and IL-8 specific primers 5′- ATGACTTCCAAGCTGGCCGTG-3′ 
and 5′-GGAGTATGTCTTTATGCACTGACATCT -3′, according to the following thermal cycling 
protocol: 95°C for 3 min, 95°C 45 s, 53°C 1 min, 72°C 2 min (30 cycles), 72°C 8 min. The PCR 
products were analysed on 1.5% agarose gels, stained with ethidium bromide and subsequently 
visualized. The intensities of the final IL-8 RT-PCR products were quantified by using density 
scanning analysis on each band relative to the corresponding GAPDH band.
Mouse pulmonary inflammation model. Female BALB/c mice (8–10 weeks old) were used and 
experiments were performed in accordance with guidelines of the Swedish National Board for 
Laboratory Animals at Lund University, Lund, Sweden. Anesthetized mice were challenged with 50 
µg OMV proteins in 50 µl PBS. The suspension was administered into both nostrils. Control mice 
were correspondingly administered 50 µl PBS only. Mice were euthanized, lungs were removed 
and fixed with 10% formalin in PBS at 3 h (3 mice in each group) and 6 h (2 mice in each group). 
Several lung specimens from each mouse were embedded in paraffin, sectioned and stained with 
eosin and haematoxylin or with a rat anti-mouse neutrophil mAb (NIMP-R14; Abcam, Cambridge, 
MA, USA) and examined for signs of inflammation. Neutrophils were counted in three random 
microscopy fields, and plotted as an average count per field. 
Statistical analysis. The Student’s t-test was used to determine statistical differences for unpaired 
comparisons with Welch correction if variances were non-homogenous. Significant values were 
defined as *P ≤ 0.05; **P ≤ 0.01. All data are expressed as mean ≤ SEM, and n corresponds to 
the number of experiments performed. 
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deciphering the genetic basis of Moraxella catarrhalis 
complement resistance: a critical role for the disulphide 
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abSTraCT
The complement system is an important innate defence mechanism, and the ability to resist 
complement-mediated killing is considered a key virulence trait of the respiratory tract pathogen 
M. catarrhalis. We studied the molecular basis of complement resistance by transcriptional 
profiling and Tn-seq, a genome-wide negative-selection screenings technology. Exposure of M. 
catarrhalis to human serum resulted in increased expression of 84 genes and reduced expression 
of 134 genes, among which genes encoding ABC transporter systems and surface proteins UspA1 
and McaP. By subjecting a ~15,800 transposon mutant library to serum, mutants of 53 genes 
were negatively selected, including the key complement-resistance factor uspA2H. Validation 
with directed mutants confirmed Tn-seq phenotypes of uspA2H and 11 newly identified genes, 
with mutants of MCR_0424, olpA, MCR_1483, and dsbB most severely attenuated. Detailed 
analysis showed that both components of the disulphide bond formation (DSB) system, DsbB 
and DsbA, were required for complement-resistance in multiple isolates, and fulfil a critical role in 
evasion of IgG-dependent classical pathway-mediated killing. Lipooligosaccharide (LOS) structure 
and membrane stability were severely affected in ΔdsbA strains, suggesting a pivotal role for the 
DSB system in LOS structure safeguarding and membrane stability maintenance.
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InTroduCTIon
Moraxella catarrhalis is an important cause of respiratory tract infections in humans. This human-
restricted Gram-negative diplococcus frequently colonizes the nasopharyngeal cavity of young 
children, with about two-thirds of all children being colonized within their first year of life. In 
contrast, colonization rates are considerably lower in healthy adults, approximately 3-5% (1). 
Mainly when host conditions allow, such as an immature immune system in young children or 
underlying disease such as chronic obstructive pulmonary disease (COPD) in adult patients, M. 
catarrhalis is able to cause disease. Along with non-typeable Haemophilus influenzae (NTHi) 
and Streptococcus pneumoniae, it is one of the three major etiological agents associated with 
otitis media (OM) during childhood. Further, it is the second most common cause of COPD 
exacerbations after NTHi (2, 3). 
The complement system is a first line innate defence mechanism against invading pathogenic 
microorganisms and bacterial clearance is considered its main goal (4). Complement activation 
is triggered by various bacterial components and leads to deposition of complement factors on 
the bacterial surface, which may result in direct lysis of Gram-negative pathogens through pore-
formation by the membrane attack complex (MAC) but also in opsonization for phagocytosis. 
Two distinct M. catarrhalis phylogenetic lineages exist, of which lineage 1 predominantly harbours 
complement-resistant isolates and lineage 2 mainly contains isolates that are complement-sensitive 
(5, 6). Importantly, almost all COPD- and OM-associated M. catarrhalis isolates belong to the first 
lineage and are resistant to complement-mediated killing (6), and this capacity can be considered 
an important virulence trait of M. catarrhalis. Several studies have examined the mechanisms of 
M. catarrhalis complement resistance. For example, UspA2/A2H, and to a lesser extent UspA1, 
have been shown to bind both complement components C4-binding protein and C3, resulting 
in inhibition of the classical and alternative complement activation pathways, respectively (7, 8). 
In addition, UspA2/A2H also interferes with the terminal stages of the complement pathway, the 
formation of the MAC (9). Other factors linked to complement-resistance of M. catarrhalis are 
outer membrane protein (OMP) CD (10), OMP E (11), CopB (12), and the lipooligosaccharide 
(LOS) structure (13), although the exact mechanism by which they affect complement-resistance 
is not characterized yet. M. catarrhalis surface molecules are critical for complement resistance but 
they are also targeted by antibodies that subsequently trigger complement activation. Structural 
modulation of antigenic molecules, for instance as described for the UspAs (14, 15), or by altering 
their expression (16), could also serve to limit complement activation. 
The goal of this study was to further unravel the molecular mechanisms driving M. catarrhalis 
complement resistance using two approaches. First, we examined the transcriptional adaptation 
of M. catarrhalis upon serum exposure. Next, a combination of high density mariner transposon 
mutagenesis, genome-wide targeted sequencing of transposon insertion sites (Tn-seq; (17)), and 
advanced data analysis using ESSENTIALS (18), allowed a detailed inventory of all genes required 
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for complement resistance of M. catarrhalis. Validation experiments with directed gene deletion 
mutants confirmed the importance of uspA2H and 11 newly identified genes for M. catarrhalis 
complement resistance. Finally, we performed a detailed analysis of the contribution of one of the 
identified targets, the disulphide bond formation (DSB) system, to the ability of M. catarrhalis to 
withstand complement-mediated killing.
reSulTS
differential gene expression upon serum exposure. As a first approach to examine the 
interaction between M. catarrhalis BBH18 and human serum, gene expression patterns upon 
exposure to normal human serum (NHS) were analysed using microarrays. In total, increased 
expression (> 2.5-fold) of 84 genes and reduced expression of 134 genes was found in 10% 
NHS relative to the serum dilution buffer alone (Table S1). Importantly, no significant expression 
changes were observed upon incubation of M. catarrhalis in NHS compared to heat-inactivated 
NHS (NHS-HI) (data not shown), indicating that expression alterations were not necessarily 
dependent on complement activity. 
The genes with the most prominent increased expression as a result of NHS exposure encode 
several hypothetical proteins (e.g. MCR_1214, MCR_1803, and MCR_1883), a major facilitator 
superfamily protein (MCR_1211), a putative membrane protein (MCR_1805), putative iron-
dependent peroxidase (MCR_0120), phage integrase (MCR_1640), and the imelysin family protein 
(MCR_0119), with fold-changes ranging from 5.3 to 11.5. Genes with increased expression in 
NHS were distributed over a variety of functional classes (Fig. 1A), although no specific functional 
class was found to be significantly enriched among this gene set. The gene pool with reduced 
expression due to NHS exposure was significantly enriched for genes belonging to the “transport 
and binding proteins” and “DNA metabolism” categories (Fig. 1A). More specifically, gene 
expression of several ABC transporter systems was lower, including components of ABC transporter 
systems for nitrate (ntrABCD), phosphate (pstABCS), and molybdate (modAB). In addition, 
pathways linked to nitrate and molybdenum appeared to be affected, with lower expression of 
nitrate reductase (narGHJ) and molybdenum cofactor biosynthesis genes (moaABCDE). 
Interestingly, lower expression in the presence of NHS was found for six genes encoding 
highly antigenic proteins (MCR_1283, MCR_1295, MCR_1619, MCR_1652, MCR_1672, and 
MCR_1683) (19). Further, lower gene expression was found for 19 genes encoding predicted 
surface exposed or extracellular proteins, which included UspA1 and McaP. In contrast, gene 
expression of surface proteins previously linked to complement resistance of M. catarrhalis such 
as uspA2H, ompCD, and ompE was not altered.
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To validate gene expression patterns as profiled using microarrays after 60 min NHS exposure, 
we performed RT-qPCR analysis on a selection of 18 genes. The RT-qPCR log2 fold-change (NHS/
PBS-G) correlated significantly with log2 fold-change obtained by microarray analysis (Fig. 1B and 
Table S2). To further validate our findings, microarray data after 60 minutes was compared to 
RT-qPCR analysis for a subset of 11 genes on RNA samples obtained at an earlier time point; 30 
minutes exposure to NHS and PBS-G (Fig. S1 and Table S2). A highly significant correlation was 
found between these two time points as well.
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Fig. 1. differential gene expression in M. catarrhalis bbH18 upon serum exposure. (A) Functional class 
distribution of differentially expressed genes in NHS (n = 6) compared to the serum dilution buffer (PBS-G) (n 
= 5). Bars illustrate the percentage of each functional class that was differentially expressed, with the absolute 
number of genes per class given next to each bar. Functional class enrichment was determined using Fishers 
exact test and corrected for multiple testing, * Q-value < 0.05. (B) Correlation between microarray expression 
profiling (x-axis) and RT-qPCR validation (y-axis). Data shown are microarray log2 fold-change NHS relative 
to PBS-G and RT-qPCR log2 fold-change NHS versus PBS-G. Correlation was determined with a two-tailed 
Pearson correlation test. 
Genes essential for complement-resistance of M. catarrhalis. To identify novel genes 
required for complement resistance of M. catarrhalis, a large transposon mutant library of the 
complement-resistant M. catarrhalis strain BBH18 (20) was exposed to 40% NHS or NHS-HI as 
a control. The composition of the mutant library before and after challenge was profiled by 
massive parallel sequencing of transposon insertion sites (Tn-seq; (17)) and data analysis with the 
ESSENTIALS pipeline (18). Library read-out by next-generation sequencing instead of microarrays 
as previously reported for M. catarrhalis (20) has significantly increased resolution, allowing us to 
precisely identify and track all individual transposon insertions within the library. Analysis of the 
library before NHS challenge revealed that it consisted of ~15,800 unique transposon insertion 
mutants, which allowed the analysis of 1,341 (~71%) M. catarrhalis protein-encoding genes for 
their role in complement resistance. Genes not represented in our library were either essential for 
growth of BBH18, were underrepresented because their corresponding mutants have a growth 
defect, or were non-essential but not inactivated by transposon elements during mutagenesis. 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
248  |  Chapter 3.4
The Tn-seq screen identified 53 genes potentially required for complement resistance, as their 
corresponding transposon mutants were negatively selected from the population upon incubation 
in NHS (defined as at least 2-fold attenuated survival in NHS relative to NHS-HI after 30 min 
and 3-fold after 60 min) (Table 1). As expected, transposon insertion mutants of the major M. 
catarrhalis complement-resistance factor uspA2H (21) showed severely attenuated (355-fold) 
survival in NHS already after 30 min.
Table 1. Genes required for complement resistance as identified by Tn-seq
Locus a Gene Product Log2 FC  
30 min b
Log2 FC  
60 min b
Insertion 
mutants
Attenuated 
insertion 
mutants 60 
min
MCR_0035 a dsbB disulfide bond formation protein B -1.3 -3.4 14 12
MCR_0117 a - putative lipoprotein -1.2 -2.4 7 5
MCR_0118 - hypothetical protein -1.9 -2.2 2 1
MCR_0142 ihfA integration host factor subunit alpha -1.8 -3.2 2 2
MCR_0203 - putative membrane protein -2.4 -2.6 2 2
MCR_0246 - hypothetical protein -1.8 -2.7 4 3
MCR_0249 - XRE family transcriptional regulator -7.9 -7.7 2 1
MCR_0329 a uspA2H ubiquitous surface protein A2H UspA2H -8.7 -8.5 24 22
MCR_0371 znuC zinc ABC transporter ATPase subunit 
ZnuC
-1.1 -1.9 11 6
MCR_0384 atpC ATP synthase F1 epsilon subunit -6.6 -6.5 3 1
MCR_0422 a serB phosphoserine phosphatase SerB -2.6 -5.7 13 12
MCR_0424 a - hypothetical protein -5.4 -7.5 4 4
MCR_0613 a - PpiC-type peptidyl-prolyl cis-trans 
isomerase
-2.0 -3.1 16 13
MCR_0706 - putative membrane protein -1.3 -2.4 1 1
MCR_0798 tolQ motA/TolQ/ExbB proton channel -1.2 -2.5 1 1
MCR_0830 a engD GTP-dependent nucleic acid-binding 
protein EngD
-2.1 -3.1 16 13
MCR_0874 mnmC tRNA U-34 5-methylaminomethyl-2-
thiouridine biosynthesis protein MnmC
-1.1 -1.7 21 9
MCR_0888 a aroA 3-phosphoshikimate 
1-carboxyvinyltransferase
-2.6 -3.1 15 6
MCR_0890 folB dihydroneopterin aldolase -6.8 -6.8 2 1
MCR_0903 - hypothetical protein -6.7 -8.1 3 3
MCR_0948 - hypothetical protein -1.7 -2.2 1 1
MCR_0963 - hypothetical protein -1.8 -2.6 4 2
MCR_0990 - hypothetical protein -9.7 -8.9 3 2
MCR_0996 a - hypothetical protein -1.7 -2.0 5 3
MCR_1019 - hypothetical protein -2.2 -2.9 3 3
MCR_1047 clpS ATP-dependent Clp protease adaptor 
protein ClpS
-1.2 -2.2 8 5
MCR_1100 aroQ 3-dehydroquinate dehydratase type II -2.4 -2.1 9 5
MCR_1115 a - PpiC-type peptidyl-prolyl cis-trans 
isomerase
-1.6 -2.9 13 11
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MCR_1169 - uncharacterised protein family 
(UPF0070) family protein
-1.9 -2.8 4 3
MCR_1189 lgt6 glucosyltransferase Lgt6 -1.7 -1.7 13 5
MCR_1201 - AsnC family transcriptional regulator -1.9 -1.9 7 4
MCR_1212 - putative membrane protein -7.8 -7.0 1 1
MCR_1243 truA tRNA pseudouridine synthase A -1.1 -1.8 11 7
MCR_1258 - LrgA family protein -1.6 -1.9 6 3
MCR_1396 - hypothetical protein -1.1 -2.5 2 2
MCR_1421 - hypothetical protein -8.3 -7.3 1 1
MCR_1427 - hypothetical protein -2.9 -6.5 2 1
MCR_1456 - hypothetical protein -6.5 -7.5 1 1
MCR_1483 a - putative lipoprotein -8.6 -8.3 4 2
MCR_1535 - hypothetical protein -1.3 -1.7 7 4
MCR_1542 - cold shock-like protein -6.4 -6.5 3 3
MCR_1546 ilvC ketol-acid reductoisomerase -1.3 -2.1 5 3
MCR_1629 - hypothetical protein -2.4 -2.2 3 2
MCR_1661 - conserved hypothetical protein -2.8 -3.1 4 1
MCR_1677 - putative pterin-4-alpha-carbinolamine 
dehydratase 
-3.8 -5.5 2 2
MCR_1693 - hypothetical protein -3.8 -8.8 2 2
MCR_1696 glmU bifunctional UDP-N-acetylglucosamine 
diphosphorylase/glucosamine-1-
phosphate N-acetyltransferase
-4.2 -5.2 5 2
MCR_1761 a olpA Opa-like protein A -2.7 -7.1 19 19
MCR_1797 - Hsp33 protein -2.0 -3.1 16 8
MCR_1854 - hypothetical protein -4.1 -4.9 2 2
MCR_1855 hisB imidazole glycerol-phosphate 
dehydratase
-1.5 -2.3 10 6
MCR_1866 - hypothetical protein -2.0 -5.0 2 2
MCR_1895 - hypothetical protein -1.3 -2.3 2 2
a Selected for validation using directed gene deletion mutants, b FC; log2 fold-change reads NHS/NHS-HI
Candidate gene selection and validation using directed gene deletion mutants. For 
validation of Tn-seq phenotypes, directed gene deletion mutants were generated for twelve 
genes in M. catarrhalis BBH18, among which uspA2H and one gene of which expression was 
increased upon serum exposure, namely MCR_0424 encoding a hypothetical protein. Gene 
deletion mutants were assayed for their survival in NHS relative to NHS-HI. Survival of all tested 
gene deletion mutants in the presence of NHS was significantly decreased relative to survival of 
their parental wild-type strain (Fig. 2A). Importantly, the observed increase in serum sensitivity 
of mutants was not the result of growth defects, as no difference in survival between directed 
mutant strains and wild-type was observed in NHS-HI (Fig. S2). A highly significant correlation 
was found between the Tn-seq fold-change (NHS/NHS-HI) and the fraction survival of the directed 
gene deletion mutants in NHS relative to NHS-HI (CFU counts NHS/NHS-HI) (Fig. 2B). 
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Next to the uspA2H mutant, the most severe loss of complement resistance was observed 
after deletion of genes encoding a hypothetical protein (MCR_0424), a putative lipoprotein 
(MCR_1483), the outer membrane Opa-like protein A (OlpA), and the disulphide bond formation 
protein B (DsbB), with survival in NHS after 60 min ranging from 0.04 to 4.1% relative to 
NHS-HI. In addition to dsbB, two other genes involved in protein folding were required for 
complement resistance, namely those encoding the PpiC-type peptidyl-prolyl cis-trans isomerases 
MCR_0613 and MCR_1115, although to a lesser extent than dsbB. Further, we confirmed the 
role in complement resistance of genes encoding the outer membrane lipoprotein MCR_0117, 
phosphoserine phosphatase (serB), GTP-dependent nucleic acid-binding protein (engD), 
3-phosphoshikimate 1-carboxy-vinyltransferase (aroA), and the hypothetical protein MCR_0996. 
All eleven newly identified complement resistance genes of M. catarrhalis BBH18 are conserved 
across disease-associated lineage 1 M. catarrhalis isolates (22-24), with the exception that olpA 
(MCR_1761) is not conserved in ATCC 43617, which is a lineage 1 isolate sensitive to NHS (data 
not shown). 
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Fig. 2. Validation of Tn-seq identified genes required for M. catarrhalis bbH18 serum resistance. 
(A) Survival of M. catarrhalis BBH18 directed gene deletion mutants in 40% NHS relative to NHS-HI (n ≥ 3). 
Statistical significance was tested relative to wild-type with a two-way ANOVA and Bonferroni post-hoc test. 
For all experiments, data shown are means and SEM. * P < 0.05, *** P < 0.001. (B) Correlation between 
attenuation determined by Tn-seq (x-axis) (n = 4) and use of directed mutants (Y-axis) (n ≥ 3). Data shown are 
log2 Tn-seq fold-change (NHS/NHS-HI) and log2 fraction survival (CFU NHS/NHS-HI) of gene deletion mutants. 
Correlation was determined with a two-tailed Pearson correlation test. 
disulphide bond formation proteins are required for serum resistance. One of the mutants 
that showed severely attenuated complement-resistance was that of dsbB, which is involved in 
oxidative protein folding (25) (Fig. 2). To assess the importance of dsbB for complement resistance 
in other M. catarrhalis lineage 1 isolates, directed gene deletion mutants were generated in 
strains O35E, 46P47B1, 103P14B1, RH4, and C072. Deletion of dsbB from O35E, 46P47B1, and 
103P14B1 resulted in an even more strongly reduced survival in NHS compared to BBH18, but 
only mild attenuation was found after deletion of dsbB from RH4 and no loss of complement 
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resistance was observed for C072ΔdsbB (Fig. 3A-F). BLASTp analysis did not reveal the presence 
of a second dsbB gene in strains RH4 and C072. Further, the DsbB protein is highly conserved 
across seroresistant lineage M. catarrhalis isolates, with only a single polymorphism at position 57 
(alanine or valine) (Fig. S3A). However, no association of the complement-phenotype upon dsbB 
deletion and presence of either amino acid at that position was found. 
These results point to an important role for the disulphide bond formation (DSB) system 
in complement resistance of M. catarrhalis. The DSB system consists of two enzymes: DsbA, a 
periplasmic protein that catalyses disulphide bond formation into unfolded polypeptides, and the 
inner membrane protein DsbB, which reoxidizes the reactive cysteine pair in DsbA, enabling the 
formation of new disulphide bonds (25). Analysis of the M. catarrhalis BBH18 transposon mutant 
library composition before the NHS challenge showed that dsbA mutants were not present in 
the library and were therefore not examined in our genetic screen. Using a directed mutagenesis 
approach, dsbA gene deletion mutants of strains BBH18 and O35E could be generated. Growth 
of BBH18 and O35E dsbA mutants in standard BHI broth was attenuated compared to their 
parental wild-type strains (data not shown), providing a possible explanation for their absence 
in the transposon mutant library. Exposure to active complement resulted in rapid killing of both 
BBH18 and O35E dsbA mutant strains, whereas their survival was not attenuated in NHS-HI (Fig. 
4AB). In analogy to the DsbB proteins, DsbA was found to be highly conserved in seroresistant-
lineage M. catarrhalis isolates (Fig. S3B). 
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Fig. 3. Serum resistance of M. catarrhalis dsbB directed gene deletion mutants. Survival of dsbB 
mutants in BBH18 (A), O35E (B), 46P47B1 (C), and 103P14B1 (D) in 40% NHS was highly attenuated. Loss 
of serum resistance was only minor in RH4ΔdsbB (E) and no loss was observed after dsbB deletion in C072 
(F). Statistical significance between survival in NHS versus NHS-HI (n ≥ 4) was determined on log10-tranformed 
data with a Mann-Whitney test. For all experiments, data shown are means and SEM. * P < 0.05, ** P < 
0.01, *** P < 0.001.
To confirm that the observed phenotypes were indeed due to loss of DSB system genes, 
mutants were genetically complemented by expression of the coding sequences from the 
complementation plasmid pSV001 (20). Since multiple attempts to generate complemented 
BBH18 dsb mutants failed, genetic complementation was performed in the O35E genetic 
background. Complemented mutants were readily obtained for O35EΔdsbB after direct 
transformation of ligation mixtures, but complementation of the dsbA mutant proved to be 
more difficult. Complemented dsbA mutants were only obtained after transformation with an 
excess (~1.5 µg) of the dsbA complementation plasmid pSV005 that was first isolated from 
O35E wild-type, suggesting reduced transformability of the O35E dsbA mutant. Further, no 
transformants containing the empty complementation plasmid pSV001 were obtained for the 
O35E dsbA mutant strain. Genetic complementation of O35E dsbB and dsbA mutants restored 
gene expression to levels comparable to (dsbA, 1.6-fold) or even higher than (dsbB, 5.7-fold) 
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wild-type (Fig. 5A). Despite these higher expression levels, complement-resistance was restored to 
wild-type levels (Fig. 5B), while no effect on expression and complement resistance was observed 
in O35EΔdsbB containing the empty complementation plasmid (data not shown). Noteworthy, 
we observed that dsbB expression was lower in the O35E dsbA mutant and partially restored after 
genetic complementation.
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Fig. 4. Serum resistance of M. catarrhalis dsba directed gene deletion mutants. Complement 
resistance was severely abolished after deletion of dsbA from BBH18 (A) and O35E (B). Statistical difference 
between survival in NHS versus NHS-HI was determined on log10-tranformed data with a Mann-Whitney test 
(n ≥ 4). For all experiments, data shown are means and SEM. ** P < 0.01, and *** P < 0.001.
Importantly, it is unlikely that M. catarrhalis complement resistance mechanisms mediated 
by UspA1/A2/A2H are affected in the DSB mutants because these proteins contain none or only 
one cysteine residue. To confirm this, we examined protein UspA2 (O35E) and UspA2H (BBH18) 
levels in membrane fractions and sequenced their phase-variable repeat regions. Expression of 
uspA2 is subject to phase variation and regulated by AGAT-repeats located upstream of the start 
codon (26). Both O35E wild-type and O35EΔdsbA contained 15 AGAT-repeats, and although 
O35EΔdsbB harboured 14 AGAT-repeats instead of 15, RT-qPCR analysis showed that uspA2 
gene expression was similar to wild-type (data not shown). In addition, analysis of membrane 
fractions showed that the high-molecular weight band representing UspA2 (27, 28) was detected 
in all O35E DSB system mutants and complemented mutant strains (Fig. S4A). UspA2H levels in 
BBH18 are dependent on a poly(A) repeat close to the 5’ end of the gene (28). The BBH18 wild-
type strain contains 8 adenine nucleotides, which was found in both BBH18 ΔdsbB and ΔdsbA. 
In line, high-molecular weight bands corresponding to UspA2H were present at similar levels in 
wild-type BBH18 and in BBH18 DSB system mutants (Fig. S4B). 
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Fig. 5. Genetic complementation of M. catarrhalis o35e dSb system mutants. (A) RT-qPCR analysis 
showed restored expression of both dsbB and dsbA in genetically complemented O35EΔdsbB and ΔdsbA 
(n ≥ 3). Lower expression of dsbB was observed after deletion of dsbA. (B) Complement resistance of O35E 
DSB system mutants in 40% NHS was restored to wild-type levels by trans expression of dsbB from pSV004 
and dsbA from pSV005. Statistical significance (n ≥ 4) of mutant versus wild-type in NHS was tested on log10-
tranformed data with a Mann-Whitney test. For all experiments, data shown are means and SEM. * P < 0.05, 
** P < 0.01, and *** P < 0.001.
Killing of dSb system mutants is mediated by the classical complement pathway. To 
investigate which complement pathway was responsible for killing of DSB system mutant strains, 
activation of the classical pathway was blocked through addition of EGTA. Blocking the classical 
pathway prevented killing of both dsbB and dsbA mutants of BBH18 and O35E (Fig 6A-D). To 
further confirm that classical complement pathway activity is indeed responsible for killing of DSB 
system mutants, we depleted IgG from NHS. Incubation of BBH18 and O35E wild-type strains 
with IgG-depleted NHS showed low residual IgG surface binding, indicating efficient depletion 
of IgGs (Fig. 6E). Although the binding of IgG to BBH18 and O35E wild-type and DSB system 
mutants did not differ significantly (Fig. 6F), IgG was shown to be essential for killing of both DSB 
system mutants in the two strain backgrounds (Fig. 6G-I). 
The dSb system is important for membrane stability and affects loS. To address the stability 
of the outer membrane of the O35E DSB system mutants, we analysed their sensitivity to EDTA, 
a divalent cation chelator that interrupts the intermolecular associations between LOS phosphate 
groups (29). Although loss of viable wild-type BBH18 and O35E was observed in the presence 
of EDTA due to the destabilization of the outer membrane, BBH18 and O35E dsbA mutants 
were significantly more sensitive than wild-type, while no detectable effects were observed after 
deletion of dsbB. Genetic complementation of O35EΔdsbA resulted in slightly enhanced survival, 
although this effect was not significant (Fig. 7A). This could be the result of its severe phenotype 
and the fact that dsbB expression was lower in O35EΔdsbA relative to wild-type.
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Fig. 6. Classical complement pathway mediated killing of dSb system mutants is dependent on 
IgG. (A-D) No killing of DSB system mutants was observed after blocking of the classical pathway by addition 
of EGTA. Statistical significance (n ≥ 4) between survival in NHS versus NHS-HI was determined on log10-
tranformed data with a Mann-Whitney test. (E-F) Flow cytometry analysis of IgG-binding to wild-type BBH18 
and O35E strains. Efficient depletion of IgG from NHS (n = 3) (E). IgG-binding of wild-type and DSB system 
mutants was comparable (n = 3) (F). Statistical significance was determined on the mean fluorescence intensity 
(MFI) with an unpaired t-test with Welch’s correction. (G-J) Incubation of DSB system mutants of strain BBH18 
(G and H) and O35E (I and J) in 10% NHS, IgG-depleted NHS, and NHS-HI, showed no complement-mediated 
killing after IgG-depletion. Statistical significance (n ≥ 3) was tested on log10-transformed data with a two-way 
ANOVA and the Bonferroni post-hoc test. For all experiments, data shown are means and SEM. * P < 0.05, 
** P < 0.01, *** P < 0.001.
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To examine the effect of loss of DSB system genes on LOS structure, we analysed the LOS migration 
patterns of mid-log cultures of wild-type, mutants, and complemented mutant strains of equal 
optical density. Loss of dsbA from BBH18 (LOS type B) resulted in a smaller LOS band, whereas 
two higher intensity bands were observed for the O35E (LOS type A) dsbA mutant compared 
to the wild-type. The LOS bands of the complemented O35E dsbA mutant were of comparable 
intensity as the wild-type. LOS migration patterns and band intensities of both O35E and BBH18 
dsbB mutants were virtually indistinguishable from wild-type, as confirmed by a comparable 
intensity ratio between bands 1 and 2 (Fig. 7B).
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Fig. 7. deletion of dsba genes reduces membrane stability and affects loS. (A) Incubation during 
2h in the presence of 25 mM EDTA resulted in significant loss of viable O35E and BBH18 dsbA mutants 
relative to wild-type. The complemented O35E dsbA mutant showed slightly increased survival compared to 
ΔdsbA, although this did not reach statistical significance. No reduced survival was observed for dsbB and 
complemented dsbB mutant strains. Statistical significance was determined on log10-transformed data with 
a two-way ANOVA and the Bonferroni post-hoc test (n ≥ 4). Data are shown as means and SEM. * P < 0.01, 
** P < 0.01, *** P < 0.001. (B) LOS migration pattern analysis using Tris-glycine SDS-page and silver staining. 
In the LOS type A strain O35E two higher intensity LOS bands (indicated with 2 and 3) were observed after 
deletion of dsbA compared to wild-type, which was restored after genetic complementation. LOS migration 
and band intensities of O35E ΔdsbB and the complemented dsbB mutant were not affected, as indicated by 
a comparable ratio between bands indicated with 2 and 1. In BBH18, expressing a type B LOS structure, loss 
of dsbA resulted a smaller sized LOS band, indicated as band 4. 
dISCuSSIon
The complement system is an important element of the innate defence against pathogenic 
bacteria (30, 31) and respiratory tract pathogens like M. catarrhalis are exposed to increased levels 
of complement during OM (32) and exacerbations of COPD (33). The ability to resist complement-
mediated killing is considered to be a key virulence trait of M. catarrhalis. Here we aimed to 
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expand current knowledge of the molecular mechanisms underlying the interaction between 
M. catarrhalis and serum using a combination of two genome-wide approaches: examination 
of gene expression upon NHS exposure and identification of genes essential for complement 
resistance by the high-throughput negative screenings technology Tn-seq (17). NHS exposure 
resulted in large transcriptional alterations in M. catarrhalis BBH18 with 84 genes showing 
increased and 134 decreased expression, which are likely to reflect the complex nature of serum-
induced stress. Application of Tn-seq to NHS exposure led to the identification of 53 genes that 
are required for complement resistance of M. catarrhalis BBH18. We observed only a limited 
overlap between differential gene expression and gene essentiality during NHS exposure, as only 
5 genes (ihfA, MCR_0424, MCR_1212, MCR_1542, and ilvC) identified by Tn-seq were also 
differentially expressed. However, the overlap between genes that were differentially expressed 
and those predicted to be obligate essential or required for fitness (i.e. not or underrepresented 
in the library) was considerably higher; 18 genes with increased expression and 43 genes with 
decreased expression (Table S1). This may suggest that genes essential to handle serum stress are 
also critical for the general physiology of M. catarrhalis. 
In addition to their frequently observed role in immune evasion, surface-exposed proteins 
are also targeted by antibodies that activate the classical complement pathway (34, 35). The 
observed reduced expression of 19 genes encoding surface-exposed and extracellular proteins 
upon exposure to serum may be a way to limited complement activation. In line, we also observed 
lower expression of 6 genes encoding highly antigenic M. catarrhalis proteins, identified as such 
whilst screening surface-expressed small fragment library with human patient sera (19).
Our Tn-seq screen identified 53 potential novel complement resistance genes of M. 
catarrhalis BBH18 and validation with directed gene deletion mutants confirmed the role of 11 
newly identified complement resistance genes, underscoring the potential of Tn-seq to identify 
conditionally essential genes. Several of these genes were found to be linked to virulence in other 
bacterial pathogens. For example, the M. catarrhalis OlpA protein is highly similar to neisserial 
Opa adhesins (36) that are also implicated in complement resistance, i.e. complement exposure 
of Neisseria gonorrhoeae led to the selection of Opa-positive variants that were more resistant 
than Opa-negative variants (37, 38). Further, we identified several genes that also play a role 
in pathogenesis of the respiratory tract pathogen S. pneumoniae, i.e. protein folding enzymes 
peptidyl-prolyl cis-trans isomerases (PPIases) are required for upper airway colonization (39) 
and engD, encoding an highly conserved GTPase, is required for invasiveness in an intranasal 
murine challenge model (40). In the periodontitis causative agent Porphyromonas gingivalis 
SerB is secreted as an effector protein and affects cytokine production, including suppression of 
interleukin-8 (IL-8) (41). 
Interestingly, in addition to their importance in complement resistance of M. catarrhalis, 
MCR_1483 and aroA were also found to be required for cellular adhesion (42) and MCR_0996 
was previously shown to be required during iron-starvation (20). Apparently, these genes fulfil or 
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affect essential virulence mechanisms in M. catarrhalis. In Salmonella enteritidis deletion of aroA, 
involved in the biosynthesis of aromatic amino acids, led to reduced complement resistance, 
which was not only caused by defective aromatic metabolite biosynthesis but also by a defective 
cell wall and outer membrane function (43). The MCR_1483 gene encodes a lipopeptide of 48 
amino acids in length and shares 58% identity with LppL of Pseudomonas sp. GM102 (58%), 
but the functional role of LppL is unknown (44). Noteworthy, MCR_0424 was higher expressed 
upon NHS exposure and deletion of this gene severely attenuated survival in NHS. Unfortunately, 
no functional role is known for MCR_0424, as this predicted cytoplasmic protein contains no 
conserved protein domains and has no orthologs in other species. 
As expected uspA2H, encoding a key complement resistance factor (21), was identified as 
one of the top hits in our Tn-seq screen. However, we did not identify all factors that were 
previously shown to be important for complement resistance, such as ompCD (10), ompE (11), 
copB (12), and LOS lipid A and 3-deoxy-D-manno-2-octulosonic acid (KDO)-core biosynthesis 
genes kdtA (45), kdsA (46), lpxX (47), and lpxA (48). Of these, ompCD, kdtA, kdsA, lpxX, and lpxA 
were not represented by transposon mutants in our library, most likely because mutants of these 
genes have attenuated in vitro growth, as was previously reported by others (10, 45-48). The 
importance of the LOS glycosyltransferases for complement-resistance is less well-characterized 
and may vary between the different LOS serotypes (49). Although transposon mutants of LOS 
glycosyltransferase genes of strain BBH18 (lgt1, lgt2B/C, lgt3, lgt5, and lgt6) were present in the 
mutant library, exposure to NHS only negatively selected mutants of lgt6, which is responsible for 
attachment of the first glucose to the LOS lipid A-KDO core (50). Finally, our failure to identify 
other known complement-resistance factors could be the result of rescue by secreted factors 
or outer membrane vesicles containing virulence factors (51) derived from other transposon 
insertion mutants in the library that still harbour the wild-type allele.
One of the most interesting factors contributing to complement-resistance of M. catarrhalis 
identified in our study was the DSB system. This system consists of the periplasmic DsbA protein 
that directly catalyses formation of disulphide bonds and DsbB, an inner membrane protein that 
reoxidizes DsbA. Formation of disulphide bonds is important for cell integrity and involved in the 
production of proteins associated with virulence in many bacterial pathogens (25). Experiments 
with dsbB directed gene deletion mutants in multiple strains confirmed the role of the DSB 
system in M. catarrhalis complement resistance, although only a mild reduction in complement 
resistance was observed upon deletion of dsbB in strain RH4, and no attenuation in strain C072. 
As DsbB was found to be highly conserved other factors could compensate the loss of dsbB in 
these two isolates, or complement resistance may occur by DsbB-independent mechanisms. For 
instance, glutaredoxin 3 may catalyse disulphide bond formation in the periplasm independently 
of DsbB, which in Escherichia coli relies on glutathione biosynthesis (52). Deletion of dsbA 
conferred a more pronounced attenuated complement resistance than deletion of dsbB from 
BBH18 and O35E, probably due to the lack of disulphide bonding activity in these dsbA mutants. 
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The role of the DSB system was further underscored by restored resistance against complement-
mediated killing after genetic complementation of both O35EΔdsbB and ΔdsbA. While dsbA 
expression was comparable in wild-type and the complemented mutant, expression of dsbB was 
5.7-fold higher than wild-type upon genetic complementation, which could potentially affect 
disulphide bond formation homeostasis. Further, we observed that deletion of dsbA resulted in 
reduced expression of dsbB (partially restored after complementation of dsbA) indicating that 
dsbB expression requires co-expression of dsbA. Alternatively, dsbB expression may be indirectly 
affected due to lack of DsbA-dependent activation of two-component systems, as has been 
described for E. coli and Salmonella enterica (53, 54).
Noteworthy, we observed a very low transformation efficiency of O35EΔdsbA with the 
dsbA complementation plasmid pSV005, and no transformants were obtained with the empty 
complementation plasmid (pSV001), which suggests that the natural transformability may be 
affected in this mutant. Natural transformation of M. catarrhalis relies on type IV pili which are 
potentially dependent on the DSB system as has been shown for Neisseria meningitidis (55). 
As mentioned, the DSB system has been implicated in pathogenesis in many species (25). 
For example, in a signature-tagged mutagenesis screen of H. influenzae, dsbB was found to be 
required for systemic infection of infant rats (56) and directed deletion of dsbA from H. influenzae 
resulted in attenuated complement resistance (57). Virulence factors reported to rely on disulphide 
bond formation are for example the N. meningitidis PilQ subunit of the above-mentioned type-IV 
pili (55), the H. influenzae heme transporter HbpA (57), and pertussis toxin of Bordetella pertussis 
(58). At present, no DSB system protein targets are known for M. catarrhalis. Proteome analysis 
of DSB system mutants, e.g. as described for E. coli (59), could be used to identify both potential 
direct DSB system substrates as well as proteins indirectly affect by los of DSB system genes. 
Importantly, UspA1/A2/A2H-mediated complement resistance is not likely to rely (directly or 
indirectly) on DSB system activity, as they do not contain multiple cysteine residues and appeared 
to be present in membrane fractions at equal levels in wild-type and mutant strains. Furthermore, 
UspA autotransporter proteins exert their own insertion into the outer membrane (60) and are 
not known to require supportive transport systems dependent on disulphide bond formation.
Although the exact mechanism by which the DSB system affects complement resistance 
remains as yet unknown, we showed that dsbA, encoding the catalytic unit of the DSB system, is 
required to maintain membrane stability as well as to preserve a correct LOS structure, whereas 
both were not affected in dsbB mutants. Interestingly, we observed different effects in a LOS 
type A (O35E) and type B (BBH18) background, with higher intensity LOS bands and a smaller 
sized LOS, respectively. Further, we showed that IgG-dependent classical pathway activation was 
required for killing of DSB system mutants, although DSB system mutants and their wild-type 
counterparts bound equal amounts of IgG. This suggests that the multitude of other antigenic 
proteins was still sufficient to facilitate IgG-binding, or that small changes in IgG-binding, not 
detected by flow-cytometry, caused attenuated complement resistance. Along the same line, 
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Verduin et al. showed that complement resistant isolates activated complement to the same 
extent or slightly better than complement sensitive isolates, and that the activation of complement 
was IgG-dependent (61). 
In conclusion, we applied expression profiling and Tn-seq technology to shed new light on 
the molecular basis of M. catarrhalis complement resistance, a key virulence trait of disease-
associated M. catarrhalis strains. The novel insight obtained in transcriptional adaptation upon 
serum exposure and the discovery of several novel genes required for complement-resistance, 
including the DSB system, increases our understanding of M. catarrhalis pathogenesis and will 
aid new research in this field. Importantly, there is still a lack of understanding of the functional 
role of a large part of the M. catarrhalis genome. Therefore, the availability of a high-throughput 
screenings technology and data analysis pipeline to identify conditionally essential genes in M. 
catarrhalis as outlined in this study, provides an excellent opportunity to unravel the role of these 
uncharacterized genes. 
MaTerIalS and MeTHodS 
bacterial strains, plasmids, and growth conditions. M. catarrhalis strains (Table S3) were 
routinely cultured on brain heart infusion (BHI) agar plates at 37°C in an atmosphere containing 
5% CO2 or in BHI broth at 37°C with agitation (200-250 rpm). Transposon mutant libraries, gene 
deletion mutants, and genetically complemented strains were cultured in BHI in the presence 
of 30 µg ml-1 spectinomycin (BHI-spec) and/or 15 µg ml-1 kanamycin. Aliquots of bacteria were 
routinely stored in the presence of 20-25% glycerol at -80°C. 
Gene expression profiling during nHS exposure. Assays were performed with pooled normal 
human serum (NHS, GTI diagnostics) diluted in PBS supplemented with 0.15% gelatin (PBS-G) 
and 1 mM CaCl2 and 0.2 mM MgCl2 (Ca
2+
 and Mg
2+). To limit day to day variation, two fully 
independent microarray expression profiling studies during NHS exposure were performed, 
indicated hereafter as experiment A and B. Independent cultures of M. catarrhalis BBH18 were 
expanded to mid-log phase (OD620nm, 1.0 to 1.2), washed in 4 volumes PBS-G, and resuspended in 
5 volumes PBS-G (Ca2+ and Mg
2+). Bacterial suspensions (~6·107 CFU/ml) were mixed in a 1:1 ratio 
with 20% NHS (experiment A; n = 3, experiment B; n = 3) or PBS-G (Ca2+ and Mg
2+) (experiment 
A; n = 3, experiment B; n = 2) and incubated at 37°C with agitation (200 rpm). Ten percent NHS 
was sufficient to induce rapid killing of M. catarrhalis BBH18ΔuspA2H (data not shown). Bacterial 
suspensions were sampled after 0, 30 (experiment A only), and 60 min exposure and immediately 
treated with RNAprotect Bacteria Reagent (Qiagen) and RNA was isolated as previously described 
(23). Total RNA (5 µg) was labeled according to standard NimbleGen gene expression array 
protocols. Cy3-labelled cDNA probes were hybridized to custom-designed NimbleGen M. 
catarrhalis BBH18 expression arrays, described previously (20). Expression data was analysed 
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using Arraystar software (DNASTAR) with Quantile RMA normalization. Statistical analysis was 
performed using CyberT unpaired two-conditions data analysis (http://cybert.ics.uci.edu/). Genes 
were considered to be differentially expressed at a fold-change >2.5 or <-2.5 and Bonferroni 
corrected P <0.05. Genes with an average probe signal intensity of log2 < 6 in all tested conditions 
were considered not to be expressed and excluded from the analysis. Functional class distribution 
was assessed using the Institute for Genomic Sciences (IGS) classification (23) with the Fishers 
exact (one-tail) test, corrected for multiple testing according to Storey and Tibshirani (62).
Tn-seq transposon mutant library screen during nHS exposure. The M. catarrhalis BBH18 
marinerT7 transposon mutant library was described previously (20). The mutant library was pre-
cultured in quadruplicate to mid-log phase (OD620nm ~ 1.0-1.2), washed in 2 volumes PBS-G, and 
resuspended in 2.5 volume PBS-G (Ca2+ and Mg
2+). Thereafter, cultures were mixed in a 1:1 ratio 
with 80% NHS or heat-inactivated NHS (NHS-HI, 30 min at 56°C) diluted in PBS-G (Ca2+ and 
Mg2+), and incubated at 37°C with agitation (200 rpm). Mutants were recovered (> 100 CFU/
mutant) after 0, 30, and 60 min exposure to either condition and allowed to expand to OD620 
of 0.75-1.0. Of these cultures, 0.5 ml was mixed with 0.5 ml 50% glycerol in BHI and stored 
at -80°C. The aliquots (1 ml) of the recovered libraries were used to inoculate 5 ml BHI-spec 
medium, expanded to OD620 of 0.2-0.4, and chromosomal DNA was isolated using Genomic-tip 
20/G columns. 
Tn-seq analysis of M. catarrhalis mariner transposon mutant libraries. The Tn-seq 
technology was used to profile the relative abundance of each mutant in the library, essentially as 
described in Burghout et al. (63). For data analysis, FASTQ files were processed via the ESSENTIALS 
analysis pipeline (http://bamics2.cmbi.ru.nl/websoftware/essentials/essentials_start.php) (18). Tn-
seq barcode sequences were used to attribute the sequence reads to the individual samples. 
Sequence reads were aligned to the BBH18 reference genome (23) with a minimal match of 16 
nt and collected per unique insertion site (TA dinucleotide sequence) and per gene. Fold-change 
between read counts obtained from the NHS (challenge) and NHS-HI (control) conditions were 
calculated. In addition, the library composition was analysed directly after the addition of NHS. 
Initial selection criteria for genes of which mutants were affected by the presence of complement 
were a log2 fold-change of < -1 or > 1, Bonferroni corrected P < 0.05, and a Benjamini & Hochberg 
(BH) false discovery rate (FDR) < 0.05. To reduce the number of false-positives, this initial list was 
subjected to a number of filtering steps. Firstly, genes without sequence reads in both NHS and 
NHS-HI, at one time point but not the other were removed from the list. Secondly, genes with 
a fitness score lower than log2 of -3 were excluded, with the fitness score defined as the ratio 
between actual measured sequence reads and expected sequence reads based on possible TA-
insertions sites and library size (24). Thirdly, genes with a fold-change of more than 2.5 between 
60 and 0 minutes incubation in NHS-HI were excluded from the analysis, as we considered it 
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more likely that the corresponding mutants had a growth advantage in NHS-HI than that they 
were actually attenuated for survival in NHS. In addition, genes with less than 100 sequence reads 
before challenge were eliminated. From this list, we selected genes that showed attenuation/
enrichment of at least log2 1 (2-fold) after 30 min and 1.585 (3-fold) after 60 min NHS exposure. 
Finally, we eliminated genes that were not expressed in the presence of NHS (experiment A as 
described above), resulting in a total of 53 genes of which mutants were found to be affected by 
NHS relative to NHS-HI.
Generation of directed mutants. Directed gene deletion mutants of M. catarrhalis BBH18 
were generated by allelic exchange of the target gene with a spectinomycin resistance cassette 
as described earlier (20). Mutants were checked by PCR for recombination at the desired location 
on the chromosome. The first generation directed mutant strains were used to generate PCR 
products containing the spectinomycin resistance cassette and gene flanking regions, which was 
crossed back into the BBH18 wild-type strain. These PCR products were also used to generate 
gene deletions in other M. catarrhalis strains. Primers used in this study are listed in Table S4.
Genetic complementation of o35e dSb system directed mutants. Gene expression in O35E 
DSB system mutants was restored by trans expression of the gene from the pSV001 plasmid, 
essentially as described in De Vries et al. (20). Briefly, the coding and upstream sequences were 
amplified and ligated into the BamHI and SacI sites of pSV001 (KanR), yielding pSV004 (dsbB 
complementation plasmid) and pSV005 (dsbA complementation plasmid). The ligation mixture 
for dsbB complementation (pSV001 and dsbB insert) was directly transformed into O35EΔdsbB. 
To obtain the complemented O35E dsbA mutant, the ligation mixture was first transformed 
into O35E wild-type, as attempts to directly transform the ligation mixture (pSV001 and dsbA 
insert) in O35EΔdsbA were not successful. Thereafter, the resulting pSV005 complementation 
plasmid was isolated from O35E wild-type using the HighSpeed plasmid midi kit (Qiagen), 
and subsequently O35EΔdsbA was transformed with 1.5 micrograms of pSV005. Attempts to 
generate complemented DSB system mutants in a BBH18 background failed. 
Serum resistance assays with directed gene deletion mutants. For Tn-seq validation, wild-
type and mutant strains were pre-cultured to mid-log phase (OD620nm ~ 1.0-1.2), washed in 4 
volumes PBS-G, and resuspended in 5 volumes PBS-G (Ca2+ and Mg
2+). This bacterial suspension 
(~6·107 CFU/ml) was mixed in a 1:1 ratio with 80% NHS or NHS-HI diluted in PBS-G (Ca2+ and 
Mg2+), and incubated at 37°C with agitation (200 rpm). Bacteria were enumerated after 0, 30, 
and 60 min exposure by plating 10-fold dilutions. Statistical significance (n ≥ 3) was tested 
on log10-transformed data with a two-way ANOVA and the Bonferroni post-hoc test. Follow-
up experiments with DSB system mutants were performed as described above and classical 
complement pathway activity was blocked through the addition of EGTA to a final concentration 
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of 20 mM. Statistical significance (n ≥ 4) was tested on log10-tranformed data with a Mann-
Whitney test. For assays with IgG-depleted NHS, bacteria were washed in 4 volumes PBS-G and 
resuspended in 10 volumes PBS-G (Ca2+ and Mg
2+). Bacteria (~1.8·106 CFU/ml) were mixed in a 
1:1 ratio with 10% IgG-depleted NHS, NHS, or NHS-HI, and CFU counts were determined after 0, 
30, and 60 min exposure by plating 10-fold dilutions. Statistical significance (n ≥ 3) was tested on 
log10-transformed data with a two-way ANOVA and the Bonferroni post-hoc test. 
Serum IgG-depletion. To deplete IgG from serum, NHS was diluted to 20% with PBS-G 
(Ca2+ and Mg
2+), mixed with 1/20 volume washed ProtG Sepharose beads (Sigma Aldrich), and 
incubated for 2 h on a rotating wheel at 4°C. After removal of the ProtG beads by centrifugation, 
IgG-depleted serum was diluted to a final concentration of 10% with PBS-G (Ca2+ and Mg
2+) 
and stored at -80°C. As a control, incubation steps were also conducted without ProtG beads to 
account for potential loss in complement activity.
quantification of IgG-binding and IgG-depletion by flow cytometric analysis. Hank’s 
buffered salt solution (HBSS, Lonza) without Ca2+ and Mg
2+
 supplemented with 5% heat-
inactivated fetal calf serum was used for all dilution and wash steps. Bacterial strains were 
pre-cultured to early-log phase (OD620nm ~ 0.5). Next, IgG-binding was assessed by incubation 
in 5 % NHS-HI or IgG-depleted NHS-HI for 1h at 37°C. Bacteria were fixed during 15 min in 
2% paraformaldehyde at room-temperature, incubated with FITC-conjugated anti-human IgG 
during 30 min at 4°C, and analysed on a LSRII flow cytometer (BD Biosciences). Acquired data 
was analysed using FlowJo version 7.6.3 and statistical analysis (n = 3) was performed on mean 
fluorescence intensity (MFI) using an unpaired t-test with Welch’s correction.
rT-qPCr expression analysis. For expression analysis of dsbA and dsbB, strains were expanded 
to OD620nm ~ 1.0 (n = 3) and RNA was isolated as previously described (23). For validation of 
microarray gene expression profiling during NHS exposure, RNA was isolated as described 
above (n ≥ 2). DNA-free total RNA (500 ng) was reverse transcribed into cDNA using the iScript 
cDNA synthesis kit (Biorad). Real-time quantitative PCR (RT-qPCR) reactions were performed 
using SsoAdvanced SYBR Green Supermix (Biorad) on a CFX96 real-time PCR machine (Biorad). 
Expression of dsbA and dsbB in mutant and complemented mutant strains was calculated 
relative to wild-type. Expression of candidate genes selected for validation of expression profiles 
during NHS exposure were calculated relative to PBS-G treated samples. RT-qPCR reactions were 
performed twice for each biological replicate. Expression fold-changes were calculated with the 
ΔΔCt method and the rpoD or gyrA gene as a reference (64). 
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Membrane stability assay. Bacterial strains were cultured to mid-log phase (OD620 ~1.0). The 
bacterial culture was mixed in a 1:1 ratio with fresh BHI medium and ethylenediaminetetraacetate 
(EDTA) was added to a final concentration of 25 mM. CFUs were determined after 0 and 2 h 
by plating 10-fold dilution series. Statistical significance was assessed on log10-transformed data 
with a two-way ANOVA and a Bonferroni post-hoc test (n ≥ 4). 
loS migration pattern analysis. LOS preparations were generated from mid-log phase (OD620 
~1.0) cultures through the proteinase K-ethanol precipitation method as described elsewhere 
(65). LOS preparations (2 µl) were separated on a Tris-glycine SDS-page gel and visualized by silver 
staining (66). Gel imaging was performed using a FluorChem E system and LOS band intensities 
were quantified with AlphaView software v3.3.1. 
analysis of uspa2/a2H protein expression. Wild-type and mutant strains were cultured 
until OD620nm of 1.0 to 1.2, harvested by centrifugation, and outer membranes were isolated 
as described as detailed in: http://www.bio-protocol.org/wenzhang.aspx?id=957, followed by a 
trichloroacetic acid precipitation. Expression of UspA proteins was examined using Western blot 
analysis with a rabbit anti-UspA serum (7) at a dilution of 1:2000 as described earlier (20).
Sequencing and microarray data. All microarray have been deposited in the NCBI Gene 
Expression Omnibus (GEO) database (www.ncbi.nlm.nih.gov/geo/) under GEO Series accession 
number GSE52552. Tn-seq sequence data can be found on the ESSENTIALS website (http://
bamics2.cmbi.ru.nl/websoftware/essentials/links.html). 
Statistical analysis. Statistical analyses were performed in GraphPad Prism 5.0 (GraphPad 
Software) unless indicated otherwise, with P < 0.05 considered to be significant.
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Fig. S1. Correlation between microarray expression profiling (60 min) and rT-qPCr (30 min). The 
fold-change (NHS/PBS-G) after 60 min (experiment A and B) as determined with microarrays (x-axis) correlated 
significantly with RT-qPCR data obtained for a subset of 12 genes after 30 min exposure (experiment A) 
(y-axis) (experiment A; NHS n = 3, PBS-G n =3, and experiment B; NHS n = 3 and PBS-G = 2). The correlation 
between these two time points was determined with a two-tailed Pearson correlation test.
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BBH18         MTMPNYRTLNIILSLIMVAGSVYAIGYLQNYLMLDPCPLCIFQRIGLWIMGIFALLAAII 60
O35E          MTMPNYRTLNIILSLIMVAGSVYAIGYLQNYLMLDPCPLCIFQRIGLWIMGIFALLAAII 60
46P47B1       MTMPNYRTLNIILSLIMVAGSVYAIGYLQNYLMLDPCPLCIFQRIGLWIMGIFALLAAII 60
103P14B1      MTMPNYRTLNIILSLIMVAGSVYAIGYLQNYLMLDPCPLCIFQRIGLWIMGIFALLVAII 60
RH4           MTMPNYRTLNIILSLIMVAGSVYAIGYLQNYLMLDPCPLCIFQRIGLWIMGIFALLVAII 60
C072          MTMPNYRTLNIILSLIMVAGSVYAIGYLQNYLMLDPCPLCIFQRIGLWIMGIFALLVAII 60
7169          MTMPNYRTLNIILSLIMVAGSVYAIGYLQNYLMLDPCPLCIFQRIGLWIMGIFALLAAII 60 
BC1           MTMPNYRTLNIILSLIMVAGSVYAIGYLQNYLMLDPCPLCIFQRIGLWIMGIFALLAAII 60
BC7           MTMPNYRTLNIILSLIMVAGSVYAIGYLQNYLMLDPCPLCIFQRIGLWIMGIFALLAAII 60
BC8           MTMPNYRTLNIILSLIMVAGSVYAIGYLQNYLMLDPCPLCIFQRIGLWIMGIFALLAAII 60
101P30B1      MTMPNYRTLNIILSLIMVAGSVYAIGYLQNYLMLDPCPLCIFQRIGLWIMGIFALLVAII 60
12P80B1       MTMPNYRTLNIILSLIMVAGSVYAIGYLQNYLMLDPCPLCIFQRIGLWIMGIFALLVAII 60
43617         MTMPNYRTLNIILSLIMVAGSVYAIGYLQNYLMLDPCPLCIFQRIGLWIMGIFALLAAII 60
              ******************************************************** ***
BBH18         NPRQKLVRLILWVGSMVGTLWGFGVAARHTWIHYAPSAQPPACGPGLEYWVQTMPMSKVL 120
O35E          NPRQKLVRLILWVGSMVGTLWGFGVAARHTWIHYAPSAQPPACGPGLEYWVQTMPMSKVL 120 
46P47B1       NPRQKLVRLILWVGSMVGTLWGFGVAARHTWIHYAPSAQPPACGPGLEYWVQTMPMSKVL 120
103P14B1      NPRQKLVRLILWVGSMVGTLWGFGVAARHTWIHYAPSAQPPACGPGLEYWVQTMPMSKVL 120
RH4           NPRQKLVRLILWVGSMVGTLWGFGVAARHTWIHYAPSAQPPACGPGLEYWVQTMPMSKVL 120
C072          NPRQKLVRLILWVGSMVGTLWGFGVAARHTWIHYAPSAQPPACGPGLEYWVQTMPMSKVL 120
7169          NPRQKLVRLILWVGSMVGTLWGFGVAARHTWIHYAPSAQPPACGPGLEYWVQTMPMSKVL 120 
BC1           NPRQKLVRLILWVGSMVGTLWGFGVAARHTWIHYAPSAQPPACGPGLEYWVQTMPMSKVL 120
BC7           NPRQKLVRLILWVGSMVGTLWGFGVAARHTWIHYAPSAQPPACGPGLEYWVQTMPMSKVL 120 
BC8           NPRQKLVRLILWVGSMVGTLWGFGVAARHTWIHYAPSAQPPACGPGLEYWVQTMPMSKVL 120
101P30B1      NPRQKLVRLILWVGSMVGTLWGFGVAARHTWIHYAPSAQPPACGPGLEYWVQTMPMSKVL 120
12P80B1       NPRQKLVRLILWVGSMVGTLWGFGVAARHTWIHYAPSAQPPACGPGLEYWVQTMPMSKVL 120
43617         NPRQKLVRLILWVGSMVGTLWGFGVAARHTWIHYAPSAQPPACGPGLEYWVQTMPMSKVL 120
              ************************************************************
BBH18         TTVLTGNGDCGMIDWTLMGLSIPAQAMILFMIIALIQVIILKKILSNNR 169
O35E          TTVLTGNGDCGMIDWTLMGLSIPAQAMILFMIIALIQVIILKKILSNNR 169
46P47B1       TTVLTGNGDCGMIDWTLMGLSIPAQAMILFMIIALIQVIILKKILSNNR 169
103P14B1      TTVLTGNGDCGMIDWTLMGLSIPAQAMILFMIIALIQVIILKKILSNNR 169
RH4           TTVLTGNGDCGMIDWTLMGLSIPAQAMILFMIIALIQVIILKKILSNNR 169
C072          TTVLTGNGDCGMIDWTLMGLSIPAQAMILFMIIALIQVIILKKILSNNR 169
7169          TTVLTGNGDCGMIDWTLMGLSIPAQAMILFMIIALIQVIILKKILSNNR 169
BC1           TTVLTGNGDCGMIDWTLMGLSIPAQAMILFMIIALIQVIILKKILSNNR 169
BC7           TTVLTGNGDCGMIDWTLMGLSIPAQAMILFMIIALIQVIILKKILSNNR 169
BC8           TTVLTGNGDCGMIDWTLMGLSIPAQAMILFMIIALIQVIILKKILSNNR 169
101P30B1      TTVLTGNGDCGMIDWTLMGLSIPAQAMILFMIIALIQVIILKKILSNNR 169
12P80B1       TTVLTGNGDCGMIDWTLMGLSIPAQAMILFMIIALIQVIILKKILSNNR 169
43617         TTVLTGNGDCGMIDWTLMGLSIPAQAMILFMIIALIQVIILKKILSNNR 169
              *************************************************
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BBH18         MKFALKTALLTTMLSVATLAQANFVEGQDYKVLPNPETIAGDVIVVREFFWYGCPHCYHL 60
O35E          MKFALKTALLTTMLSVATLAQANFVEGQDYKVLPNPETIAGDVIVVREFFWYGCPHCYHL 60
46P47B1       MKFALKTALLTTMLSVATLAQANFVEGQDYKVLPNPETIAGDVIVVREFFWYGCPHCYHL 60
103P14B1      MKFALKTALLTTMLSVATLAQANFVEGQDYKVLPNPETIAGDVIVVREFFWYGCPHCYHL 60
RH4           MKFALKTALLTTMLSVATLAQANFVEGQDYKVLPNPETIAGDVIVVREFFWYGCPHCYHL 60
C072          MKFALKTALLTTMLSVATLAQANFVEGQDYKVLPNPETIAGDVIVVREFFWYGCPHCYHL 60
7169          MKFALKTALLTTMLSVATLAQANFVEGQDYKVLPNPETIAGDVIVVREFFWYGCPHCYHL 60
BC1           MKFALKTALLTTMLSVATLAQANFVEGQDYKVLPNPETIAGDVIVVREFFWYGCPHCYHL 60
BC7           MKFALKTALLTTMLSVATLAQANFVEGQDYKVLPNPETIAGDVIVVREFFWYGCPHCYHL 60
BC8           MKFALKTALLTTMLSVATLAQANFVEGQDYKVLPNPETIAGDVIVVREFFWYGCPHCYHL 60
101P30B1      MKFALKTALLTTMLSVATLAQANFVEGQDYKVLPNPETIAGDVIVVREFFWYGCPHCYHL 60
12P80B1       MKFALKTALLTTMLSVATLAQANFVEGQDYKVLPNPETIAGDVIVVREFFWYGCPHCYHL 60
43617         MKFALKTALLTTMLSVATLAQANFVEGQDYKVLPNPETIAGDVIVVREFFWYGCPHCYHL 60
              ************************************************************
BBH18         EPHMQKWAKTRPADVAFFQTPAAMNPVWEVGARGFYAAQQLDAQEKTHQALFDAVHKDGN 120
O35E          EPHMQKWAKTRPDDVAFFQTPAAMNPVWEVGARGFYAAQQLDAQEKTHQALFDAVHKDGN 120
46P47B1       EPHMQKWAKTRPADVAFFQTPAAMNPVWEVGARGFYAAQQLDAQEKTHQALFDAVHKDGN 120
103P14B1      EPHMQKWAKTRPADVAFFQTPAAMNPVWEVGARGFYAAQQLDAQEKTHQALFDAVHKDGN 120
RH4           EPHMQKWAKTRPADVAFFQTPAAMNPVWEVGARGFYAAQQLDAQEKTHQALFDAVHKDGN 120
C072          EPHMQKWAKTRPDDVAFFQTPAAMNPVWEVGARGFYAAQQLDAQEKTHQALFDAVHKDGN 120
7169          EPHMQKWAKTRPADVAFFQTPAAMNPVWEVGARGFYAAQQLDAQEKTHQALFDAVHKDGN 120
BC1           EPHMQKWAKTRPADVAFFQTPAAMNPVWEVGARGFYAAQQLDAQEKTHQALFDAVHKDGN 120
BC7           EPHMQKWAKTRPADVAFFQTPAAMNPVWEVGARGFYAAQQLDAQEKTHQALFDAVHKDGN 120
BC8           EPHMQKWAKTRPADVAFFQTPAAMNPVWEVGARGFYAAQQLDAQEKTHQALFDAVHKDGN 120
101P30B1      EPHMQKWAKTRPADVAFFQTPAAMNPVWEVGARGFYAAQQLDAQEKTHQALFDAVHKDGN 120
12P80B1       EPHMQKWAKTRPADVAFFQTPAAMNPVWEVGARGFYAAQQLDAQEKTHQALFDAVHKDGN 120
43617         EPHMQKWAKTRPADVAFFQTPAAMNPVWEVGARGFYAAQQLDAQEKTHQALFDAVHKDGN 120
              ************ ***********************************************
BBH18         RNIISSQQELGNWYASKGIDKAKFDSLYNSFAVTTKIERAKAAATRYGLSGVPAVVVHGK 180
O35E          RNIISSQQELGNWYASKGIDKAKFDSLYNSFAVTTKIERAKAAATRYGLSGVPAVVVHGK 180
46P47B1       RNIISSQQELGNWYASKGIDKAKFDSLYNSFAVTTKIERAKAAATRYGLSGVPAVVVHGK 180
103P14B1      RNIISSQQELGNWYASKGIDKAKFDSLYNSFAVTTKIERAKAAATRYGLSGVPAVVVHGK 180
RH4           RNIISSQQELGNWYASKGIDKAKFDSLYNSFAVTTKIERAKAAATRYGLSGVPAVVVHGK 180
C072          RNIISSQQELGNWYASKGIDKAKFDSLYNSFAVTTKIERAKAAATRYGLSGVPAVVVHGK 180
7169          RNIISSQQELGNWYASKGIDKAKFDSLYNSFAVTTKIERAKAAATRYGLSGVPAVVVHGK 180
BC1           RNIISSQQELGNWYASKGIDKAKFDSLYNSFAVTTKIERAKAAATRYGLSGVPAVVVHGK 180
BC7           RNIISSQQELGNWYASKGIDKAKFDSLYNSFAVTTKIERAKAAATRYGLSGVPAVVVHGK 180
BC8           RNIISSQQELGNWYASKGIDKAKFDSLYNSFAVTTKIERAKAAATRYGLSGVPAVVVHGK 180
101P30B1      RNIISSQQELGNWYASKGIDKAKFDSLYNSFAVTTKIERAKAAATRYGLSGVPAVVVHGK 180
12P80B1       RNIISSQQELGNWYASKGIDKAKFDSLYNSFAVTTKIERAKAAATRYGLSGVPAVVVHGK 180
43617         RNIISSQQELGNWYASKGIDKAKFDSLYNSFAVTTKIERAKAAATRYGLSGVPAVVVHGK 180
              ************************************************************
BBH18         YVVSGEDAKVPQVVDFLINKVREEKQ 206
O35E          YVVSGEDAKVPQVVDFLINKVREEKQ 206
103P14B1      YVVSGEDAKVPQVVDFLINKVREEKQ 206
46P47B1       YVVSGEDAKVPQVVDFLINKVREEKQ 206
103P14B1      YVVSGEDAKVPQVVDFLINKVREEKQ 206
RH4           YVVSGEDAKVPQVVDFLINKVREEKQ 206
C072          YVVSGEDAKVPQVVDFLINKVREEKQ 206
BC1           YVVSGEDAKVPQVVDFLINKVREEKQ 206
BC7           YVVSGEDAKVPQVVDFLINKVREEKQ 206
BC8           YVVSGEDAKVPQVVDFLINKVREEKQ 206
101P30B1      YVVSGEDAKVPQVVDFLINKVREEKQ 206
12P80B1       YVVSGEDAKVPQVVDFLINKVREEKQ 206
43617         YVVSGEDAKVPQVVDFLINKVREEKQ 206
              ************************** 
B    DsbA
Fig. S3. alignment of M. catarrhalis dSb system proteins. ClustalW alignment of DsbB (A) and DsbA (B) 
proteins of seroresistant lineage M. catarrhalis isolates (22) showed high levels of conservation. Differences in 
amino acid composition are color coded and indicated with an arrow. 
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Fig. S4. analysis of uspa2/a2H expression in membrane fractions of dSb system mutants. 
Membrane fractions of wild-type, DSB system mutant and complemented mutant strains were analysed by 
Western blot analysis using a polyclonal α-UspA rabbit serum (7). (A) Analysis of UspA2 levels in M. catarrhalis 
O35E DSB system mutants and complemented mutant strains. The high molecular weight band (open arrow) 
representing UspA2 (27, 28) was detected in all strains, indicating the deletion of DSB system genes did 
not affected UspA2 levels in strain O35E. (B) Analysis of UspA2H levels in M. catarrhalis BBH18 DSB system 
mutants and mutants of UspA2H and UspA1. High molecular weight bands (open arrows) that were lacking 
in BBH18 ΔuspA2H were detected in both BBH18 DSB-system mutant strains.
Table S1. differentially expressed genes in M. catarrhalis bbH18 upon exposure to 10% normal 
human serum (nHS). Please refer to: insert link http://onlinelibrary.wiley.com/doi/10.1111/mmi.12475/ 
suppinfo. 
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Table S3. bacterial strains and plasmids used in this study
Strain or plasmid Relevant feature(s) a Reference
Moraxella catarrhalis    
BBH18 Wild-type isolate (67)
BBH18 ΔdsbB dsbB (MCR_0035) deletion mutant, SpecR This study
BBH18 ΔMCR_0117 putative lipoprotein (MCR_0117) This study
BBH18 ΔuspA2H uspA2H (MCR_0329) deletion mutant, SpecR This study
BBH18 ΔserB serB (MCR_0422) deletion mutant, SpecR This study
BBH18 ΔMCR_0424 hypothetical protein (MCR_0424) deletion mutant, SpecR This study
BBH18 ΔMCR_0613 PpiC-type peptidyl-prolyl cis-trans isomerase (MCR_0613) deletion 
mutant, SpecR
This study
BBH18 ΔengD engD (MCR_0830) deletion mutant, SpecR This study
BBH18 ΔaroA aroA (MCR_0888) deletion mutant, SpecR (42)
BBH18 ΔMCR_0996 hypothetical protein (MCR_0996) deletion mutant, SpecR (20)
BBH18 ΔMCR_1115 PpiC-type peptidyl-prolyl cis-trans isomerase (MCR_1115) deletion 
mutant, SpecR
This study
BBH18 ΔuspA1 uspA1 (MCR_1198) deletion mutant, SpecR (20)
BBH18 ΔMCR_1483 Putative lipoprotein (MCR_1483) deletion mutant, SpecR (42)
BBH18 ΔolpA olpA (MCR_1761) deletion mutant, SpecR (20)
BBH18 ΔdsbA dsbA (MCR_ 1827) deletion mutant, SpecR This study
O35E Wild-type isolate (68)
O35E ΔdsbB dsbB deletion mutant, SpecR This study
O35E ΔdsbB + dsbB dsbB deletion mutant, SpecR, complemented with pSV004, KanR This study
O35E ΔdsbA dsbA deletion mutant, SpecR This study
O35E ΔdsbA + dsbA dsbA deletion mutant, SpecR, complemented with pSV005, KanR This study
46P47B1 Wild-type isolate (22)
46P47B1 ΔdsbB dsbB deletion mutant, SpecR This study
103P14B1 Wild-type isolate (22)
103P14B1 ΔdsbB dsbB deletion mutant, SpecR This study
RH4 Wild-type isolate (67)
RH4 ΔdsbB dsbB deletion mutant, SpecR This study
C072 Wild-type isolate (22)
C072 ΔdsbB dsbB deletion mutant, SpecR This study
Escherichia coli
DH5α Host for pGSF8 and pR412T7 plasmids
XL1-blue Host for pGEMT-easy plasmids
Plasmids
pR412T7 Donor for SpecR cassette (69)
pGSF8 Donor for mariner transposon, containing SpecR cassette and mmeI 
restriction sites
(63)
pSV001 Derivative of pWW115, KanR (20)
pSV004 Derived from pSV001,dsbB coding sequence plus upstream region 
cloned in BamHI and SacI sites
This study
pSV005 Derived from pSV001,dsbA coding sequence plus upstream region 
cloned in BamHI and SacI sites
This study
a SpecR, spectinomycin resistance, KanR, kanamycin resistance cassette
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3.4
Table S4. oligonucleotide primers used in this study
Primer name Target a Sequence (5’- 3’)
Primers for generation of directed mutants
PBpR412_L SpecR cassette GCCGCTCTAGAACTAGTGG 
PBpR412_R SpecR cassette GATACCCCTCGAATTGACGC
PBTnMr9 SpecR cassette control primer CAATGGTTCAGATACGACGAC
dsbB-L1-FW1 dsbB (MCR_0035) left flank TGCACATCATGGCAGTAACC
dsbB-L2-RV1 dsbB (MCR_0035) left flank CCACTAGTTCTAGAGCGGCGCCACCATGATGAGTGACAAG
dsbB-R2-FW1 dsbB (MCR_0035) right flank GCGTCAATTCGAGGGGTATCTCATCGCTTTGATTCAGGTG
dsbB-R1-RV1 dsbB (MCR_0035) right flank AAGACATGGCGATCCTTGAG
dsbB-C-RV1 dsbB (MCR_0035) control primer ATGATCCAAAGCCCAATACG
CvdGMCR_0117_L1 MCR_0117 left flank TTGATGCCCAAGCTGTGTAG
CvdGMCR_0117_L2 MCR_0117 left flank CCACTAGTTCTAGAGCGGCACGCCAAAGCCATTACACTC
CvdGMCR_0117_R1 MCR_0117 right flank GCGTCAATTCGAGGGGTATCCAAGACCTTGGTATCGG
CvdGMCR_0117_R2 MCR_0117 right flank AGGTTCGGTGGGTTTATCTG
CvdGMCR_0117_C MCR_0117 control primer TTGTGTTGGTGCTGTTGCAC
uspA2H-L1-FW1 uspA2H (MCR_0329) left flank AGCTAAGCTCGAGGGTTTGG
uspA2H -L2-RV1 uspA2H (MCR_0329) left flank CCACTAGTTCTAGAGCGGCGAGTAATCGCCTGTGGCTTG
uspA2H -R2-FW1 uspA2H (MCR_0329) right flank GCGTCAATTCGAGGGGTATCTCTGGCGTTTAAAGCTGGTG
uspA2H -R1-RV1 uspA2H (MCR_0329) right flank CAATTTTTGACGCCCAATG
uspA2H -C-RV1 uspA2H (MCR_0329) control primer AAATGAACCTGCACCTGTGG
CvdGMCR_0422-L1 serB (MCR_0422) left flank TATGCCACGGATGATCATGC
CvdGMCR_0422-L2 serB (MCR_0422) left flank CCACTAGTTCTAGAGCGGCATGGCATCAGCATCTTCATC
CvdGMCR_0422-R2 serB (MCR_0422) right flank GCGTCAATTCGAGGGGTATCGCTTGAGGATGGTGATGAC
CvdGMCR_0422-R1 serB (MCR_0422) right flank GGTAAAGTTAGCATCGCCAC
CvdGMCR_0422-C serB (MCR_0422) control primer TTAGACGCTGCTCTTCAAGC
CvdGMCR_0424-L1 MCR_0424 left flank GGCTCATCAACATAAGGCTC
CvdGMCR_0424-L2 MCR_0424 left flank CCACTAGTTCTAGAGCGGCTGGCAAATGATGAGCAACGG
CvdGMCR_0424-R2 MCR_0424 right flank GCGTCAATTCGAGGGGTATCAGGTCACAGGCTAGATTACC
CvdGMCR_0424-R1 MCR_0424 right flank TTGGCGTATGGCTTAATGGC
CvdGMCR_0424-C MCR_0424 control primer TCTTGGCTTGATGGTGTCAC
CvdGMCR_0613_L1 MCR_0613 left flank GTATTGCACAAAGTGCTGGC
CvdGMCR_0613_L2 MCR_0613 left flank CCACTAGTTCTAGAGCGGCAAGTGCCTACCAAAACCAGC
CvdGMCR_0613_R1 MCR_0613 right flank GCGTCAATTCGAGGGGTATCATGCACTCAAGGCACAGTAG
CvdGMCR_0613_R2 MCR_0613 right flank ATCAGATGCCGAGCTTGATG
CvdGMCR_0613_C MCR_0613 control primer GCTCATTTGGTTGAATGGCG
CvdGMCR_0830_L1 serB (MCR_0830) left flank CTTCAAGCACTGACACAACG
CvdGMCR_0830_L2 serB (MCR_0830) left flank CCACTAGTTCTAGAGCGGCTGGTAAGCCGACAATACCAC
CvdGMCR_0830_R1 serB (MCR_0830) right flank GCGTCAATTCGAGGGGTATCAAGATGGCGATGTGATGC
CvdGMCR_0830_R2 serB (MCR_0830) right flank CTGATCGCCACATTGATACG
CvdGMCR_0830_C serB (MCR_0830) control primer ATACCTGCTTTGGTGAGTGC
CvdGMCR_1115_L1 MCR_1115 left flank ATCAGCATATACTGCCTCCG
CvdGMCR_1115_L2 MCR_1115 left flank CCACTAGTTCTAGAGCGGCTTGTGACACAAGGCTTGTG
CvdGMCR_1115_R1 MCR_1115 right flank GCGTCAATTCGAGGGGTATCGGCTCAAGAAGATTGGTTGC
CvdGMCR_1115_R2 MCR_1115 right flank TGGTTTTCTGGACGAGATGG
CvdGMCR_1115_C MCR_1115 control primer AGCGACAATACCGTCATGAC
dsbA-L1-FW1 dsbA (MCR_1827) left flank ATCGCTGGCAGAGTTTATGC
dsbA-L2-RV1 dsbA (MCR_1827) left flank  CCACTAGTTCTAGAGCGGCGCATGGTTGTGAGTAATGCTG
dsbA-R2-FW1 dsbA (MCR_1827) right flank GCGTCAATTCGAGGGGTATCATGCCAAAGTGCCTCAAGTC
dsbA-R1-RV1 dsbA (MCR_1827) right flank ACGCAGGCGTTATTTGAATG
dsbA-C-RV1 dsbA (MCR_1827) control primer CCACTTCCCACACTGGATTC
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Primers for genetic complementation of dsbB and dsbA (restriction sites are underlined)
C-dsbB-FW1-BamHI dsbB primer with BamHI restriction site GCGGATCCCCTACCGCTGAAGCATAAAAC
C-dsbB-RV1-SacI dsbB primer with SacI restriction site GCGAGCTCAAATGCTGTATTTATCGGTTGTTAC
C-dsbA-FW1-BamHI dsbA primer with BamHI restriction site GCGGATCCAACGAAACCTTAAGAAAACTGTTG
C-dsbA-RV1-SacI dsbA primer with SacI restriction site GCGAGCTCTGGGTTATTGTTTTTCTTCACG
Primers for RT-qPCR analysis
HB_Mc_dsbBF dsbB expression primer TGGCAGCTCGTCATACTTGG
HB_Mc_dsbBR dsbB expression primer TGGTCTGCACCCAATACTCAAG
Q-O35E_dsbA-FW1 dsbA expression primer AATCGAGCGCGCCAAA
Q-O35E_dsbA-RV1 dsbA expression primer AGGCACGCCAGATAGACCAT
Q-rpoD-FW1 rpoD expression primer (reference gene) GCAGCAGTACTAGCCTCTGTTGAA
Q-rpoD-FW1 rpoD expression primer (reference gene) CCGTACCCATCTCACGCATA
Q-gyrA-FW1 gyrA expression primer (reference gene) CATACGCCGAAGATCCAAATATT
Q-gyrA-RV1 gyrA expression primer (reference gene) GATACCGCTTCTGCCATGGATA
Q-ompE-FW1 ompE expression primer AATTTGGATACAAAGCGCTGAGT
Q-ompE-RV1 ompE expression primer TGCTGCGGTTGCGGTTA
Q-ompCD-FW1 ompCD expression primer AAATGCAACTGCAACCATTGAA
Q-ompCD-RV1 ompCD expression primer CTGGTTGTAGCGTGCACTTGA
Q-BBH18_uspA2H-FW3 uspA2H expression primer AAAACTGCGATTGATGCCAAT
Q-BBH18_uspA2H-RV3 uspA2H expression primer TCTGCTGTCGCTGCAAACTT
HB_MCR_1198F uspA1 expression primer GCAACTTTACCATCGCCCAGTA
HB_MCR_1198R uspA1 expression primer ATACCGCAGCTTGACCATTGT
HB_Mc_mcaPF mcaP expression primer CGCTTGATACACGCAATAAAATAGA
HB_Mc_mcaPR mcaP expression primer ATGCTGGTTAGGTCGTGCAAT
HB_MCR_0038F nrtCD expression primer AGCCAAAACCCCAAATTTATCA
HB_MCR_0038R nrtCD expression primer TCCAACCATGCCCAAATAAAA
HB_MCR_0754F modA expression primer CATCAGCCCATGCAGACCTT
HB_MCR_0754R modA expression primer TATTGATGTCTTCAACAGCATTGGT
HB_MCR_1732F pstA expression primer GGTGCGTACCACAGAAAGCA
HB_MCR_1732R pstA expression primer TTTGGTGTGCCTAGTGCATAGC
HB_MCR_1441F pilO expression primer GCGATTTTACCAACCATTCAAAA
HB_MCR_1441R pilO expression primer ACTGCTGGGCTTTATGATATTTAGTG
HB_MCR_1442F pilMN expression primer AACAAGCAGATCAAGCGATGAG
HB_MCR_1442R pilMN expression primer CGCTGGCTGTATCATATCTTTGG
HB_MCR_0110F MCR_0110 expression primer AGCACTTGGTGCCTGTGTGA
HB_MCR_0110R MCR_0110 expression primer TGCACTGGATTGAGCGTATCA
HB_MCR_0119F MCR_0119 expression primer ACGGTCAGAGCCGATTGC
HB_MCR_0119R MCR_0119 expression primer TGCTTCTAAGTCAGCTTCATGGTT
HB_MCR_0120F MCR_0120 expression primer TTGCTAAACGTAGCGGATTGC
HB_MCR_0120R MCR_0120 expression primer TGACCTGTTTTTGGATCAATGC
HB_MCR_0451F MCR_0451 expression primer GGCCCGATTGGTGATTCAG
HB_MCR_0451R MCR_0451 expression primer TGACAGGCGTTCTTCAATATGATT
HB_MCR_1211F MCR_1211 expression primer TGTTTGCTTGGTTGATGCTGA
HB_MCR_1211R MCR_1211 expression primer ACGCAATTATCTGACAAAACCAAGA
HB_MCR_1212F MCR_1212 expression primer TGAGCAATCAAACCCCTCTTTT
HB_MCR_1212R MCR_1212 expression primer CAAAGACCACAACAGCAGCAA
HB_MCR_1214F MCR_1214 expression primer CGATAAAAAACCAACAGGACGAGTA
HB_MCR_1214R MCR_1214 expression primer TTTTGATTGGGCGACCAAGT
HB_MCR_1805F MCR_1805 expression primer CCATATGGTTGGTCAGTGGCTAT
HB_MCR_1805R MCR_1805 expression primer CAGCCAAAGTATCGCACGAGTA
a SpecR, spectinomycin resistance, KanR, kanamycin resistance
3.5 
effect of influenza a virus infection and human 
lactoferrin supplementation on Moraxella catarrhalis 
infection in mouse models of respiratory disease
Stefan P.W. de Vries, Saskia van Selm, Fred J.H. van opzeeland, Peter W.M Hermans, 
Marien I. de Jonge, dimitri a. diavatopoulos, Hester J. bootsma
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abSTraCT
Moraxella catarrhalis is a human-restricted mucosal pathogen causing childhood otitis media and 
exacerbations of chronic obstructive pulmonary disease in adults. Animal models of infection 
are key to study bacterial pathogenesis. Unfortunately, M. catarrhalis is unable to establish 
prolonged nasopharyngeal colonization or infection in mice. Here we examined if M. catarrhalis 
colonization and infection of mice could be potentiated by influenza A virus (IAV)-priming or 
by the supplementation of human lactoferrin (hLf), a known growth factor of M. catarrhalis. 
Although M. catarrhalis BBH18 was detected in the nasopharynx up to 48 h after intranasal 
infection, prior infection with IAV or supplementation of hLf did not facilitate M. catarrhalis 
replication in the nasopharynx or middle ear cavity. However, the supplementation of hLf had a 
transient (up to 8 h) positive effect on M. catarrhalis survival in the lungs. Although M. catarrhalis 
was still recovered at levels of ~105 colony forming units from the lungs after 18 h, no synergistic 
effects were found for the different treatments at this time point. Together, this study provides 
new directions to further optimize murine models of M. catarrhalis respiratory tract infections.
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3.5
InTroduCTIon
M. catarrhalis is an exclusively human Gram-negative mucosal pathogen. Although this bacterium 
was traditionally considered a harmless commensal of the upper respiratory tract, nowadays it is 
increasingly being viewed as a true respiratory pathogen. It is the third most common bacterial 
cause of otitis media (OM) after Streptococcus pneumoniae and non-typeable Haemophilus 
influenzae (NTHi), being responsible for up to 20% of bacterial OM cases (1-3). In addition, M. 
catarrhalis is frequently isolated during exacerbations of chronic obstructive pulmonary disease 
(COPD) and estimated to be responsible for 10 to 15% of COPD exacerbations (4, 5). Importantly, 
respiratory tract infections in humans are frequently a result of synergistic and antagonistic 
interactions between bacterial pathogens and viruses (6), and these interactions may also 
contribute to the pathobiology of M. catarrhalis infections. 
Clinically relevant animal models that mimic (aspects of) human disease are valuable as 
they help to elucidate the pathogenesis of bacterial infections and can be used to design and 
test vaccines. Murine models are often used because of easy accessibility, relatively low costs, 
availability of reagents, and the possibility for genetic manipulation (7). Unfortunately, efforts to 
induce infections of mice with M. catarrhalis have thus far been unsuccessful as the bacterium 
is unable to establish prolonged nasopharyngeal colonization or infection (8-10). Consequently, 
there is a lack of mouse models to study relevant disease aspects of M. catarrhalis, such as 
acute or chronic OM, or low-grade lung infections that mimic exacerbations of COPD. Most 
mouse experimental infection studies with M. catarrhalis have therefore resorted to the so-called 
mouse pulmonary clearance model, in which complete clearance normally occurs within 24 hours 
after administration (11-14), or to artificial OM models in which bacteria are directly injected 
in the middle ear bulla (15). Although efforts to induce nasopharyngeal colonization or OM in 
chinchillas were successful (16-19), they are not easily accessible. Therefore, the development 
of a generally accessible small-animal model that accurately and reproducibly reflects human M. 
catarrhalis infections would be of significant benefit. 
There may be several explanations as to why M. catarrhalis does not efficiently infect mice, 
i.e. essential growth nutrients may be absent or cannot be taken up, or adhesion receptors may 
be species-specific. For instance, the acquisition of iron contributes to infection (20), however, in 
vivo iron is complexed with host high-affinity iron-binding proteins, e.g. lactoferrin, transferrin, 
and heme, and therefore not freely available. M. catarrhalis is potentially iron-starved in mice as it 
is unable to grow on non-human complexed iron sources (21). Therefore, a strategy to promote 
survival or growth of M. catarrhalis in mice is the supplementation of complex iron sources of 
human origin, as has successfully been used for Neisseria meningitidis (22). In this study, the 
administration of human transferrin (hTf) in combination with influenza A virus (IAV)-priming 
potentiated N. meningitidis-induced sepsis in mice. 
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Alternatively, respiratory viruses are well-known to alter susceptibility to bacterial infections by 
disturbing the commensal flora, inducing epithelial barrier damage, or viral-induced inflammation 
(6, 23, 24). IAV is a known risk factor in the development of bacterial OM in children. IAV infects 
the epithelial cells of the respiratory tract, which usually results in mild symptoms but can lead 
to more serious complications such as viral pneumonia. Our laboratory has developed mouse co-
infection models for IAV with S. pneumoniae and NTHi, which result in higher bacterial loads and 
natural dissemination to the middle ears and the development of bacterial OM (25, 26).
In this study, we explored two strategies to enhance the susceptibility of mice to M. catarrhalis 
infection: 1) IAV-priming and 2) supplementation of human lactoferrin (hLf), which is the main 
iron-carrier on mucosal surfaces (27). These strategies were tested in two mouse models of 
infection, i.e. the standard lung infection (pulmonary clearance) model for M. catarrhalis and an 
adapted OM model, which employs a pressure cabin to migrate bacteria from the nasopharynx to 
the middle ear cavity, and has previously been successfully used for S. pneumoniae (28).
reSulTS
Pulmonary clearance model. In the pulmonary clearance model (11), naïve adult BALB/c mice 
were first infected intranasally with IAV strain Udorn/307/72 (H3N2) or mock treated. Previous 
studies have shown that this strain reproducibly infects mice and that viral infection progresses to 
the lungs and middle ears within days after infection (29, 30). Three days following IAV infection, 
mice were infected intranasally with 108 colony forming units (CFU) of M. catarrhalis strain BBH18 
in a volume of 50 μl to ensure delivery into the lungs. The M. catarrhalis inoculum used to infect 
the mice was either supplemented with 0.1 mg of hLf or with mock (Fig. 1A). Bacterial clearance 
was assayed after 3, 8, and 18 h. High bacterial loads of up to ~108 CFU were detected in the 
lungs 3 h post-infection, which rapidly decreased to approximately 105 CFU over the course of 
the next 15h (Fig. 1B). Infection with IAV resulted in a transient increase in bacterial loads in the 
nasopharynx and lungs at the 3 h time point, however, these effects did not extent to the 8 h 
time point (Fig. 1BC). Surprisingly, IAV-infected mice even showed accelerated clearance of M. 
catarrhalis from the lungs 18 h post-infection (Fig. 1B). Conversely, hLf supplementation resulted 
in enhanced bacterial survival in the lungs up to the 8 h time point (Fig 1B). However, this hLf-
dependent potentiation appeared to be restricted to the lower respiratory tract, as no effect was 
observed in the nasopharynx (Fig. 1C). Of note, the hLf supplementation seemed to neutralize 
the enhanced clearance of M. catarrhalis from the lungs and nasopharynx, which was observed 
with IAV 18 h post-infection (Fig. 1BC). 
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Fig 1. effect of IaV-priming and hlf supplementation on M. catarrhalis pulmonary clearance. (A) 
Seven week old female BALB/C mice were intranasally infected with 104.5 PFU IAV or mock treated three days 
prior to infection with M. catarrhalis. When indicated the M. catarrhalis inoculum was supplemented with 
hLf (0.1 mg per mice). Mice were intranasally infected with M. catarrhalis (108 CFU in 50 μl) three days after 
IAV-priming, and CFU counts were determined in the nose (B) and lungs (C) after 3, 8, and 18 h. (B-C) Each 
symbol represents one mouse and the line indicates the mean CFU count per group. Statistical differences 
relative to the M. catarrhalis only control group were determined with a Mann–Whitney test, * P < 0.05 and 
** P < 0.01.
oM model. In this model, naïve adult BALB/c mice were also first primed with IAV or mock 
treated. Three days post IAV infection, mice were infected intranasally with 107 CFU M. catarrhalis 
BBH18 in a volume of 10 μl with or without 0.1 mg hLf. Inoculations with such a small volume 
normally restrict infection to the nasopharynx (31). To ensure delivery of M. catarrhalis to the 
middle ears, mice were placed in a pressure cabin after administration (Fig. 2A), a strategy which 
we previously employed to induce pneumococcal OM (28). At 24 and 48 h post-infection bacterial 
counts were monitored. Nasopharyngeal colonization by M. catarrhalis was detected 24 h post-
infection at levels of ~104 CFU, however, no differences in bacterial load were observed between 
the different groups. After 48 h, mice already started to clear the infection, evident from reduced 
bacterial loads, with at least one mouse in each group having no detectable M. catarrhalis in the 
nasopharynx. In line with our findings in the pulmonary clearance model, mice that were IAV-
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primed appeared to clear the infection more rapidly, i.e. more mice had undetectable levels of 
M. catarrhalis in the nose (Fig. 2B). Although nasopharyngeal colonization by M. catarrhalis was 
detected up to 48 h after infection, we were unable to detect any bacteria in the middle ears at 
any of the time-points.
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Fig 2. effect of IaV-priming and hlf supplementation on M. catarrhalis infection in an oM model. 
(A) Seven week old female BALB/C mice were intranasally infected with 104.5 PFU IAV or mock treated three 
days prior to M. catarrhalis infection. M. catarrhalis was administrated intranasally in a volume of 10 μl at 
107 CFU, after which mice were transferred to a pressure cabin and the pressure was increased to 40 kPa 
to facilitate migration of the inoculum to the middle ear (28). Bacterial loads were examined in the nasal-
associated lymphoid tissue (NALT) (B) as well as in both ears after 24 and 48 h. CFU counts of the ears are not 
displayed as no bacteria were detected. Each symbol represents one mouse and the line indicates the mean 
CFU count per group. No statistical differences were detected relative to the M. catarrhalis only control group 
(Mann–Whitney test).
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3.5
dISCuSSIon
Animal models can help to understand the complex interactions between the host and pathogen. 
At present, the availability of animal models to study the pathobiology of M. catarrhalis is limited 
as M. catarrhalis does not persistently colonize the nasopharynx of mice or disseminates to the 
lungs or ears. Hence, we sought to examine whether IAV-priming or supplementation with hLf 
facilitates the establishment of M. catarrhalis infection in mice. 
In mice, IAV-priming has previously been shown to enable natural progression of both S. 
pneumoniae and NTHi from the nasopharynx via the Eustachian tube to the middle ears (25, 
26). In this study, we found that co-infection with IAV did not result in M. catarrhalis OM. 
Although colonization of the nasopharynx was established up to 48 h after infection, no viable 
bacteria were recovered from the middle ears, despite the use of a pressure cabin to deliver M. 
catarrhalis to the middle ear cavity (28). This suggests that M. catarrhalis is rapidly cleared from 
the middle ear cavity, and sampling at earlier time points after administration would help in 
determining the actual clearance rate from the middle ears. The use of a higher infection dose 
(~109 CFU), as reported by Kawano et al., could potentially enable induction of OM in our model, 
although in this study M. catarrhalis was directly injected in the middle ear bulla (15). Of note, 
IAV-priming appeared to result in a more rapid clearance from both the lungs and the nose. 
Interestingly, this effect was not observed when hLf was co-administered. A possible explanation 
for this observation is the fact that hLf also has antiviral activity (32). The lack of IAV-mediated 
potentiation of M. catarrhalis infection points towards intrinsic differences with other pathogens 
that share the same niche, i.e. S. pneumoniae and NTHi. We have recently demonstrated that 
the IAV-induced proinflammatory response in the middle ear drives pneumococcal OM, and is 
dictated by the viral hemagglutinin (24). The IAV-induced proinflammatory response may be of 
less importance for M. catarrhalis to cause OM and potentially also for NTHi; they are both 
potent inducers of a proinflammatory response (33, 34). However, it is also possible that the IAV-
induced proinflammatory response protects against M. catarrhalis infection. The desialylation of 
host glycoproteins by IAV neuraminidase (NA) has been suggested to promote S. pneumoniae 
adherence to the respiratory tract epithelium (35). Conversely, adhesion of M. catarrhalis to 
respiratory tract epithelial cells is dependent on the sialylation of host glycoconjugate proteins; 
NA-treatment reduced epithelial adherence of M. catarrhalis (36). 
Given the rapid clearance of M. catarrhalis from different host niches, we hypothesized that 
the unavailability of essential nutrients limits the replication of M. catarrhalis in mice. We found 
that supplementation with hLf had a transient positive effect on M. catarrhalis infection, which 
could potentially be enhanced by repeated supplementation to reach a higher, more effective 
concentration of hLf. The systemic administration of hTf by intraperitoneal injection enhanced N. 
meningitidis sepsis, however, the authors of the respective study also demonstrated that the use 
of transgenic mice expressing hTf was even more effective (22). 
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Future attempts to optimize current and/or develop novel M. catarrhalis murine models of 
infection may be focused on testing other viruses which have been more clinically associated with 
M. catarrhalis infections, e.g. corona or adeno viruses (23). Further, the inability of most human 
respiratory tract pathogens to effectively infect rodent species may originate in a different innate 
(immune) host defense (7), or the microbiota preventing M. catarrhalis replication and infection. 
Therefore, a detailed comparison of early human and murine induced immune responses, and 
testing M. catarrhalis in knock-out mice of innate defense pathways such as MyD88 or TRIF (37), 
may give us new directions on how to improve murine models for M. catarrhalis. An alternative 
strategy to enable M. catarrhalis to establish infection in mice would be to use transgenic mice 
expressing human receptors, e.g. CEACAM1 (38). In this study, we have also shown that hLf 
supplementation positively affects M. catarrhalis survival in mice, and hLf dose optimization may 
further improve this model to enable study of M. catarrhalis pathogenesis and testing of vaccines.
MaTerIalS and MeTHodS
bacterial and viral strains, and growth conditions. M. catarrhalis strain BBH18 was isolated 
from sputum of a COPD patient during an exacerbation (39). BBH18 was routinely cultured on 
brain heart infusion (BHI) agar plates at 37°C in an atmosphere containing 5% CO2 or in BHI 
broth at 37°C with agitation (200-250 rpm). For mouse infections, M. catarrhalis BBH18 was 
grown to mid-log phase (OD620nm ~ 1.0-1.2) and aliquots were stored in the presence of 20% 
glycerol at -80°C. 
Viral stocks of IAV strain Udorn/307/72 (H3N2) were prepared in embryonated eggs. Infected 
allantoic fluid was centrifuged for 10 min at 1000 xg at 4°C and aliquots were stored at -80°C 
until use. Viral titers were determined by plaque assays on Madin-Darby canine kidney cells (40).
Mouse infections models. Groups of five 7-week old, female, specific pathogen-free (SPF) 
BALB/c mice (Harlan, Horst, The Netherlands) were infected with 104.5 PFU IAV or allantoic fluid 
(mock control) in one nostril without anesthesia. Three days post IAV-priming, mice were infected 
with M. catarrhalis under light anesthesia; 1.5-2.5% (v/v) isoflurane over oxygen and N2O. Prior 
to infection, bacterial aliquots were washed one time in PBS and resuspended in PBS or PBS 
supplemented with 0.1 mg hLf (Sigma Aldrich) per infection dose. 
For the pulmonary clearance model, mice were intranasally infected with 108 CFU M. 
catarrhalis in a volume of 50 μl. Mice were sacrificed 3, 8, and 18 h post-inoculation under 
inhalation anesthesia for terminal bleeding by oribital punction, followed by cervical dislocation. 
Cardiac perfusion was performed with ~10 ml PBS and bacteria were recovered from the nose by 
lavage, 0.5 ml per naris, and lungs were removed and homogenized in 2 ml PBS as described in 
Cron et al. (31). Bacteria were enumerated by plating 10-fold dilution series on BHI agar plates. 
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For the OM model, intranasal infections were performed with 107 CFU M. catarrhalis in 10 
μl. After administration, mice were transferred to a pressure cabin, in which the pressure was 
increased to 40 kPa, with 5 kPa per 15 sec, to facilitate migration bacteria to the middle ear 
cavity as described previously (28). Mice were sacrificed 24 and 48 h post-infection and perfused 
as described above. Bacteria were recovered from nasal-associated lymphoid tissue (NALT) which 
was homogenized in 1 ml PBS, and the bulla’s enclosing the right and the left middle ear were 
dissected from the temporal bones and homogenized in 1 ml PBS.
ethical statement. All animal experiments were performed with approval of the Animal 
Experimentation Committee of the Radboud University Medical Centre, Nijmegen, the 
Netherlands (Permit Number: RU-DEC2011-128) in accordance with the Dutch Experiments on 
Animals Act. All experimental procedures except for infection with IAV were conducted under 
inhalation anesthetics to minimize suffering.
Statistical analysis. Statistical analyses of bacterial loads between tested conditions were 
performed with a Mann–Whitney test in GraphPad Prism 5.0 (GraphPad Software), with P < 0.05 
considered to be significant.
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Moraxella catarrhalis is an opportunistic respiratory tract pathogen that is responsible for 
significant health problems in humans. It is a common cause of otitis media (OM) in young 
children and exacerbations of chronic obstructive pulmonary disease (COPD) in adults (1, 2). 
The interaction of M. catarrhalis with its host is initiated by the entry of bacterium of the upper 
airways and can either result in clearance or establishment of colonization. Direct clearance is a 
consequence of an efficient host innate defense. Generally, colonization of the upper airways is 
considered a prerequisite for disease and transmission to other individuals (3, 4). M. catarrhalis 
colonization prevalence peaks during early childhood, potentially due to waning of maternal 
antibodies (5), and in patients with underlying illness such as COPD, but is negligible in healthy 
adults (6, 7), indicating that colonization is more likely to occur when host resistance is reduced. 
The high incidence may also suggest that M. catarrhalis is successful in adaptation to the 
microenvironment of the upper airways. Under most circumstances, the host is successful in 
controlling the microbial population in the upper respiratory tract, however, unbalance of this 
microenvironment may permit bacterial replication, dissemination of M. catarrhalis to other sites 
like the middle ears or lungs, and progression to a disease state. Of importance, the ability to 
establish infection is affected by the pathogenic potential of the strain. There are two distinct M. 
catarrhalis phylogenetic lineages, often referred to as the seroresistant and serosensitive lineage. 
Strains from the seroresistant lineage are more frequently isolated from diseased individuals 
and display a more pathogenic profile; the vast majority are complement resistant and adhere 
efficiently to respiratory tract epithelial cells (8, 9). Over the past years, our knowledge of the 
interplay between M. catarrhalis and its host has steadily increased. This thesis contributes to 
a further understanding of the molecular aspects of M. catarrhalis pathogenesis by detailed 
characterization of the genome of both phylogenetic lineages in Section 2 and studies into 
mechanisms contributing to M. catarrhalis persistence in its human host in Section 3.
WHole GenoMe SequenCInG: FroM SPeCIeS-WIde GenoMe 
CHaraCTerIZaTIon To a FraMeWorK For oMICS-drIVen reSearCH
General M. catarrhalis genome characteristics. We performed whole genome sequence 
analysis of a panel of 13 seroresistant and 18 serosensitive lineage isolates, representing diverse 
niches from diseased and healthy hosts (Section 2). This enabled further elucidation of M. 
catarrhalis biology; in silico modeling of its metabolic potential, biosynthetic pathways, and 
potential virulence mechanisms. The average size of the M. catarrhalis genome is ~1.9 Mb and 
encodes ~2,000 genes. A comparison with respiratory tract pathogens sharing the same host 
niche revealed that the genome size and gene count of M. catarrhalis was comparable to that of 
non-typeable Haemophilus influenzae (NTHi) (10), but its genome is smaller and contains fewer 
genes relative to Streptococcus pneumoniae (11). Our analysis also indicated that M. catarrhalis 
is more homogeneous in terms of gene content than both NTHi and S. pneumoniae (11, 12). 
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Previously, M. catarrhalis was considered to be a relatively heterogeneous species (8, 9, 13). 
However, here we provide evidence that the pathogen possesses limited genetic diversity. 
evolution and phylogeny. Before M. catarrhalis became a member of the genus Branhamella 
(later renamed Moraxella), belonging to the family Moraxellaceae, it was named Neisseria 
catarrhalis because of its phenotypic similarities to commensal Neisserial species (2, 14, 15). We 
showed that the majority of the proteins encoded by the M. catarrhalis BBH18 genome were 
most similar to Psychrobacter (61.6%) and Acinetobacter species (5.2%), which both also group 
within the Moraxellaceae (16). In contrast, only 1.6% had a best BLASTp-hit with Neisserial 
species proteins, justifying the current taxonomic position of M. catarrhalis and the exclusion 
from the genus Neisseria (14, 17, 18) (Chapter 2.1). Classification of the Moraxellaceae is mostly 
based on 16S rRNA sequencing and genetic transformability (exchange of genetic markers 
via natural transformation), but is still not comprehensive and evolving continuously (17-20). 
To date, the only other sequenced Moraxella species is M. macacae 0408225, isolated from 
a cynomolgus macaque with bloody nose syndrome (21). Despite its clear divergence, 65% 
of its genes had orthologs in M. catarrhalis (21) and both genome structures were reasonably 
conserved, indicating that they share a common ancestor (Chapter 2.4). Sequencing of other 
species within the Moraxella genus, with special emphasis on those species also associated with 
human infections such as M. lacunata (22), and species causing infections in other mammals, e.g. 
M. bovis (23) and M. porci (24), would contribute to the understanding of host specificity and 
evolution of the Moraxella genus. 
Despite the clear separation of the phylogenetic lineages, M. catarrhalis is likely to be a single 
species as indicated by the possession of nearly identical core genomes, a reasonably conserved 
genome organization, as well as horizontal gene flow between the lineages (Chapter 2.4). The 
horizontal transfer of core gene alleles was equally prevalent intra- as inter-lineage, indicating that 
the higher allelic variation within the serosensitive lineage can be attributed to this lineage being 
older, negating that the lineages evolved by different evolutionary mechanisms as proposed by 
Wirth et al. (9). Further, we found that both lineages must have been separated for an extended 
period and neither lineage appeared to be obviously ancestral to the other. However, genome 
sequencing of other closely related species is necessary to accurately determine the ancestral 
relationship of the seroresistant and serosensitive lineage. Finally, a question that remains is: how 
and when did these lineages diverge and when were they reunited in the human nasopharynx?
Although there was high degree of similarity between both M. catarrhalis phylogenetic 
lineages and known virulence factors were almost universially conserved (Chapters 2.3 and 2.4), 
our understanding of the mechanisms that underlie their phenotypic differences remained rather 
limited. We identified 49 genes unique to the serosensitive lineage, which may function as anti-
virulence genes (25), and 33 genes exclusive to the seroresistant lineage, representing potential 
candidates for virulence studies. A large proportion of the seroresistant lineage-specific genes 
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were predicted to be involved in phosphate metabolic pathways, which may contribute to the 
higher virulence potential of seroresistant lineage isolates, as shown for pathogenic Escherichia 
coli (26). It is plausible that these phosphate metabolic genes are involved in a nucleotide second 
messenger system controlling virulence-associated gene expression (27), however, it remains to 
be investigated if they indeed affect expression of virulence-associated genes in M. catarrhalis. 
Further, as these phosphate metabolism genes were higher expressed at ex vivo temperatures 
(26°C) (28), a condition considered to trigger virulence in M. catarrhalis (29, 30), but reduced 
under serum-stress (Chapter 3.4), it would be of importance to identify the conditions that 
activate and repress this system. In spite of the identification of lineage-exclusive genes, 
no individual genes were specific to complement-resistant isolates or to isolates that adhere 
efficiently to epithelial cells (Chapter 2.4), which is in line with previous findings by Hays et al. 
(31). This suggests that a combination of genes or expression differences drive virulence potential 
in M. catarrhalis. Transcriptome and proteome profiling of isolates from both lineages could 
be particularly relevant as expression may vary between the lineages as reported for uspA1 (8, 
32). In addition, RNAseq could be applied to study expression of non-coding RNAs and anti-
sense transcripts, which can potentially be responsible for the phenotypic difference (33). Of 
note, single nucleotide polymorphisms (SNPs), insertions/deletions, and possession of particular 
domains may result in different protein properties as is the case for UspA2, with the ability to 
inhibit complement-mediated killing not being inherited in all variants (34). Finally, sequencing of 
seroresistant lineages isolates that lack one of the key virulence traits of M. catarrhalis, i.e. being 
complement sensitive and/or displaying low efficient adherence, could generate new insight in 
our understanding of M. catarrhalis virulence. 
Metabolism and nutrient acquisition. Accommodation to fluctuations in nutrient availability 
is expected to play a key role in survival of M. catarrhalis during colonization or infection of the 
human airways but also whilst being transmitted between individuals. As this area was relatively 
unexplored for M. catarrhalis, we studied this detail as part of Section 2 by modeling central 
metabolic pathways, pathways that fuel them, and mechanisms to cope with the side/waste-
products, e.g. handling of oxidative stress. Comparative genome analysis highlighted nearly 
identical metabolic potential in all sequenced M. catarrhalis isolates (35) and revealed that M. 
catarrhalis is likely to rely on assimilation of fatty acids and acetate for growth (16). 
Respiration of nitrogen oxides is important for energy generation in many bacterial pathogens 
under limited oxygen availability and indispensable for persistence in their hosts, e.g. protection 
against nitric oxide produced by macrophages (36). Although no gene deletion mutants of M. 
catarrhalis denitrifying enzymes are assessed in animal models, several lines of evidence indicate 
that denitrification is key to M. catarrhalis host persistence, which is rather a paradox as M. 
catarrhalis is an obligate aerobic microbe. Expression of genes encoding denitrifying enzymes 
(16, 37) was increased under several pathogenesis-related conditions, e.g. increased expression 
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of nitrate reductase subunits was found in biofilms (38), during colonization of the chinchilla 
upper respiratory tract (39), and adherence to pharyngeal epithelial cells, with the exception that 
it was reduced after exposure to human serum (Chapter 3.4). Further, deletion of genes required 
during iron-starvation resulted in elevated expression of nitrate reductase genes (40), however, no 
differential expression was observed under iron-limiting conditions (38). Although upregulation 
of denitrifying enzymes appears to be central to the response to various stress conditions, they 
were not identified as (conditionally) essential in our transposon mutant library screens (Section 
3), possibly as a consequence of the aerobic conditions within these models. We anticipate that 
denitrifying enzymes could be essential under microaerophilic conditions as for example for 
intracellular and subepithelial survival of M. catarrhalis, e.g. in tonsil or adenoid tissue (41).
HoST-PaTHoGen InTeraCTIon
The interaction of M. catarrhalis and its human host is a highly dynamic process and imbalance 
or failure to induce a proper defense is thought to enable M. catarrhalis to expand and persist in 
the human airways (42). The host immune system plays a key role in the anti-bacterial defense 
and conditions that increase susceptibility include for example an immature immune system in 
young children or underlying disease such as COPD in adult patients. Importantly, the defense 
towards invading bacterial pathogens is not limited to the innate and adaptive immune system 
but also includes withholding of essential nutrients to restrict bacterial replication, a strategy that 
is coined nutritional immunity (43). The complex interaction of M. catarrhalis with its host was 
studied in detail in Chapter 3. 
Growth during iron-starvation. Iron is essential for both pathogenic bacteria and their host as 
it functions as a cofactor or prosthetic group in numerous cellular and metabolic processes (44). 
However, within the human body pathogens are confronted with free iron concentrations that 
are far below the level required to support growth, a consequence of effective iron sequestration 
by host high-affinity iron-binding proteins such as lactoferrin, transferrin, and hemoglobin (44). 
These iron-binding proteins are associated with different host niches, with for example lactoferrin 
being the main iron-carrier on mucosal surfaces. To counteract this, different mechanisms have 
evolved in these pathogens that enable iron acquisition from various host sources. Similar to 
other bacterial pathogens including Neisseria meningitidis, M. catarrhalis increases expression of 
these iron-acquisition factors upon exposure to low iron levels (38, 45). 
To determine the genetic requirements for M. catarrhalis growth during iron-starvation we 
established mariner transposon mutagenesis in M. catarrhalis and developed an improved version 
of the genomic array footprinting (GAF) technology (46, 47), a high-throughput negative selection 
screen to profile large mutant library pools. We identified and validated the requirement of five 
novel genes for growth during iron-starvation, with deletion of yggW encoding a potential heme 
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trafficking protein resulting in the most severe attenuation. The transcriptome of the yggW mutant 
strain indicated an altered redox balance, which may be the result of an improper functioning of 
the cytochromes in the respiratory chain due to a reduced heme loading of cytochromes. Our GAF 
screen also indicated that iron-acquisition systems are functionally redundant in M. catarrhalis as 
none of the known systems were found to be required for growth upon iron-starvation. This 
suggests that iron acquisition is a focal point during pathogenesis of M. catarrhalis. In this light, 
a recent study demonstrated that a surplus of iron triggers virulence of pathogenic bacteria, with 
enhanced epithelial adherence, invasion, and translocation of enteric pathogens in response to 
increasing levels of iron (48). In contrast, cellular adherence of Bordetella pertussis was enhanced 
upon iron-starvation (49). We observed that a reduced ability to cope with iron-starvation, i.e. 
mutants attenuated for growth during iron-starvation, lowered the efficiency of adherence to 
pharyngeal and lung epithelial cell lines, suggesting a link between iron metabolism and virulence 
in M. catarrhalis. 
Complement resistance. The complement system is a crucial player in the innate defense 
against pathogenic bacteria with opsonization for phagocytosis and direct lysis as well as being an 
effector system for antibodies as its key mechanisms. The ability to evade complement-mediated 
host defenses is an important determinant in bacterial pathogenesis. Resistance to complement-
mediated killing is considered beneficial for M. catarrhalis during progression to a disease state; 
increased levels of complement were detected during OM (50) and exacerbations of COPD (51), 
but seemingly less important in a colonization state since a large fraction of isolates derived from 
healthy carriers were complement sensitive (9). In other respiratory tract pathogens such as NTHi 
and S. pneumoniae, complement evasion affects the ability of these species to cause (invasive) 
disease. More specifically, NTHi isolates from the middle ears during OM or from lungs of COPD 
patients were more resistant to complement-mediated lysis than colonizing isolates (52, 53), and 
S. pneumoniae isolates that bind lower levels of C3 were more capable to cause OM or invasive 
disease such as sepsis (54).
The ability of M. catarrhalis to resist complement-mediated lysis is highly prevalent in disease-
associated M. catarrhalis isolates (8, 9). In Chapter 3.4 we investigated the molecular mechanisms 
responsible for M. catarrhalis complement-resistance. Again using a negative selection screen, 
Tn-seq (55), in which next-generation sequencing instead of microarrays was employed to profile 
the transposon mutant libraries, we identified 52 genes of which mutants showed increased 
sensitivity to human serum. In contrast to mutant library screens with other Gram-negatives like 
NTHi (52, 53) and uropathogenic E. coli (56) where the majority of the identified genes were 
involved in lipopolysaccharide (LPS) biosynthesis and modifications, we only identified a single M. 
catarrhalis lipooligosaccharide (LOS) gene (lgt6) as being required for complement resistance. This 
suggests that mechanism(s) of complement resistance may differ markedly for M. catarrhalis, and 
potentially rely more on protein factors like uspA2H, encoding the key complement resistance 
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factor in M. catarrhalis (57). In addition to uspA2H, novel genes were identified to be required for 
complement resistance of M. catarrhalis, among which genes encoding MCR_0424 (hypothetical 
protein), MCR_1483 (a putative lipoprotein), outer membrane Opa-like protein A (OlpA) (58), and 
disulfide bond formation protein B (DsbB). Analogous to H. influenzae (59), the disulfide bond 
formation (DSB) system was critical for complement resistance in multiple M. catarrhalis isolates. 
The formation of disulfide bonds by the DSB machinery is crucial for the functionality of numerous 
proteins and besides being important for cell integrity it is strongly linked to virulence in many 
pathogenic bacteria (60). The M. catarrhalis DSB system is essential for evasion of IgG-dependent 
classical pathway-mediated killing, and our results indicated a pivotal role for the DSB system in 
safeguarding of the LOS structure and membrane stability maintenance. Further investigation is 
needed to unravel the exact mechanism by which the DSB system affects complement resistance 
in M. catarrhalis, however, knowledge of pathways in M. catarrhalis that rely on disulfide bond 
formation is virtually non-existing. Proteome analysis of DSB system mutants as reported for 
E. coli (61) could be used to identify both direct substrates and indirect pathways affected by 
inactivation of DSB system genes. Candidate pathways include type IV pili biosynthesis pathways 
affecting natural transformation (62) and LOS transport system genes. For instance, a protein that 
may link the DSB system to LOS is MCR_1113, which is the homolog of the E. coli LPS transport 
protein D (LptD). Recent work in E. coli showed that DsbA-dependent disulfide bond formation 
within LptD is required for translocation of LPS precursors from the periplasm across the outer 
membrane (63). 
Although proteins and other surface exposed structures play an active role in evading the 
complement system, e.g. UspAs neutralizing C3 (64) and binding the complement inhibitor C4-
binding protein (65), they also trigger complement activation, resulting in complement deposition 
and bacterial lysis. Potential strategies employed by pathogens to limit complement activation 
are: structural modulation of antigenic molecules, for instance as described for UspAs (66, 67) 
or alteration of their expression (68). We found that M. catarrhalis lowered gene expression 
of several antigenic molecules including UspA1 and McaP upon serum exposure. However, no 
differential expression was observed for the complement resistance factors uspA2H, ompCD, 
and ompE, which rather showed high level base-line expression (Chapter 3.4). Overall, it suggest 
that M. catarrhalis maintains expression of factors indispensable for complement resistance and 
reduces expression of factors that solely trigger complement activation. 
outer membrane vesicles. We addressed the role of outer membrane vesicles (OMVs) in the 
interaction of M. catarrhalis and its host in Chapter 3.3. OMVs are secreted by many bacterial 
pathogens and can serve as delivery vehicles for virulence factors. This allows interaction with the 
host or other prokaryotes in the absence of direct contact (69), and may access areas within the 
host that are inaccessible to whole bacteria. OMVs can be particularly important for M. catarrhalis 
as virulence-associated type III, IV, V and VI protein secretion systems (70) were not detected in 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
General discussion & future perspectives  |  297
4
its genome ((16, 35, 71) and Chapter 2.4). M. catarrhalis OMVs were detected during in vitro 
growth but were also observed in infected patient tissues (72, 73). Biological roles attributed to 
M. catarrhalis OMVs include complement evasion by binding of C3 (72) and redirection of B-cell 
driven adaptive immune response by acting as decoys (73). Proteome profiling of these vesicles 
showed that they contain a whole arsenal of virulence factors including UspA1/A2H, OmpE, 
MID/Hag, and CopB. OMVs bound to human alveolar epithelial cells and were internalized after 
interaction with Toll-like receptor 2 (TLR-2), likely resulting in the observed pro-inflammatory 
response after OMV binding. In mice, these OMVs induced ruffling of the epithelial surface and 
influx of neutrophils (Chapter 3.3). The extent to which OMVs contribute to pathogenesis at 
physiological concentrations remains to be elucidated. Of relevance, M. catarrhalis OMVs have 
a profound effect on other co-colonizing pathogens, e.g. protection of NTHi to complement-
mediated attack (72) or during treatment with beta-lactams (74). Taken together, OMVs are 
associated with a variety of biological functions and potentially contribute significantly to the 
pathogenesis of M. catarrhalis. 
In line with the proinflammatory response observed after OMV binding, we observed that 
M. catarrhalis attachment to pharyngeal epithelial cells predominantly induced proinflammatory 
genes but also genes associated with prevention of epithelial barrier damage (Chapter 3.2). 
Given the frequent polymicrobial nature of upper respiratory tract colonization and infection, it 
is likely that the involved players affect each other but also influence the host response (75). In 
this light, we monitored the epithelial response during co-adherence of both M. catarrhalis and 
S. pneumoniae. Preliminary analysis indicated that the response to M. catarrhalis overwhelms 
the response to S. pneumoniae (data not shown). Overall, the abundant inflammatory response 
induced by M. catarrhalis is expected to contribute to COPD exacerbations and pathogenesis of 
OM (76, 77), and may play an important role in facilitating S. pneumoniae progression to the 
middle ear and its ability to cause OM (78, 79).
adherence to respiratory tract epithelial cells. Colonization of the upper airways does not 
necessarily result in disease but represents a critical step towards disease and enables transmission 
to other individuals. Adhesion to the epithelial cells lining the respiratory tract mucosa is a 
prerequisite for colonization and infection, consequently, efficient adhesion is considered a crucial 
virulence trait of M. catarrhalis. To mediate adhesion M. catarrhalis expresses multiple molecules 
on its surface that interact with receptors present on epithelial cells. The plethora of M. catarrhalis 
molecules involved in adherence is thought to facilitate attachment to different anatomical sites 
within its host, e.g. nasopharynx, middle ears, and lungs. 
To study the molecular mechanisms contributing to cellular adhesion we screened a transposon 
mutant library with pharyngeal and lung epithelial cells using Tn-seq (55) (Chapter 3.2). This 
resulted in the identification of novel factors required for cellular adhesion, such as the putative 
outer membrane lipoprotein MCR_1483. The MCR_1483 protein potentially fulfills classical 
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criteria of an adhesin being deposited on the surface (16). In addition to factors that potentially 
bind to structures exposed on epithelial cells, we also identified genes that are expected to 
indirectly affect adherence of M. catarrhalis, i.e. lgt1 involved in LOS biosynthesis (80). Although 
LOS structures are critical for adherence to host cells in several respiratory tract pathogens (81), 
it is likely that LOS alterations affect the surface display of “true” adhesins. Further, we observed 
that adherence levels of M. catarrhalis were relatively high, even that of isolates considered to 
adhere with low efficiency, i.e. serosensitive lineage isolates (Chapter 2.4), when compared to 
NTHi (Jeroen Langereis, personal communication) and S. pneumoniae (82). This could possibly be 
ascribed to the negative surface charge of M. catarrhalis (83). 
The expression of M. catarrhalis adhesins is influenced by environmental and host conditions, 
with levels of UspA1 being increased upon cold-shock (26°C) (29), whereas expression of the 
adhesins MID and McaP was reduced in the Chinchilla nasopharynx (39). This potentially reflects 
an immune evasion strategy and is in line with the reduced expression of antigenic molecules 
found upon human serum exposure. The response of M. catarrhalis early after adhesion to human 
pharyngeal epithelial cells indicated that adhesion factors were constitutively expressed at high 
levels, suggesting that they are not subject to transcriptional regulation on a population level. 
Expression changes in adherent bacteria was mainly restricted to metabolic pathways, including 
increased expression of genes involved in fatty acid beta-oxidation and denitrification, but also 
ABC transporter system genes.
Murine respiratory tract infection models. Animal models are important to elucidate 
mechanisms of pathogenesis and for testing of vaccine candidates. Unfortunately, M. catarrhalis 
is unable to establish prolonged nasopharyngeal colonization or infection in mice (78, 84-86). 
In Chapter 3.5, we explored if a viral trigger could enhance the susceptibility of mice to M. 
catarrhalis colonization and infection. However, while for both S. pneumoniae and NTHi pre-
infection with influenza A virus (IAV) led to induction of OM in mice (52, 87), this was not 
observed for M. catarrhalis. Instead, IAV-priming appeared to result in a slightly more rapid 
clearance of M. catarrhalis from the lungs and nose, which indicates that there are intrinsic 
differences in the conditions that underlie infection by these respiratory tract pathogens, e.g. 
induction of inflammation or availability of host receptors for bacterial attachment. In addition, 
we examined the effect of human lactoferrin supplementation as M. catarrhalis is potentially iron 
starved in mice because it is unable to acquire iron from non-human complexed iron sources (88). 
When the M. catarrhalis inoculum to infect mice was supplemented with human lactoferrin, an 
important iron-carrier on mucosal surfaces, we observed a transient positive effect on survival of 
M. catarrhalis in the lungs. Future studies aimed at prolonging M. catarrhalis colonization and 
infection of mice could be directed at the role of the murine commensal flora and innate defense 
in preventing infection, or investigation of the in vivo transcriptional response of M. catarrhalis to 
identify metabolic or other stress factors driving its rapid clearance.
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FroM GenoMe-WIde STudIeS ToWardS InTerVenTIon STraTeGIeS
Most infections caused by M. catarrhalis can be treated with antibiotics (1), however, it involves 
the risk of development of antibiotic resistance. Strategies aimed to reduce the overuse of 
antibiotics are for example watchful waiting as already applied in some countries or infection-
control by vaccination. With a large proportion of genes common to all M. catarrhalis isolates, a 
vaccination approach appears to be suitable (35). The challenge is to identify target antigens that 
elicit an appropriate immune response and are conserved across (clinically relevant) isolates of M. 
catarrhalis. To date, a number of candidates have been tested to various extents in vitro and in 
animal models, including UspA1, MID/Hag, purified LOS and LOS-conjugates, reviewed in (89, 
90). Importantly, efficacy may be negatively affected when targeting phase variable antigens such 
as the UspAs (91) and MID/Hag (92), or LOS that is reported to be subject to serotype drifting (32). 
Taken together, this suggests that a multivalent vaccine is required to achieve sufficient protection 
against M. catarrhalis. Since respiratory tract infections are often poly-microbial in nature (75, 
93), a vaccination approach targeting the three most common respiratory tract pathogens, S. 
pneumoniae, NTHi, and M. catarrhalis, may be successful to reduce disease burden.
A complete genome sequence combined with extensive protein cellular localization predictions 
provides a valuable resource to select vaccine candidates (16, 85). This already led to discovery and 
animal model testing of novel vaccine targets (84, 85). Recently, screening of a large M. catarrhalis 
peptide library with human patient sera provided a new way to select potential antigenic vaccine 
candidates for M. catarrhalis (86). Conceptually, targets that are required for virulence may be 
considered to be under positive selective pressure, i.e. preferred for survival inside the host, and 
as such represent interesting vaccine candidates. Therefore, in addition to the genes identified 
as being indispensable during iron-starvation, cellular adhesion, and exposure to human serum, 
it would be relevant to screen M. catarrhalis transposon mutant libraries in advanced in vitro 
models, e.g. ciliated airway epithelial cells (94), and improved animal models of infection. In 
addition to the identification of conditionally essential genes, the construction of high-density 
transposon mutant libraries in M. catarrhalis enables identification of obligate essential genes 
(95), here defined as genes essential for in vitro growth. These essential genes often play a critical 
role in fundamental biological processes including DNA replication, cell division, transcription and 
translation, and in general are highly conserved in nature (56, 96), making them attractive drug 
targets. In a broader perspective, combining analysis of high-density transposon mutant libraries 
in S. pneumoniae, NTHi, and M. catarrhalis with advanced integrative bioinformatics, could yield 
drugable targets that aid the development of co-infection treatment regimens (Mobegi et al. 
submitted).
To develop acellular vaccines for a wide range of bacterial pathogens, OMVs are currently 
under investigation, e.g. for Bordetella pertussis (97) and N. meningitidis (98), and are of interest 
for M. catarrhalis. The immune stimulatory and modulatory capacity of M. catarrhalis OMVs 
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and their ability to deliver proteins across host barriers, could be used for the development of a 
multivalent vaccine conferring protection against multiple respiratory tract pathogens. Potential 
strategies to modulate vaccine efficacy are for example modifications of the M. catarrhalis LOS 
structure (99) and use of OMVs from either the seroresistant or serosensitive lineage as donor 
strains, which may vary in their immunogenicity. 
ConCludInG reMarKS and FuTure PerSPeCTIVeS
The studies described in this thesis provide new insight into pathogenesis of M. catarrhalis at 
multiple levels, including a detailed characterization of its genome and evolution of the species. 
This information proved to be an invaluable resource in our studies of M. catarrhalis under host-
specific stress conditions. Using conditionally essential gene analysis, were able to associate 
numerous uncharacterized genes to phenotypic (virulence) characteristics of M. catarrhalis, 
demonstrating that although a gene may not meet obvious characteristics of a virulence factor, it 
can still be required for bacterial fitness and thus virulence. The still relatively limited understanding 
of genome to function in M. catarrhalis is underscored by the fact that we were only able to 
predict a function for two-thirds of the protein-encoding genes in M. catarrhalis BBH18, which 
is considerably lower than found for NTHi and S. pneumoniae (Mobegi et al. in preparation). For 
future research, integrative analysis of conditionally essential genes in a wide range of in vitro 
challenge models, e.g. oxidative stress, cold-shock, growth on different substrates, and in animal 
models or body fluids including sputum, may also provide detailed insight into the specific stress 
conditions that are relevant within each specific host niche. An important remaining question 
is: what mechanisms exactly drive the phenotypic difference of the seroresistant or serosensitive 
lineages? It is plausible that this is mediated by an extremely low number of genes, expression 
differences, or as by yet unrecognized epigenetic mechanisms. 
We anticipate that this thesis research will be instrumental for further exploration of 
commensal and pathogenic behaviour of M. catarrhalis. Arguments for this can be found in recent 
epidemiological data, which suggests that M. catarrhalis disease may increase as a consequence 
of the effectiveness of S. pneumoniae conjugate vaccines. This led to altered nasopharyngeal 
colonization patterns and studies reporting an increase in the proportion of airway infection 
caused by M. catarrhalis (100-102). Of particular interest is the role of M. catarrhalis in the human 
microbiota. The presence of members of the Moraxella genus was higher in lungs of COPD and 
asthma patients (103, 104) and tended to be more prevalent in nasopharyngeal flora of acute 
OM patients (105) compared to healthy individuals. Although not investigated as part of this 
thesis, biofilm formation in chronic infections is considered an important mechanism through 
which prolonged infection of the host may be established (106). Importantly, auto-inducer-2 
mediated enhanced biofilm formation observed in M. catarrhalis and NTHi co-infection resulted 
in increased resistance to antibiotic treatment and host-clearance (107). It is of interest to further 
examine the mechanisms involved in this phenomenon. 
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In conclusion, knowledge of the response of M. catarrhalis to host selective pressure in 
a commensal state and during disease, combined with understanding of the genetic factors 
allowing adaptation and survival under these stress conditions, is indispensable to characterize 
the role of M. catarrhalis in respiratory tract diseases.
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nederlandSe SaMenVaTTInG
Moraxella catarrhalis is een bacteriële ziekteverwerker van de luchtwegen bij mensen. M. 
catarrhalis veroorzaakt middenoorontsteking (otitis media, OM) bij jonge kinderen en verergert 
chronische obstructieve longziekten (COPD) bij volwassenen. Het samenspel tussen M. catarrhalis 
en zijn gastheer begint bij het binnendringen van de bovenste luchtwegen en kan resulteren in 
directe klaring of in dragerschap, ook wel kolonisatie genoemd. Dragerschap van M. catarrhalis 
in bovenste luchtwegen piekt tijdens de eerste levensjaren in kinderen en in patiënten met 
onderliggende ziekten zoals COPD, maar is verwaarloosbaar in gezonde volwassenen. Dit geeft 
aan dat een verlaagde afweer de kans op kolonisatie verhoogd. Onder normale condities is de 
mens instaat om de microbiële populatie in de luchtwegen te controleren. Echter een onbalans in 
dit leefmilieu kan leiden tot vermenigvuldiging van M. catarrhalis en resulteren in verspreiding naar 
bijvoorbeeld de middenoren of de longen. Er zijn twee afzonderlijke M. catarrhalis subpopulaties, 
ook wel bekend als de seroresistente en serosensitieve subpopulaties, welke verschillen in hun 
ziekmakend vermogen. M. catarrhalis isolaten behorende tot de seroresistente subpopulatie 
worden veelvuldig uit patiënten geïsoleerd. Isolaten van de seroresistente subpopulatie hebben 
een meer ziekmakend profiel dan isolaten van de serosensitieve subpopulatie; het overgrote deel 
van de seroresistente subpopulatie is ongevoelig voor het humane complement-systeem en is 
in staat om zich efficiënt aan cellen te hechten die het oppervlak van de luchtwegen bekleden. 
Het onderzoek beschreven in dit proefschrift draagt bij aan een beter begrip van M. catarrhalis 
pathogenese door middel van een gedetailleerde karakterisatie van het genoom van beide 
subpopulaties (sectie 2) en studies gericht op de bacteriële mechanismen die bijdragen aan 
dragerschap en infectie van de gastheer (sectie 3).
Van KaraKTerISaTIe Van HeT M. catarrhalis GenooM naar een 
Kader Voor FunCTIoneel PaTHoGeneSe onderZoeK 
algemene karakterisatie van het M. catarrhalis genoom. Om de biologie van M. catarrhalis 
verder te kunnen ontrafelen hebben we de DNA nucleotidenvolgorde van het genoom van 
verschillende M. catarrhalis stammen bepaald, ook wel bekend als genoom sequencing. Hiervoor 
hebben we een collectie M. catarrhalis isolaten gebruikt die bestond uit stammen afkomstig uit 
beide subpopulaties, verkregen uit zowel patiënten als dragers en geïsoleerd uit verschillende delen 
van de luchtwegen (sectie 2). Met behulp van de genoom sequenties hebben we de metabole 
en biosynthetische routes van M. catarrhalis in kaart gebracht. Ook konden we mechanismen 
voorspellen die betrokken zijn bij het ziekmakend vermogen ofwel virulentie van M. catarrhalis. 
We vonden dat het genoom van M. catarrhalis bestaat uit ~1.9 miljoen nucleotiden die coderen 
voor ongeveer 2000 genen. Een vergelijking met andere luchtwegpathogenen liet zien dat 
zowel de grootte van het M. catarrhalis genoom als het aantal genen vergelijkbaar was met niet-
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typeerbare Haemophilus influenzae (NTHi). Echter, het M. catarrhalis genoom was kleiner dan dat 
van Streptococcus pneumoniae en bevatte daarnaast minder genen. Op basis van aanwezigheid 
van genen vertonen M. catarrhalis isolaten onderling meer gelijkenis dan isolaten van NTHi en S. 
pneumoniae. Ondanks dat M. catarrhalis tot dusver werd gezien als een relatief diverse species 
vonden wij dat er slechts sprake was van een beperkte genetische diversiteit.
evolutie en fylogenie. Alvorens M. catarrhalis werd beschouwd als een lid van het genus 
Moraxella werd het Neisseria catarrhalis genoemd vanwege “waarneembare” kenmerken 
(fenotypes) die overeenkwamen met onschadelijke Neisseria species. Op basis van de eiwitten 
die gecodeerd zijn in het M. catarrhalis genoom konden we de huidige indeling in het genus 
Moraxella bevestigen. Slechts 1.6% van de M. catarrhalis eiwitten bleek het meest te lijken op 
eiwitten van Neisseria species, daarmee konden we de uitsluiting van M. catarrhalis van het 
genus Neisseria verder bevestigen (hoofdstuk 2.1). Tot dusver is er slechts één andere Moraxella 
species gesequenst, dit betreft de species M. macacae die geïsoleerd werd uit een primaat, de 
makaak. Ongeveer tweederde van de genen van M. cacacae heeft een ortholoog gen (afkomstig 
uit dezelfde voorouder) gen in M. catarrhalis. De organisatie van het genoom is tevens redelijk 
vergelijkbaar in beide species. Het is dus waarschijnlijk dat M. catarrhalis en M. macacae 
afstammen van een gezamenlijke voorouder (hoofdstuk 2.4).
Ondanks de duidelijke scheiding tussen de subpopulaties lijkt M. catarrhalis wel degelijk 
één enkele species te zijn. De subpopulaties bezitten vrijwel identieke kern-genomen, de 
genoomorganisatie is vergelijkbaar en er is sprake van uitwisseling van genen tussen de beide 
subpopulaties. De frequentie van overdracht van genen bleek vrijwel gelijk te zijn tussen de twee 
subpopulaties als binnen een enkele subpopulatie. De variatie in gen-sequenties is groter in de 
serosensitieve populatie in vergelijking met de seroresistente populatie. Eerder werd gedacht 
dat dit het resultaat was van verschillende evolutie mechanismen in de beide subpopulaties. 
Onze bevindingen suggereren dat de grotere gen-sequentie variatie in de serosensitieve populatie 
kan worden toegeschreven aan het feit dat de serosensitieve subpopulatie ouder is. We hebben 
aanwijzingen gevonden dat de M. catarrhalis subpopulaties al lange tijd gescheiden waren en dat 
geen van beide subpopulaties een duidelijk voorouder was van de andere (hoofdstuk 2.4). Het is 
nog onduidelijk hoe en wanneer de subpopulaties zijn gescheiden en wanneer ze weer in contact 
kwamen in de moderne mens.
Er zijn duidelijke overeenkomsten tussen de twee M. catarrhalis subpopulaties en bekende 
virulentiefactoren bleken voor te komen in vrijwel alle isolaten van beide subpopulaties. Om 
het verschil in ziekmakend vermogen tussen de seroresistente en serosensitieve subpopulaties 
beter te kunnen begrijpen hebben we gezocht naar genen die enkel voorkwamen in één van 
de subpopulaties. We vonden 49 genen die uniek waren voor de serosensitieve subpopulatie, 
en die mogelijk functioneren als anti-virulentie genen. Tevens vonden we 33 genen die alleen 
voorkwamen in isolaten uit de seroresistente subpopulatie en daarom potentiële kandidaten zijn 
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voor virulentie studies. Een groot deel van deze genen is betrokken bij fosfaat-metabolisme en 
draagt mogelijk bij aan het grotere ziekmakend vermogen van isolaten van de seroresistente 
subpopulatie, zoals eerder werd beschreven voor Escherichia coli. Ondanks dat we genen hebben 
gevonden die subpopulatie-specifiek waren, hebben we geen genen kunnen identificeren die 
alleen voorkwamen in isolaten welke resistent zijn tegen het menselijke complementsysteem 
of isolaten die zich efficiënt hechten aan cellen die het oppervlak van de luchtwegen bekleden 
(hoofdstuk 2.4). Het sequencen van genomen van isolaten uit de seroresistente subpopulatie 
die één van de virulentie eigenschappen missen, bijvoorbeeld complementsysteem gevoelige 
isolaten, kan leiden tot nieuwe inzichten om virulentie in M. catarrhalis beter te begrijpen. 
Metabolisme en opname van voedingsstoffen. Tijdens dragerschap en infectie van de 
menselijke luchtwegen is het belangrijk voor een luchtwegpathogeen om zich aan te kunnen 
passen aan veranderingen in de beschikbaarheid van voedingstoffen. Omdat dit aspect nog 
nauwelijks onderzocht was voor M. catarrhalis hebben we dit in meer detail bestudeerd door 
het in kaart te brengen van het metabolisme en de manier waarop de bijbehorende zij- en 
afvalproducten verwerkt kunnen worden. Deze analyse liet zien dat verschillende M. catarrhalis 
isolaten vrijwel dezelfde metabole processen moeten kunnen uitvoeren. Op basis van deze 
analyses verwachten we dat M. catarrhalis voor groei afhankelijk is van vetzuur- en acetaat-
metabolisme (sectie 2).
De afbraak van stikstofoxiden, ofwel denitrificatie, is belangrijk voor diverse bacteriële 
pathogenen om energie te kunnen genereren onder zuurstof-limiterende condities en is nodig 
voor overleving in de gastheer. In de mens wordt M. catarrhalis blootgesteld aan zuurstofarme 
condities in het middenoor tijdens OM en vorming van biofilms; een laag bacteriën omgeven 
door zelfgeproduceerd slijm. Genexpressie analyses lieten zien dat denitrificatie mogelijk een 
belangrijke rol speelt in de overleving van M. catarrhalis in de mens. De expressie van de nitraat 
reductase genen, verantwoordelijk voor de omzetting van nitraat naar nitriet, was verhoogd tijdens 
diverse pathogenese-gerelateerde condities; een verhoogde genexpressie werd waargenomen in 
biofilms, gedurende kolonisatie van de bovenste luchtwegen in chinchilla’s, en tijdens hechting 
aan farynx-epitheelcellen (hoofdstuk 3.2). Daarentegen was de expressie van nitraat reductase 
genen lager wanneer M. catarrhalis in contact kwam met menselijk serum (hoofdstuk 3.4). We 
vonden dat de genen die coderen voor denitrificerende enzymen niet essentieel waren voor 
overleving onder de door ons geteste pathogenese-gerelateerde condities; tijdens groei onder 
ijzer-limiterende condities, hechting aan luchtwegepitheelcellen en contact met menselijk serum. 
Dit is mogelijk het gevolg van de zuurstofrijke condities in onze experimenten. We verwachten 
dat genen betrokken bij denitrificatie wel essentieel zijn bij overleving in bijvoorbeeld biofilms. 
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GaSTHeer-PaTHoGeen InTeraCTIe
Het samenspel tussen M. catarrhalis en de mens is een dynamisch proces; er wordt aangenomen 
dat een onbalans of het uitblijven van een adequate (immuun-) respons de vermenigvuldiging 
en overleving van M. catarrhalis in de bovenste luchtwegen mogelijk maakt. In sectie 3 van dit 
proefschrift hebben we de complexe interactie tussen M. catarrhalis en zijn gastheer verder in 
detail bestudeerd.
Groei tijdens ijzer-limitatie. IJzer is essentieel voor zowel bacteriële pathogenen als voor hun 
gastheer omdat het een hulpfactor is in cellulaire en metabole processen. In de mens is ijzer 
niet vrij beschikbaar voor ziekteverwekkers omdat ijzer-bindende eiwitten zoals lactoferrine en 
transferrine ervoor zorgen dat het ijzer is afgeschermd. Echter, pathogenen hebben mechanismen 
ontwikkeld om te groeien onder deze ijzer-limiterende condities; ze kunnen onder andere ijzer 
“stelen” van de menselijke ijzer-bindende eiwitten. 
Om te bestuderen welke mechanismen M. catarrhalis nodig heeft om te groeien onder 
ijzer-limiterende condities, hebben we een geavanceerd screenings-systeem opgezet waarmee 
we kunnen bepalen welke genen in het M. catarrhalis genoom nodig zijn voor overleving van 
de bacterie onder door ons gekozen condities. Dit systeem, mariner transposon mutagenese 
genaamd, is gebaseerd op het maken van een groot aantal mutanten waarin genen willekeurig 
geïnactiveerd zijn door de insertie van een transposon element. Een aantal van deze mutanten bij 
elkaar wordt een mutantenbank genoemd. Wanneer we zo’n mutantenbank blootstellen aan een 
stressconditie heeft dit als gevolg dat individuele mutanten die deze conditie niet kunnen overleven 
uit de mutantenbank verdwijnen (negatieve selectie). Om te bepalen welke mutanten er in de 
mutantenbank zitten en welke mutanten er als gevolg van stressconditie verdwijnen uit de bank 
(door inactivatie van een belangrijk gen), hebben we een bestaande uitleesmethode, de “genomic 
array footprinting” (GAF) technologie, verder verbeterd. Met behulp van een mutantenbank van 
28.000 mutanten en GAF hebben we vijf genen geïdentificeerd die noodzakelijk waren voor 
groei van M. catarrhalis onder ijzer-limiterende condities. De deletie van het yggW gen, coderend 
voor een potentieel heem-transporterend eiwit, resulteerde in een ernstig verminderde groei 
onder ijzer-limiterende condities. Het genexpressie profiel van deze yggW mutant duidde erop 
dat er sprake was van een verstoorde redoxbalans. Onze GAF screen liet tevens zien dat ijzer-
opname systemen in M. catarrhalis functioneel overbodig zijn; de tot dan toe bekende systemen 
bleken niet noodzakelijk te zijn voor groei onder ijzer-limiterende condities. Dit toonde aan dat 
het verkrijgen van ijzer belangrijk is tijdens M. catarrhalis pathogenese. In onze studie zagen we 
tevens dat een verminderde capaciteit om te groeien onder ijzer-limiterende condities resulteerde 
in een lagere hechting aan faryngeale- en longepitheelcellen, wat suggereert dat ijzermetabolisme 
en virulentie gekoppeld zijn in M. catarrhalis (hoofdstuk 3.1)
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Complementresistentie. Het complementsysteem speelt een cruciale rol in de aangeboren 
afweer tegen pathogene bacteriën. Tijdens OM en verergering van COPD zijn de complement 
niveaus verhoogd. Het is daarom van belang voor M. catarrhalis om ongevoelig te zijn voor 
lysis door het complementsysteem. Vrijwel alle ziekte-geassocieerde M. catarrhalis isolaten zijn 
ongevoelig voor het afdoden door het complementsysteem. De moleculaire mechanismen die 
betrokken zijn bij M. catarrhalis complementresistentie hebben we ook bestudeerd met behulp 
van een mutantenbank screen. Het uitlezen van de samenstelling van de mutantenbank werd 
hier uitgevoerd door middel van zogenaamde transposon-sequencing (Tn-seq), gebruik makend 
van nieuwe generatie sequencing technologie. Dit resulteerde in de identificatie van 52 genen die 
nodig waren voor M. catarrhalis om te kunnen overleven in de aanwezigheid van menselijk serum 
(bron van complementfactoren). Naast het uspA2H gen, een belangrijke complementresistentie 
factor in M. catarrhalis, hebben we tot dan toe onbekende complementresistentie genen 
geïdentificeerd, o.a. genen die coderen voor MCR_0424 (hypothetisch eiwit), MCR_1483 
(een mogelijk lipoproteïne), buitenmembraan Opa-achtig eiwit A (OlpA), en het disulfidebrug 
vormend eiwit B (DsbB). Het disulfidebrug vormend (DSB) systeem bleek noodzakelijk te zijn 
voor complementresistentie in M. catarrhalis. De vorming van disulfide bruggen is nodig voor het 
functioneren van vele eiwitten, de integriteit van de bacterie en speelt tevens een cruciale rol in 
virulentie van ziekteverwekkende bacteriën. Het DSB systeem van M. catarrhalis bleek essentieel 
te zijn om lysis door de klassieke route van het complementsysteem te voorkomen; mutanten die 
genen van het DSB systeem misten werden effectief gedood door het complement systeem. De 
klassieke route van het complement systeem is afhankelijk van IgG antilichamen die structurele 
moleculen op het oppervlak van M. catarrhalis binden. Wanneer we deze IgG antilichamen uit 
het menselijk serum haalden vond er geen complement-gemedieerde lysis meer plaats. Het DSB 
systeem bleek invloed te hebben op de suikerstructuren, lipooligosaccharide (LOS) genoemd, op 
de M. catarrhalis buiten membraan, en was belangrijk voor het waarborgen van de stabiliteit van 
de membraan (hoofdstuk 3.4). 
Ondanks dat eiwitten en andere oppervlaktestructuren een actieve rol spelen in het ontwijken 
van het complementsysteem, kunnen ze het complementsysteem ook juist activeren. De activatie 
van het complementsysteem leidt tot het binden van complementfactoren op het bacterieoppervlak 
en kan resulteren in lysis van M. catarrhalis. We vonden dat M. catarrhalis de genexpressie van 
diverse complement-activerende moleculen, ook wel antigenen genaamd, verlaagde wanneer 
het blootgesteld werd aan serum. Dit betrof onder andere UspA1 en McaP, welke betrokken 
zijn bij hechting van M. catarrhalis aan het luchtwegepitheel. In tegenstelling, de expressie van 
complementresistentie genen uspA2H, ompCD en ompE bleef onveranderd; deze genen hadden 
een hoge basale expressie. Om lysis door het menselijke complementsysteem te voorkomen lijkt 
M. catarrhalis dus expressie van complementresistentie factoren te waarborgen maar de expressie 
te verlagen van factoren die slecht het complement systeem activeren (hoofdstuk 3.4).
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buitenmembraanblaasjes. De meeste Gram-negatieve ziekteverwekkers waaronder M. 
catarrhalis scheiden buitenmembraanblaasjes (OMVs) uit in hun omgeving. In deze sferische 
structuren is ook een deel van het binnenste van de bacterie ingesloten. Via deze OMVs is contact 
met de gastheer mogelijk zonder direct contact. De OMVs bevatten een diversiteit aan eiwitten 
maar ook LOS. OMVs spelen mogelijk een grote rol in het transport van virulentiefactoren in 
M. catarrhalis omdat het genoom geen genen bevat die coderen voor virulentie-geassocieerde 
eiwittransportsystemen van het type II, IV, V en IV. Een analyse van de eiwitsamenstelling van M. 
catarrhalis OMVs liet zien dat deze een arsenaal aan virulentiefactoren bevatten. We hebben 
laten zien dat OMVs van M. catarrhalis zich hechten aan longepitheelcellen. Na het binden aan 
longepitheelcellen via de Toll-achtige receptor 2 (TLR-2), een oppervlakte-receptor die microbiële 
structuren herkent, werd M. catarrhalis opgenomen door de cellen. De interactie met TLR-2 
is waarschijnlijk (deels) verantwoordelijk voor de waargenomen ontstekingsrespons na het 
binden van OMVs. De toediening van M. catarrhalis OMVs in de longen van muizen resulteerde 
in opruwing van het longepitheel en toestroom van neutrofielen, een soort witte bloedcel 
(hoofdstuk 3.3). 
Overeenkomstig met de ontstekingsrespons waargenomen na OMV binding, zagen we dat 
hechting van M. catarrhalis aan farynx-epitheelcellen ook resulteerde in hogere expressie van 
ontstekingsgenen maar ook van genen betrokken bij het beschermen van de epitheelbarrière 
tegen schade (hoofdstuk 3.2). Er wordt aangenomen dat de overvloedige ontstekingsrespons 
geïnduceerd door M. catarrhalis bijdraagt aan het verergeren van COPD en de pathogenese van 
OM.
Hechting aan luchtwegepitheelcellen. Het binden van M. catarrhalis aan het luchtwegepitheel 
is een voorwaarde voor dragerschap en infectie. Dit is onder andere afhankelijk van M. catarrhalis 
oppervlaktemoleculen die binden aan receptoren op de epitheelcellen. Een efficiënte hechting 
is een cruciaal virulentiemechanisme voor M. catarrhalis. Om nieuwe factoren te vinden die 
betrokken zijn bij de hechting van M. catarrhalis aan luchtwegepitheelcellen hebben we een 
mutantenbank screen gedaan met zowel farynx- als longepitheelcellen. In deze studie hebben 
we een aantal nieuwe factoren geïdentificeerd welke de hechting van M. catarrhalis beïnvloeden. 
Een van de factoren was MCR_1483, een voorspeld buitenmembraan lipoproteïne. Naast 
factoren welke mogelijk direct binden aan epitheelcelreceptoren hebben we tevens factoren 
gevonden waarvan verwacht wordt dat deze de hechting van M. catarrhalis indirect beïnvloeden, 
bijvoorbeeld het lgt1 gen dat betrokken is bij LOS biosynthese (hoofdstuk 3.2).
Een genexpressie analyse van M. catarrhalis direct na hechting aan epitheelcellen liet zien 
dat hechtingsfactoren standaard hoog tot expressie kwamen. Dit suggereert dat expressie 
van deze genen niet op populatieniveau gereguleerd wordt. We vonden dat veranderingen in 
genexpressie in gehechte M. catarrhalis zich voornamelijk beperkte tot metabole processen 
waaronder vetzuuroxidatie en denitrificatie genen, evenals een aantal ABC transportersysteem 
genen (hoofdstuk 3.2). 
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luchtweginfectiemodellen in muizen. Diermodellen zijn belangrijk in pathogenese onderzoek 
maar ook voor het testen van vaccinkandidaten. M. catarrhalis is niet in staat om de bovenste 
luchtwegen van muizen te koloniseren of om infecties te veroorzaken. We hebben onderzocht 
of een virale stimulus de gevoeligheid van muizen voor M. catarrhalis dragerschap en infectie 
kon verhogen. Ondanks dat pre-infectie van muizen met influenza A virus S. pneumoniae en 
NTHi OM faciliteerde, resulteerde dit voor M. catarrhalis in een versnelde klaring uit de longen 
en neus. Dit geeft aan dat er intrinsieke verschillen zijn in de condities welke ten grondslag 
liggen aan infecties door deze luchtwegpathogenen. Omdat M. catarrhalis niet in staat is om 
ijzer te verkrijgen van niet-menselijke ijzerbronnen is er mogelijk sprake van een ijzertekort tijdens 
infectie in muizenmodellen. Het toevoegen van menselijk lactoferrine aan de M. catarrhalis 
bacteriën voor de muisinfectie zorgde voor een tijdelijk (tot 8 uur) verbeterde overleving van M. 
catarrhalis in de longen (hoofdstuk 3.5).
Van GenooM-brede STudIeS naar InTerVenTIe STraTeGIeën 
De meeste M. catarrhalis infecties kunnen met antibiotica behandeld worden, echter er is een 
risico op het ontwikkelen van antibioticumresistentie. Doordat een groot aantal genen aanwezig 
is in vrijwel alle M. catarrhalis isolaten is vaccinatie een strategie om infecties te voorkomen. 
Het is een uitdaging om antigenen te identificeren die aanwezig zijn in (klinisch relevante) M. 
catarrhalis isolaten en die bij vaccinatie een gewenste immuunrespons teweegbrengen. Indien 
vaccinatie gericht is op antigenen die fase-variabel tot expressie komen zoals de UspAs en MID/
Hag kan het de doeltreffendheid van een vaccin negatief beïnvloeden. Het ontwikkelen van een 
vaccin gericht op meerdere antigenen, ofwel een multivalent vaccin, is waarschijnlijk nodig om 
voldoende bescherming op te wekken tegen M. catarrhalis. 
Een collectie van volledige genoomsequenties biedt ons een waardevol inzicht in de mogelijke 
antigenen die M. catarrhalis tot expressie brengt. Indien we dit combineren met een voorspelling 
van de lokalisatie van deze antigenen in M. catarrhalis kunnen we potentiële vaccinkandidaten 
identificeren. Vaccinkandidaten die nodig zijn voor het ziekteverwekkend vermogen van M. 
catarrhalis zijn extra interessant omdat deze mogelijk onder positieve selectiedruk staan; ze 
dragen bij aan de overleving in de mens. Het genereren van mutantenbanken in M. catarrhalis 
maakt het mogelijk om genen te identificeren die nodig zijn onder specifieke (stress)-condities 
(conditioneel essentieel, zoals beschreven in dit proefschrift. Het is ook mogelijk om met behulp 
van deze mutantenbanken genen te identificeren die strikt noodzakelijk zijn voor de overleving 
van het micro-organisme (obligaat essentieel). Obligaat essentiële genen spelen vaak een rol in 
fundamentele biologische processen en zijn aanwezig in vrijwel alle M. catarrhalis isolaten. Dit 
feit maakt dat ze interessante kandidaten voor zowel vaccinatie als andere interventiestrategieën 
zijn. Luchtweginfecties worden vaak door meerdere ziekteverwekkers tegelijk veroorzaakt, ook 
wel polymicrobiële infecties genoemd. Een vergelijkende analyse van obligaat essentiële genen 
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in drie meest voorkomende luchtwegpathogenen in mensen, S. pneumoniae, NTHi en M. 
catarrhalis, kan mogelijk leiden tot de ontdekking van nieuwe targets voor behandeling en biedt 
mogelijkheden voor het behandelen van polymicrobiële infecties.
ConCluderende oPMerKInGen en ToeKoMSTPerSPeCTIeVen
De studies beschreven in dit proefschrift bieden nieuwe inzichten in de pathogenese van M. 
catarrhalis op diverse niveaus waaronder een gedetailleerde karakterisatie van het genoom 
en evolutie van de species. Deze informatie bleek waardevol te zijn voor onze studies van M. 
catarrhalis onder verschillende gastheer-gerelateerde stresscondities (sectie 3). Met behulp van 
conditioneel essentiële genanalyse hebben we diverse (tot dusver niet gekarakteriseerde) genen 
kunnen koppelen aan ziekteverwekkende eigenschappen van M. catarrhalis. Het relatief beperkte 
begrip van de relatie tussen genoom en functie in M. catarrhalis werd duidelijk uit het feit dat 
we slechts een functie konden voorspellen voor twee derde van de M. catarrhalis BBH18 genen. 
Het succes van pneumococcen vaccins heeft ervoor gezorgd dat er een verschuiving heeft 
plaatsgevonden in dragerschapspatronen in de bovenste luchtwegen. In een aantal studies is 
er een toename van M. catarrhalis luchtweginfecties waargenomen. In de longen van COPD en 
astmapatiënten, evenals in de nasale flora van OM patiënten, heeft men een hogere prevalentie 
van bacteriën behorende tot het genus Moraxella aangetroffen in vergelijking tot gezonde 
mensen. Het is daarom van belang om de rol van M. catarrhalis in de menselijke luchtwegflora 
verder te bestuderen. 
We concluderen dat een goede kennis van de respons van M. catarrhalis op gastheer-
gerelateerde stresscondities tijdens dragerschap en tijdens ziekte, gecombineerd met begrip van 
de genetische factoren nodig voor overleving onder deze stresscondities, onmisbaar is om de rol 
van M. catarrhalis in luchtweginfecties te begrijpen.
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Eindelijk, de laatste pagina’s van dit proefschrift kunnen nu geschreven worden. Het vreugdevolle 
moment is daar om terug te blikken op de afgelopen jaren en ieder te bedanken die op 
welke manier dan ook, bewust of onbewust, mij heeft geholpen bij het gereedkomen van dit 
proefschrift. De vele zetjes in de rug, wijze lessen en hulp op zowel het wetenschappelijke als 
sociale vlak, waren zeer welkom!
Beste prof. dr. Hermans, ofwel beste Peter, bedankt voor je vertrouwen in mij en dat je mij 
de kans hebt gegeven om een promotietraject te starten in je lab. Met een uitzonderlijke dosis 
gedrevenheid en on-Limburgse directheid heb je gezorgd dat er dingen gebeurden en dat er 
kansen werden gecreëerd; bedankt dat je dit ook voor mij hebt gedaan. Het was een voorrecht 
om onder jouw hoede opgeleid te worden tot onderzoeker. Veel succes in je nieuwe functie bij 
Crucell en veel geluk met Ria en de kinderen, waar jullie leven je ook mag brengen. 
Beste dr. Bootsma, beste Hester, eer wie de eer toekomt, een mooi moment om jou te 
bedanken voor je enorme bijdrage aan de totstandkoming van dit proefschrift. Je uitzonderlijke 
geduld, inzet en betrokkenheid maken je tot een droombegeleider voor iedere promovendus. Je 
inzicht (en overzicht) in wetenschappelijk onderzoek, je schrijfcapaciteiten, en het altijd bereid 
zijn om anderen te helpen zijn met recht bewonderingswaardig te noemen. Ik had me geen 
betere begeleidster kunnen wensen. Petje af voor jou! Ik wens je het allerbeste in je nieuwe 
functie bij het RIVM en veel geluk in je leven samen met Ingrid.
Leden van de manuscriptcommissie, prof. dr. van Soolingen, prof. dr. Siezen en prof. dr. van 
Dijl, bedankt voor jullie tijd en expertise om dit proefschrift te beoordelen.
Vergeet niet waar je vandaan komt. Mijn interesse voor laboratoriumonderzoek werd 
aangewakkerd op de middelbare en hogere laboratoriumopleiding. In deze tijd ben ik een aantal 
docenten en stagebegeleiders tegengekomen die me op het juiste moment wisten te motiveren 
en het vertrouwen te geven om weer een stapje extra te zetten. In het bijzonder wil ik graag dr. 
Huub op den Camp bedanken, beste Huub, bedankt dat ik altijd bij je terecht kon voor hulp of 
een goed advies maar ook dat je me gedurende het hele traject hebt willen coachen. 
Mijn eerste stappen in de wereld van de infectieziekten werden gemaakt bij Nobilon te 
Boxmeer. Hier is het me duidelijk geworden dat dit is waar mijn onderzoekshart ligt. Beste dr. 
Thomas Luijkx, dr. Marien de Jonge en dr. Piet Nuijten, jullie enthousiasme en gedrevenheid zijn 
zeer aanstekelijk! Bedankt dat ik hier tijdens mijn laatste masterstage een paar maanden in mee 
mocht draaien.
Mede-VSOE-projectgenoten, bedankt voor de fijne samenwerking binnen ons project. Peter, 
je kritische blik op mijn werk en het fungeren als biochemische helpdesk waren zeer waardevol. 
Jeroen, ondanks dat we binnen het project redelijk onze eigen weg gingen stond je altijd klaar 
om mij of mijn studenten te helpen met dingen waar ik weinig verstand van had, dank hiervoor. 
Dear colleagues from Intercell, thank you very much for our collaboration. 
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Ook dank aan alle coauteurs. Dr. John Hays, bedankt voor je input bij het MMBR review artikel. 
Dr. van Hijum, beste Sacha, bedankt dat we van je bioinformatica expertise gebruik konden 
maken voor het eerste volledig gesequenste M. catarrhalis genoom. Dear prof. dr. Riesbeck, 
dear Kristian, thank you for the opportunity to collaborate in the OMV proteomics study. I highly 
appreciate that you were so kind to include me as a co-author. To our respected colleagues 
from the States. Dear prof. dr. Ehrlich, dear Garth, thank you for our pleasant collaboration on 
the genomic characterization of the M. catarrhalis species. I highly appreciate your openness 
and willingness to take a step back to create possibilities for me as young researcher. Dear dr. 
Josh Earl, it was a pleasure working with you. Hopefully, our latest genome paper will soon be 
accepted for publication!
Op het moment dat ik mijn promotieonderzoek bij het LKI startte was het LKI-LKO lab een 
heel stuk kleiner. Liever gezegd, het kantoor voor de nieuwelingen stond nog leeg. Gelukkig 
werd het kantoor in sneltreinvaart gevuld met een stel nieuwe collega’s. Het AIO kantoor (met 
Aldert als postdoc “indringer”) was een zeer prettige omgeving! Er was altijd tijd voor geintje 
een gezellig praatje maar ook voor serieuze zaken. Stan, Stefanie, Daan, Aldert en Esther, onder 
het genot van menig Nespressootje en Chokotoff (uit Stefanie’s fameuze blik) hebben we vaak 
een momentje van ontspanning gehad om even de frustraties uit te weg te ruimen en gezellig 
te kletsen. Betere kamergenoten had ik me niet kunnen wensen, super bedankt hiervoor! Beste 
Aldert, het was zeer handig om een bioinformaticus naast me te hebben zitten. Bedankt dat 
je altijd bereid was om me te helpen en hopelijk werken we in de toekomst nog vaker samen. 
Dimitri en Saskia, bedankt voor jullie hulp met het dierexperimenteel hoofdstuk. Hi Lori, ondanks 
dat je officieel prima Nederlands spreekt is het niet je grootste hobby, maar we houden stug vol, 
wanneer komt die zachte G er nu? Bedankt dat ik altijd bij je terecht kon voor een goed gesprek. 
Iedereen van het LKI en LKO hier niet bij naam en toenaam genoemd, bedankt voor alle hulp en 
advies met de proefjes, maar nog belangrijker, voor alle gezellig koffiepauzes, labuitjes en borrels. 
Het lab LKI&LKO was een fijne plek om te werken en ik heb er veel mooie herinneringen aan 
overgehouden.
Alle analisten van het LKI en LKO, ontzettend bedankt dat jullie ervoor zorgden dat in het lab 
alles op rolletjes liep, het maakte proefjes doen stukken makkelijker. Beste Marc bedankt voor 
je hulp met het M. catarrhalis adherentie werk en het runnen van een hele berg microarrays en 
qPCR’s. Hey Christa, of het nu pneumokokken of Moraxella’s zijn, een mutantje meer of minder 
maakt voor jou niet uit. Super dat het je zelfs nog gelukt is om het complementatieconstruct voor 
ons serum-resistentie artikel in elkaar te sleutelen. En niet te vergeten, Elles en Fred bedankt voor 
jullie hulp bij het dierexperimenteel hoofdstuk. Hicham, sorry dat ik steeds achter je broek zat 
voor het LOS-gelletje, zeer gewaardeerd. Ada, wat zouden we zonder jou moeten? Bedankt dat 
ik altijd op je kon rekenen als er wat geregeld moest worden.
Hey maestro, beste Daan, je hebt dezelfde lange route genomen als ik. Top dat je na de 
masteropleiding ook bij het LKI bent komen werken. We hebben tijdens onze studie en promotie 
een hoop lol gehad maar je stond ook altijd voor me klaar wanneer het nodig was. Ook al zien we 
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elkaar op het moment niet al te vaak, als we elkaar zien is het ook meteen als vanouds gezellig. 
Hopelijk blijven we nog lang goede vrienden. Bedankt dat je mijn paranimf wilt zijn, alvast een 
warming-up voor je eigen promotie!
In mijn tijd bij LKI hebben een aantal studenten een belangrijke bijdrage geleverd aan dit 
proefschrift. Beste Katja, Daphne, Paola, Alke, Kirstin en Rob jullie hulp was zeer welkom; zonder 
jullie hulp was dit proefschrift een stuk dunner geweest. Ik hoop dat ik jullie niet al te hard heb 
laten zwoegen en dat het voor jullie een leuke en leerzame tijd is geweest. Ik wens jullie allen het 
beste voor de toekomst. 
Zonder vrienden die je op het rechte pad houden en zorgen voor de broodnodige afleiding 
was er van dit proefschrift weinig terecht gekomen. Alle vrienden uit Venray en Nijmegen, bedankt 
voor de nodige gezelligheid in de kroeg, tijdens kookavondjes, carnaval of gewoon tijdens een 
bakje koffie. Ik hoop dat ik jullie allemaal niet teveel vermoeid heb mijn promotiefrustraties. Hey 
Nick en Merijn, jullie zijn mijn beste maatjes en onze vriendschap betekent erg veel voor mij. In de 
afgelopen jaren zijn onze leventjes af en toe flink overhoop gegooid. Jullie waren er voor mij in 
de mooie maar ook in de moeilijkere tijden. Hopelijk bevinden we ons weer in rustiger vaarwater. 
Proost op een mooie toekomst! Lieve Angela, we hebben het einde van dit proefschrift niet 
gehaald maar daarom zeker niet minder bedankt voor alles wat je in de loop van de jaren voor 
me hebt gedaan en natuurlijk ook een dikke knuffel voor Ebbe en Ninte. Lieve Maaike, je weet 
precies wanneer ik ergens mee zit en even wat raad nodig heb. Je neemt een speciaal plekje in 
mijn leven in. Suzan en Maurice bedankt voor jullie warme vriendschap. 
Beste Gerben & Maartje, Johan en Esther, Nick en Marijke, het is flink wat jaartjes geleden dat 
we zijn afgestudeerd aan het HLO maar gelukkig zijn we nog steeds goede vrienden. De borrels, 
weekendjes weg en wintersport zijn iedere keer weer uitermate gezellig. Hopelijk houden we dit 
nog lang vol! Fijn om zo’n stel vrienden te hebben. Beste Gerben, samen gestart op het MLO en 
doorgegaan naar het HLO. Je bent de meest nuchtere persoonlijkheid die ik ken! Fijn om je als 
vriend te hebben en ik ben erg blij dat je me wilt bijstaan als paranimf.
Lieve pap en mam, bedankt voor jullie liefde en onvoorwaardelijke steun. Altijd kon ik op jullie 
bouwen, niets was teveel gevraagd. Ik heb enorm veel waardering voor alles wat jullie voor mij 
gedaan hebben en nog steeds doen. Roy, broeder, erg fijn om zo’n broertje te hebben, ik hoef je 
maar te vragen en je staat voor me klaar. Suzanne en jij hebben nog wat van me tegoed.
Lieve Marleen, wat ben ik blij dat jij in mijn leven bent gekomen. Samen met jou is alles veel 
leuker, lekker samen genieten van het leven! Bij jou kan ik mezelf zijn en voel ik me op mijn best. 
Al snel waren we erachter dat we samen verder wilde. Ik wilde graag naar het buitenland, jij wist 
het nog niet zo zeker. Uiteindelijk hebben we de grote stap gezet om het gewoon te gaan doen. 
Het heeft flink wat voeten in de aarde gehad, maar gelukkig, je bent nu ook hier in Cambridge. 
We gaan er samen wat moois van maken. Lieve schat, ik hou van jou!
Proost op jullie allen!
Stefan
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Stefan Petrus Wilhelm de Vries werd geboren op 21 maart 1983 te Venray. In 1999 behaalde hij zijn 
MAVO diploma aan het Raaylandcollege in Venray en startte hij met de opleiding Biotechnologie 
aan het Middelbare Laboratorium Onderwijs, Gilde Opleidingen te Blerick. Tijdens deze opleiding 
liep hij stage bij de afdeling Microbiologie van de Radboud Universiteit te Nijmegen. In 2003 
begon hij de opleiding Biochemie aan het Hoger Laboratorium Onderwijs van de Hogeschool 
van Arnhem en Nijmegen. Hij liep vervolgens stage bij de afdeling Fungal Genomics van de 
Wageningen Universiteit en bij de afdeling Celbiologie van het Radboud Universitair Medisch 
Centrum te Nijmegen. Na het behalen van zijn bachelordiploma in 2006 startte hij met de 
masteropleiding Medische Biologie aan de Radboud Universiteit te Nijmegen. Tijdens zijn stage 
bij de afdeling Moleculaire Biologie bestudeerde hij de rol van het SS18-SSX fusie-eiwit in 
synoviaal sarcoma (dr. E. Middeljans en prof. dr. H.G. Stunnenberg). Een afsluitende stage werd 
uitgevoerd bij de afdeling Bacteriologische R&D van Nobilon (MSD, Boxmeer) waar hij werkte 
aan de moleculaire karakterisatie van een reizigersdiarree vaccin (dr. T.A. Luijkx en dr. P.J. Nuijten). 
Na het behalen van zijn masterdiploma (cum laude) in 2009 begon hij als promovendus bij de 
afdeling Kindergeneeskunde Infectieziekten van het Radboud Universitair Medisch Centrum te 
Nijmegen onder begeleiding van dr. H.J. Bootsma en prof. dr. P.W.M. Hermans. De resultaten van 
zijn promotieonderzoek zijn beschreven in dit proefschrift. Stefan werkt momenteel als Research 
Associate aan de ontrafeling van de biologie van de voedselpathogeen Campylobacter jejuni. Dit 
onderzoek wordt uitgevoerd in de bacteriële infectiegroep onder leiding van dr. A.J. Grant en 
prof. dr. D.J. Maskell, afdeling Diergeneeskunde, Universiteit van Cambridge in Engeland. 
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